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Research to date has suggested that fatty acids (FAs) may affect the immune system, 
through their (and those of their metabolites) effects on membranes, mediators, and gene 
expression. However, despite the research carried out, there still exist gaps of knowledge 
where further research is required. In addition, programming by diet in pregnancy may 
affect the immune system, due to stress and/or structural and functional changes to immune 
cells, but whether this effect is long-lasting is uncertain. In order to address some of these 
gaps in knowledge, experiments were conducted to examine the effects of dietary FAs on 
immune outcomes in rodent models of clinical relevance and the effect of maternal protein 
restriction on immune outcomes in two later generations.  
The first experiment investigated the effect of diets differing in FA composition on 
the recall response in a mouse model of influenza vaccination. A diet rich in salmon oil 
resulted in enhanced ear swelling (measured after 48 hours) compared with diets rich in 
linseed oil, sunflower oil or beef tallow, suggesting that long chain n-3 FAs increase the 
TH1 response. The different effects of salmon oil compared with the other diets appears to 
relate to the lower n-6 fatty acid status that occurs with salmon oil feeding. The second 
experiment investigated the effect of diets differing in FA composition in a mouse model 
of allergic sensitisation (to ovalbumin). There was reduced immediate hypersensitivity to 
ovalbumin in mice fed a diet rich in salmon oil and increased immediate hypersensitivity in 
mice fed a diet rich in beef tallow, but there was no effect of diet on airway responsiveness 
to ovalbumin. Beef tallow feeding also raised IgE in blood and elevated IL-4 production by 
anti-CD3 stimulated splenocytes. The salmon oil did not affect IgE or cytokine profiles. 
The results suggest that the n-3 FAs found in salmon oil decrease TH2-mediated responses 
to an allergen and that such responses are increased by a diet rich in saturated FAs. The 
third experiment examined the effect of diets differing in FA composition fed during rat 
pregnancy on the abundance of different immune cells in blood and lymphoid organs of the 
offspring at weaning and beyond. The FA profile of the dams at the end of lactation 
reflected dietary intake in pregnancy, but no changes were found in immune cell 
abundance of offspring. The fourth experiment examined the effect of diets rich in α-
linolenic acid (ALA, a short chain n-3 FA) or linoleic acid (LA, a short chain n-6 FA) in 
mouse pregnancy on allergic sensitisation to ovalbumin in the offspring. Diets were given 
during pregnancy alone, in both gestation and lactation, or during lactation alone, and 
compared to a low-fat control. The ALA-rich diet in gestation and lactation and the LA-
rich diet in gestation reduced ear swelling in the offspring. Despite these differences, there 
were no effects on lung function or immune markers. The fifth experiment investigated the 
effect of protein restriction in rat pregnancy on the immune system of the offspring over 
two generations. No differences were seen between groups in the F1 generation. Protein 
restriction reduced TH and B-cell abundance in the spleen and thymus of F2 males.  
In conclusion, dietary fatty acids can alter immune responses, and there may be an 
effect of FAs in pregnancy on the immune response in the offspring but such effects may 
not be long lasting. Protein restriction during pregnancy, which is stress inducing, appears 
to have an effect on immune cell abundance that is manifested at the second generation of 
offspring.    ii  iii 
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Chapter 1.  Literature Review   2   3 
1.1. Introduction 
The experiments described in this thesis use rat and mouse models to examine the 
effect of dietary fatty acids and diet in pregnancy on aspects of the immune system. The 
literature review therefore provides background information on the immune system, diet in 
pregnancy and fatty acids. Previous studies investigating the effect of fatty acids and diet 
in pregnancy on the immune system will also be discussed, along with their limitations, 
and areas requiring further research. 
 
1.2. The Immune System 
The word “immunity” is derived from the Latin word “immunis” meaning exempt 
from service or liability, with the word “immune” meaning being secure from a contagion 
[1]. This state is achieved by the actions of the immune system, which acts to defend the 
body from pathogenic bacteria, viruses and fungi, functioning by the complex interaction 
of various cells and molecules. 
 
1.2.1.  Cells of the Immune System 
The main cells of the immune system are lymphocytes (T-, B- and NK cells), 
dendritic cells, mononuclear phagocytes (monocytes and macrophages) and granulocytes 
(basophils, eosinophils and neutrophils), which are collectively known as leukocytes (or 
white blood cells when in the bloodstream). The relative proportions of these cells in 
peripheral blood of humans, rats and mice are shown in Table 1-1. Humans appear to 
produce relatively more cells of the innate immune system than mice or rats. Whilst this 
may mean an increase in difficulty in translating research from this thesis which uses rat 
and mice models, to the situation occurring in humans, animal models provide several 
benefits making them suitable for research, such as reduced gestation time, ease of control 
of diet and environmental factors, ease of availability of tissue samples etc. In addition, 
data from this thesis focuses on the adaptive immune response. However, differences 
between the human immune system cell abundance, and that of the mice and rat should be 
noted.   4 
Table 1-1: Different leukocytes (as a proportion of total leukocytes) in the blood of humans 
and rats. Human data are taken from Harrison 
[2], and rat and mouse data taken from 
Wolfenson and Lloyd 
[3]. 
Leukocytes  Human
  Rat  Mouse 
Neutrophils  45 - 74  9 - 34  10 - 40 
Lymphocytes  16 - 45  65 - 85  55 – 95 
Eosinophils  0 - 7  0 - 6  0 – 4 
Monocytes  4 - 10  0 - 5  0.1 – 0.35 
Basophils  0 - 2  0 - 1.5  0 – 0.3 
All blood cells originate from the same progenitors, haematopoietic stem cells in 
bone marrow, and their development is regulated by cytokines and related growth factors 
(Figure 1-1). Cytokines produced during immune responses can also regulate the 
differentiation of these stem cells, altering the balance of the types of cells produced.  
 
Figure 1-1: Haematopoiesis. The stem cell differentiates in the bone marrow under the 
influence of various soluble growth factors. SCF, stem cell factor; LIF, leukaemia inhibitory 
factor; IL-3, interleukin-3, multi-CSF; GM-CSF, granulocyte-macrophage colony-
stimulating factor; M-CSF, monocyte colony-stimulating factor; EPO, erythropoietin; TPO, 
thrombopoetin; TNF, tumour necrosis factor. Taken from Delves et al. 
[4]. 
 
1.2.1.1.  Lymphocytes 
There are three classes of lymphocytes – B-cells, T-cells and NK cells. B- and T-
cells function in adaptive immunity, whilst NK cells are involved in innate immunity. T-
cells can be further subdivided into T helper (TH) cells, cytotoxic T-cells (CTLs), and 
regulatory T-cells (TREGS), depending on the CD markers they express. CD phenotype and 
function of these cells are detailed in Table 1-2.   5 
Table 1-2: Types of T-cell, CD markers expressed, and function. 
T-cell  CD markers  Function 





-  Stimulate B-cell growth and differentiation (humoral 
immunity, see 1.2.3.2.1) 







+  Kill virus-infected cells, tumour cells, rejection of 









Suppress activation of the immune system, 
maintaining tolerance to self-antigens 
Regulates development and function of TREGS 
Although lymphocytes express different proteins, such as CD markers and antigen 
receptors, they are morphologically indistinguishable.  
B-cells remain in bone marrow while they mature, whilst T-cells mature in the 
thymus. Maturation involves a series of sequential steps, causing changes in the expression 
of different genes and surface markers, and acquisition of functional capabilities. This is 
summarised in Figure 1-2.   6 
 
Figure 1-2: Steps in the maturation of B- (top) and T-cells (bottom). TdT, terminal 
deoxyribonucleotidyl transferase. Figure adapted from Abbas and Lichtman 
[5]. 
NK cells function in innate immunity to kill infected cells, and cells that do not 
express class I MHC molecules. They are phenotypically distinct from T- and B-cells; 
human NK cells are CD56
+ CD3
- lymphocytes 
[6]. Whilst development of T- and B-cells 
has been extensively studied, NK cell development is less well understood 
[4, 7]. Current 
thinking suggests that NK cells may mature in the thymus and bone marrow, giving rise to 
distinct phenotypes and functional capabilities depending on the site of development 
[8].   7 
Prior to antigen stimulation, lymphocytes are termed naïve. They are approximately 
8 to 10 µm in diameter 
[5], and are in the G0 stage of the cell cycle. Following stimulation, 
lymphocytes enter the G1 phase of the cell cycle, where they transcribe genes that were 
previously silent, synthesize new proteins, grow to 10 to 12 µm in diameter, and are known 
as large lymphocytes or lymphoblasts 
[5]. 
Lymphocytes then undergo mitosis, resulting in rapid proliferation, known as 
clonal expansion, and differentiate into effector cells or memory cells. Effector cells 
(CTLs, TH cells, antibody-secreting B-cells) act to remove the antigen, whilst memory cells 
allow a faster and greater response to subsequent exposure to the same antigen. Memory 
cells express surface markers that distinguish them from naïve mature T- and B-cells, and 
effector cells, and can exist in the body for many years following after the original 
exposure to the antigen. More detail on the activities of effector cells can be found in 
section 1.2.3.2. 
 
1.2.1.2.  Antigen-Presenting Cells 
Antigen-presenting cells (APCs) display captured antigens to lymphocytes, and 
provide the signals necessary for lymphocyte activation. All nucleated cells can present 
cytosolic antigens to CTLs, using class I MHC molecules. Specialised APCs, such as 
dendritic cells, macrophages and B-cells present extracellular antigens to TH cells using 
class II MHC molecules. This is summarised in Figure 1-3.   8 
 
Figure 1-3: Presentation of antigens by antigen presenting cells. Picture A shows the 
presentation of an extracellular antigen to TH cells, which results in macrophage or B cell 
activation and elimination of the antigen. Picture B shows the presentation of a cytosolic 
antigen to a CTL, and lysis of the antigen-expressing target cell. Picture taken from Abbas 
and Lichtman 
[5]. 
Dendritic cells are found in lymphoid organs, skin epithelia, gastrointestinal and 
respiratory tracts, and most parenchymal organs. They are easily identifiable by their 
membranous projections. Monocytes originate in bone marrow, and are 10 to 15 µm in 
diameter. They mature into macrophages when they settle in tissues, and can be activated 
by external stimuli, such as microbes, into different morphological forms. Macrophages are 
present in all organs and connective tissues, and are also involved in innate immunity. 
Figure 1-4 shows dendritic cells, a monocyte and a macrophage.   9 
 
Figure 1-4: Antigen presenting cells. Picture A shows a light micrograph of cultured dendritic 
cells. Figure B shows an electron micrograph of a peripheral blood monocyte. Figure C shows 




1.2.1.3.  Mast cells 
Mast cells, along with basophils and eosinophils are the effector cells of immediate 
hypersensitivity reactions and allergy (see 1.2.4). Mast cell progenitors migrate to 
peripheral tissues where they differentiate into mature cells. Cells vary in shape, have 
round nuclei, and membrane-bound granules and lipid bodies in the cytoplasm. In the 
granules are acidic proteoglycans, which bind basic dyes. An electron micrograph of a 
mast cell is shown in Figure 1-5. Mast cells induce the acute inflammatory reaction of 
innate immunity. 
 
Figure 1-5: An electron micrograph of a resting mast cell, containing membrane bound 
granules. Taken from Lawson et al. 
[9]. 
 
1.2.1.4.  Granulocytes 
Granulocytes contain granules in their cytoplasm and can be sub-classified into 
neutrophils, eosinophils and basophils depending on the colour and morphology of the 
granules when stained with Romanowsky stains (Figure 1-6).   10 
 
Figure 1-6: Granulocytes. Picture A shows a human peripheral blood basophil stained with 
Wright. Picture B shows an eosinophil stained with May-Grünwald-Giemsa. Picture C shows 
a neutrophil stained with Wright. Figure adapted from figures 12.2A, 11.1, 10.9A in 
Wintrobe’s Clinical Hematology 
[10]. 
Basophils are not usually present in tissues, but circulate in the blood, from where 
they can be recruited to sites of infection. They produce histamine and heparin, like mast 
cells, and are involved in the inflammation reactions of both immediate and late-phase 
reactions of immediate hypersensitivity.  
Eosinophils circulate in the blood after maturation in the bone marrow. They are 
common in peripheral tissues, but their abundance increases at sites of late-phase 
inflammation. Activated eosinophils, along with basophils and mast cells, release lipid 
mediators, including platelet activating factor (PAF), prostaglandins and leukotrienes, 
which are involved in the pathological processes of allergy. Eosinophils are also 
responsible for the killing of helminthic parasites. 
Neutrophils are the most abundant circulating leukocyte and mediate the earliest 
stages of the inflammatory response. Neutrophils circulate in the blood for about six hours 
unless they are recruited to sites of infection. If there is no infection, they undergo 
programmed cell death.  
 
1.2.2.  Tissues of the Immune System 
The cells of the immune system are present circulating the blood and lymphatic 
system, in anatomically defined lymphoid organs (bone marrow, thymus, spleen and lymph 
nodes) and as scattered cells in almost all tissues. The lymphoid organs and lymphatic 
system are shown in Figure 1-7.   11 
 
Figure 1-7: Schematic view of tissues of the immune system. Taken from Klaus 
[11]. 
 
1.2.2.1.  Bone Marrow 
The bone marrow is the site of generation of all adult blood cells (haematopoiesis), 
and maturation of these cells except T-cells and some NK cells (see 1.2.1.1). In embryonic 
and early life, haematopoiesis occurs in other sites, such as the blood islands of the yolk 
sac, the para-aortic mesochyme, the liver and the spleen. Haematopoiesis occurs in the red 
marrow, whilst yellow marrow contains fat-filled cells; approximately 4 x 10
11 cells are 
produced in the bone marrow of adults every day 
[12]. Blood cell precursors mature and 
leave the bone marrow, entering the vascular circulation. 
 
1.2.2.2.  Thymus 
The thymus is a bi-lobed organ situated above and in front of the heart, and is the 
site of maturation of T-cells and some NK cells. Each lobe is further divided into smaller 
lobes, which consist of a medulla and cortex. The cortex is densely packed with T-cells,   12 
whilst the medulla contains fewer. The thymus also contains non-lymphoid epithelial cells, 
bone marrow-derived macrophages, dendritic cells, and has a rich blood supply. The 
medulla has structures known as Hassall’s corpuscles, which are made up of whorls of 
keratinised epithelial cells. Hassall’s corpuscles act to dispose of degenerating thymocytes 
(i.e. lymphocytes in the thymus). A micrograph of a thymus is shown in Figure 1-8. The 
thymus increases in size up until puberty, after which it progressively shrinks (involutes). 
 
Figure 1-8: Micrograph of the thymus of a child (which is not involuted unlike that of an 
adult). C, cortex; M, medulla; S, septa. Taken from Stevens and Lowe 
[13]. 
 
1.2.2.3.  Spleen 
The spleen is located on the left hand side of the body, below and behind the 
stomach, and is the major site of immune responses to blood-borne antigens. It is supplied 
by a single splenic artery, which enters the capsule at the hilum, and subsequently divides 
into smaller branches. The spleen contains both T- and B-cells, in segregated areas, known 
as periarteriolar lymphoid sheaths and lymphoid follicles respectively. The latter are edged 
by an area called the marginal zone, which contains lymphocytes and macrophages. These 
areas make up the white pulp of the spleen, whilst the red pulp is made up of erythrocytes, 
macrophages, sparse lymphocytes and plasma cells. A micrograph of the spleen is shown 
in Figure 1-9.   13 
 
Figure 1-9: Micrograph of the spleen. A, central artery; R, red pulp; W, white pulp. Taken 
from Stevens and Lowe 
[13]. 
 
1.2.2.4.  Lymph Nodes 
Adaptive immune responses to lymph-borne antigens are instigated in lymph 
nodes; these are small nodular masses found on the lymphatic system (a vast network of 
channels that extends throughout the body). As with the spleen, lymph nodes consist of a 
medulla and cortex, and T- and B-cells are segregated into different areas (parafollicular 
cortex and lymphoid follicle respectively). T- and B-cells enter the lymph node through the 
artery, and are attracted to their respective sections by chemokines; CCR7 attracts T-cells 
and CXCR5 attracts B-cells. 
Lymph is the fluid of the lymphatic system which has previously drained body 
tissues. By being filtered though lymph nodes, foreign antigens can be displayed to T-cells 
and induce an immune response. Lymph enters through afferent lymphatic vessels, drains 
into the cortex and medullary sinus, and leaves through the efferent lymphatic vessel in the 
hilum.  
In order to mount an immune response, lymphocytes must move continuously 
through the body via the blood stream and lymphatic system (lymphocyte recirculation). 
Particular kinds of lymphocytes may be attracted to certain regions, whilst others are not, 
due to a process known as lymphocyte homing. This is achieved predominately by means 
of adhesion molecules on lymphocytes, endothelial cells and the extracellular matrix, as 
well as the presence of chemokines produced in the endothelium and tissues. 
Naïve T-cells leave the blood and enter lymph nodes through high endothelial 
venules. If they encounter an antigen, they become activated and return to the circulation 
through efferent lymphatic vessels, and the thoracic duct, which ultimately allows arterial 
circulation. From here, they pass to the peripheral sites of infection or inflammation   14 
(through the action of E- and P-selectins and integrins) where they act to eliminate 
pathogens. If naïve T-cells in lymph nodes do not encounter an antigen, they re-enter 
circulation through an efferent lymphatic vessel and continue on to other lymph nodes. 
 
1.2.3.  The Immune Response 
There are two functional components of the immune system, known as innate and 
adaptive immunity.  
 
1.2.3.1.  Innate Immunity 
Innate immunity describes the parts of the system which only recognise microbial 
pathogens, but respond rapidly. It has no memory (a subsequent immunological challenge 
will not result in a faster and more intense response), and cells do not respond to individual 
types of microbes or molecules, but rather to the more generic structures (termed 
“patterns”) shared by many different microbes, and which are required for their survival. 
Innate immunity is achieved through the actions of physical and chemical barriers 
(epithelial cells and their secretions), cells (macrophages, neutrophils and NK cells), and 
complement proteins in the blood. 
Epithelial surfaces form physical barriers between the external environment and the 
body, thus preventing microbes from entering, provided they remain intact. They also 
produce peptides with antibiotic activity, such as defensins, whose synthesis is increased in 
response to inflammatory cytokines such as interleukin (IL)-1 and tumour necrosis factor 
(TNF)-α. These are produced by macrophages and other cells (including epithelia), as a 
result of the presence of microbes in the body. Epithelial sites house intraepithelial T-
lymphocytes (in barrier epithelia) and the B-1 subset of B-cells (in serosal cavaties). 
Macrophages, neutrophils, mast cells and NK cells act when microbes have penetrated the 
epithelial barrier into tissues or circulation. Macrophages and neutrophils act to 
phagocytose microorganisms, whilst NK cells release cytotoxic granule proteins to cause 
apoptosis of target cells. In addition, macrophages produce IL-12, which stimulates NK 
cells and T-cells to produce interferon (IFN)-γ. This in turn activates macrophages to 
destroy phagocytosed microorganisms, promotes the production of TH1 cells and induces 
cell-mediated immune responses (described further in 1.2.3.2.2). 
The complement system consists of plasma proteins that are activated by 
microorganisms and cause their destruction, as well as inflammation. There are three 
separate components termed the classical pathway, the alternative pathway and the lectin   15 
pathway. In the classical pathway, C1 (a plasma protein) detects immunoglobulin (Ig) M, 
IgG1 or IgG3 antibodies on the surface of microorganisms. In the alternative pathway, 
certain microbial cell surface structures are recognised. The lectin pathway uses mannose-
binding lectin (a plasma protein) to recognise and bind to microbial glycoproteins and 
glycolipids. If any of these pathways is triggered, there is sequential recruitment and 
conversion of complement proteins into protease complexes. The resulting proteins each 
have different effector functions; C3b regulates the late steps of complement activation, 
resulting in the production of peptides that stimulate inflammation (C5a), and polymerise 
C9, which forms the membrane attack complex. The membrane attack complex is 
responsible for creating holes in plasma membranes and subsequent lysis of the 
microorganism. The end result is death of the microbe and acute inflammation (through 
mast cell activation). In addition, production of the complement protein C3d is the second 
signal required for B-cell activation (the first is antigen) thereby inducing humoral immune 
responses. Complement activation is inhibited by regulatory proteins present on normal 
host cells, but absent from microbes, thereby preventing injury to host cells. 
 
1.2.3.2.  Adaptive Immunity 
Adaptive immunity is stimulated by exposure to both microbial and non-microbial 
pathogens. Immune cells recognise antigens present on pathogens, and this triggers a 
specific immune response. Somatic recombination of gene sections allows the production 
of a vast array of receptors on immune cells, and although one cell will only recognise one 
antigen, the sheer number of cells in the immune system allows recognition of, and 
response to, an enormous number and variety of antigens. It has been estimated that 
humans can recognise 10
11 different antigens 
[14]. Repeated exposure to an antigen-bearing 
pathogen will result in a faster and more magnified response, described as memory. There 
are two types of adaptive immunity, known as humoral- and cell-mediated immunity.  
 
1.2.3.2.1.  Humoral-mediated Immunity 
Humoral-mediated immunity operates through B-cells and the antibodies they 
produce, which act on extracellular microbes. Each B-cell expresses a set of antibodies on 
its surface specific for one particular antigen. Binding of the antigen to the antibody causes 
clonal expansion, and subsequent maturation of B-cells into plasma cells (which secrete 
antibodies), or memory cells (longer lasting cells that are responsible for the memory of 
adaptive immunity). T-helper cells are required for the proliferation and differentiation of 
B-cells. In response to CD40 binding and cytokines, B-cells in peripheral lymphoid tissues   16 
can undergo heavy chain isotype switching, resulting in the production of antibodies with 
different types of heavy chains, such as γ, α and ε. These antibodies have different effector 
functions. Isotype switching and antibody functions are shown in Figure 1-10. 
 
Figure 1-10: Isotype switching. In response to CD40 binding and certain cytokines, B-cells 
can produce progeny with different antibody isotypes. Taken from Abbas and Lichtman 
[5]. 
Antibodies act through several effector mechanisms. Binding of microbes to B-
cells results in the production of antibodies, which neutralise microbes and their toxins by 
opsonising them and promoting their uptake by phagocytosis, causes antibody-dependent 
cellular cytotoxicity, and complement activation. This leads to lysis of microbes, 
phagocytosis of microbes that are opsonised with complement fragments, and 
inflammation.  
 
1.2.3.2.2.  Cell-mediated Immunity 
Cell-mediated immunity is a result of the activities of T-cells, which target 
intracellular microbes that exist within host cells, where they are inaccessible to antibodies. 
There are four main types of T-cells, which can be identified by the proteins expressed on 
their cell surface, known as “cluster of differentiation” or CD, proteins. T-cells that are 
CD4
+CD8
- are T-helper (TH) cells, and can be further subdivided into TH1 and TH2 cells. 
CD4
-CD8
+ T-cells are cytotoxic T-cells (CTLs), and are responsible for the killing of 
virus-infected cells. TH1 cells recognise class II MHC-associated peptide antigens   17 
presented by antigen presenting cells, while CTLs recognise class I MHC-associated 
peptide antigens expressed by phagocytes with ingested microbes. Both T-cells secrete 
cytokines that cause macrophages to kill ingested microbes, and stimulate inflammation. 
Alternatively, CTLs recognise class I MHC-associated peptide antigens of microbes 
present in the cytoplasm of infected cells, and kill them. 
TH2 cells secrete the cytokines IL-4, IL-5 and IL-10; IL-4 stimulates the production 
of antibodies by B-cells, and acts to promote the proliferation and differentiation of TH2 
cells from naïve T-helper cells. IL-5 acts to activate eosinophils to destroy helminthic 
parasites, whilst IL-10 and IL-4 inhibit macrophage activation. TH2 cells are also 
responsible for immediate hypersensitivity reactions (see 1.2.4).  
There are several different factors which interact to determine whether T-helper 
cells are of the TH1 or TH2 phenotype. The cytokine IFN-γ stimulates the production of 
TH1 cells, whilst IL-4 and IL-10 inhibit TH1 production, and stimulate TH2 proliferation. 
The cytokines that stimulate TH1 and TH2 proliferation are also produced by that type of 
cell, with the result that the T-helper cell phenotype becomes increasingly polarised in one 
direction. Factors that alter the balance of these cytokines, therefore also have the potential 
to alter the ability of the host to mount an effective cell-mediated immune response and to 
alter the likelihood of development of allergy (explored further in 1.4). 
Regulatory T-cells are CD4
+ with the majority also expressing CD25 
[15], and are 
responsible for the down-regulation of self-reactive T-cells (reviewed by Wing et al. 
[16]). 
Impaired activity of regulatory T-cells can lead to autoimmune disease and atopy 
[17]. The 
final type of T-cell is CD4
-CD8




1.2.4.   Hypersensitivity Reactions and Disease 
The immune system is not flawless; inappropriate immune responses can occur that 
lead to tissue damage. Reactions are due to normal immune responses occurring, but in a 
way that is excessive or improper, and results in tissue injury. Such reactions are known as 
hypersensitivity reactions and there are four types, classified by the type of immune 
response and effector mechanisms responsible.  
Immediate (Type I) hypersensitivity (IH) reactions (allergy or atopy) occur when 
an immune response arises as a result of exposure to a protein, or chemical bound to a 
protein (an allergen), and are caused by TH2 cells. They occur rapidly (within minutes) 
following exposure to the antigen 
[5]. Recognition of an allergen can lead TH2 cells to 
change production of antibodies in B-cells to the IgE type. IgE is secreted and binds to   18 
mast cells. Repeated exposure to the allergen causes mast cell activation, and subsequent 
release of mediators responsible for the clinical signs of allergy (e.g. histamine, 
leukotrienes). 
There are two phases to IH, an immediate and late-phase. Vascular and smooth 
muscle responses to mediators are characteristic of the immediate reaction, whereas in the 
late-phase reaction, leukocyte recruitment and inflammation occur. Reactions are manifest 
in several ways, including skin and mucosal allergies, food allergies and systemic 
anaphylaxis. Asthma is caused by repeated immediate and late-phase reactions in the lung. 
This results in intermittent and reversible obstruction of the airway, chronic bronchial 
inflammation with eosinophils, hypertrophy of bronchial smooth muscle, and hyper-
reactivity to bronchoconstrictors (e.g. LTC4, LTD4, LTE4 and PAF). Allergic rhinitis is an 
IH reaction to allergens such as plant pollen or house dust mites in the upper respiratory 
tract. This results in mucosal oedema, leukocyte and eosinophil accumulation, mucus 
secretion, coughing, sneezing, and difficulty breathing. Food allergies can cause increased 
peristalsis, increased fluid secretion from intestinal epithelia, vomiting and diarrhoea. 
Utricaria and eczema are characteristic of IH reactions in the skin. 
Type II hypersensitivity is mediated by antibodies other than IgE. It occurs when 
antibodies bind to antigens on certain cells. As a result, inflammatory cells are recruited 
and activated, and normal cell function is hindered, which induces tissue damage. 
Examples of diseases caused by this type of hypersensitivity include Goodpasture’s 
syndrome, acute rheumatic fever, Myasthenia gravis, Graves’ disease, insulin-resistant 
(Type II) diabetes, and pernicious anaemia 
[5]. 
Type III hypersensitivity occurs when antigen-antibody complexes form in the 
circulation and are deposited in vessel walls. As with type II hypersensitivity, 
inflammatory cells are recruited and activated, and cell function hindered, resulting in 
tissue injury. Examples of diseases that result from this include systemic lupus 
erythematosus, polyarteritis nodosa, poststreptococcal glomerulonephritis and serum 
sickness 
[5]. Whilst production of antibody-antigen complexes occurs during normal 
immune responses, it is only when they are produced at excessive levels or not removed 
efficiently that they become deposited in tissues and cause disease. 
Type IV hypersensitivity is caused by T cells that either trigger delayed-type 
hypersensitivity (DTH) or directly kill target cells. This response occurs several hours after 
antigen exposure, and reaches its maximum at 24 – 48 hours, before subsiding 
[4]. In DTH, 
TH1 cells (and sometimes CTLs) respond to tissue antigens by secreting cytokines that 
cause inflammation and activate phagocytes, resulting in tissue injury. Examples of   19 
pathological conditions caused by DTH include insulin-dependent (Type I) diabetes, 
multiple sclerosis, rheumatoid arthritis, sarcoidosis and contact dermatitis 
[4]. Direct killing 
of target cells is mediated by CTLs, and occurs since CTLs cannot distinguish between 
viruses that are or are not cytopathic.    20 
1.3. Fatty Acids 
1.3.1.  Nomenclature and Dietary Sources 
Fatty acids are organic compounds that contain a hydrocarbon chain of varying 
length, and a terminal carboxyl group 
[18]. They have chain lengths varying from 2 to over 
30 carbon atoms, the commonest ranging between 12 and 22 
[19]. They may be saturated 
(contain no double bonds), monounsaturated (contain one double bond) or polyunsaturated 
(contain more than one double bond). Chain length, the number and position of the double 
bond(s), and whether the double bond is in the cis or trans configuration confer different 
physical and chemical properties on the fatty acid. 
Fatty acids are classified by three different nomenclatures; systematic naming, 
common naming, and shorthand notation. Systematic notation is based on the number of 
carbons and doubled bonds present in the acyl chain. Difficulties arise in naming 
unsaturated fatty acids, as the double bond may be in several different positions in the acyl 
chain, and even in different orientations (cis or trans configuration), and these must 
therefore be clearly identified 
[18]. Alternatively, fatty acids can be given a common name, 
or be described by shorthand notation, which describes the number of carbons present in 
the acyl chain (a) and the number of double bonds present (b) in the form a : b. In the case 
of unsaturated fatty acids, the position of the first double bond is also identified, in the 
form ω-x, where x denotes the carbon on which it appears, counted from the methyl group. 
ω-x can also be written as n-x (Figure 1-11). Thus, oleic acid, which has 18 carbons and 
one double bond on the ninth carbon, is denoted by 18:1 n-9. Table 1-3 lists the names and 
sources of common fatty acids.   21 
Table 1-3: Nomenclature and sources of fatty acids. Taken from Calder and Burdge 
[18]. 
Systematic name  Common name  Shorthand 
notation 
Sources 
Ethanoic  Acetic  2:0  Fermentation of fibre in colon 
Propanoic  Propionic  3:0  Fermentation of fibre in colon 
Butanoic  Butyric  4:0  Fermentation of fibre in colon; Milk 
Hexanoic  Caproic  6:0  Milk 
Octanoic  Caprylic  8:0  Milk 
Decanoic  Capric  10:0  Milk; Coconut oil 
Dodecanoic  Lauric  12:0  Milk; Coconut oil 
Tetradecanoic  Myristic  14:0  Milk 
Hexadecanoic  Palmitic  16:0  Milk; Eggs; Animal fats; Meat; Cocoa 
butter; Palm oil (other vegetable oils 
contain lesser amounts); Fish oils 
Octadecanoic  Stearic  18:0  Milk; Eggs; Animal fats; Meat; Cocoa 
butter 
cis 9-Hexadecenoic  Palmitoleic  16:1 n-7  Desaturation of Palmitic acid; Fatty 
fish; Fish oils 
cis 9-Octadecenoic  Oleic  18:1 n-9  Desaturation of stearic acid; Milk; 
Eggs; Animal fats; Meat; Cocoa 




Elaidic    Animal (ruminant) fats 
cis 9-Octadecenoic  Vaccenic     
trans 11-
Octadecenoic 
trans Vaccenic    Animal (ruminant) fats 
cis 9, cis 12-
Octadecadienoic 
Linoleic  18:2 n-6  Cannot be synthesised in mammals; 
Some milks; Eggs; Animal fats; Meat; 
Most vegetable oils, especially corn, 




α-Linolenic  18:3 n-3  Cannot be synthesised in mammals; 
Green leaves; Some vegetable oils, 




γ-Linolenic  18:3 n-6  Synthesised from linoleic acid; 
Borage and evening primrose oils 
All-cis 11,14,17-
Eicosatrienoic 
Mead  20:3 n-9  Synthesised from oleic acid; Indicator 





20:3 n-6  Synthesised from γ-linolenic acid 
All-cis 5,8,11,14-
Eicosatetraenoic 
Arachidonic  20:4 n-6  Synthesised from linoleic acid via γ-




Eicosapentaenoic  20:5 n-3  Synthesised from α-linolenic acid; 




Docosapentaenoic  22:5 n-3  Synthesised from α-linolenic acid via 





Docosahexaenoic  22:6 n-3  Synthesised from α-linolenic acid via 
eicosapentaenoic acid; Fatty fish; Fish 
oils 
   22 
 
Figure 1-11: Examples of n-3 (top), n-6 (middle) and n-9 (bottom) unsaturated fatty acids.  
Unsaturated fatty acids are classified according to the carbon on which the double bond 
nearest to the methyl group is positioned. Thus, n-3 PUFAs have their double bond nearest to 
the methyl group on carbon three, while n-6 PUFAs have their closest double bond on carbon 
six. 
Whilst most double bonds in naturally-occurring fatty acids tend to be in the cis 
configuration, trans double bonds do occur (e.g. in intermediates of fatty acid biosynthesis, 
in ruminant fats, cows’ milk, plant lipids and some seed oils) 
[18].  
 
1.3.2.  States of Fatty Acids in the Body 
Fatty acids are absorbed from the diet, and circulate through the bloodstream in 
four main states; as triacylglycerols, phospholipids, cholesteryl esters and non-esterified 
fatty acids. 
 
1.3.2.1.  Triacylglycerols (TAGs)  
Triacylglycerols (TAGs, triglycerides) are composed of three fatty acids attached 
by ester bonds to a molecule of glycerol (Figure 1-12). Most of the fat eaten, and stored by 
humans is in this form 
[20-22]. 
 
Figure 1-12: The general structure of a triacylglycerol. Triacylglycerols consist of three fatty 
acids attached to a glycerol molecule. 
The sn (stereospecific numbering) system is a useful method of identifying specific 
carbon molecules to which fatty acids are attached. With the hydroxyl group on the middle 
carbon of the glycerol group drawn to the left, the carbon above it becomes sn-1, the 
middle carbon sn-2 and the lower carbon sn-3 (Figure 1-13).   23 
 
Figure 1-13: Stereospecific numbering (sn) system for substituted glycerides. With the 
hydroxyl group of the middle carbon drawn to the left, the carbon above becomes carbon 
one, and the R-group (in this case R') is said to be at position sn-1. The middle carbon is 
carbon two (and R'' is at position sn-2), and the bottom carbon is carbon three (R''' is 
therefore at position sn-3). 
 
1.3.2.2.  Phospholipids (PLs) 
Phospholipids (PLs) consist of two fatty acids attached usually by ester bonds to 
the sn-1 and sn-2 positions of a glycerol molecule with a head group that includes a 
phosphate molecule attached at the sn-3 position (Figure 1-14). The head group of PLs can 
vary. There are five main PL classes, as shown in Table 1-4. 
 
Figure 1-14: The general structure of phospholipids.  Phospholipids consist of two fatty acids 
attached to a glycerol backbone, with a phosphate group and a variable head group (see text).   24 
Table 1-4: Major phospholipid classes. Taken from Burdge et al. 
[23]. 
Name  Head group  Location 
Phosphatidylcholine  Choline  Outer leaflet of cell membranes, monolayer enclosing 
plasma lipoproteins. 
Phosphatidylethanolamine  Ethanolamine  Inner leaflet of cell membranes, small amount in plasma. 
Phosphatidylserine  Serine  Inner leaflet of cell membranes 
Phosphatidylglycerol  Glycerol  Inner leaflet of cell membranes, pulmonary surfactant 
Phosphatidylinositol  Inositol  Anchor for proteins in the cell membranes.  
Polyphosphorylated forms important in cell signalling 
PLs are important components of membranes, and form effective barriers. The fatty 
acid composition of phospholipids can alter the physical and chemical properties of the 
compound, and therefore affect membrane fluidity. 
 
1.3.2.3.  Cholesteryl Esters (CEs) 
Cholesterol and cholesteryl esters (CEs) are also important components of 
membranes, as well as being precursors of vitamin D, steroid hormones and bile salts. The 
general structure of a CE is shown in Figure 1-15. 
 
Figure 1-15: The general structure of a cholesteryl ester. 
 
1.3.2.4.  Non-Esterified Fatty Acids 
Non-esterified fatty acids (NEFAs, sometimes called free fatty acids) are attached 
non-covalently to albumin in the blood; this allows the otherwise insoluble fatty acids to 
become soluble, and be transported throughout the body. Each molecule of albumin has 
binding sites for around three NEFAs 
[24]. NEFAs have a very short half-life in the blood, 
and are predominately used as an energy source 
[18]. Plasma NEFA concentration varies 
through the day, with levels inversely reflecting those of plasma glucose and insulin 
[24].  
 
1.3.3.  Digestion and Absorption of Fatty Acids  
TAGs are digested in the stomach and small intestine by gastric lipase (formerly 
called lingual lipase) and pancreatic lipase, respectively, to form NEFAs and 2-  25 
monoacylglycerols. There are also lipases present in breast milk that digest milk fats in 
neonates 
[21]. Pancreatic lipase is quantitatively the most important enzyme in TAG 
hydrolysis after weaning, whilst in infants, gastric lipase is more important 
[24]. A co-lipase 
is secreted from the pancreas, and is required to ensure pancreatic lipase binds to the lipid / 
aqueous interface so that it can hydrolyse TAGs 
[21]. Cholesterol is absorbed only as free 
cholesterol, and CEs must therefore be hydrolysed by cholesterol esterase before 
absorption. PLs are hydrolysed by phospholipases in the small intestine to form a fatty acid 
and lysophosphatidylcholine. 
Lipid digestion products are solubilised with bile salt micelles, producing a form 
more readily absorbed. Short and medium-chain NEFAs in the intestinal epithelial cells 
move directly into the blood, where they circulate bound to albumin 
[24]. The remaining 
products of lipid digestion are re-synthesized into their former compounds (mainly TAGs), 
and are complexed with apolipoproteins to form chylomicrons. Chylomicrons are absorbed 
into the lacteal glands, from where they can circulate in the lymphatic system or pass into 
the blood via the thoracic duct. Chylomicrons in the blood bind to lipoprotein lipase (LPL) 
on the endothelial cell surface of capillaries of tissues such as adipose tissue and muscle 
[18, 
24]. LPL hydrolyses chylomicrons to release fatty acids which can then be re-esterified 
inside the tissue for storage or used for oxidation 
[24]. LPL activity is regulated by diet and 
hormones such as insulin, such that activity is high in the fed state and low in the fasted 
state 
[24]. This allows dietary fatty acids to be channelled to adipose tissue rather than 
peripheral tissues 
[18]. Chylomicrons are the main form in which dietary fatty acids are 
transported 
[24].  
Lipoproteins are large complexes of lipid and protein, which differ in composition 
and metabolic functions 
[18]. In addition to chylomicrons, there are three other main classes 
of lipoproteins. These are very-low-density-lipoprotein (VLDL), low-density-lipoprotein 
(LDL), and high-density-lipoprotein (HDL). As density of these lipoproteins increases, 
particle size decreases, as do the ratio of lipid to protein and ratio of TAGs to PLs and 
cholesterol 
[18]. Lipoprotein characteristics are shown in Table 1-5.    26 
Table 1-5: Characteristics of the major lipoprotein classes.  There are other lipoprotein fractions and sub fractions not shown here. VLDL, very low density 
lipoprotein; LDL, low density lipoprotein; HDL, high density lipoprotein; TAG, triacylglycerol; CE, cholesterol ester; PL, phospholipid. Taken from Frayn 
[24]. 
Fraction  Density range (g/ml)  Diameter (nm)  Major lipids  Major apolipoproteins
1  Composition (% by weight)
2 
          Protein  TAG  Cholesterol  PL 
Chylomicrons  <0.950  80 – 1000  Dietary TAG  B48, AI, AII, C, E  1  90  5  4 
VLDL  0.950 – 1.006  30 – 80  Endogenous TAG  B100, C, E  10  65  13  13 
LDL  1.019 – 1.063  20 – 25  Cholesterol and CE  B100  20  10  45  23 
HDL  1.063 – 1.210  9 – 15  CE and PL  AI, AII, C, E  50  2  18  30 
1 Apolipoprotein C refers to the presence of apolipoproteins CI, CII, and CIII, which are usually found together. 
2 Proportions shown are approximate and vary within each major class. 
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VLDL is synthesized in the liver. As with chylomicrons, its main role is delivery of 
TAGs to tissues. LDL is formed by repeated hydrolysis of VLDL. During this process, an 
intermediate product is formed, known as intermediate-density lipoprotein (IDL); IDL has 
a short half life in the body and is usually found at low concentrations 
[24]. LDL is the 
means by which cholesterol is carried to peripheral tissues, and is the lipoprotein 
responsible for the deposition of cholesterol in the arterial wall in atherosclerosis. HDL is 
responsible for the reverse process; it removes cholesterol from tissues and transports it to 
the liver for catabolism. 
 
1.3.4.  Biosynthesis of Fatty Acids 
Saturated fatty acids (SFAs), monounsaturated fatty acids (MUFAs) and some 
polyunsaturated fatty acids (PUFAs) can be synthesized in the body. 
 
1.3.4.1.  SFA Biosynthesis 
All mammals can synthesize SFAs de novo in a cyclical series of reactions in 
which two carbon units (derived from acetyl CoA) are added to a growing carbon chain. 
The main sites for this process are the liver, adipose tissue, and lactating mammary glands 
[18, 21, 24]. 
Acetyl CoA is formed in the mitochondria, and transported to the cell cytosol, 
where it is carboxylated to malonyl CoA by the enzyme acetyl-CoA carboxylase. Malonyl 
CoA and acetyl CoA then undergo a condensation reaction, followed by reduction and 
dehydration reactions and then a further reduction reaction. These steps are catalysed by a 
group of enzymes that collectively form the multi-enzyme complex fatty acid synthase 
[19]. 
This is shown in Figure 1-16. The end-product of these reactions is usually palmitic acid 
(16:0), with some stearic acid (18:0) formed by elongation reactions 
[18, 19]. However, 
enzymes are present in certain tissues that act to release medium chain saturated fatty 
acids. For example, caprylic acid (8:0) and capric acid (10:0) are produced in mammary 
glands of some species, and are characteristic fatty acids of their milk 
[18, 21]. 
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Figure 1-16: Fatty acid biosynthesis. Acetyl CoA is carboxylated to form malonyl CoA by 
acetyl CoA carboxylase (1). Acetyl CoA and malonyl CoA attach to the enzyme fatty acid 
synthase (FAS) (2) where they are condensed to form acetoacetyl ACP (3).  FAS then 
catalyses a series of reactions so that the fatty acid is reduced (4), dehydrated (5) and further 
reduced (6) to form a four carbon saturated fatty acid. The cycle then repeats (7) to allow the 
further addition of two carbons from malonyl CoA to the growing carbon chain. Thus, on the 
first cycle the R group is H, on the second cycle the R group is CH2CH3, the third cycle the R 
group is CH2CH2CH2CH3 and so on. Adapted from Murray et al. 
[25] 
 
1.3.4.2.  MUFA Biosynthesis 
SFAs can be converted to MUFAs through the introduction of a double bond. This 
process is known as desaturation and is carried out by the enzyme ∆9-desaturase (also 
known as stearoyl CoA desaturase or SCD), as the double bond is usually inserted between 
carbons 9 and 10 
[19]. It allows the production of MUFAs of the n-9 and n-7 family. 
Examples include the conversion of stearic acid (18:0) to oleic acid (18:1 n-9), and of 
palmitic acid (16:0) to palmitoleic acid (16:1 n-7) 
[18]. This process occurs in the 
endoplasmic reticulum and has been identified in a wide range of organisms (bacteria, 
yeasts, algae, higher plants, protozoa and animals); rates of desaturation are usually quite 
rapid 
[18, 19]. 
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1.3.4.3.  PUFA Biosynthesis 
All eukaryotes and some bacteria are able to produce PUFAs. Mammals, unlike 
plants, do not have the enzymes required to insert a double bond between carbon 9 and the 
methyl group in the acyl chain, and hence are unable to synthesize the simplest n-3 or n-6 
PUFAs de novo. However, other n-3 and n-6 PUFAs can be synthesized by metabolism of 
α-linolenic acid (ALA) or linoleic acid (LA) respectively (Figure 1-17). These two fatty 
acids are therefore known as essential fatty acids, as their presence is required in the 
mammalian diet.  
 
Figure 1-17: Biosynthetic pathway of polyunsaturated fatty acids. Stearic acid and oleic acid 
are absorbed from the diet or created by de novo synthesis. Enzymes are shown in red and 
green - those in green only occur in plants, whilst red enzymes are present in both plants and 
mammals. Adapted from Calder and Burdge 
[18]. 
The elongation and desaturation reactions shown in Figure 1-17 occur in the 
endoplasmic reticulum of the cell; β-oxidation (retroconversion) occurs in peroxisomes 
[21]. 
In mammals, the cells of the liver are able to carry out the complete pathway shown in 
Figure 1-17, and this is the main site of elongation and desaturation 
[18]. Therefore the liver 
converts ALA to docosahexaenoic acid (DHA), and LA to arachidonic acid (AA); these 
products can then be circulated to other tissues 
[21].   30 
All three unsaturated fatty acid families require the ∆6-desaturase enzyme to 
catalyse the first step in the pathway in Figure 1-17, and this is the rate-limiting step in 
PUFA biosynthesis 
[19]. The preferred substrate of the enzyme is ALA, followed by LA, 
and finally oleic acid 
[19]. However, the level of LA in the human diet is usually high 
enough to overcome the problem of substrate preference, and allow significant amounts of 
AA to be produced 
[19]. Indeed, the pathway of n-6 PUFA metabolism is quantitatively the 
most important. In the absence of the essential fatty acids ALA and LA, oleic acid has 
reduced competition for metabolism by ∆6-desaturase, and mead acid accumulates in 
tissues. This end-product is usually present in trace amounts, and as such, its presence at 
high levels can be used as an indicator of essential fatty acid deficiency 
[18, 19, 21]. 
 
1.3.5.  Roles of Fatty Acids in the Body 
Fatty acids are metabolic fuels (storage, transport and release of energy), 
components of cell membranes, and regulators of gene expression. The longer chain fatty 
acids AA, dihomo-γ-linolenic acid (DGLA), eicosapentaenoic acid (EPA) and DHA are 
also precursors for lipid mediator synthesis. In addition, complex lipids (esters of long 
chain fatty acids) provide mechanical protection as well as thermal and electrical 
insulation, and free fatty acids form micelles and function as soaps and detergents, due to 
their amphipathic nature 
[20].  
 
1.3.5.1.  Fatty Acids in Thermogenesis 
There are two types of adipose tissue in the body, known as white and brown 
adipose tissue. White adipose tissue (WAT) comprises the majority of adipose tissue in 
adult humans 
[24]. In WAT, fat is stored as a single droplet, which usually almost fills the 
cell. The cytoplasm, mitochondria and nucleus are confined to a thin layer around the 
outside. Brown adipose tissue (BAT), however, has a different physiological structure from 
WAT. Fat is stored as multiple lipid droplets in BAT cells, and mitochondria are 
considerably more numerous compared to WAT, giving rise to the characteristic brown 
colour of the tissue.  
Both BAT and WAT are storage sites for lipids. However, BAT has an additional 
role - producing heat. This is achieved by uncoupling proton flow from ATP production. 
Mitochondria pump H
+ ions from out of the mitochondrial matrix, and into the site 
between the two membranes, thereby creating a proton gradient. Protons return to the 
matrix through the enzyme ATP synthase, which converts ADP and inorganic phosphate to   31 
ATP. In BAT mitochondria, there is a protein channel known as uncoupling protein 1 
(UCP1, formerly known as thermogenin), which allows the H
+ ions to return to the matrix, 
and produces heat. Thermogenesis by BAT is not a constitutive process; it is induced by 
the sympathetic nervous system 
[24]. Nor is it universal; it is found in hibernating animals 
and infants, both of which have a real necessity for heat production 
[24]. However, in 
contrast to human infants, adult humans do not appear to have significant amounts of BAT, 
and for them heat loss is a greater issue than heat generation 
[24]. 
 
1.3.5.2.  Fatty Acids as Metabolic Fuels 
Fatty acids are stored in adipose tissue as TAGs. During conditions of low-energy 
availability, or high-energy demand (growth, reproduction or sustained mechanical work) 
fatty acids are hydrolysed from TAGs in adipose tissue by triacylglycerol lipase (hormone-
sensitive lipase, HSL). This releases NEFAs, which then circulate bound to albumin and 
are transported to other tissues 
[18, 19, 24]. HSL activity is inhibited by insulin, so that during 
conditions of high fatty acid availability (i.e. following a meal), fatty acids are stored in 
adipose tissue rather than being mobilised from it for metabolism 
[24]. NEFAs are important 
metabolic fuels during conditions of low carbohydrate availability, such as during 
starvation and endurance exercise 
[18, 24]. 
Fatty acids are oxidised in the mitochondrial matrix after conversion to their fatty 
acyl CoA derivatives. Short- and medium-chain fatty acid CoAs readily pass into the 
matrix. Long-chain fatty acyl CoAs, however, require carnitine palmitoyl transferase for 
their transport. Fatty acid oxidation (β-oxidation) consists of the progressive removal of 
acetyl CoA from the carboxyl end of the fatty acyl CoA 
[18] (Figure 1-18). Fatty acid 
oxidation is overall the reverse of fatty acid synthesis, with oxidation, hydration, oxidation 
and cleavage reactions occurring in oxidation, as opposed to the condensation, reduction, 
dehydration and reduction reactions that occur in fatty acid synthesis.   32 
 
Figure 1-18: Fatty acid oxidation. This cyclical process consists of the release of acetyl CoA 
from the fatty acyl CoA molecule by a series of oxidation (1 and 3), hydration (2), and 
cleavage (4) reactions. Reaction 4 produces an acetyl CoA molecule and a fatty acyl CoA. 
Acetyl CoA is used in the tricarboxylic acid cycle, whilst the fatty acyl CoA undergoes 
another repeat of the fatty acid oxidation cycle. This continues until two acetyl CoA 
molecules are the sole products of reaction 4. Adapted from Murray et al. 
[25]. 
ATP is produced by the acetyl CoA molecules passing through the tricarboxylic 
acid cycle. Fatty acids produce on average 37 kJ/g (9 kcal/g) 
[19]. β-oxidation also occurs in 
peroxisomes. Peroxisomal β-oxidation has a greater specificity than mitochondrial β-
oxidation, but is particularly involved in oxidation of long-chain fatty acids 
[25]. 
 
1.3.5.3.  Fatty Acids in Membranes 
The widely held understanding of cell membrane structure is the fluid mosaic 
model, proposed by Singer and Nicholson 
[25, 26]. This suggests that the membrane consists 
of a bilayer of lipids, with proteins embedded into it, resulting in an asymmetric, or 
“mosaic” structure. In addition, the membrane is “fluid”, as lipids can rapidly move across 
the membrane (lateral diffusion) as well as rotate. To a lesser and slower extent, lipids can 
also move from one side of the bilayer to the other (flip-flop).  
The major lipids in membranes are glycerolipids 
[27]. Glycerolipids can be classified 
into two groups; phosphoglycerides (which contain phosphorous and are also known as 
phospholipids) and glycosylglycerides, which contain a sugar constituent, but no 
phosphorous 
[28]. However, some compounds can be classified in both groups as they 
contain phosphorous and sugar residues, e.g. sphingomyelin. Phospholipids predominate in 
higher animals, whilst glycosylglycerides are more widespread in plants 
[28]. Both 
phospholipids and glycosylglycerides contain fatty acids esterified at the sn-1 and sn-2   33 
positions 
[28]. A second major class of lipids present in membranes are sphingolipids, 
which contain a sphingosine backbone rather than glycerol, and fatty acids as side chains 
[28]. These lipids are particularly widespread in nervous tissue 
[28]. Examples of 
sphingolipids include sphingomyelin, sphingosine and ceramide; some of these act as 
signalling molecules. Sterols such as cholesterol are important in membranes, and can also 
be found in less abundantly in mitochondria, Golgi complexes and nuclear membranes 
[25]. 
Cholesterol provides stability to membranes 
[28]. 
A further role for fatty acids in membranes, and an update to the fluid mosaic 
model, are lipid rafts. These are small (10–200 nm), heterogeneous, highly dynamic, 
sterol- and sphingolipid-rich domains, and are areas of the membrane involved in cellular 
processes such as signal transduction 
[29]. Lipid rafts have a different lipid composition 
from the rest of the membrane (high in cholesterol and glycosphingolipids), and not all 
rafts have the same composition of proteins and / or lipids. They are more fluid than other 
areas of the membrane 
[30]. Lipids provide anchors for proteins, and there are four major 
types of covalently bound lipids for membrane proteins (Table 1-6). Of these, only 
myristoylation and palmitoylation involve fatty acids directly (myristic and palmitic acid, 
respectively). Caveolae are a subclass of lipid rafts that contain caveolin-I, a cholesterol-
binding protein. 
Table 1-6: Lipid anchors for proteins. Taken from Gurr et al. 
[28]. 
Type  Attachment  Examples 
Myristoylation  Co-translational; glycine at N-terminus  cAMP protein kinase; G-
proteins (Go, Gi); various viral 
proteins 





Prenylation  Post-translational; cysteine near C-
terminus. Separate enzymes for farnesyl 
or geranylgeranyl groups. Often 
carboxymethylated 
Ras proteins; G-protein (γ 
subunits); lamin B 
GPI  Post-translational; at C-terminus; sensitive 
to phospholipase C 
Alkaline phosphatise; 5' – 
nucleotidase; 
acetylcholinesterase 
The fatty acid composition of membranes is often characteristic for the cell and 
membrane type, but can be affected by numerous factors, including stage of the cell cycle, 
age, presence of stimuli, environment and diet 
[25, 31]. Changes in membrane composition 
can cause changes in function. The fatty acid composition of cell membranes affects their   34 
fluidity. An increased number of double bonds in unsaturated fatty acids, and / or increase 
in cis-bonds mean that membrane lipids are less tightly packed and therefore more fluid 
[19, 
25]. This in turn can affect cell function, as fluidity is necessary for appropriate interactions 
between membrane proteins or proteins and lipids to occur, for example in receptor 
functioning, enzyme activity, transporters and signal transduction mechanisms 
[18]. Other 
lipid factors that can affect membrane functional ability include the type of lipid head 
group present (as this alters surface charge and potential), chain length of fatty acyl groups 
(must be the correct for the size of the transmembrane protein sections) and cholesterol 
inclusion (affects lipid lateral mobility) 
[28]. 
 
1.3.5.4.  Fatty Acids and Gene Regulation 
In addition to those described previously, fatty acids have further roles in cell 
signalling. For example, phospholipases C and D hydrolyse membrane phospholipids to 
produce diacylglycerols (DAGs) and phosphatidic acid, both of which are second 
messengers 
[18]. Cell signalling by fatty acids can also affect gene expression indirectly, as 
they are involved in the regulation of transcription factors. An example of this is the 
transcription factor family peroxisome proliferation-activated receptors (PPARs), whose 
ligands are fatty acids or their derivatives. There are three main isoforms of PPARs, as 
shown in Table 1-7. Fatty acids have different potencies in activating PPARs. For example, 
n-3 PUFAs are more effective than n-6 PUFAs, and PUFAs are more potent than SFAs 
[24].   35 
Table 1-7: The main classes of peroxisome proliferation-activated receptors (PPARs). The 
isoforms PPAR-γ1 and PPAR-γ2 are produced from the same gene by different promoters. 
CPT-1, carnitine palmitoyltransferase-1; FAAR, fatty acid activated receptor; FABP, fatty 
acid binding protein. Taken from Frayn 
[24]. 
Receptor  Other 
names 
Main tissue distribution  Genes whose expression 






PPAR-α    Liver (main site).  
Also kidney, heart, muscle, 
brown adipose tissue 
Apolipoprotein AI 
Apolipoprotein AII  
Enzymes of peroxisomal 
fatty acid oxidation 
Liver FABP 
CPT-1 
Enzymes of mitochondrial 
fatty acid oxidation 
Apolipoprotein CIII 
PPAR-δ  PPAR-β, 
NUC 1, 
FAAR 
Widespread  Not known, although 
HDL concentrations 
increase with activation 
Not known 
PPAR-γ1    Widespread at low levels     
PPAR-γ2    Adipose tissue  Factors involved in 
adipocyte differentiation 
Adipose tissue FABP 
Lipoprotein lipase 








1.3.5.5.  Fatty Acids and Eicosanoid Production 
The PUFAs DGLA, AA and EPA can be converted to eicosanoids, following their 
release from membrane phospholipids (Figure 1-19). Stimuli inducing their production 
include histamines, cytokines, and proteolytic and lipolytic enzymes 
[32].   36 
 
Figure 1-19:  Synthesis of eicosanoids from γ-linolenic acid and arachidonic acid (top), and 
eicosapentaenoic acid (EPA) (bottom). COX, cyclo-oxygenase; DGLA, dihomo-γ-linolenic 
acid; HETE, hydroxyeicosatetraenoic acid; LOX, lipoxygenase; LT, leukotrienes; PG, 
prostaglandin; TX, thromboxane. 
Eicosanoids are oxygenated fatty acids present in low concentrations in the body 
[21], and comprise prostaglandins, prostacyclins, thromboxanes, leukotrienes and lipoxins. 
The type of eicosanoid produced depends on which enzyme the cell expresses (i.e. COX 
(cyclo-oxygenase), 5-LOX, (lipoxygenase) or 15-LOX); these enzymes are present in all 
mammalian cells except erythrocytes 
[32]. Eicosanoids induce many important 
physiological effects (Table 1-8), such as those seen in immune responses (e.g. 
inflammation, pain, fever).    37 
Table 1-8: Physiological effects of some eicosanoids. PG, prostaglandin; LT, leukotriene; 
HETE, hydroxyeicosatetraenoic acid; LX, lipoxin; SRS-S, Slow-reacting substance of 
anaphylaxis. Taken from Fernandez et al. 
[32]. 
Response  Eicosanoid 
Vasodilation, capillary permeability  PGA, PGD, PGE1, PGE2, PGI2, TXA2 
Muscle tone  PGF2 
Slow muscle contraction  LTC4, LTD4, LTE4 (SRS-A) 
Smooth muscle contraction  LTC4, LTD4 
Chemoattractant for T cells  PGE2, LTB4 
Immune suppression  LTB4 
Chemotaxis  HETEs, LTB4, LXA 
Platelet functions  TXA2, PGI2 
Pain mediator  PGE2, PGI2 
 
1.3.5.6.  Prostaglandins and Derivatives 
Prostaglandins all contain a five-membered ring, and are categorised according to 
the position of their functional groups into nine classes, denoted by names PGA to PGI. 
Within this, individual prostaglandins are identified using numbers, e.g. PGE1. The main 
functions of prostaglandins include bronchoconstriction, inhibition of platelet-activating 
factor (PAF) production, cytotoxicity, and regulation of inflammation, and immunity 
[32]. 
Prostacyclin (PGI2) causes vasodilation, and prevents platelet aggregation 
[33]. 
Thromboxanes are derivatives of prostaglandins; their effects are antagonistic to 
prostacyclin, causing arterial constriction and platelet aggregation 
[33, 34]. Thromboxanes 
and prostacyclin are produced by vascular smooth muscle, endothelium and platelets 
[32]. 
 
1.3.5.6.1.  Leukotrienes 
There are at least six different types of leukotrienes 
[35]. Leukotrienes increase 
permeability of small blood vessels, contract smooth muscle, and attract neutrophils to 
sites of infection 
[5, 36, 37]. 
 
1.3.5.6.2.  Lipoxins 
Lipoxins contain a conjugated tetraene structure and three alcohol groups; two 
subclasses, lipoxin A and lipoxin B, have been identified 
[37]. Both lipoxins A and B inhibit 
NK cell cytotoxicity, and lipoxin A dilates small blood vessels 
[37]. 
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1.3.6.  Dietary Intake of Fats 
Fatty acids can be formed in the body by the elongation and desaturation reactions 
described in 1.3.4, but the conversion of ALA to EPA and DHA is limited in humans 
[38, 
39], and diet is the main source of fatty acids 
[24]. Fats come from a variety of sources in the 
diet (Figure 1-20). Most fat eaten is in the form of TAGs, phospholipids, glycolipids, 
complex lipids and cholesterol, and fatty acids are components of all but the latter. Fatty 





Sugar, preserves & 
confectionary
Potatoes & savoury snacks
Miscellaneous
Milk & milk products
Meat & Meat products
Fruits & nuts
Fish & Fish products
Fat spreads
Egg & egg dishes
Drinks
Cereal & cereal products
 
Figure 1-20: Dietary sources of total fat in the diet of British adults in the National Diet and 
Nutrition Survey 2000 / 2001. Constructed using data from Henderson et al. 
[40]. 
Dietary fat sources (e.g. milk, eggs, fish etc) have characteristic fatty acid 
compositions, although such compositions may be subject to alteration or variation. Cows’, 
sheep and goats’ milks contain high levels of short and medium chain fatty acids, and low 
levels of PUFAs. There are also small amounts of a large variety of branched and odd 
chain fatty acids in ruminant milks; nature and levels depend on type of feed they receive 
[19]. Storage fats of poultry and animals tend to be high in SFAs and MUFAs, whilst the 
meat contains significant levels of PUFAs 
[18]. Fatty acids in eggs are mostly SFAs and 
MUFAs found in the egg lipoproteins, whilst the yolk is rich in PUFAs in phospholipids 
[18, 19]. Fish can be classified into lean or oily (fatty) fish based on their fat deposition. Lean 
fish, such as cod, store lipids as TAGs in their liver, whilst oily fish, such as mackerel, 
salmon, herring and tuna, store their lipids as TAGs in their flesh. The exact fatty acid 
composition of fish varies according to diet and season, but fish are characteristically high 
in long-chain n-3 PUFAs 
[19]. In some species such as herring, however, there is a   39 
predominance of long-chain MUFAs 
[19]. Typical fatty acid compositions of milk, eggs, 
meats, animal fats and fish oils are shown in Table 1-9.   40 
Table 1-9: Typical fatty acid composition of milk, eggs, animal fat depots, animal meats and fish oils. Data are shown as g fatty acid per 100 g total fatty acids. Taken 
from Calder and Burdge 
[18]. 
  ≤ 12:0  14:0  16:0  18:0  16:1 n-7  18:1 n-9  18:2 n-6  18:3 n-3  20:4 n-6  20:5 n-3  22:6 n-3 
Cows' milk  13  12  26  11  3  28  2  1  0  0  0 
Cows' milk
a  10  8  17  8  <1  21  35  1  0  0  0 
Goats' milk  21  11  27  10  2  26  2  1  0  0  0 
Sheep milk  24  12  25  9  3  20  2  1  0  0  0 
Human milk  6  7  27  10  4  35  7  1  some  trace  some 
Egg yolk  0  0  29  9  4  43  11  <1  some  0  some 
Pig fat (lard)  <1  1  29  15  3  43  9  1  0  0  0 
Poultry fat  some  1  27  7  9  45  11  0  0  0  0 
Poultry fat
b  some  1  22  6  5  27  35  0  0  0  0 
Beef fat (suet)  some  3  26  5  9  45  2  1  0  0  0 
Lamb fat  some  3  21  20  4  41  5  0  0  0  0 
Pork  some  <1  19  12  2  19  26  1  8  0  0 
Chicken  some  <1  23  12  6  33  18  1  6  0  0 
Beef  some  <1  16  11  2  20  26  1  13  0  0 
Lamb  some  <1  22  13  2  30  18  4  7  0  0 
Herring oil
c  some  9  15  1  7  16  1  <1  1  10  5 
Menhaden oil
c  some  8  22  3  11  21  2  2  2  14  8 
Cod liver oil
c  some  5  15  3  10  15  2  <1  1  10  8 
a Cows fed supplement containing LA and protected against rumen biohydration 
b Chickens fed diet rich in LA 
c Also contain 4 – 40 g 20:1 n-9 and 22:1 n-9 per 100 g total fatty acids   41 
The fatty acid composition of plant membrane lipids is less variable between 
different leaf types, with five fatty acids accounting for more than 90% of the total 
(palmitic, palmitoleic, oleic, linoleic and α-linolenic) 
[18, 19]. Green leafy vegetables are an 
important source of ALA in the human diet 
[18, 19]. In contrast to this, there is a wide 
variation of fatty acids in seed oils. Often, one fatty acid predominates that is characteristic 
to a particular species and has an unusual structure 
[18, 19]. Fatty acid composition of 
selected seed oils is shown in Table 1-10.  42 
Table 1-10: Fatty acid composition of selected seed oils consumed by humans. Data is shown as g fatty acid per 100 g total fatty acids. Rapeseed oil fatty acids are shown 
for both high and low erucic forms. Older varieties of rapeseed contain nearly 60% erucic acid, which was reported to be toxic, and so newer varieties are lower in erucic 
acid (achieved through breeding) 
[18]. Data taken from British Nutrition Foundation 
[19]. 
 Oil  8:0  10:0  12:0  14:0  16:0  18:0  20:0  22:0  16:1  18:1  18:2  18:3   Others 
Coconut  8  7  48  16  9  2  1  0  trace  7  2  0  0    
Corn  0  0  0  1  14  2  trace  trace  trace  30  50  2  1    
Olive  0  0  0  trace  12  2  trace  0  1  72  11  1  1    
Palm  0  0  trace  1  42  4  trace  0  trace  43  8  trace  2    
Palm kernel  4  4  45  18  9  3  0  0  0  15  2  0  0    
Peanut  0  0  trace  1  11  3  1  3  trace  49  29  1  2    
Rapeseed (Low erucic)  0  0  0  trace  4  1  1  trace  2  54  23  10  5    
Rapeseed (High erucic)  0  0  0  trace  4  1  1  trace  trace  24  16  11  10
a  33
b 
Soybean  0  0  trace  trace  10  4  trace  trace  trace  25  52  7  2    
Sunflower  0  0  trace  trace  6  6  trace  trace  trace  33  52  trace  3    
a 20:1 
b 22:1   43 
There are large differences in fatty acid intake between countries, ranging from 
under 20 g/day in some developing countries, to more than 150 g/day in certain developed 
countries 
[18]. There have also been large changes in fat consumption over time, a pattern 
which looks set to continue, particularly with the increase in availability of low fat foods. 
Figure 1-21 shows the changes in consumption of saturated and polyunsaturated fat, and 
vegetable oil among adults in the UK from 1966 onwards. Much of this change reflects 
improved consumption habits, for example changing from butter to margarine and from 
animal fats to vegetable oils 
[18, 19]. 
 
Figure 1-21: Trends in consumption of saturated fat, polyunsaturated fat and vegetable oil in 
the UK since 1966. Taken from Devereux and Seaton 
[41]. 
The Committee of Medical Aspects of Food 
[42] has made recommendations for fat 
intake in the UK, expressed as average population values. These are shown in Table 1-11, 
along with the average intakes in British adults in 2000/2001. On average, 13.5 g of LA 
and 1.7 g of ALA is consumed by adult men in the UK daily; for women these figures are 
9.3 g and 1.2 g respectively 
[18].   44 
Table 1-11: Fat recommendations in the UK, shown as percentage of energy both including 
and excluding alcohol 
[42] and the average British adult intakes in 2000 / 2001 
[40]. COMA, 
Committee on Medical Aspects of Food Policy; FA, fatty acid; MUFA, monounsaturated fatty 
acid; PUFA, polyunsaturated fatty acid; SFA, saturated fatty acid. 
  COMA recommendations 
(% energy) 
 
Average British adult intakes (% 
energy) 




Men  Women 
Total fat  < 33  < 35  35.8  34.9 
SFAs  < 10  < 11  13.4  13.2 
MUFAs  12  13  12.1  11.5 
 cis PUFAs      6  - 10  6.5 - 11  6.4  6.3 
trans FAs  < 2  < 2  1.2  1.2 
   45 
1.4. Fatty Acids and the Immune System 
In the years 1950 to 1974 in Upernavik District in Greenland there was a low 
incidence of asthma and related diseases 
[43], accompanied by a high intake of n-3 PUFAs 
found in high amounts in sea mammals and fish 
[44]. Other epidemiological studies have 
shown a similarly low level of allergic disease in populations with a high fish intake 
[45, 46]. 
In contrast, in countries, such as the UK, Australia, New Zealand, Sweden, Finland, the 
United States and Canada, there has been an increased incidence of allergies and related 
diseases, accompanied by an increased consumption of n-6 PUFAs 
[47]. These observations 
lead to the idea that dietary fat, and in particular the balance of n-3 and n-6 PUFAs, may 
affect allergy development 
[47, 48] as a result of the different effects of these classes of fatty 
acids on immune cell functions according to their properties described in section 1.2.5. In 
fact, different fatty acids have been shown to affect immune cell functions and immune 
responses in many model systems; it is not possible to review the entirety of this literature 
here but extensive reviews may be found elsewhere 
[49-51]. In the sections below, the effects 
of fatty acids on immune functions relevant to the studies conducted in this thesis will be 
described. The earlier work has used a) cell culture experiments where isolated cells have 
been exposed to individual fatty acids, b) studies in laboratory rodents where the fat 
composition of the diet has been manipulated, c) studies in humans where specific fats or 
fatty acids have been provided most often in the form of capsules consumed on a daily 
basis. Each of these approaches has advantages and disadvantages. One difficulty of 
interpreting the findings from many of these studies, irrespective of the approach used, is 
the nature of the control. For example in an animal study investigating the effect of an 
increase in dietary n-3 PUFAs, it is not entirely clear whether the control should be a diet 
rich in saturated fat or in n-6 PUFAs or representing some sort of balanced fatty acid 
composition and different effects of the n-3 PUFA-rich diet may be seen in comparison to 
each of these other diets.  
 
1.4.1.  T-Cells 
1.4.1.1.  Effect of SFAs 
Diets high in SFAs have been shown not to affect lymphocyte proliferation 
compared to low-fat diets 
[52], to reduce proliferation but less so than high PUFA diets 
[53-
60] and even to increase proliferation compared to low fat and high PUFA diets 
[61, 62]. 
Moussa et al. 
[57] demonstrated that a high fat (200 g lipid / kg) coconut oil diet reduced 
proliferation of splenic lymphocytes compared to a low fat (50 g / kg) coconut oil diet. One   46 
study investigated the effect of individual SFAs on lymphocyte proliferation directly: 
Jeffery et al. 
[63] showed that rat lymphocyte proliferation is enhanced most by a diet rich 
in palmitic acid in the sn-2 position of dietary TAGs. In cell culture, addition of stearic 
acid has been shown to inhibit T-cell proliferation, whilst palmitic acid and myristic acid 
did not significantly affect it 
[64]. Studies have found no effect of SFAs on levels of T-cells 
in the rat compared to fish oil (FO) 
[59, 65, 66] or LA 
[59, 65, 66]. 
 
1.4.1.2.  Effect of n-3 PUFAs 
ALA-rich diets have been shown to have no effect on T-cell abundance in humans 
in comparison to low ALA 
[67],  DHA 
[68] or AA 
[68]. Soybean oil diets have been shown to 
reduce lymphocyte proliferation in rats compared to low fat feeding 
[57, 58, 60], or coconut oil 
diets 
[57], and in mice compared to low soybean oil 
[69]. However, soybean oil diet 
experiments are complicated by the fact that they are rich in LA, as well as containing 
ALA, and it is therefore unclear whether effects seen are due to n-3 or n-6 PUFAs. Jeffery 
et al. 
[70] found a relationship between LA and splenic lymphocyte proliferation, and an 
inverse relationship between level of ALA and splenic lymphocyte proliferation in rats 
although neither relationship was linear. Feeding ALA-rich diets suppresses spleen T-cell 
proliferation compared to feeding diets low in ALA 
[67, 71], diets rich in HCO 
[62], sunflower 
oil 
[71], canola oil, corn oil and lard 
[72]. However, some researchers have found no 
significant effect of ALA-rich diets in humans on lymphocyte proliferation compared to 
diets low in ALA 
[68, 73]. In cell culture, addition of ALA has been shown to inhibit T-cell 
proliferation 
[64]. 
EPA has been shown to have no effect on level of T-cells in humans 
[74] or rats 
[75, 
76] compared to SFAs
[74], ALA 
[75, 76], DHA 
[75], AA 
[75] or GLA 
[74, 75]. DHA has been 
shown to have no effect on absolute number or proportion of lymphocytes that are T-cells 
in humans 
[68, 77] or rats 
[75, 76] compared to ALA 





75], or GLA 
[68, 75]. Increased consumption of fish as part of a low fat diet has been found to 
have no effect on level of T-cells in humans 
[78]. FO has been shown to have no effect of 
absolute number or proportion of lymphocytes that are T-cells in humans 
[68, 79] or rats 
[59, 




[59, 65, 66, 79], GLA 
[59, 65, 66, 68, 79] or OA 
[59, 65, 66, 79]. 
Feeding FO to rabbits 
[80], chickens 
[72], rats 
[59, 66, 81, 82], or mice 
[61] suppresses T-
cell proliferation compared to feeding low fat 
[59, 66, 78, 81], HCO 
[61, 66, 82], lard 
[72], linseed 
[80], safflower 
[59, 66, 82], or corn oils 
[72]. Fish or FO supplementation in humans has also 
been reported in some studies to suppress lymphocyte proliferation compared to baseline   47 
values 
[68, 78, 83-85] or high SFA+MUFA+n-6 PUFA intake 
[86]. However, other studies have 
shown an increase in T-cell proliferation as a result of FO provision in mice compared to 
corn oil 
[87] or baseline values 
[88]. EPA has been shown to reduce T-cell proliferation 
compared to LA supplementation 
[89]. Feeding DHA 
[68, 77], EPA 
[74] or both EPA and DHA 




[77, 79] or baseline values or no additional n-3 PUFAs 
[68, 73]. 
However, EPA and DHA have both been shown to reduce lymphocyte proliferation in rats 
[75, 90] and mice 
[91] compared to ALA 
[90], soybean oil 
[75] or LA 
[91]. Again, position of the 
fatty acid in the dietary TAG may influence its effects or lack thereof on the immune 
system; Kew et al. 
[76] showed that moderate supplementation of EPA in position sn-1(3) 
of TAG increased lymphocyte proliferation in rats compared to ALA. In addition, dietary 
supplementation with salmon (to a predicted level of 2.3 g EPA and 3.6 g DHA) has been 
shown to have no effect on T-cell proliferation in humans, compared to a low fish diet 
[92]. 




1.4.1.3.  Effect of n-6 PUFAs 
Studies have shown that LA-rich diets can reduce lymphocyte proliferation in mice 
[53, 55, 61, 93, 94], guinea pigs 
[54], and rats 
[52, 59, 62, 66, 95] compared to low fat diets 
[55, 59, 66, 95] or 
SFA-rich diets 
[52-55, 61, 62, 66, 93, 94]. However, other studies report no effect of LA on 
lymphocyte proliferation in experimental animals 
[96-99]and humans 
[79] compared to SFAs 
[96, 99], ALA 
[97], or FO 
[79, 97-99]. In cell culture, addition of LA has been shown to inhibit 
human lymphocyte proliferation 
[64]. LA-rich diets have been shown to have no effect on 
levels of T-cells in humans 
[79] or rats 
[59, 65, 66] compared to FO 
[59, 65, 66, 79], or SFAs 
[59, 65, 
66]. 
AA has been shown to have no effect on level of T-cells in rats compared to GLA, 
EPA or DHA 
[75] or in humans compared to a low AA diet 
[68, 100]. AA has been shown to 
have no effect on lymphocyte proliferation compared to low AA or baseline values 
[68, 101], 
in mice, compared to LA 
[91], or when added to cultures of human T-cells 
[64]. 
 
1.4.2.  T-Helper Cells 
1.4.2.1.  Effect of SFAs 
SFAs have been shown not to affect TH cell numbers in the rat compared to a low 
fat diet 
[63], FO 
[59, 65, 66] or LA 
[59, 65, 66].   48 
1.4.2.2.  Effect of n-3 PUFAs 
ALA-rich diets or supplements have been shown to have no effect on levels of 
circulating TH cells in humans 
[67, 68] or rats 




[71] or AA 
[68]. 




[91] compared to SFAs 
[74], ALA 
[76] or LA 
[91]. DHA supplements have been found to 
have no effect of levels of TH cells in humans 
[68, 77] rats 
[76] or mice 
[91] compared to ALA 
[68, 76], FO 
[68], LA 
[77, 91] or AA 
[68]. Reports have suggested that FO has does not affect 
level of TH cells in rats 
[59, 65, 66, 81] or humans 
[68, 79] compared to SFAs 
[59, 65, 66], ALA 
[68], 
LA 
[59, 65, 66, 79, 81] or AA 
[68]. Increased consumption of fish in a low fat diet has been shown 
to have no effect on level of TH cells in humans 
[78]. 
 
1.4.2.3.  Effect of n-6 PUFAs 
LA-rich diets may not affect TH cells in humans 
[79] or rats 
[59, 65, 66, 71, 81] compared 
to SFAs 
[59, 65, 66], ALA 
[71] or FO 
[59, 65, 66, 79, 81].  
 
1.4.3.  Cytotoxic T-Cells  
1.4.3.1.  Effect of SFAs 
SFAs do not appear to affect level of CTLs in the rat 
[59, 63, 65, 66] compared to a low 
fat diet 
[63], FO 
[59, 65, 66] or LA 
[59, 65, 66]. 
 
1.4.3.2.  Effect of n-3 PUFAs 
ALA-rich diets or supplements have been shown to have no effect on level of CTLs 
in humans 
[67, 68] compared to low ALA 
[67], DHA 
[68], FO 
[68] or AA 
[68]. 
DHA supplementation has been shown to have no effect on levels of CTLs in 
humans 
[68, 77] or rats 
[76] compared to ALA 
[68, 76], LA 
[77] or AA 
[68]. However, Jolly et al. 
[91] found DHA supplementation reduced CD8
+ expression in mice, compared to LA 
supplementation. EPA has been shown to have no effect on level of CTLs in humans 
[74], 
rats 
[76] or mice 
[91] compared to SFAs 
[74], ALA 
[76] or LA 
[91]. FO supplementation has 
been shown to have no effect on level of CTLs in humans 
[68, 79] or rats 
[59, 65, 66, 81] 
compared to ALA 
[68], LA 
[59, 65, 66, 79, 81] AA 
[68] or SFAs 
[59, 65, 66]. However, Meydani et al. 
[78] found an increase in CTL expression in humans on a low fat, high fish diet, compared 
to baseline values.   49 
1.4.3.3.  Effect of n-6 PUFAs 
LA-rich diets or supplements have been shown to have no effect on level of CTLs 
in humans 
[79] or rats 
[59, 65, 66, 71, 81] compared to SFAs 
[59, 65, 66], FO 
[59, 65, 66, 79, 81] or ALA 
[71].  
Reports suggest that AA has no effect on level of CTLs in humans 
[68, 100] or mice 
[91] compared to a low AA diet 
[91, 100], ALA 
[68], DHA 
[68] or FO 
[68]. 
 
1.4.4.  T-Cell Derived Cytokines 
1.4.4.1.  Effect of SFAs 
Wallace et al. 
[61] showed IL-2 and IL-4 production in mice was higher following 
coconut oil feeding than fish and safflower oil (SAFO) feeding; IL-2 production was also 
higher than low fat feeding. Addition of stearic acid to cell cultures of human lymphocytes 
caused a reduction in IL-2 production, whilst myristic acid and palmitic acid had no effect 
[64]. 
 
1.4.4.2.  Effect of n-3 PUFAs 
Berger et al. 
[97] found no effect of linseed oil diets on IL-2 production in mice in 
comparison to SAFO or FO. ALA-rich diets or supplements have been shown to have no 
effect on IL-2 
[67, 73, 102], IL-10 
[73] or IFN-γ 
[73] production in humans in comparison to FO 
[73, 102], LA 
[102] or low ALA or no additional supplementation 
[67, 73]. The addition of ALA 
to cell cultures of human lymphocytes reduced IL-2 production 
[64]. 
Kelley et al. 
[77] showed no effect of supplementation of 6 g DHA per day to 
humans, compared to supplementation with LA. The addition of EPA or DHA to cell 
cultures of human lymphocytes has been shown to reduce IL-2 production 
[64]. However, 
Jolly et al. 
[91] showed that both EPA and DHA reduced IL-2 production in mice compared 
to LA supplementation.   50 
Berger et al. 
[97] and found no effect of FO diets on IL-2 production in mice 
compared to linseed or SAFO, and Turek et al. 
[102] found no effect of FO on IL-2 
production in pigs compared to corn oil or linseed oil, whilst other studies have 
demonstrated a reduction of IL-2 production following FO supplementation compared to 
baseline values 
[84] or coconut oil supplementation 
[61]. Wallace et al. 
[61] also demonstrated 
a reduction in IFN-γ production, but no difference in IL-4 production as a result of FO 
supplementation, compared to coconut oil supplementation. However, Fernandes et al. 
[87] 
found FO supplementation to increase IL-2 production by splenocytes from female 
(NZB/NZW) F1 (BW) mice (an animal model for human SLE (systemic lupus 
erythematosus)) compared to those receiving corn-oil based diets. The same study found 
no difference in IL-4 production between the two groups. In humans, FO has been shown 
to have no effect on production of IL-2 
[73, 79], IL-4 
[88], IL-10 
[73, 79] or IFN-γ 
[73, 79] 
compared to ALA 
[73], LA 
[79] or no additional supplementation or baseline values 
[73, 88]. 
Other studies have shown a decrease in IL-2 
[85, 103] and IFN-γ 
[88, 103] production as a result 
of FO supplementation, compared to no additional supplementation or baseline values. 
 
1.4.4.3.  Effect of n-6 PUFAs 
Diets high in LA have been shown to have no effect on IL-2 
[79, 91, 97] or IL-4 
[61], 
IL-10 or IFN-γ 
[79] production in mice 
[61, 87, 91, 97] or humans 
[79] compared to SFAs 
[61], 
ALA 
[97] or FO 
[79, 87, 91, 97]. In contrast, Wallace et al. 
[61] found IL-2 production was lower 
following feeding of n-6 rich diets compared to high SFA diets. Yaqoob et al. 
[93] found 
SAFO diets increased IL-2 production in mice compared to low fat and HCO diets. The 
same study found no effect on IL-4, IL-10 or IFN-γ production. In cell cultures of human 
lymphocytes, the addition of LA has been shown to reduce IL-2 production 
[64]. 
Thies et al. 
[68] found no effect of AA supplementation on IL-2 or IFN-γ production 
by older humans compared to those receiving ALA, DHA or FO. Kelley et al. 
[100] found 
no effect of AA supplementation on IL-2 production by younger men compared to a 
control receiving a low AA diet. In cell cultures of human lymphocytes, the addition of AA 
has been shown to reduce IL-2 production 
[64]. 
 
1.4.5.  B-cells 
1.4.5.1.  Effect of SFAs 
Diets high in SFAs have been shown to have no effect on B-cell proliferation in 
mice 
[56, 94, 99] and cats 
[104] compared to diets rich in n-3 PUFAs 
[104], FO diets 
[99] or corn   51 
[56, 94, 99], but cause increased proliferation compared to low fat diets 
[56]. SFA-rich diets 
have been shown to have no effect on level of B-cells in rats 
[59, 65, 66] compared to FO 
[59, 65, 
66] or LA 
[59, 65, 66]. 
SFA-rich diets have been shown to cause lower IgG production 
[53, 55, 56] but higher 
IgM production 
[55] or no difference in IgM production 
[53, 56] compared to LA 
[53, 55] or high 
PUFA diets 
[56]. 
   52 
1.4.5.2.  Effect of n-3 PUFAs 
Olson et al. 
[69] found no difference between a high (20 g / 100 g) or low (5 g / 100 
g) of soybean oil level on B-cell proliferation in mice. However, this is complicated by the 
presence of n-6 PUFAs in soybean oil. ALA has been shown to increase B-cell 
proliferation, and antibody titres in rabbits, in comparison to FO and LA 
[80]. ALA-rich 
diets or supplements have been shown to have no effect on level of circulating B-cells 
[67, 
68] compared to low ALA 
[67], DHA 
[68], FO 
[68] or AA 
[68], or on serum concentrations of 
IgG and it subclasses, IgA or salivary IgG in humans or rats, compared to LA 
[71]. 
DHA has been shown to have no effect on IgG production in humans 
[77], antibody 
titre in response to influenza in humans 
[105] or number of B-cells in humans  compared to 
ALA 
[68] or AA 
[68], or in rats 
[75, 76] compared to ALA 
[76], LA 
[77, 105], AA 
[75], or EPA 
[75]. 
EPA appears to have no effect on level of B-cells in rats 
[75, 76] compared to ALA 
[76], DHA 
[75], or AA 
[75], or humans, compared to SFAs 
[74]. Miles et al. 
[74] also demonstrated an 
increase in IgG2 plasma concentration, and reduction of IgE plasma concentration of 
young men as a result of 2.0 g EPA supplementation for 7 weeks, at the end of 
supplementation compared to baseline values. FO has been shown to increase antibody 
titres in chickens 
[72] compared to corn, canola, or linseed oil, and reduce Ig+ expression in 
splenocytes of female (NZB/NZW) F1 (BW) mice (a model of human SLE) compared to 
corn oil 
[87]. FO appears to have no effect on levels of circulating B-cells in humans 
[68, 79] 
or rats 
[59, 65, 66] compared to SFAs 
[59, 65, 66], ALA 
[68], LA 
[59, 65, 66, 79], or AA 
[68]. Increased 
dietary supplementation with fish has been shown to have no effect on B-cell proliferation 
in humans 
[78, 92].  
 
1.4.5.3.  Effect of n-6 PUFAs 
B-cell proliferation has been shown not to be affected by diets high in n-6 PUFAs 
in mice 
[53, 99] and chickens 
[72] compared to those receiving SFA diets 
[53, 72, 99], linseed oil 
[72] or FO diets 
[72]. However, Morrow et al. 
[56] found an increase in B-cell proliferation in 
mice receiving a corn oil diet compared to those receiving a lard-based diet. Friend et al. 
[54] found reduced antibody titre in guinea pigs fed a maize-oil diet compared to those on a 
tallow-diet. LA rich diets or supplements have been shown to have no effect on circulating 
levels of B-cells in humans 
[79] or rats 
[59, 65, 66, 71] compared to SFAs 
[59, 65, 66], ALA 
[71] or 
FO 
[59, 65, 66, 79]. 
AA supplementation to humans has been shown to have no effect on B-cell 
proliferation 
[101], antibody titre 
[100], or absolute or percentage numbers of B-cells in   53 
circulation in humans 
[68, 100] or rats 
[75] compared to low AA 
[100, 101], ALA 
[68, 75], DHA 
[68, 
75], EPA 
[75], or FO 
[68] supplementation. 
 
1.4.6.  Delayed-Type Hypersensitivity 
There are numerous in vivo measures of immune responses, one of which are 
measures of delayed-type hypersensitivity (DTH) responses. DTH responses are local cell-
mediated responses produced in an individual as a result of receiving an injection into the 
skin of an antigen they are sensitive to. 24 – 48 h after this injection, the subsequent 
induration can be measured to provide an in vivo quantification of the cell mediated 




1.4.6.1.  Effect of SFAs 
Reports have suggested SFAs may have no effect on DTH response in mice 
[56, 107] 
and rabbits 
[80] compared to ALA 
[80], FO 
[80] or LA 
[56, 80, 107]. However, Friend et al. 
[54] 
demonstrated an increased DTH response in guinea pigs fed a high SFA diet compared to 
those on a high PUFA diet. 
 
1.4.6.2.  Effect of n-3 PUFAs 
Studies have shown both no effect of ALA in DTH response in humans in 
comparison to no additional n-3 PUFAs or FO 
[73] or baseline values 
[67], and in rabbits in 
comparison to LA, FO or SFAs 
[80].  
DTH response has been reported to be unaffected by EPA 
[74], DHA 
[77] or EPA + 
DHA in humans 






[74]. Similarly, DTH response has been found to not be affected by FO in rabbits, 
compared to LA, ALA and SFAs 
[80] or increased fish consumption in adults 
[92]. However, 
other studies have reported a reduction in DTH as a result of consumption of EPA or DHA 
compared to LA 
[89], FO (compared to low fish oil) 
[108], or no EPA 
[109] or increased 
consumption of fish 
[78]. 
 
1.4.6.3.  Effect of n-6 PUFAs 
Studies have reported no effect on DTH response of LA-rich diets in mice 
[56] or 
rabbits 
[80], compared to SFA-rich 
[56, 80], ALA or FO 
[80] diets. However, Friend et al. 
[54]   54 
found reduced DTH response in guinea pigs fed a high LA diet compared to those on a 
high SFA diet. Kelley et al. 
[101] found no effect of AA supplementation on DTH response 
in men, compared to men not receiving additional AA.    55 
1.5. Mechanisms for the Effect of PUFAs 
PUFAs can affect the immune system through several different mechanisms. 
PUFAs may alter the activation of intracellular signalling pathways, activation of lipid-
raft-associated proteins, regulation of gene expression / activity of transcription factors, 
and the production of eicosanoids. 
 
1.5.1.  Intracellular Signalling Pathways 
Intracellular signalling pathways may be affected by PUFAs indirectly due to the 
use of phospholipids to form second messengers such as DAGs, ceramide and phosphatidic 
acid. DAGs activate sphingomyelin ceramide-phosphohydrolase to release ceramide, and 
some isoforms of protein kinase C (PKC) 
[24]. DAGs and their metabolites also act to alter 
mitogen-activated-protein-kinases (MAPKs) 
[110], thereby affecting pathways they control, 
such as proliferation and differentiation 
[111]. Ceramide can be converted to sphingosine, 
which activates certain phospholipases, and sphingosine-1-phosphate 
[112]. 
Phosphatidylserine is required for PKC activation 
[18]. Changes in the fatty acyl chains 
attached to the glycerol moieties of these compounds have the potential to affect the 
compounds’ properties, and thus intracellular signalling. DAGs synthesized with two 
SFAs, or a SFA and an unsaturated fatty acid have been shown to be induce less activity in 
PKC than dioleoylglycerol or diarachidonylglycerol 
[113]. Synthesizing DAGs with AA, 
DHA or EPA has been shown to induce differences in activation level of PKC 
[110, 114] and 
MAPKs 
[115]. Activity of rat spleen PKC has been shown be affected by combinations of 
phosphatidylserine and DAG with different fatty acid compositions 
[116]. Fatty acids may 
also play a more direct role in control of intracellular signalling, due to their modulatory 
effects on PKC 
[117]. 
 
1.5.2.  Lipid-Raft-Associated Proteins 
Dietary PUFAs can affect the composition of lipid rafts, further than the increased 
abundance of the dietary fatty acid in membranes. Fan et al. 
[118] showed that mice 
receiving a FO-based diet had a decreased sphingolipid content of lipid rafts compared to 
those receiving a corn oil-based diet. As lipid rafts are responsible for the function and 
localisation of many receptors involved in T-cell signalling, it follows that changes in the 
composition and biophysical properties of lipid rafts due to dietary fatty acids could 
therefore impact on the functioning and signalling of T-cells. PUFAs may act though 
displacing signalling proteins from lipid rafts, thus inhibiting T-cell signal transduction.   56 
EPA treatment to cell cultures of Jurkat T-cells has been shown to reduce expression of IL-
2Rα 
[119] on T-cells, and to displace a signalling protein called “linker for activation of T-
cells”, and other signalling proteins from lipid rafts 
[120]. Jurkat T-cells treated with a 
variety of PUFAs, showed a displacement of the acylated proteins attached to the inner 
membrane, such as the Src family of kinases (and the linker for activation of T-cells), but 
retained GPI-anchored proteins attached to the outer membrane 
[121]. 
 
1.5.3.  Gene Expression 
PUFAs may affect the immune system through alteration of transcription factor 
activity and subsequent modification of gene expression. This occurs due to a direct action 
on ligand-binding transcription factors (nuclear receptors), or effects on membrane or 
cytoplasmic signalling factors which affect transcription factor activity. Two of the main 
transcription factors affected by fatty acids and involved in regulation of the immune 
system are PPARs and NF-κB. 
PPARs are nuclear receptor ligand-activated transcription factors activated by fatty 
acids (see 1.3.5.4). Three main forms exist, which are PPAR-α, -β, and -γ. Fatty acids have 
different potencies in activating PPARs; n-3 PUFAs are more effective than n-6 PUFAs, 
and PUFAs are more potent than SFAs 
[24]. PPARs have numerous roles in immune 
regulation, such as inhibition of inflammation, cellular proliferation and differentiation and 
apoptosis 
[122]. PPAR-α and -γ are expressed in dendritic cells, and T- and B-cells 
(reviewed by Daynes and Jones 
[123]). Most of these roles stem from the ability of PPARs 
to regulate activity of NF-κB, STATs (signal transducers and activators of transcription), 
AP1 (activator protein 1) and NFAT (nuclear factor of activated T-cells) (reviewed by 
Daynes and Jones 
[123]).  
NF-κB is a transcription factor that has an important role in the regulation of genes 
involved in both the innate and adaptive immune system. It regulates the synthesis of 
cytokines such as IL-1, IL-2, IL-6, TNF-α and IFN-β, cytokine receptors such as IL-2R, 
adhesion molecules and enzymes involved in mediator synthesis. It is activated by the 
phosphorylation and subsequent release of IκB (inhibitory κB), one of its subunits, which 
allows NF-κB to move to the nucleus, and bind to the response elements on its target 
genes. Phosphorylation of IκB can occur through the actions of PKC, the activities of 
which, as stated previously, can be affected by fatty acids. 
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1.5.4.  Eicosanoids 
One link between PUFA and the immune system is through the actions of 
eicosanoids (see 1.3.5.5). Immune cell membranes contain more AA than DGLA or EPA, 
and therefore AA is usually the principal precursor for eicosanoid synthesis 
[51]. As can be 
seen in Figure 1-19, AA is converted to PGE2 under the influence of the COX enzymes. 
PGE2 has many roles in regulating immune function including influencing T helper 
cell activation and proliferation (reviewed by Tilley et al. 
[124]). A mechanism underlying 
this appears to be that PGE2 prevents the hypomethylation of CpG islands in the promoter 
region of the IFN-γ gene 
[125]. Since hypomethylation of the IFN-γ promoter region is 
required for transcription 
[126], this will cause a reduction in level of production of IFN-γ. 
IFN-γ is known to enhance the proliferation of TH1 cells (see 1.2.3.2.2). However, substrate 
availability for eicosanoid synthesis will be affected by dietary availability of precursors, 
and this provides a means by which to manipulate immune cell abundance and function. 
Thus, an excess of n-6 PUFAs in the diet may result in polarisation of TH cells away from 
the TH1 and towards the TH2 phenotype. Since TH2 cells promote allergic hypersensitivity, 
n-6 PUFAs might increase the potential to develop allergy 
[47]. n-3 PUFAs are not 
converted to PGE2 and act to decrease PGE2 production (reviewed by Calder et al. 
[127]), 
may therefore allow hypomethylation of IFN-γ, and potentially enhance TH1 polarisation 
and reduce the likelihood of allergy development.   58 
1.6. Programming 
In 1989, Barker et al. proposed a link between low birth weight and high risk of 
developing ischemic heart disease in adulthood 
[128]. This research was further developed to 
link exposure to certain factors in utero with health in adulthood. The theory behind this is that 
by sensing environmental cues, the foetus is able to adapt itself for the environment into which 
it expects it will be born, thereby potentially providing advantage in the future by increasing 
likelihood of survival. These changes are known as predictive adaptive responses, and it is 
thought that phenotypic changes are more likely to have long-lasting effects if they occur in 
early life 
[129]. It is important to note, however, that the predictive adaptive responses may 
prove detrimental if the environment changes in later life and adaptations are irreversible 
[129]. 
As such, this theory has been further examined in several models of adult disease, for example 
low birth weight (data for birthweight is relatively easy to obtain from records) has been linked 
to increased likelihood of Type II diabetes, the metabolic syndrome and high blood lipids in 
adulthood 
[129]. The theory was then further developed to examine the effect of pre-natal 
nutrition on health, and the term “programming” introduced to describe the physiological 
changes induced by stimuli or insults during critical windows of development on health in later 
life 
[130]. These stimuli or insults may be due to them inducing, deleting or impairing the 
development of a somatic structure, or causing irreversible physiological changes 
[131].  
 
1.6.1.  Programming of the Immune System 
Significant development of the immune system occurs peri-natally 
[132]. Therefore, it is 
possible that in utero programming may have an effect on the immune system that is seen in 
later life, due to changes induced in the structure and function of immune cells. One such 
factor that may induce programming are the type of fatty acids available to the foetus during 
development and foetal growth. 
 
1.6.1.1.  Programming of the Immune System by Fatty Acids 
Fatty acids are known to affect the immune system (see 1.4), but whether they can 
affect the immune system during development of the foetus, and if any effects last into 
adulthood is less clear. It would be sensible to assume they are likely to because of their roles 
in gene regulation and their effects in influencing the development and maturation of the 
immune system. Research carried out in the University of Southampton suggests that altering 
the intake of n-3 and n-6 fatty acids in pregnancy can affect the fatty acid composition and 
function of immune cells of rat foetuses 
[133]. However, as cells were taken from rats before 
parturition, it is uncertain whether effects are long-lasting. Olsen et al. 
[134] demonstrated a   59 
reduction in asthma diagnosis in children aged 16 years old whose mothers had consumed fish 
oil capsules (2.7 g n-3 PUFAs) compared to those receiving olive oil or no capsules during 
pregnancy. Studies involving human pregnancies are complicated by the fact that nutritional 
interventions must occur later in pregnancy than those involving animals, for example, for 
whom conception can be controlled more easily and therefore interventions may start as soon 
as the animal is identified as being pregnant, or likely to be so. As such, any effects that may 
have occurred due to a critical window earlier in pregnancy would be more likely to be missed 
in studies involving humans. It is also unclear whether fatty acid intake in pregnancy can affect 
sensitisation to allergens in offspring, which is of particular interest as sensitisation to allergens 
has been shown to be present at birth, suggesting that the factors that lead to sensitisation are 
active in the foetus 
[132, 135], and as such they may be affected by fatty acid intake. Again, 
whether any effects are irreversible and long-lasting remains to be determined. 
 
1.6.1.2.  Programming of the Immune System by Stress 
Pre-natal stress can be induced by a number of different methods, and whilst the 
effect of protein restriction in pregnancy on the immune system has not been looked at 
directly, the effect of other types of pre-natal stress on the immune system have been. In 
rats, environmental stress in pregnancy has been shown to reduce T- and B-cell 
proliferation in offspring 
[136], and levels of IgG in serum 
[137], whilst social stress has been 
shown to reduce abundance of TH cells in the offspring 
[138]. More recently, an effect on the 
second generation of diet from the F0 generation has been discovered 
[139]. There are no 
systematic studies of the effect of this maternal protein restriction on immune function in 
the offspring in the next or subsequent generations.     60 
1.7. Summary, Hypotheses and Objectives 
Research to date has suggested that fatty acids may affect the immune system, 
through their (and those of their metabolites) effects on membranes, mediators, and gene 
expression. However, despite the research carried out, there still exist gaps of knowledge 
where further research is required. In addition, programming by fatty acids may affect the 
immune system, due to induction of stress and/or structural and functional changes to 
immune cells, but whether this effect is long-lasting is uncertain. In order to address some 
of these gaps in knowledge of the effect of programming and of fatty acids on the immune 
system, the experiments detailed in the following chapters were carried out. These 
experiments aimed to examine the effects of fatty acids and / or programming of foetal 
physiology on different aspects and at different stages of development of the immune 
system, and functional consequences of these changes, in models of clinical relevance. 
 
1.7.1.  Effect of Dietary Fatty Acids on the Murine Immune 
Response using Vaccination as an Immune Challenge 
(Chapter 2) 
The study described in Chapter 2 investigates the effect of diets differing in fatty 
acid composition on the recall response in a mouse model of vaccination, using Influvac 
(an influenza vaccine). The study set out to test the hypothesis that altering intake of fatty 
acids may cause structural and functional changes in the immune system of the mouse, 
causing an increased or decreased recall immune response to Influvac.  
 
1.7.2.  The Effect of Dietary Fatty Acids on a Mouse Model 
of Allergic Sensitisation (Chapter 3) 
The study described in Chapter 3 aimed to determine the effect of diets differing in 
fatty acid composition on the immune response in a mouse model of allergy to the egg 
protein ovalbumin. It set out to test the hypothesis that altering intake of fatty acids may 
cause structural and functional changes in the immune system of the mouse, causing 
increased or decreased susceptibility to the allergen to which the mice had been sensitised.   61 
1.7.3.  Effect of Fatty Acids in Pregnancy on Markers of 
Immune Function in the Offspring (Chapter 4) 
The study described in Chapter 4 aimed to investigate the longevity of any effect of 
maternal dietary fatty acids in rat pregnancy on markers of immune status, in particular the 
types of T- and B-lymphocytes. It set out to test the hypothesis that altering maternal fatty 
acid intake can cause structural changes in foetal and / or maternal immune cells, which in 
turn may cause long-lasting effects on immune function.  
 
1.7.4.  Effect of Early Exposure to Fatty Acids on Later 
Allergic Sensitisation Examined using a Mouse Model 
(Chapter 5) 
The study described in Chapter 5 aimed to determine the effect of diets differing in 
fatty acid composition, given during gestation and / or lactation, on the immune response 
in a mouse model of allergy to the egg protein ovalbumin. It was hypothesized that altering 
intake of fatty acids may cause structural and functional changes in the immune system of 
the mouse, causing them to become more or less susceptible to their allergy. In addition, 
mice may be more susceptible to the effects of fatty acids during gestation than lactation, if 
this is a critical window of fatty acid effect on immune system development. 
 
1.7.5.  Effect of a Low Protein Diet in Pregnancy on the 
Immune System of Offspring in Two Generations (Chapter 6) 
The study described in Chapter 6 aimed to determine the effect on the immune 
system over two generations of diets consumed during rat pregnancy that provided 
adequate or low protein. It was hypothesized that protein restriction in pregnancy would 
cause changes in lymphoid tissue cell abundance and weight, and that changes observed in 
the F1 generation would be seen in the F2 generation. 
 







Chapter 2.  Effect of Dietary Fatty Acids on the 
Murine Immune Response using Vaccination 
as an Immune Challenge   64   65 
2.1. Introduction 
Host defence against pathogens includes the inflammatory response. Therefore, the 
widely reported anti-inflammatory effects of long chain n-3 PUFAs may prove detrimental 
in situations where an increased immune response is required, for example during viral 
infection. However the effect of n-3 PUFAs on integrated immune responses in vivo is not 
well described. Therefore a vaccination model was used to evaluate and compare the 
effects of various fatty acid rich diets on the immune response in vivo. The vaccination 
was with the seasonal influenza vaccine. This model was chosen as it has the benefit of 
inducing an immune response to a virus, without inducing the symptoms of infection. In 
addition, the use of an in vivo model has the advantage that the immune response as a 
whole can be examined. This offers an advantage over studies that have evaluated 
individual components of the response separately and by studying cells ex vivo. The 
responses and effects seen in such studies may not reflect the in vivo situation and may not 
reflect the entire integrated response. The study was carried out in collaboration with the 
University of Utrecht where the model had been established. The author was involved in 
tissue and data collection on the day of euthanisation, whilst Dr. Astrid Hogenkamp and 
Dr. Naomi van Vlies at the University of Utrecht carried out feeding and experiments prior 
to this. The author analysed all data produced. 
 
2.1.1.  Influenza 
The influenza (“flu”) virus is classified into three strains (A, B, and C) based on 
antigenic differences in two of the internal proteins, nucleoprotein and matrix protein 
[140]. 
Strains B and C are predominately found in humans, whilst strain A can infect several 
species, and even cross species barriers 
[141]. Strains A and B are the two types which 
commonly cause disease in humans 
[140]. Strain A is further categorised based on 
haemagglutinin (H) and neuraminidase (N) surface antigens, with fifteen subtypes of H 
and nine subtypes of N identified 
[140]; the 2009 flu pandemic was caused by the virus 
influenza A (H1N1), commonly referred to as “Swine flu” 
[142].  
The influenza virus infects the cells of the upper respiratory system, and is 
characterised by fevers, and chills, often with accompanying cough, sore throat, head ache 
and muscular pain 
[143]. During infection, the influenza virus binds to sialic acid-containing 
cell surface glycoproteins. The virus is endocytosed, and the low pH of the endosomes 
causes virus and endosome membranes to fuse. This causes the release and import into the 
nucleus of viral nucleocapsids, and subsequently mRNA synthesis by viral polymerases.   66 
Viral mRNAs are transported to the nucleus, and undergo viral mRNA replication and 
secondary mRNA synthesis. The result of this is a second round of synthesis of viral RNA 
and proteins, encapsulation and export from the nucleus of viral nucleocapsids, and 
budding from the plasma membranes of mature virions. This is summarised in Figure 2-1. 
 
Figure 2-1: Infection of cells by the influenza virus, and subsequent viral replication. The 
influenza virus is endocytosed, and fuses with the endosome membrane. Viral mRNA is 
replicated, and secondary mRNA replication occurs. Viral mRNA and proteins are 
encapsulated, and mature virions bud from the plasma membrane. H, haemagglutinin; M, 
matrix protein; M2, M2 channel protein; N, neuraminidase; NP, nucleoprotein; NS1, NS2, 
proteins not found in mature virus; PB1, PB2, PA, polymerase complex. Adapted from 
Meanwell and Krystal 
[144]. 
Cells act to limit spread of the virus through innate and adaptive immune 
responses; via transcription factor systems, which result in the production of chemokines 
and cytokines, antigen presentation by APCs, and activation of apoptotic pathways 
[143]. 
These are summarised in Figure 2-2.   67 
 
Figure 2-2: Innate and adaptive immune responses to viruses. Innate immunity is mediated 
by type I IFNs, which prevent infection, and NK cells which kill infected cells. Adaptive 
immunity is mediated by antibodies, which neutralise infection, and CTLs, which kill infected 
cells. Figure taken from Abbas and Lichtman 
[5]. 
The exact chemokines produced vary depending on the type of cell infected 
[143]. 
However, the end result is the same – recruitment of immune cells to the site of infection. 
Cytokines meanwhile, activate the host anti-viral defence systems. The main cytokines 
produced are type I IFNs (α and β). These act to inhibit viral replication in infected and 
uninfected cells by inducing an “anti-viral state” 
[5]. This is a term used for a cell which has 
reacted to type I IFN and is resistant to viral infection, because type I IFN has induced 
production of several enzymes, such as 2′, 5′ oligoadenylate synthase, which affects 
transcription of viral RNA and DNA, and viral replication. Type I IFNs increase the 
development of TH1 cells in humans, as well as the expression of class I MHC molecules, 
which are recognised by CTLs, thereby increasing recognition of virus infected cells and 
efficiency of CTLs 
[5]. NK cells kill infected cells, including those in which the virus has 
prevented class I MHC expression. NK cells also respond to IL-12, produced by 
macrophages, and produce IFN-γ, which in turn activates macrophages to destroy 
phagocytosed microbes. NK cells, in common with CTLs, have granules that contain 
perforin, a protein which creates pores in target cells. They also contain granzymes, 
enzymes that pass through the membranes of target cells, and induce apoptosis. By 
inducing apoptosis of influenza virus-infected cells, NK cells (and CTLs) eliminate 
established infection. NK cells are an important defence mechanism against viruses during 
the early stages of infection 
[5]. 
Antiviral antibodies function to prevent virus attachment and entry into cells. This 
is achieved through attachment to the viral envelope or capsid antigens, opsonisation of 
viral particles and promotion of their clearance by phagocytes; activation of the   68 
complement system is also involved, and acts to promote phagocytosis. Antibodies are able 
to neutralise extracellular viruses, but are unable to unable to enter cells, and therefore 
cannot act once the virus penetrates cells and start to replicate. This instead, is the role of 
CTLs, which act on cells containing intracellular viruses. Cells that are not APCs, such as 
tissue cells, may be phagocytosed by APCs, in particular dendritic cells, to allow antigen 
presentation, in a process known as “cross-presentation”. Presentation of antigen to naïve 
CD8+ cells, results in activation and proliferation of CTLs, and induction of cell death of 
infected cells. 
 
2.1.2.  Dietary Fatty Acids and Influenza 
Section 1.4 reviewed studies examining the influence of fatty acids on different 
aspects of immune function or the immune response. These studies have revealed that 
amongst the different fats, oils and fatty acids tested, the long chain n-3 fatty acids EPA 
and DHA exert the greatest effect, although not all findings are consistent. Most often an 
impairment in immune cell function is caused by these fatty acids. Such an impairment 
would not be desirable when it is necessary to mount an immune response e.g. during 
vaccination or infection. However the effect of different fats, oils and fatty acids on 
responses to vaccination or infection are not well investigated. Furthermore the exact 
effects of n-3 fatty acids are often unclear because comparisons have been made to 
different “controls” in different studies. Finally, many studies in experimental animals 
have used extremely high fat diets, which are not usually consumed by those animals. 
Therefore there is a need to evaluate long chain n-3 fatty acids in comparison to common 
saturated and n-6 fatty acids and shorter chain n-3 fatty acids in suitable models of immune 
challenge. Vaccination and subsequent DTH response to the vaccine present a useful 
model for such a comparison. A DTH response is shown in Figure 2-3.    69 
 
Figure 2-3: In delayed-type hypersensitivity reactions, CD4+ cells, and sometimes CD8+ cells, 
secrete cytokines in response to antigens, which stimulate cytokine production and phagocyte 
activation, causing inflammation and tissue injury. APC, antigen presenting cell. Taken from 
Abbas and Lichtman 
[5]. 
Although many studies have demonstrated a suppressive effect of long chain n-3 
fatty acids on various aspects of immune function, these observations have often been seen 
against a very high fat background and they are counter to the anticipated action of these 
fatty acids. Prostaglandin (PG) E2 derived from the n-6 fatty acid arachidonic acid has been 
shown to impair T cell function and the production of key cytokines like IL-2 and IFN-
γ 
[145]. Since long chain n-3 fatty acids reduce PGE2 production 
[105], they should enhance T 
cell function and improve the vaccination and DTH responses.  
Whilst no studies to date have examined the effect of dietary fatty acids on 
vaccination with an influenza vaccine in rodents, several studies have exposed mice to the 
influenza virus by inhalation. Schwerbrock et al. 
[146] infected male BALB/C mice with the 
influenza virus following two weeks of feeding diets containing corn oil (5 g/100 g diet) or 
a combination of fish and corn oil (4 g fish oil plus 1 g corn oil/100 g diet). They 
demonstrated a reduced lung inflammation in fish oil fed mice, but also a higher mortality 
rate, higher lung viral load 7 days after infection, and longer recovery period following 
infection. Splenic NK cell activity was lower in fish oil than corn oil fed mice, but there 
was no difference in lung NK cell activity. The authors also reported a reduction in CD8
+ 
T-cells in lungs of fish oil fed mice. Byleveld et al. 
[147] infected BALB/C mice after 
feeding diets containing sunflower oil (3 g/100 g diet) in combination with 17 g of either 
fish oil or tallow/100 g diet for fourteen days. Fish oil fed mice had higher virus titres 1 
and 5 days after infection, reduced lung IFN-γ production, and serum IgG and IgA specific 
antibodies. No difference was seen in IFN-α / β production in lungs, or ratio of CD4
+ to 
CD8
+ T-cells in the bronchial lymph node, between dietary groups. The authors interpreted 
these results as the fish oil fed mice showing reduced viral clearance, associated with 
reduced IFN-γ and immunoglobulin production, compared to the tallow group. A later 
study by the same group, using the same experimental procedures also showed reduced   70 
CTL cytotoxicity in the fish oil group, despite the increased splenic lymphocyte 
proliferation in response to the virus compared to the tallow group 
[148].  
The influenza immunization model has been used to examine the effect of dietary 
fatty acids on immune response in other species. Newborn piglets receiving 0.63 %  
arachidonic acid (AA) and 0.34 % docosahexaenoic acid (DHA) in a milk formula for 
thirty days, had reduced influenza-specific CD4+ and CD8+ ex vivo proliferative 
responses, and increased IL-10 production compared to animals receiving sows milk or 
unsupplemented milk formula, following immunization 
[149]. Kelley et al. 
[101] found an 
increased proliferation response to the influenza virus following immunisation in adult 
males receiving 1.5 g AA/day for 130 days. The differences between the two studies may 
be explained by AA supplementation in combination with DHA having a different effect 
from sole supplementation with AA, level of supplementation, and differences in length of 
supplementation period, species used and age of subjects. 
 
2.1.3.  Mouse Model of Vaccination 
Vaccination with killed or attenuated pathogens provides a means of examining the 
in vivo immune response to the pathogen, without inducing symptoms of the disease that 
live pathogens would do 
[106]. Repeat vaccination can be used to examine recall responses 
(DTH) to the immune challenge. Influvac is a vaccine that contains an attenuated form of 
the influenza virus. By feeding mice diets containing different fatty acids prior to 
vaccination, it is possible to examine the effect of dietary fatty acids on the immune system 
in an in vivo model of immune response. C57BL6 mice were used as they have a TH1 
dominant immune response 
[150]. 
 
2.1.4.  Aims of the Study 
This study aimed to determine the effect of diets differing in fatty acid composition, 
including different levels and different types of n-3 and n-6 fatty acids, on the immune 
response in a mouse model of vaccination using Influvac. Altering intake of fatty acids 
may cause structural and functional changes in the immune system of the mouse, causing 
them to become more or less able to respond to the influenza virus.  
In order to achieve this aim, six diets were fed to mice from 3 to 4 weeks of age 
until 8 to 9 weeks of age. One diet used salmon oil as the fat source; this diet is high in 
long chain n-3 fatty acids (EPA plus DHA). The second diet used soybean oil as the fat    71 
source; this diet contains a balance of plant n-3 and n-6 fatty acids. The third diet used 
sunflower oil as the fat source; this diet is rich in the n-6 fatty acid linoleic acid. The fourth 
diet used linseed oil as the fat source; this diet is rich in the short chain plant n-3 fatty acid 
α-linolenic acid (ALA). The fifth diet used tallow as the fat source; this diet is rich in 
saturated fatty acids. These five experimental diets were high in fat (13 % by weight). The 
final diet used was standard chow, a low fat (3 % by weight of the diet) diet whose fat 
source is soybean oil. 
 
2.1.5.  Hypotheses 
This study set out to test the following hypotheses: 
•  Feeding the salmon oil diet will increase the immune response to Influvac. 
•  Feeding the sunflower oil diet will reduce the immune response to Influvac. 
•  Feeding the beef tallow diet will reduce the immune response to Influvac. 
•  Feeding the linseed oil diet will increase the immune response to Influvac compared to 
the sunflower oil diet, as ALA can be converted to EPA, but will be less effective than 
the salmon oil diet, as fatty acid metabolism is a less effective way of producing EPA 
than direct provision in the diet.  
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2.2. Materials and Methods 
2.2.1.  Animals, Diets and Materials 
2.2.1.1.  Animals 
3 to 4 week old male C57BL6 mice were obtained from Charles River (Maastricht, 
The Netherlands). Animals were housed in groups of four in shoebox cages, and kept at 
22°C ± 2°C, under a 12 hour light: 12 hour dark cycle in temperature and light-controlled 
room in the animal facility at the Pharmacology Department, University of Utrecht. 
Animals had ad libitum access to tap water and 150 g food was provided on alternate days. 
Animal care and use were performed in accordance with the guidelines of the Dutch 
Committee of Animal Experiments. 
 
2.2.1.2.  Diets 
The high-fat (130 g fat/kg diet) experimental diets (sunflower oil, salmon oil, 
soybean oil, linseed oil and tallow) and low-fat (30 g fat/kg diet) soybean oil-based chow 
(CRM-1) were obtained from Special Diet Services (Witham, Essex, UK). Experimental 
diets were produced by replacing 10 % of the wheat content of CRM (P) (diet formulated 
by Special Diet Services) with either sunflower oil, salmon oil, soybean oil, linseed oil or 
tallow and vitamin E levels were standardised to 181 IU/kg diet. The nutrient composition 
of diets is shown in Appendix One. The fatty acid composition of each diet is described in 
Section 2.3.1. 
 
2.2.1.3.  Materials 
Influvac (2005/2006) was from Solvay Pharmaceuticals B.V. (Weesp, The 
Netherlands). Stimune was from Cedi-diagnostics, Lelystad, The Netherlands. Phosphate 
buffered saline (PBS) was from BioWhittaker, Verviers, Belgium. Sandwich ELISAs were 
from PharMingen (San Diego, CA, USA). RPMI-1640 was from Roche Applied Science 
(Burgess Hill, UK). RNA-later was from Qiagen (Crawley, UK). Foetal calf serum (FCS), 
penicillin and streptomycin were from Life Technologies (Gaithersburg, MD, USA).  
Antibodies were from AbD Serotec (Oxford, UK). FACS buffer was prepared by adding 
1% BSA (Roche Diagnostics, GmbH, Mannheim, Germany) to PBS.  Fix / perm buffer and 
permeabilisation buffer were from EBioscience (San Diego, CA). Diff-Quick was from 
Dade AG (Düdingen, Switzerland). 
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2.2.2.  Methods 
An overview of the study design is shown in Figure 2-4. Forty-eight male C57BL6 
mice were randomised to receive one of the six diets (n = 8/diet) fourteen days before 
vaccination (at day -14).  Vaccination was carried out at days 0 and 14. Delayed-type 
hypersensitivity (DTH) tests were carried out on days 10 and 11. Euthanisation occurred 
by intra peritoneal injection of 1 ml 10 % urethane on day 23 ± 1.  
 
Figure 2-4: Schematic diagram of experiment examining the effect of dietary fatty acids on a 
vaccination mouse model. DTH, Delayed-Type Hypersensitivity. 
 
2.2.2.1.  Vaccination of Mice with Influvac 
Mice were vaccinated with Influvac at days 0 and 14. 100 µl of Influvac was added 
to 4.9 ml PBS and 5 ml of the adjuvant Stimune. Mice received of 100 µl of this solution 
by subcutaneous injection.  
 
2.2.2.2.  Determination of DTH Response to Influvac 
DTH response was measured on day 10 and 11. This involved intracutaneous 
injection of Influvac into both ears. Duplicate measurements of ear thickness were made 
bilaterally with an engineer's micrometer (Mitotoyo, Veenendaal, Netherlands) before 
injection and 24 h after Influvac injection. 
 
2.2.2.3.  Fatty Acid Analysis of Diet and Erythrocytes 
At euthanisation, blood was collected by cardiac puncture, transferred into EDTA 
tubes and stored on ice. Blood samples were centrifuged at 14000 rpm for five minutes, 
and plasma removed for antibody analysis (see 2.2.2.4). Erythrocytes were washed with 
PBS containing 5 mM EDTA and then centrifuged at 14000 rpm for five minutes. This 
step was repeated a further two times. Erythrocytes were then resuspended in an equal 
volume of PBS and EDTA and stored at -80 °C until analysis. Erythrocytes and samples of 
diet were analysed for fatty acids. Samples of plasma were adjusted to 0.8 ml with 0.9 % 
NaCl, if 0.8 ml sample volume of plasma was not available. 50 µg of 15:0 
(Dipentadecanoyl PC) was added as an internal standard. 5 ml of chloroform : methanol   74 
(2:1 v/v) , which contained BHT (50 mg/l) as antioxidant, and then 1 ml 1 M NaCl were 
added to samples before vortexing. Samples were centrifuged at 2000 rpm for 10 minutes 
with a low brake. The lower phase was collected by aspiration and then dried under 
nitrogen at 40 °C. 
Fatty acid methyl esters were prepared by adding 0.5 ml dry toluene to samples, 
before vortexing. 1 ml methanol containing 2 % (v/v) H2SO4 was added and then gently 
mixed. Samples were heated at 50 °C for 2 hours. After cooling, 1 ml of neutralising 
solution (0.25 M KHCO3 (25.03 g/l), 0.5M K2CO3 (69.1 g/l)) was added before the 
addition of 1 ml dry hexane. Samples were centrifuged at 1000 rpm for 2 minutes with low 
brake. The upper phase, which contains the fatty acid methyl esters, was collected and then 
dried under nitrogen at 40 °C. 1 ml dry hexane was added to samples and vortexed, before 
being transferred to a gas chromatography (GC) vial. 2 µl of sample was injected by a 
Hamilton syringe into an HP6890 series GC system (Hewlett Packard) fitted with a 30 m x 
32 mm BPX70 capillary column, with film thickness of 0.25 µm. The carrier gas was 
helium at a rate of 2.0 ml / min, and the split / splitless injector was used at a ratio of 10:1. 
The temperature profile was as follows: initial temperature 115°C,
 hold 2 minutes, ramp 
10°C/minutes to 200°C, hold 10 minutes, ramp
 60°C/minutes to 245°C, and hold 4 minutes 
Separation was recorded and analysed with GC Chemstation (Agilent technologies) 
software. Fatty acid methyl esters were identified by comparison with standards run 
previously. 
 
2.2.2.4.  Analysis of Plasma Immunoglobulin Concentrations 
Plasma concentrations of IgG1 and IgG2a were determined using sandwich 
ELISAs, following the manufacturer’s instructions. 
 
2.2.2.5.  Analysis of Immune Tissue, Fat and Liver 
Spleen, thymus, epididymal fat pads and liver were removed and weighed. Bone 
marrow cells were collected by cutting between the metaphysis and diaphysis at both ends 
of both femurs, and flushing out bone marrow using a 21G x 1 1/2" needle and 10 ml 
syringe containing PBS. 
 
2.2.2.6.  Histological Analysis of the Thymus 
For histological analysis, part of the thymus was stored in formaldehyde (10 % 
neutral buffered formalin) for at least 24 h before being processed using a LEICA TP1020   75 
Automatic Tissue Processor. Tissues were embedded in paraffin using a LEICA EG 1150c.  
5 µm sections were cut, and stained with haematoxylin/eosin. Cortex/medulla ratio was 
determined by examining the surface area of the cortex and medulla using an Olympus 
BX50 microscope (Zoeterwoude, The Netherlands) and Image Pro Plus software 
(IPWIN32; from Media Cybernetics, Silver Spring, MD, USA). 
 
2.2.2.7.  Determination of Cytokine Production by 
Splenocytes 
IFN-γ, IL-4 and IL-10 production by spleen cells in response to Influvac was 
analysed. A single cell suspension was prepared by mashing cells through 70 µm nylon cell 
strainers (BD Biosciences, Franklin Lakes, NJ, USA) with 10 ml PBS. Cells were counted 
using a Bürker-Türk counting-chamber (Karl Hecht Assistant KG, Sondheim/Röhm, 
Germany) and 8 million cells removed for FACS analysis (see 1.2.2.11). The remainder of 
the cells were collected by centrifugation at 1300 rpm for five minutes, and resuspended in 
RPMI containing 1% penicillin/streptomycin, 10 % FCS, and 20 µM β-mercaptoethanol. 8 
x 10
5 spleen cells per well were cultured in 96-well round-bottom plates (Greiner Bio-One, 
Kremsmuenster, Austria) in the presence or absence of 0.1 µg/ml Influvac. Cells were 
cultured for 5 days at 37 °C in 5 % CO2. Supernatants were removed and stored at -80 °C 
prior to ELISA analysis. The lower detection limits of the ELISAs were 16 pg/mL for IFN-
γ, 16 pg/mL for IL-4 and 63 pg/mL for IL-10. 
 
2.2.2.8.  Determination of Cell Subsets in Lymphoid Tissues 
using Flow Cytometry 
Flow cytometry (FACs) uses light to classify cells based on their differences in 
light scatter and fluorescence. When light hits the cells, it is scattered in either a forward or 
sideways direction. Forward scatter (FSC) is related to the size of the cell, whilst side 
scatter (SSC) depends on the granular content of the cell. Although FSC and SSC are 
unique for every cell, the same cell types (i.e. lymphocytes, granulocytes, monocytes) 
produce similar FSC and SSC measurements, and therefore can be clustered on a dot plot 
(cytogram) of SSC against FSC, as shown in Figure 2-5. Thus, cell types can be identified 
from a heterogeneous sample.    76 
 
Figure 2-5: Cytogram of lysed whole blood analysed by flow cytometry, showing how types of 
cells can be identified by differences in forward scatter (FSC, measures size of the cell) and 
side scatter (SSC, measures granular content of cell). Thus, cells of interest can be selected by 
gating – the bottom gate shows lymphocytes, the middle gate shows monocytes, and the top 
gate shows granulocytes.  
Once the cell type of interest has been selected by gating, cells can be further 
analysed for properties such as the expression of cell surface proteins, provided they have 
been stained with a fluorescent probe. A typical quadrant plot (in this case for lymph node 
cells stained with antibodies to CD3 and CD8) is shown in Figure 2-6.   77 
 
Figure 2-6: Quadrant plot showing typical results from analysis by flow cytometry. CD3 is 
measured along the horizontal axis and CD8 along the vertical axis. The horizontal and 
vertical black lines show where boundaries lie for determining whether cells are positive 
(above or to the right of the line) or not for these proteins. Therefore, a dot in the top left 
quadrant represents a CD3-CD8+ cell, in the top right quadrant a dot represents a 
CD3+CD8+ cell, in the bottom left cells are CD3-CD8- and in the bottom right quadrant 
appears cells that are CD3+CD8-. 
The number of cells in each quadrant can be used to determine the proportion of 
cells expressing each CD protein. For example, in Figure 2-6, cells in the top left quadrant 
are CD3
-CD8
+, those in the top right are CD3
+CD8
+, bottom left shows CD3
-CD8
-, and 
bottom right cells are CD3
+CD8
-.  
In flow cytometry, measurements are made rapidly and separately on each cell in 
turn, rather than producing averages of the sample as a whole. It also has the advantage 
that more than one stain can be used on the same sample to provide multiple 
measurements, as was the case in Figure 2-6, where two stains were used (anti-CD3 and 
anti-CD8). 
Single cell suspensions of thymus and bone marrow were made as for spleen cells 
2.2.2.7), although blocking buffer (FACS buffer + 5 % FCS) was used instead of PBS. 
Cells were counted (2.2.2.8), and 8 x 10
6 spleen cells, 2 x 10
6 thymus cells, and 1 x 10
6 
bone marrow cells added to 2 ml blocking buffer. After thirty minutes, cells were collected 
by centrifugation at 1300 rpm for five minutes, and resuspended in FACS buffer (PBS 
containing 1 % BSA). 2 x 10
5 cells were added to a 96-well round-bottom plate that 
contained 50 µl antibody and left in the dark at room temperature for 60 minutes. For 
CD4/CD25/FoxP3, twice as many cells were added to each well. Antibodies used are listed 
in Table 2-1.   78 
Table 2-1: Antibodies used for FACS analysis 
Antibody  Cell type identified  Spleen  Thymus  Bone 
marrow 
Anti-CD3/anti-CD4/anti-CD8  T-cells, TH cells, CTLs  X  X   
Anti-CD3/anti-CD4/anti-
CD62 
L-selectin expressing TH 
cells 
X  X   
Anti-CD3/antiCD4/anti-CD69  Activated TH cells  X  X   
Anti-CD19  B-cells  X    X 
Anti-F4-80  Macrophages  X     
Anti-CD4/anti-CD25/anti-
FoxP3 
TREG cells  X  X   
 
2.2.2.8.1.  Analysis with antibodies excluding CD4/CD25/FoxP3 
For all wells except the CD4/CD25/FoxP3, plates were centrifuged at 1300 rpm for 
five minutes, and supernatants discarded. Cells were resuspended in 150 µl FACS buffer, 
and re-centrifuged at 1300 rpm for five minutes, and supernatants discarded. This step was 
repeated twice more, but using only 100 µl FACS buffer. Cells were resuspended with 100 
µl FACS buffer, and analysed using a Becton Dickinson FACSCalibur flow cytometer 
(Breda, The Netherlands) and FCS Express version 3 software (De Novo Software, Los 
Angeles, CA, USA), which recorded 10000 events per sample. 
 
2.2.2.8.2.  Analysis with CD4/CD25/FoxP3 Antibodies 
CD4/CD25/FoxP3, plates were centrifuged at 1300 rpm for five minutes, and 
supernatants discarded. Cells were resuspended in 150 µl FACS buffer, centrifuged at 1000 
rpm for five minutes and supernatants discarded. Cells were resuspended in 200 µl 
Fix/Perm buffer, and incubated for thirty minutes at 4 °C. Plates were centrifuged at 1800 
rpm for ten minutes, the supernatant discarded, and 150 µl permeabilisation buffer added. 
This was left for ten minutes in the dark, before being centrifuged at 1800 rpm for ten 
minutes, and the supernatant discarded. This step was repeated. Cells were resuspended 
in100 µl blocking buffer, and plates left in the dark for fifteen minutes. 10 µl anti-FoxP3 
was added to each well, and plates incubated for thirty minutes at 4 °C. Plates were 
centrifuged at 1800 rpm for ten minutes and supernatant discarded. Cells were washed 
twice with FACS buffer, resuspended in FACS buffer, and analysed as for plates in 
2.2.2.8.1. 
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2.2.2.9.  Statistical Analysis 
Results were analysed using SPSS version 15.0. Parameters were analysed using 
Levene’s test of homogeneity to ensure groups had equal variances, in which case they 
were compared using one-way analysis of variance (ANOVA), followed by post-hoc 
testing (Tukey). If Levene’s test showed unequal variances to be present, groups were 
compared using the Kruskal-Wallis test. Where this was used, it is reported in the results 
section. If the Kruskal-Wallis test indicated a significant effect, Mann-Whitney U 
independent group comparisons tests were then carried out to compare each combination 
of groups.  
   80 
2.3. Results 
2.3.1.  Fatty Acid Content of the Different Diets 
Fatty acid composition of diets is shown in Appendix One. Abundance of fatty 
acids of interest is shown in Figure 2-7. 
 
Figure 2-7: Profile of individual and total n-3 and n-6 PUFAs in the diets used 
The control (chow) and soybean oil diets had similar profiles of fatty acids, but the 
total amounts of fatty acids were different: the control diet was formulated to contain a 
lower percentage (3 %) of fat than the high fat (13 %) experimental diets. The linseed oil 
diet was rich in the short chain n-3 fatty acid ALA. The salmon oil diet was rich in the long 
chain n-3 fatty acids EPA and DHA. The sunflower oil diet was rich in the n-6 fatty acids 
LA. The tallow diet had a low PUFA content, but a similar, if slightly higher n-3 : n-6 ratio 
to the soybean oil diet. 
 
2.3.2.  Body weight of Mice fed the Different Diets 
Body weight in mice fed the different diets is shown in Figure 2-8.   81 
 
Figure 2-8: Body weight of mice fed the different diets. Data are mean + SEM. * denotes 
differences between body weights at different time points. 
At day 7, mice in the salmon oil group were heavier than those in the control group. 
At all other time points, including the day of tissue collection (day 23; data not shown) 
there was no difference in body weight between dietary groups. 
 
2.3.3.  Tissue Weights of Mice fed the Different Diets 
Tissue weights of mice fed the different diets are shown in Table 2-2. Liver weight 
was lowest in the salmon oil group. Animals receiving sunflower oil or tallow diets had 
heavier livers compared to those receiving the soybean oil diets. Where liver weight was 
expressed proportionally to body weight, there were no significant differences between 
dietary groups. There were also no differences between dietary groups in the absolute or 
relative weight of any other tissue measured, including spleen and thymus.   82 
Table 2-2: Tissue weights of mice fed the different diets. Fat signifies epididymal fat.  Data 
are mean + SEM. Values different letters are significantly different. BW, body weight. 











Spleen (g)  0.13 ± 0.02  0.09 ± 0.01  0.09 ± 0.00  0.10 ± 0.00  0.11 ± 0.01  0.11 ± 0.01 
Spleen (% BW)  0.49 ± 0.06  0.39 ± 0.02  0.37 ± 0.01  0.39 ± 0.01  0.45 ± 0.02  0.42 ± 0.03 
Thymus (g)  0.06 ± 0.01  0.05 ± 0.01  0.05 ± 0.01  0.05 ± 0.00  0.05 ± 0.00  0.05 ± 0.00 
Thymus (% BW)  0.22 ± 0.05  0.21 ± 0.02  0.20 ± 0.02  0.21 ± 0.01  0.21 ± 0.02  0.21 ± 0.01 
Liver (g)  1.39 ± 0.12
bc  1.26 ± 0.04
bc  1.14 ± 0.03
a  1.25 ± 0.02
b  1.33 ± 0.01
c  1.33 ± 0.03
c 
Liver (% BW)  5.55 ± 0.48  5.19 ± 0.12  4.79 ± 0.07  4.95 ± 0.05  5.19 ± 0.10  5.32 ± 0.12 
Fat (g)  0.27 ± 0.03  0.27 ± 0.02  0.29 ± 0.02  0.29 ± 0.02  0.29 ± 0.02  0.30 ± 0.02 
Fat (% BW)  1.08 ± 0.10  1.11 ± 0.07  1.23 ± 0.10  1.14 ± 0.07  1.12 ± 0.07  1.20 ± 0.08 
 
2.3.4.  Fatty Acid Content of Erythrocytes from Mice Fed 
the Different Diets 
The content of fatty acids of interest in erythrocytes from mice fed the different 
diets is shown in Figure 2-9 (the full data set is shown in Appendix One).  83 
 
Figure 2-9: Individual and total n-3 and n-6 PUFA contents of erythrocytes from mice fed the different diets. Data are mean + SEM. Values with different letters 
denote differences between dietary groups.   84 
LA content was lower in the salmon oil and tallow group than in the linseed and 
soybean oil groups. The salmon oil group had lower LA content than the sunflower oil 
group. The linseed oil group had the highest ALA content in erythrocytes. The salmon oil 
and linseed oil groups had lower AA content than other groups. The salmon oil group had 
the highest EPA content, followed by the linseed oil dietary group. The salmon oil dietary 
group had a higher EPA content than the control, linseed oil, soybean oil and sunflower oil 
groups and a higher DHA content than all other groups. n-3 PUFA content was lowest in 
the sunflower oil group, and highest in the salmon oil and linseed oil groups. n-6 PUFA 
content was lowest in the salmon oil group. 
 
2.3.5.  DTH Response to Influvac in Mice Fed the Different 
Diets 
The effect of diet the DTH response, measured as ear swelling in response to 
Influvac, is shown in Figure 2-10. Mice in the salmon oil group showed the greatest DTH 
response and this was greater than in the beef tallow, sunflower oil and linseed oil groups. 
 
Figure 2-10: Effect of diet on ear swelling in response to Influvac in Influvac-vaccinated mice, 
measured 24 hours after injection. Data are mean + SEM. Bars with different letters are 
significantly different from one another (p < 0.05). 
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2.3.6.  Plasma Immunoglobulin Concentrations in Mice 
Fed the Different Diets 
IgG1 levels were below detection limits. IgG2a levels are shown in Figure 2-11. 
There was no effect of diet on IgG2a levels in plasma, although high fat feeding tended to 
result in a lower concentration. 
 
Figure 2-11: Plasma IgG2a concentration in mice fed the different diets. Data are mean + 
SEM.  
 
2.3.7.  Cytokine Production by Cultured Splenocytes from 
Mice Fed the Different Diets 
IFN-γ, IL-4 and IL-10 concentrations in spleen cell cultures exposed to Influvac 
were below detectable limits.  
 
2.3.8.  Histological Analysis of Thymuses from Mice Fed 
the Different Diets 
The cortex / medulla ratio of thymuses from mice fed the different diets is shown in 
Figure 2-12. There were no significant differences between dietary groups.   86 
 
Figure 2-12: Cortex/medulla ratio of thymuses from mice fed the different diets. Data are 
mean + SEM.  
 
2.3.9.  Cell Subsets in the Thymus, Spleen and Bone 
Marrow from Mice Fed the Different Diets 
Effect of diet on the proportions of different cell types in the spleen, thymus and 
bone marrow of mice is shown in Table 2-3 to Table 2-5. There was no effect of diet on 
any of the cell subsets measured.    87 
Table 2-3: Cell subsets within the thymus of mice fed the different diets. Data are mean + SEM. 
   Cells Identified  Control  Linseed oil  Salmon oil  Soybean oil  Sunflower oil  Tallow 
CD3+  T-cells  73.16 ± 12.48  73.89 ± 12.89  53.27 ± 15.10  72.40 ± 12.82  74.20 ± 13.43  53.42 ± 15.36 
CD3+ that are also CD4+  TH cells  90.32 ± 2.41  88.13 ± 2.61  85.83 ± 2.99  90.03 ± 3.11  88.95 ± 2.40  85.57 ± 3.55 
CD3+ that are also CD8+  CTLs  78.77 ± 5.52  77.78 ± 5.62  70.93 ± 6.09  78.78 ± 5.25  80.61 ± 5.31  71.20 ± 7.42 
CD3+CD4+ that are also CD62L+  L-selectin expressing TH cells  70.98 ±0.91  76.68 ± 1.64  77.29 ± 1.44  71.28 ± 1.08  72.43 ± 1.08  78.90 ± 2.37 
CD4+CD25+  TREG cells  0.41 ± 0.90  1.53 ± 0.14  1.39 ± 0.18  1.06 ± 0.17  1.64 ± 0.26  1.25 ± 0.26 
CD4+CD25+ that are also FoxP3+  TREG cells  7.26 ± 2.23  13.45 ± 2.87  10.85 ± 1.64  7.27 ± 1.76  11.11 ± 2.07  9.87 ± 2.52 
Table 2-4: Cell subsets within the spleen of mice fed the different diets. Data are mean + SEM. 
  Cells Identified  Control  Linseed oil  Salmon oil  Soybean oil  Sunflower oil  Tallow 
F4/80  Macrophages  14.42 ± 1.34  12.18 ± 1.39  11.77 ± 0.37  12.34 ± 1.37  14.51 ± 1.07  13.59 ± 0.85 
CD3+  T-cells  22.07 ± 3.45  21.40 ± 3.14  26.50 ± 1.62  22.74 ± 1.42  23.98 ± 3.68  26.40 ± 1.48 
CD3+ that are also CD4+  TH cells  56.34 ± 1.79  55.13 ± 4.02  51.28 ± 2.98  54.97 ± 1.97  57.65 ± 3.34  49.03 ± 4.37 
CD3+ that are also CD8+  CTLs  1.80 ± 0.15  1.38 ± 0.19  0.86 ± 0.26  1.53 ± 0.18  1.54 ± 0.22  1.06 ± 0.30 
CD3+CD4+ that are also CD62L+  L-selectin expressing TH cells  35.13 ± 1.49  41.62 ± 1.59  36.50 ± 2.73  31.76 ± 2.58  42.10 ± 1.05  36.47 ± 5.91 
CD3+CD4+ that are also CD69+  Activated TH cells  39.30 ± 2.65  35.68 ± 4.80  34.22 ± 2.91  38.14 ± 3.89  37.32 ± 4.80  32.88 ± 4.14 
CD19  B-cells  14.42 ± 1.34  12.18 ± 1.39  11.77 ± 0.37  13.04 ± 1.66  14.51 ± 1.07  13.59 ± 0.85 
CD4+CD25+  TREG cells  2.06 ± 0.47  2.17 ± 0.48  1.70 ± 0.62  2.07 ± 0.47  2.28 ± 0.51  1.44 ± 0.52 
CD4+CD25+ that are also FoxP3+  TREG cells  18.41 ± 2.58  16.66 ± 2.90  14.70 ± 2.30  13.82 ± 2.79  18.02 ± 2.62  14.39 ± 2.85 
CD94+  NK cells  44.21 ± 5.53  41.76 ± 4.28  33.19 ± 4.60  41.82 ± 3.64  46.99 ± 4.08  40.10 ± 4.54 
Table 2-5: B cells within the bone marrow from mice fed the different diets. Data are mean + SEM. 
   Cells Identified  Control  Linseed oil  Salmon oil  Soybean oil  Sunflower oil  Tallow 
CD19+  B-cells  4.76 ± 0.57  6.26 ± 1.48  7.40 ± 1.96  6.56 ± 1.06  6.99 ± 1.55  6.16 ± 1.38   88 
2.4. Discussion 
2.4.1.  Summary of Findings 
This study aimed to determine the effect of diets differing in fatty acid composition, 
including different types of n-3 and n-6 fatty acids, on the immune response in a mouse 
model of vaccination. This is the first time that this model has been used to investigate the 
influence of fatty acids on immune function. The study set out to test hypotheses of 
increased immune response with salmon and linseed oils and reduced immune response 
with sunflower oil and beef tallow. Using ear swelling in response to Influvac, with which 
the mice had already been vaccinated, as a measure of DTH, mice receiving salmon oil 
showed the greatest response while those receiving the tallow, sunflower or linseed oil 
diets had reduced ear swelling compared to those receiving the salmon oil diet. This 
suggests the salmon oil diet, and so long chain n-3 PUFAs, enhance the TH1 type response. 
However, examining cytokine and immunoglobulin levels, to determine the effect on TH1 / 
TH2 balance did not produce results supporting these findings. IgG1 levels of plasma and 
IFN-γ, IL-4 and IL-10 production by spleen cell cultures were below detection limits, and 
there was no effect of diet on IgG2a levels in plasma. 
The fatty acid content of red blood cells generally reflected that of the fatty acids 
present in diets. At day 7, mice in the salmon group were heavier than those in the control 
group. At all other time points, including the day of tissue collection there was no 
difference in body weight between dietary groups. Liver weight was lowest in the salmon 
oil group. Animals receiving sunflower oil or tallow diets had heavier livers compared to 
those receiving the soybean oil diets. Where liver weight was expressed proportionally to 
body weight, there were no significant differences between dietary groups. There were also 
no differences between dietary groups in the absolute or relative weight of any other tissue 
measured, including spleen and thymus. There were no significant differences in the cortex 
/ medulla ratio of mice thymuses between dietary groups. There was no effect of diet on 
the proportions of different cell types in the spleen, thymus and bone marrow. 
 
2.4.2.  Fatty Acid Content of Erythrocytes and Diets 
In general, the fatty acid content of erythrocytes reflected the fatty acid content of 
diets. The salmon oil and linseed oil groups had lower AA content of erythrocytes than 
other groups, whilst the EPA content of erythrocytes was highest in the salmon oil group, 
and higher in the linseed oil group than in other groups (excluding salmon oil). The salmon 
oil diet resulted in a higher erythrocyte DHA content than the other diets. These findings   89 
are in agreement with those of other fatty acid feeding studies which report on fatty acid 
levels in plasma, serum and erythrocytes 
[70, 71, 79, 151-156].  
 
2.4.3.  Tissue and Body Weights 
Body weights increased over the period of the trial, in accordance with findings of 
Poiley 
[157]. At day 7, mice in the salmon oil group were heavier than those in the control 
group, but there were no differences at any other time point. This may have been caused by 
factors such as stress or palatability affecting appetite. However, since food intake was not 
recorded, and animals were housed in groups of 8, it is impossible to ascertain whether this 
occurred. Body weights did not differ between dietary groups at the start or the end of the 
trial, suggesting that this factor is unlikely to have confounded results.  
Liver weight was lowest in the salmon oil group. Animals receiving sunflower oil 
or tallow diets had heavier livers compared to those receiving the soybean oil diets. Where 
liver weight was expressed proportionally to body weight, there were no significant 
differences between dietary groups. There were also no differences between dietary groups 
in the absolute or relative weight of epididymal fat, spleen and thymus.  
 
2.4.4.  DTH Response 
In this study, ear swelling was measured 24 hours after injection with Influvac, and 
as such is a measure of DTH. Here, mice receiving tallow, sunflower or linseed oil diets 
had reduced ear swelling in response to Influvac compared to those receiving the salmon 
oil diet. The observations of a high response in the salmon oil group and the low response 
in the sunflower oil and beef tallow groups are in accordance with three of the hypotheses 
being tested in this study. In addition, DTH response was higher in salmon oil fed animals 
than linseed oil fed animals and there was no significant difference between linseed oil 
feeding, and sunflower oil or tallow feeding. This observation is not in agreement with the 
fourth hypothesis being tested in this study. The difference in DTH response between 
linseed oil and salmon oil may be due to the need to convert ALA to long-chain n-3 
PUFAs especially DHA in order to see such a response. Erythrocyte DHA was higher in 
the salmon oil group than in all other groups, including the linseed oil group (erythrocyte 
EPA was similar between salmon oil and linseed oil groups), and it is possible that it is 
DHA which is responsible for the enhanced DTH response seen in the salmon oil group. 
However, using data from all animals irrespective of diet fed did not show a significant 
relationship between erythrocyte DHA and ear swelling (r = 0.148, p = 0.376). There was   90 
however a significant inverse correlation between total erythrocyte n-6 PUFAs and ear 
swelling (r = -0.345, p = 0.036), suggesting that it is exposure to n-6 fatty acids that 
determines the strength of the DTH response. The salmon oil group showed the lowest 
total erythrocyte n-6 fatty acids and this was lower than all other groups.  Amongst the n-6 
fatty acids, the relationships between erythrocyte linoleic acid and arachidonic acid and ear 
swelling both tended towards significance (r = -0.304, p = 0.067 for linoleic acid and r = -
0.289, p = 0.083 for arachidonic acid).   
 
2.4.5.  Plasma Immunoglobulin Concentrations  
There was no effect of diet on plasma IgG2a, whilst IgG1 levels were below 
detection limits. IgG2a production is promoted by TH1 cells, whilst TH2 cells promote 
IgG1 production. The ability to measure IgG2a but not IgG1 is consistent with the idea that 
C57BL/6 mice are “TH1 dominant”. Previous research on the effect of dietary fatty acids 
on levels of different classes of immunoglobulins has produced conflicting results (see 
1.4.5), and is further complicated by the fact that many papers examine the levels of total 
IgG rather than its subclasses. EPA supplementation (2.0 g/day for 7 weeks) has been 
shown to increase total IgG levels in plasma of healthy young men, when comparing 
baseline values to those taken at baseline 
[74]. There was no difference observed between 
EPA supplementation and those receiving GLA (2.0 g/d) or stearidonic acid in 
combination with GLA (1.0 g and 0.9 g/d respectively), although in these dietary groups, 
there was no effect observed between the start and end of supplementation. In the current 
study, plasma was not taken at the start of the trial, because of the size of the animals, 
which meant that insufficient sample would have been available. Therefore whether diet 
affected changes in IgG2a over time is not known from the current study. In addition, 
Miles et al. 
[74] looked only at total IgG levels. Research has not previously been carried 
out on the effect of dietary fatty acids on the level of IgG1 and IgG2a in plasma. 
 
2.4.6.  Cytokine Analysis 
IFN-γ, IL-4 and IL-10 production by spleen cell cultures in response to Influvac 
was below detectable limits. IFN-γ is a signature cytokine of TH1 cells, and IL-4 and IL-10 
are signature cytokines of TH2 cells. It cannot be determined whether dietary fatty acids 
affected the TH1 / TH2 cell balance in the current study based on these cytokines. It was not 
expected that these cytokines would be below detectable limits. Reasons for this may be 
that insufficient Influvac was used as a stimulant, that there were insufficient vaccine-  91 
specific T-cells in the cultures to measure detectable cytokine responses, or that cells were 
not cultured for a long enough period for a response to be seen. The culture conditions 
used were chosen as they had previously been used in an Influvac vaccination model 
examining the effect of prebiotics on DTH, at the same department in the University of 
Utrecht where this experiment was carried out 
[158]. However, it may be that in this model, 
conditions may not be the same when examining the effect of fatty acids on DTH as for 
determining the effect of prebiotics. 
 
2.4.7.  Histological Analysis  
The cortex/medulla ratio of thymuses was examined as previous research at the 
University of Utrecht had suggested that DHA may reduce medulla areas of the thymus (A. 
Hogenkamp, unpublished personal communication). This in turn could alter area available 
for T-cell maturation, or indicate an effect of maturation. However, there was no effect of 
fatty acids on cortex/medulla ratio of thymuses in this model. 
 
2.4.8.  Cell Analysis 
There was no effect of dietary fatty acids on cell subsets in the thymus, spleen or 
bone marrow. This is in accordance with the findings of previous research papers reviewed 
in 1.4. Any effect on TH1 / TH2 balance that might have been expected would not be 
observed in this analysis, as TH1 and TH2 cells are indistinguishable by flow cytometry. 
 
2.4.9.  Limitations 
One limitation of this study is that a maximum of eight animals per diet group were 
studied; a larger sample size may have revealed stronger findings. A second limitation is 
that fatty acid composition data for immune cells were not available and erythrocyte fatty 
acids were used to examine the relationship between fatty acid status and immune 
response. Using data for immune cells would be more appropriate for this purpose. The 
third limitation is that some of the immune responses assessed here were below the limit of 
detection and this meant that these were not useful. This is especially true for the cytokine 
profiles produced by cultured splenocytes. A longer culture period and/or a different 
concentration of the vaccine stimulant may have generated useable and useful data.  
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2.4.10.  Conclusions 
The study set out to test hypotheses of increased immune response to influenza 
vaccination with salmon and linseed oils and reduced response with sunflower oil and 
tallow. Data from measuring ear swelling, suggest that mice had an increased TH1 response 
to vaccination following feeding with salmon oil, compared to linseed oil, sunflower oil or 
tallow, in accordance with some of the hypotheses being tested. However, analysis of 
plasma immunoglobulins showed no effect of diet on IgG2a levels, and plasma levels of 
IgG1 and spleen cell culture levels of IFN-γ, IL-4 and IL-10 were below detection limit, 
and therefore could not add weight to this conclusion. It may be that levels of IgG2a may 
have been affected by supplementation in comparison to baseline values, but this was not 
measured due to the size of animals at this point. Results from this chapter suggest that 
salmon oil may not be as detrimental to the immune response and to the response to 
immune challenges like infection as was suggested by Schwerbrock et al. 
[146], as ear 
swelling in response to Influvac was higher in the salmon oil fed mice than the linseed oil, 
sunflower oil or tallow fed mice. Although the difference in DTH response between 
linseed oil and salmon oil may be due to the need to convert ALA to DHA, which appears 
to be rate-limiting, the most important difference in fatty acid composition appears to be 







Chapter 3.  The Effect of Dietary Fatty Acids 
on a Mouse Model of Allergic Sensitisation   96   97 
3.1. Introduction 
The previous chapter showed that dietary fatty acids have the potential to affect 
TH1 type immune responses. To develop this further, another area of the immune system of 
clinical importance to humans was then examined. In collaboration with the University of 
Utrecht, a study was completed in order to examine the effect of dietary fatty acids in a 
mouse model of allergic sensitisation. The author was involved in tissue and data 
collection on the day of euthanisation, whilst Dr. Astrid Hogenkamp and Dr. Naomi van 
Vlies at the University of Utrecht carried out feeding and experiments prior to this. The 
author analysed all data produced. 
 
3.1.1.  Atopy 
Atopy is a term used to describe immediate hypersensitivity (Type I) reactions, 
where an inappropriate immune reaction is caused by the action of TH2 cells. The pathway 
of immediate hypersensitivity is shown in Figure 3-1. Exposure to allergen causes antigen 
(i.e. allergen) activation of TH2 cells, and IgE production by B-cells. IgE binds to FcεRI 
receptors on mast cells, and by doing so increases expression of these receptors 
[4]. 
Repeated exposure to the allergen activates mast cells, causing the release of mediators 
(vasoactive amines, lipid mediators and cytokines). The immediate phase reaction occurs 
minutes after allergen exposure, and is caused by release and actions of vasoactive amines 
and lipid mediators (leukotrienes, prostaglandins and thromboxanes). The late phase 
reaction occurs 2 – 4 hours after allergen exposure and is caused by the action of the 
cytokines released (IL-1, IL-3, IL-4, IL-5, IL-6, IL-8, IL-9, IL-10, IL-11, IL-13, GM-CDF, 
TNF, CCL2, CCL-5 and CCL11).   98 
 
Figure 3-1: Pathway of atopy (immediate hypersensitivity). Exposure of allergen causes 
antigen activation of TH2 cells, and IgE production by B-cells. IgE binds to FCεRI receptors 
on mast cells. Repeated exposure to the allergen activates mast cells, causing the release of 
mediators. Taken from Abbas and Lichtman 
[5]. 
Depending on the site of exposure to antigen, atopy can be manifested in different 
ways, and with either a localised or generalised effect, although all have essentially the 
same cause; exposure of a sensitised individual to an allergen results in mast cell activation 
via the pathway shown in Figure 3-1. For example, exposure of antigen to the respiratory 
tract can result in asthma or allergic rhinitis, whilst exposure to the eyes can cause 
conjunctivitis. Antigen exposure in the digestive tract can cause food allergies, presenting 
with vomiting and diarrhoea, whilst exposure to the skin can lead to atopic dermatitis or 
eczema.  
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3.1.2.  Skin Prick Test / Acute Skin Response 
Injection of antigen into the skin of a sensitised individual will result in a wheal and 
flare response (the immediate phase), followed by a late phase response resulting in 
eosinophil accumulation. This is often used as a method of determining sensitisation (i.e. 
an atopic response) to a particular allergen (skin prick testing or acute skin response); the 
subject is injected with small amounts of one or more antigen(s), and the resulting 
inflammation reaction recorded and used to assess whether the individual is allergic to the 
allergen(s) or, as in this study, the effect of treatments (e.g. diet) on reducing the allergic 
response. A visualisation of the immediate and late responses in a skin prick test in humans 
is shown in Figure 3-2.   100 
 
Figure 3-2: Skin prick test to grass pollen allergen in a patient with typical summer hayfever. 
Skin prick tests were carried out 5 hours (left) and 20 minutes (right) before the photograph 
was taken. The immediate response can be seen on the right, with different allergen dilutions 
exhibiting different degrees of wheal and flare reactions. The late response can be seen on the 
left. Taken from Delves et al. 
[4]. 
 
3.1.3.  Asthma 
Asthma is a type of immediate hypersensitivity reaction that is characterised by 
intermittent and reversible obstruction of the airway, chronic inflammation of the bronchus 
with eosinophilic infiltration, hypertrophy of bronchial smooth muscle, and hyper-
reactivity to bronchoconstrictors 
[5]. There are three types of asthma; occupational asthma 
results from allergens in the workplace, extrinsic or allergic asthma is caused by atopy and 
a genetic predisposition to produce inappropriate levels of IgE; and intrinsic or idiopathic 
asthma, which is non-atopic, and the cause for which may not be known 
[4]. The study 
described in this chapter will focus on allergic asthma, using ovalbumin (egg protein) as 
the allergen. 
 
3.1.4.  Prevalence of Atopy 




[165, 166], Australia 
[167, 168] and New Zealand 
[169] have suggested an increasing 
prevalence of atopy. A more recent international study reports a generalised worldwide 
increase in asthma, allergic rhinitis and eczema prevalence 
[170]. The British Allergy 
Foundation estimates that one in four of the UK population will suffer from an allergy at 
some point in their lives 
[171] and Asthma UK reports that 5.4 million people in the UK are   101 
currently receiving treatment for asthma 
[172], which amounts to 1 in 12 of the adults and 1 
in 11 children in the UK population 
[173]. 
 
3.1.5.  Dietary Fat and Atopy 
Numerous suggestions have been made to explain the increase in prevalence of 
atopy, including environmental factors and genetic susceptibility 
[174]. One explanation for 
the general increase in prevalence of atopy has been diet, in particular a changed pattern of 
consumption of PUFAs. Consumption of n-6 PUFAs (from margarine and vegetable oils) 
has increased over the period since 1960, whilst intake of n-3 PUFAs and antioxidants 
(from fruit and vegetables) has decreased 
[41]. The mechanism behind the theory linking 
dietary PUFAs with increased atopy prevalence is that the major dietary n-6 PUFA linoleic 
acid is converted to AA, which in turn is metabolised to PGE2, TXA2, and the 4-series 
leukotrienes (Figure 1-19). PGE2 promotes differentiation of naïve T helper cells to the TH2 
phenotype which is pro-allergic (TH2 cells promote IgE production via IL-4 while IL-5 
activates eosinophils), and the 4-series leukotrienes, promote many of the manifestations of 
allergic disease, particularly at the level of the lung, such as bronchoconstriction and 
mucous production 
[41]. In contrast, as LA and ALA compete for the same enzyme, ∆6-
desaturase (Figure 1-17), a higher intake of n-3 PUFAs reduces AA abundance and its 
subsequent conversion to PGE2 and 4-series leukotrienes. Instead, EPA is metabolised to 
PGE3, TXA3, and the 5-series leukotrienes, rather than the atopy-associated PGE2 and 4-
series leukotrienes (Figure 1-19). As a result the TH1 / TH2 balance becomes less polarised 
towards the TH2 cell phenotype reducing the T and B cell drive towards atopy and, via 
reduced 4-series leukotrienes, reduced severity of allergic manifestations.  
 
3.1.6.  Mouse Model of Atopic Sensitisation 
The mouse model of atopy is described by Hessel et al. 
[175]. Briefly, BALB/C mice 
(which have a genetic predisposition to a TH2 predominant reaction 
[150]) receive an intra-
peritoneal injection of ovalbumin to create an allergic sensitivity to the protein, and four 
weeks later can be challenged with aerosolised ovalbumin, in order to induce an asthma-
like response. Following the aerosolised challenge lung function can be evaluated with a 
non-invasive oscillation technique, and independently of this several markers of the 
immune response can be determined, including mast cell degranulation, IgE levels in 
serum, and splenocyte cytokine profiles. By using this model, and feeding mice diets   102 
containing different fatty acids, it is possible to examine their effect on the immune system 
using an accepted in vivo model of allergic sensitisation. 
 
3.1.7.  Aims of the study 
This study aimed to determine the effect of diets differing in fatty acid composition, 
including different levels and different types of n-3 and n-6 fatty acids, on the immune 
response in a mouse model of allergy to the egg protein ovalbumin. Altering intake of fatty 
acids may cause structural and functional changes in the immune system of the mouse, 
causing them to become more or less susceptible to their allergy. 
In order to achieve this aim, six diets were fed to mice from 3 to 4 weeks of age 
until 8 to 9 weeks of age. The diets were the same as those used in the previous chapter. 
 
3.1.8.  Hypotheses 
This study set out to test the following hypotheses: 
•  Feeding the salmon oil diet will reduce the severity of allergic reactions 
•  Feeding the sunflower oil diet will increase the severity of allergic reactions 
•  Feeding the beef tallow diet will increase the severity of allergic reactions 
•  Feeding the linseed oil diet will decrease the severity of allergic reactions compared to 
the sunflower oil diet, as ALA can be converted to EPA, but will not be as inhibitory as 
the salmon oil diet, as fatty acid metabolism is a less effective way of producing EPA 
than direct provision in the diet.  
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3.2. Materials and Methods 
3.2.1.  Animals, Diets and Materials 
3.2.1.1.  Animals 
3 to 4 week old male BALB/C mice were obtained from Charles River (Maastricht, 
The Netherlands). Animals were housed in groups of six in shoebox cages, and kept at 
22°C ± 2°C, under a 12 hour light: 12 hour dark cycle in temperature and light-controlled 
room in the animal facility at the Pharmacology Department, University of Utrecht. 
Animals had ad libitum access to tap water and 150 g food was provided on alternate days. 
Animal care and use were performed in accordance with the guidelines of the Dutch 
Committee of Animal Experiments. 
 
3.2.1.2.  Diets 
Diets were identical to those used in the previous chapter (see 2.2.1.2). 
 
3.2.1.3.  Materials 
Ovalbumin (Grade V), methacholine, urethane and β-mercaptoethanol were 
obtained from Sigma (St. Louis, USA). Aluminium hydroxide was purchased from Pierce 
Chemical Company (Rockford, USA). Complete mini was obtained from Roche Applied 
Science (Burgess Hill, UK). Other chemicals used were from the same sources as used in 
the previous chapter. 
 
3.2.2.  Methods 
An overview of the study design is provided in Figure 3-3. BALB/C mice (n = 48) 
were randomised to receive one of six diets (n = 8/diet) twelve days before sensitisation (at 
day -12). Sensitisation was carried out at days 0 and 7. Blood was collected by tail vein 
puncture on days -12, 14 and 22. Acute skin tests were carried out on day 21 ± 1. Mice 
were challenged on days 29, 32, and 35 ± 1. Airway responsiveness was measured on days 
29 and 35 ± 1. Euthanisation occurred by intra-peritoneal injection of 1 ml 10 % urethane 
on day 36 ± 1.    104 
 
Figure 3-3: Schematic diagram of experiment examining the effect of dietary fatty acids on a 
mouse model of allergic asthma. 
 
3.2.2.1.  Sensitisation of Mice to Ovalbumin 
Mice were sensitised with ovalbumin at days 0 and 7. Sensitisation was achieved 
through two intra-peritoneal injections of 10 µg ovalbumin adsorbed onto 22.5 mg 
aluminium hydroxide in 100 µl saline.  
 
3.2.2.2.  Acute Skin Test to Ovalbumin Challenge 
An acute skin test was carried out at day 21. This used the same method as for the 
DTH response in the previous chapter, but 1 pg ovalbumin in 0.01 ml PBS was injected 
instead of Influvac, and ear swelling measured 1 hour, rather than 24 hours, after injection. 
 
3.2.2.3.  Determination of Airway Responsiveness to 
Ovalbumin 
Mice were challenged with aerosolised ovalbumin at day 29 + 1, 32 + 1 and 35 + 1, 
by exposure in a 5 L plexiglass exposure chamber. Aerosols were generated by nebulizing 
an ovalbumin solution (10 mg/mL in pyrogen-free saline) using a Pari LC Star nebulizer 
(PARI Respiratory Equipment, Richmond, VA, USA; particle size 2.5–3.1 mm) driven by 
compressed air at a flow rate of 6 L/min. Airway responsiveness was measured on day 36 
+ 1 by recording respiratory pressure curve changes in response to inhaled nebulised 
methacholine with barometric whole-body plethysmography (BUXCO, EMKA 
Technologies, Paris, France), and expressed with a measurement of airway obstruction, 
enhanced pause (Penh), using the method of Hamelmann et al. 
[176]. Briefly, animals were 
placed in the BUXCO, and pressure difference between the animal chamber and a 
reference chamber noted. Baseline values of Penh were obtained and averaged over three 
minutes. Animals were exposed to a series of aerosols, starting with a saline aerosol, and   105 
followed by methacholine aerosols doubling in concentration, concentrations ranging from 
1.56 to 50 mg/ml saline. Aerosols were generated using the Paris LC Star nebuliser 
previously described, for three minutes, and following each nebulisation, readings recorded 
for three minutes and averaged. 
 
3.2.2.3.1.  Enhanced Pause (Penh) 
Penh is a unit-less measurement of airway hyper-reactivity. It is devised from a 
calculation based on the magnitude of the peak expiratory pressure compared to the peak 
inspiratory pressure, as a factor of pause. Pause is calculated by dividing the difference 
between time taken to exhale and time taken to reduce to a set value of 36 % above the 
normal pressure of the plethysmograph, by the time taken to inhale. It is shown in Figure 
3-4. 
 
Figure 3-4: Calculation of Penh. PEP, Peak expiratory pressure (ml / s); PIP, Peak inspiratory 
pressure (ml / s); Te, Time taken for expiration (s); Ti, Time taken for inspiration (s); Tr, 
relaxation time (time taken for pressure to reduce to 36 % of the total box pressure during 
expiration. Taken from Hammelman et al. 
[176]. 
Penh is not an accurate measure of resistance, but it is useful as an indicator of 
resistance. It was chosen for use in this research, as it allows respiratory measurements to 
be made on conscious, unrestrained animals, unlike other measurements of respiration 
[177]. 
 
3.2.2.4.  Fatty Acid Analysis of Erythrocytes 
At euthanisation, blood was collected, and erythrocytes analysed for fatty acids 
using the method previously described (2.2.2.3). 
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3.2.2.5.  Analysis of Plasma Immunoglobulin Concentrations 
Plasma, collected at euthanisation, was analysed for IgG1, IgG2 and IgE using 
sandwich ELISAs, following the manufacturer’s instructions. 
 
3.2.2.6.  Analysis of Bronchoalveolar Lavage Fluid 
Following blood collection, lungs were immediately washed with 1 ml PBS 
containing 5 % BSA and 1 tablet complete mini. This was then followed with three 1 ml 
washes of pyrogen free saline, which were pooled and stored on ice. These samples of 
bronchoalveolar lavage fluid (BALF) were used for IL-5 (see 3.2.2.7) and cytospin 
analysis (see 3.2.2.8). 
 
3.2.2.7.  Determination of IL-5 Content of BALF 
Supernatants of the first millilitre of BALF were collected following centrifugation 
at 1500 rpm (500 g) for 5 min.  These were analysed for IL-5 by sandwich ELISA using 
antibody pairs and standards, according to the manufacturer’s instructions. The lower 
detection limit of the ELISA was 2 pg/mL. 
 
3.2.2.8.  Cytospin Analysis of BALF 
The cell pellet of the first ml was added to the second to fourth ml of BALF 
collected. This cell suspension was centrifuged at 1500 rpm (500 g) for 5 min at 4 °C, and 
resuspended in 0.15 ml cold PBS. The number of cells present was determined using a 
Bürker-Türk counting-chamber (Karl Hecht Assistant KG, Sondheim/Röhm, Germany). 
Cytospin preparations were made by centrifugation at 1500 rpm for 10 min. Cells were 
fixed and stained with Diff-Quick. In each Cytospin, at least 200 cells were counted and 
classified into mononuclear cells (monocytes, macrophages and lymphocytes) and 
eosinophils and neutrophils using standard morphology and staining characteristics. 
 
3.2.2.9.  Analysis of Immune Tissue, Fat and Liver 
Spleen, thymus, epididymal fat and liver were removed and processed using the 
method described in the previous chapter (2.2.2.5). 
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3.2.2.10.  Histological Analysis of the Thymus 
Histological analysis of thymus was carried out using the method described in the 
previous chapter (2.2.2.6). 
 
3.2.2.11.  Determination of Cytokine Production by 
Splenocytes 
Cultures of spleen cells were prepared as for the previous chapter and analyzed for 
IFN-γ, IL-4 and IL-10 production (2.3.7). However, cells were cultured with 0.1 µg/ml 
ovalbumin or anti-CD3, rather than Influvac. 
 
3.2.2.12.  Determination of Cell Subsets in Lymphoid Tissues 
using Flow Cytometry 
Single cell suspensions of spleen, thymus and bone marrow were prepared and 
analysed for cell subsets following the methods of the previous chapter (2.2.2.8). 
 
3.2.2.13.  Statistical Analysis 
Results were analysed using SPSS version 15.0. Parameters were analysed using 
Levene’s test of homogeneity to ensure groups had equal variances, in which case they 
were compared using one-way analysis of variance (ANOVA), followed by post-hoc 
testing (Tukey). If Levene’s test showed unequal variances to be present, groups were 
compared using the Kruskal-Wallis test. Where this was used, it is reported in the results 
section. If the Kruskal-Wallis test indicated a significant effect, Mann-Whitney U 
independent group comparisons tests were then carried out to compare each combination 
of groups.  
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3.3. Results 
3.3.1.  Body weights of Mice Fed the Different Diets 
Mice were fed the diets for 48 days ± 1. Body weights of mice fed the different 
experimental diets are shown in Figure 3-5.  




























Figure 3-5: Body weights of mice fed the different diets. Data are mean + SEM.  
At day -14 and 0, mice in the salmon oil group were heavier than those in the 
control group. At day 0, mice in the salmon oil group were also heavier than those in the 
tallow group. At day -7 and 28, the salmon oil fed mice were heavier than those in the 
control, soybean oil and tallow groups. At day 7, the salmon oil fed mice were heavier than 
those in the soybean oil group. At all other time points, including the day of tissue 
collection (day 36; data not shown), there was no difference in body weight between 
dietary groups. 
 
3.3.2.  Tissue weights of Mice Fed the Different Diets 
Tissue weights of mice fed the different diets are shown in Table 3-1.   109 
Table 3-1: Tissue weights of mice fed the different diets. Fat refers to epididymal fat. Data are 
mean + SEM. Values with different letters are significantly different from one another (p < 
0.05). BW, Body weight. 











Spleen (g)  0.19 ± 0.01  0.20 ± 0.01  0.20 ± 0.01  0.19 ± 0.01  0.17 ± 0.01  0.21 ± 0.01 
Spleen (% BW)  0.70 ± 0.04  0.73 ± 0.03  0.71 ± 0.04  0.69 ± 0.03  0.69 ± 0.02  0.74 ± 0.02 
Thymus (g)  0.06 ± 0.00  0.06 ± 0.01  0.06 ± 0.01  0.07 ± 0.00  0.05 ± 0.00  0.06 ± 0.00 
Thymus (% BW)  0.23 ± 0.01  0.23 ± 0.02  0.23 ± 0.02  0.24 ± 0.01  0.22 ± 0.01  0.23 ± 0.02 
Liver (g)  1.45 ± 0.07  1.62 ± 0.05  1.55 ± 0.04  1.56 ± 0.07  1.53 ± 0.12  1.55 ± 0.09 
Liver (% BW)  5.36 ± 0.10  5.89 ± 0.25  5.89 ± 0.17  5.72 ± 0.20  6.04 ± 0.24  5.52 ± 0.20 
Fat (g)  0.38 ± 0.04
ab  0.38 ± 0.03
ab  0.37 ± 0.03
ab  0.40 ± 0.03
ab  0.29 ± 0.05
a  0.47 ± 0.03
b 
Fat (% BW)  1.40 ± 0.15  1.36 ± 0.10  1.34 ± 0.11  1.47 ± 0.09  1.13 ± 0.18  1.66 ± 0.10 
Epididymal fat (g) was heavier in animals in the tallow group compared to those in 
the sunflower oil group. However, when epididymal fat was analysed as a percentage of 
body weight there were no significant differences among the diet groups. There was no 
effect of diet on the weight of any of the other tissues examined. 
 
3.3.3.  Fatty Acid Content of Erythrocytes from Mice Fed 
the Different Diets 
Erythrocytes were analysed for fatty acid composition. Data for all fatty acids is 
shown in Appendix Two, and data for fatty acids of interest is shown in Figure 3-6.   110 
 
Figure 3-6: Individual and total n-3 and n-6 PUFA contents of erythrocytes from mice fed the different diets. Data are mean + SEM. Values with different letters 
denote differences between dietary groups.  111 
The linseed oil, soybean oil and sunflower oil groups had highest LA content of 
erythrocytes. The linseed oil group erythrocytes showed the highest ALA content. AA 
content was higher in erythrocytes from the sunflower oil and control groups compared to 
the tallow and linseed oil. AA content was higher in erythrocytes from the soybean oil 
group than the linseed oil group. EPA content was lower in the sunflower oil, soybean oil 
and control groups than the linseed oil group. There was no difference in DHA content of 
erythrocytes between different dietary groups. Linseed oil and tallow groups showed a 
higher n-3 content of erythrocytes than control, soybean oil and sunflower oil groups. 
Erythrocytes from the linseed oil, salmon oil and tallow groups had lower n-6 content than 
erythrocytes from the soybean oil and sunflower oil groups. Erythrocytes from the control, 
soybean oil and sunflower oil diets had a similar ratio of n-3 to n-6 PUFAs; linseed oil, 
salmon oil and tallow group erythrocytes also had a similar n-3 to n-6 ratio to one another.  
 
3.3.4.  Airway Responsiveness in Mice Fed the Different 
Diets 
The effect of the diets on airway responsiveness is shown in Figure 3-7. There was 
no difference between dietary groups at any dose of methacholine used. 
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Figure 3-7: Airway responsiveness to increasing doses of methacholine in mice fed the 
different diets. Airway responsiveness was measured at day 36. Data are mean + SEM. 
 
3.3.5.  Acute Skin Test in Mice Fed the Different Diets 
The effect of the experimental diets on ear swelling in response to ovalbumin is 
shown in Figure 3-8.   113 
 
Figure 3-8: Ear swelling in response to ovalbumin in ovalbumin-sensitive mice fed the 
different diets. Data are mean + SEM. Bars with different letters are significantly different 
from one another (p < 0.05). 
Ear swelling was lowest in animals receiving the salmon oil diet; in this group swelling 
was significantly less than seen in each of the other groups. The reduction in response was 
about 50%. Animals receiving the soybean oil diet showed reduced ear swelling compared 
to those receiving the sunflower oil diet. Animals receiving the beef tallow diet showed the 
greatest ear swelling and this was significantly greater than seen in all other groups. 
 
3.3.6.  Plasma Immunoglobulin Concentrations in Mice 
Fed the Different Diets 
Antibody concentrations in plasma are shown in Figure 3-9 (IgE), Figure 3-10 
(IgG1) and Figure 3-11 (IgG2). IgE concentration in plasma was lower in mice receiving 
the soybean oil diet compared to the tallow diet. There was no effect of diet on IgG1 or 
IgG2 concentrations, although the latter was lowest in the sunflower oil group.    114 
 
Figure 3-9: Plasma IgE concentration in mice fed the different diets. Data are mean + SEM. 
Bars with different letters are significantly different from one another (p < 0.05). 
 
Figure 3-10: Plasma IgG1 concentration in mice fed the different diets. Data are mean + 
SEM.  
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Figure 3-11: Plasma IgG2a concentration in mice fed the different diets. Data are mean + 
SEM.  
 
3.3.7.  Cytokine Production by Cultured Splenocytes from 
Mice Fed the Different Diets 
CD3- and ovalbumin -stimulated production of IL-4 and IL-10 by cultured spleen 
cells is shown in Figure 3-12 to Figure 3-15: AntiCD3-stimulated IL-10 production by 
spleen cells from mice fed the different diets. Data are mean + SEM.  
There was no effect of diet on IFN-γ (data not shown), IL-10 production or 
ovalbumin-stimulated IL-4 production. Anti CD3-stimulated IL-4 production was lower in 
the control and sunflower oil groups than in the linseed oil and tallow groups.    116 
 
Figure 3-12: Ovalbumin-stimulated IL-4 production by spleen cells from mice fed the 
different diets. Data are mean + SEM.  
 
 
Figure 3-13: AntiCD3-stimulated IL-4 production by spleen cells from mice fed the different 
diets. Data are mean + SEM. Bars with different letters denote significant differences 
between groups (p < 0.05). Data were analysed using non-parametric testing.   117 
 
Figure 3-14: Ovalbumin-stimulated IL-10 production by spleen cells from mice fed the 
different diets. Data are mean + SEM.  
 
Figure 3-15: AntiCD3-stimulated IL-10 production by spleen cells from mice fed the different 
diets. Data are mean + SEM.  
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3.3.8.  IL-5 Content of BALF from Mice Fed Different Diets 
IL-5 content of BALF is shown in Figure 3-16. There was no significant difference 
between dietary groups. 
 
Figure 3-16: IL-5 concentration in BALF from mice fed the different diets. Data are mean + 
SEM.  
 
3.3.9.  Cytospin Analysis of BALF from Mice Fed the 
Different Diets 
Results from the cytospin analysis of the bronchoalveolar lavage fluid (BALF) are 
shown in Figure 3-17. There was no effect of diet on any of the parameters measured. Cells 
described as “Other” in Figure 3-17 comprise mainly epithelial cells and basophils. 
Mononuclear cells include monocytes, macrophages and lymphocytes.   119 
 
Figure 3-17: Cytospin analysis of bronchoalveolar lavage fluid from mice fed the different 
diets. Data are mean + SEM.  
 
3.3.10.  Histological Analysis of Thymuses from Mice Fed 
the Different Diets 
The cortex/medulla ratio of the thymuses from mice fed the different diets is shown 
in Figure 3-18. There were no significant differences between dietary groups.   120 
 
Figure 3-18: Cortex / Medulla ratio of thymuses from mice fed the different diets. Data are 
mean + SEM.  
 
3.3.11.  Cell Subsets in the Thymus, Spleen and Bone 
Marrow from Mice Fed the Different Diets 
The effect of the diets on the presence of different types of cell in spleen, thymus 
and bone marrow of mice is shown in Table 3-2 to Table 3-4. There was no effect of diet 
on the proportion of any of the cell types investigated in spleen, thymus or bone marrow.   121 
Table 3-2: Cell subsets within the thymus of mice fed the different diets. Data are mean + SEM. 
 Marker  Cells Identified  Control  Soybean oil  Sunflower oil  Salmon oil  Linseed oil  Beef tallow 
CD3+  T-cells  95.38 ± 0.65  94.91 ± 0.83  95.09 ± 0.80  95.68 ± 0.37  96.18 ± 0.71  96.45 ± 0.60 
CD3+ that are also CD4+  TH cells  92.42 ± 0.99  92.76 ± 0.74  91.28 ± 1.34  93.87 ± 0.59  90.76 ± 1.17  91.92 ± 1.63 
CD3+ that are also CD8+  CTLs  89.75 ± 1.07  88.60 ± 0.76  87.63 ± 1.29  89.94 ± 0.49  89.00 ± 0.78  89.64 ± 1.15 
CD3+CD4+ that are also CD62L+  L-selectin expressing TH cells  82.19 ± 3.90  84.89 ± 4.21  87.67 ± 3.76  89.83 ± 4.12  88.12 ± 2.75  88.34 ± 3.56 
CD4+CD25+  TREG cells  2.45 ± 0.82  1.67 ± 0.25  0.76 ± 0.14  1.05 ± 0.38  0.97 ± 0.29  1.51 ± 0.20 
CD4+CD25+ that are also FoxP3+  TREG cells  0.64 ± 0.37  1.73 ± 0.97  5.08 ± 2.19  4.74 ± 3.23  3.12 ± 1.21  4.05 ± 1.60 
Table 3-3: Cell subsets within the spleen of mice fed the different diets. Data are mean + SEM. 
 Marker  Cells Identified  Control  Soybean oil  Sunflower oil  Salmon oil  Linseed oil  Beef tallow 
F4/80  Macrophages  5.73 ± 1.00  5.24 ± 0.56  8.82 ± 3.56  6.76 ± 1.04  7.26 ± 0.70  7.43 ± 0.56 
CD3+  T-cells  31.25 ± 1.35  27.72 ± 1.23  27.64 ± 1.92  28.90 ± 1.01  26.29 ± 1.30  29.29 ± 1.23 
CD3+ that are also CD4+  TH cells  62.14 ± 4.75  61.14 ± 5.44  56.98 ± 5.63  54.24 ± 3.92  54.58 ± 5.24  52.60 ± 2.62 
CD3+ that are also CD8+  CTLs  2.00 ± 0.26  2.12 ± 0.32  2.17 ± 0.22  2.45 ± 0.32  1.56 ± 0.13  2.39 ± 0.30 
CD3+CD4+ that are also CD62L+  L-selectin expressing TH cells  51.31 ± 2.68  49.78 ± 2.37  49.89 ± 2.07  51.26 ± 2.91  49.07 ± 1.84  51.04 ± 2.49 
CD3+CD4+ that are also CD69+  Activated TH cells  43.80 ± 1.69  43.09 ± 2.30  46.59 ± 2.25  44.77 ± 2.33  48.46 ± 2.01  49.87 ± 1.40 
CD19  B-cells  23.45 ± 5.48  17.18 ± 1.82  21.97 ± 4.75  16.82 ± 1.79  19.25 ± 5.68  20.13 ± 1.90 
CD4+CD25+  TREG cells  5.30 ± 0.33  4.70 ± 0.53  4.84 ± 0.76  4.26 ± 0.68  4.07 ± 0.49  4.40 ± 0.56 
CD4+CD25+ that are also FoxP3+  TREG cells  7.97 ± 2.08  7.09 ± 1.55  6.99 ± 1.94  5.41 ± 1.59  8.26 ±  2.17  5.62 ± 1.62 
CD94+  NK cells  36.85 ± 1.82  28.09 ± 3.60  28.51 ± 4.90  24.40 ± 5.72  27.35 ± 3.60  23.27 ± 3.72 
Table 3-4: B cells within the bone marrow of mice fed the different diets. Data are mean + SEM. 
 Marker  Cells Identified  Control  Soybean oil  Sunflower oil  Salmon oil  Linseed oil  Beef tallow 
CD19+  B-cells  27.75 ± 2.26  26.19 ± 3.71  26.29 ±  4.80  18.99 ± 5.68  26.88 ± 5.02  30.41 ± 2.01   122 
3.4. Discussion 
3.4.1.  Summary of findings 
This study aimed to determine the effect of diets differing in fatty acid composition, 
including different types of n-3 and n-6 fatty acids, on the immune response in a mouse 
model of allergy to the egg protein ovalbumin. The study set out to test hypotheses of 
reduced severity with salmon and linseed oils and increased severity with sunflower oil 
and beef tallow. Using ear swelling in response to ovalbumin, to which the mice had been 
sensitised, as the outcome, salmon oil decreased the response and sunflower oil and tallow 
increased the response supporting the hypotheses about these fat sources. Linseed oil was 
without effect. In addition, tallow increased IgE production in plasma compared to soybean 
oil. Despite the effects of dietary fatty acids on ear swelling and IgE production there were 
no effects with regard to lung function or to immune markers measured in BALF, plasma, 
thymocytes, bone marrow or splenocytes.  
There was an increase in body weight over the 48 days of the trial; at various points 
throughout the trial there were differences in body weight between dietary groups, but 
there was no difference between groups at the start or end of the trial. There was no effect 
of diet on spleen, thymus or liver weight. Epididymal fat was higher in the tallow group 
than the sunflower oil group, when measured as an absolute figure, but there was no 
difference seen when data was analysed as a percentage of body weight. Ear swelling in 
response to ovalbumin was lower in the salmon oil group than the soybean oil group, 
which in turn was lower than that of the sunflower oil group. Animals receiving the tallow 
diet had the greatest ear swelling in response to ovalbumin. There was no effect of diet on 
airway responsiveness. The fatty acid content of erythrocytes varied between dietary 
groups and generally reflected the fatty acid content of the diet. There was no effect of diet 
on IgG1 or IgG2 concentration in plasma, IL-5 content of BALF or on cytospin analysis of 
BALF. IgE content of plasma was lower in mice receiving the soybean oil diet compared 
to those receiving the tallow diet. The cortex / medulla ratio of mice thymuses was not 
affected by diet. There was no effect of diet on ovalbumin or CD3 stimulated IFN-γ, IL-10 
production or ova-stimulated IL-4 production of splenocytes. CD3-stimulated IL-4 
production by splenocytes was lower in the control and sunflower oil group than in the 
linseed oil and tallow groups. Diet did not affect cell subsets in the spleen, thymus or bone 
marrow.  
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3.4.2.  Tissue and Body Weights 
Body weights of mice increased over the period they received the experimental 
diets (48 days ± 1), in agreement with the findings of Poiley 
[157] and the previous chapter. 
Differences in body weights between dietary groups seen at various time points through 
the trial may have been caused by factors such as stress or palatability affecting appetite. 
However, since food intake was not recorded, and animals were housed in groups of 8, it is 
impossible to ascertain whether this occurred. Body weights did not differ between dietary 
groups at the start or the end of the trial, suggesting that this factor is unlikely to have 
confounded results. Differences in body and tissue weights between the current and 
previously described trial may be due to differences in duration of the trial, nature and 
timing of immune challenge(s), and strain of mice. 
Yaqoob et al. 
[178] found epididymal fat pad weight to be smaller in safflower oil-
fed rats than hydrogenated coconut oil fed rats. In addition, the same study also showed a 
menhaden oil-fed rats to have a smaller epididymal fat pads than safflower oil-fed rats; the 
current study found no difference between epididymal fat pads in the salmon oil group and 
the sunflower oil group. This may be due to the higher fat content of the Yaqoob study (20 
%) or the fact that diet was fed to rats for ten weeks, whereas the current study fed mice for 
less than seven weeks, or perhaps even the differences in fatty acids between the safflower 
/ menhaden oils and sunflower / salmon oils. Bowen and Clandinin 
[179] found no 
difference in effect of a high or low ALA diet in the first two weeks of life on epididymal 
fat pad weight in rats. Demar et al. 
[180] found no effect of inclusion of DHA in the diet on 
spleen, liver, white adipose or visceral adipose weight in young rats.  
However, in this study, when data was analysed as a percentage of body weight, 
there was no longer a difference seen between dietary groups in terms of epididymal fat 
weight. This suggests that the tallow group had a larger fat pad than the sunflower oil 
group, but were also slightly heavier. Whilst differences in body weight were not 
significant, they appear to have been enough to account for the differences in fat depot.  
 
3.4.3.  Fatty Acid Content of Erythrocytes  
Erythrocytes were analysed for fatty acid content as a method of assessing whether 
mice were consuming the diet. Fatty acid content of erythrocytes varied between dietary 
groups, and on the whole reflected the fatty acid content of the diet, suggesting that mice 
were eating the experimental diets and fatty acids metabolised by mice as would be 
expected. The tallow group had a similar EPA content of erythrocytes to the salmon oil 
erythrocytes, unlike the findings of the previous chapter. This may be due to the slightly   124 
longer duration of the current study (48 days) compared to that of the previous chapter (37 
days). Alternatively, it may be that the two different strains of mice used in these chapters 
respond differently to fatty acids. Similar EPA levels in the tallow and salmon oil groups 
may be because of the relatively high n-3 and low n-6 content of the tallow diet, despite the 
low total PUFA content, meaning that short chain n-3 PUFAs were converted to long chain 
n-3 PUFAs because of reduced competition from n-6 PUFAs for the desaturase and 
elongase enzymes. This is also reflected in the high n-3 to n-6 ratio of erythrocytes in the 
tallow group. This is in accordance with the findings of other fatty acid feeding studies on 
fatty acid levels in plasma, serum and erythrocytes 
[70, 71, 79, 151-156].  
 
3.4.4.  Airway Responsiveness 
There was no effect of diet on airway responsiveness. Whilst the effect of fish oils 
has not been examined in this model before, the effect of conjugated linoleic acid (CLA) 
has. Jaudszus et al. 
[181] and Kanwar et al. 
[182] fed cis-9, trans-11 CLA to ovalbumin-
sensitised mice and showed a reduction in airway inflammation compared to a control 
group receiving diets containing sunflower oil 
[181] or soybean oil 
[182]. In humans, 
epidemiological studies have suggested that increased fish intake in childhood can reduce 
prevalence of asthma 
[183-186]. Nagakura et al. 
[187] supplemented asthmatic children with 
300 mg fish oil capsules (84 mg EPA and 36 mg DHA) for 10 months and observed a 
reduction in asthma symptoms and an improvement in lung function compared to a control 
group receiving 300 mg olive oil. 
 
3.4.5.  Acute Skin Test 
Ear swelling in response to ovalbumin in ovalbumin-sensitive mice is a measure of 
the immediate hypersensitivity response 
[175]. Ear swelling was lowest in animals receiving 
the salmon oil diet. Whilst several animal studies have examined the effect of fatty acids 
on delayed-type hypersensitivity 
[56, 89, 108, 188-190] or other measures of cell-mediated 
immunity 
[71, 75, 90], none have examined their effect on immediate hypersensitivity. Kull et 
al. 
[191] demonstrated a reduction in allergy and sensitisation to food and inhaled allergens 
in infants with a high fish consumption in the first year of life. Animals receiving the beef 
tallow diet showed the most ear swelling, which was significantly greater than seen in all 
other groups. Hwang et al. 
[192] demonstrated a positive correlation between saturated fatty 
acid content of erythrocytes and atopy, and a negative correlation between long chain n-3 
content and atopy in 4 – 6 year old children. Hoppu et al. 
[193] demonstrated a positive   125 
relationship between saturated fatty acid intake of the pregnant woman and positive skin 
prick test of the child. 
BALB/C and C57BL6 cell cultures produce different levels of TH1 and TH2 
cytokines 
[127], and fish oil fatty acids may have different effects when added to cells 
cultured from these two strains of mice 
[194]. Addition of EPA was found to reduce IFN-γ 
production in cell cultures of BALB/C mice, but have no effect on IL-4 production, but in 
cell cultures of C57BL6 mice it had no effect of IFN-γ and reduced IL-4 production. In 
effect, EPA was further exaggerating the polarity of the dominance of the TH cells; 
BALB/C cells became more TH2 dominant, whilst C57BL6 cells had increased TH1 
dominance. It is important to note that these in vitro experiments were carried out using 
high concentrations of EPA (50 µM). The reduction in immediate hypersensitivity in 
BALB/C mice and lack of effect on cytokine production observed with fish oil feeding the 
this chapter is in contrast to the increase in TH2 cytokines cells from BALB/C mice seen 
with EPA by May 
[194]. Perhaps differences may be observed in response to fatty acids 
when using different models. 
In the previous chapter, ear swelling was measured 24 hour after injection with 
Influvac, and as such is a measure of delayed-type hypersensitivity (DTH). There, mice 
showed reduced ear swelling in the tallow, sunflower or linseed oil diets compared to those 
receiving the salmon oil diet. Immediate hypersensitivity is a TH2 controlled response, and 
DTH is a TH1 controlled response. These findings suggest that feeding salmon oil may 
reduce TH2 responses, in both TH1 and TH2 dominant mice.  
 
3.4.6.  Antibody Production  
There was no effect of diet on IgG1 or IgG2a concentration of plasma, but IgE 
concentration was lower in mice in the soybean oil group compared to the tallow group. 
TH1 cells produce IFN-γ, which causes antibody isotype switching to IgG2a. TH2 cells, 
however, produce IL-4, which causes isotype switching to IgE, which is the antibody 
responsible for immediate hypersensitivity and promotes IgG1 production. This suggests 
that the tallow diet may induce greater immediate hypersensitivity responses than the 
soybean oil diet.  In contrast to the findings in the current study, Prickett et al. 
[195] found 
an increase in ova-specific IgE and IgG in ovalbumin-sensitive rats receiving a fish oil diet 
compared to those receiving a tallow diet. Duration of feeding was from body weight of 
100 – 125 g to 225 – 250 g. Crevel et al. 
[107] found no difference between ova-specific IgE 
and IgG levels in ovalbumin-sensitive mice receiving PUFA or SFA rich diets for ten 
weeks. Chang et al. 
[196] demonstrated a reduction of anti-ovalbumin IgG1, but no effect on   126 
anti-ovalbumin IgG2 or IgE in ovalbumin-sensitive female mice receiving ALA-rich 
(perilla oil) diet, compared to those on an LA-rich (corn oil) diet.  
 
3.4.7.  Cytokine Analysis 
IL-4, IL-5 and IL-10 are produced by activated TH2 cells; IL-4 causes naïve T-cells 
to differentiate into TH2 cells, IL-5 increases production and activation of eosinophils, 
whilst IL-10 acts to inhibit activation and growth of TH1 cells. IL-4 and IL-5 are also 
produced by activated mast cells. IFN-γ is produced by NK cells, TH1 cells and CTLs; it is 
the signature cytokine of TH1 cells, in much the same way that IL-4 is the signature 
cytokine of TH2 cells. IFN-γ activates macrophages, causes isotype switching to opsonising 
and complement-fixing antibodies, and promotes differentiation of naïve T-cells to TH1 
cells, whilst inhibiting proliferation of TH2 cells.  
There was no effect of diet on IL-5 content of BALF, or IFN-γ or IL-10 production 
by splenocytes. CD3 stimulated IL-4 production by splenocytes in control and sunflower 
oil groups was lower than in linseed oil and tallow groups. Ovalbumin-stimulated IL-4 
production by splenocytes did not differ between dietary groups. This suggests that fatty 
acids did not affect TH1 / TH2 cell balance, or eosinophil activation in ovalbumin-sensitive 
mice. Chang et al. 
[197] found a reduction in IFN-γ and IL-10, but no effect on IL-4 or IL-5 
in BALF of ovalbumin-sensitive mice receiving a diet rich in ALA (perilla oil) compared 
to one rich in LA (corn oil) for 10 weeks. In the current study, only IL-5 was examined in 
BALF, whilst IFN-γ, IL-4 and IL-10 levels were determined in splenocytes. It may have 
been that if these cytokines were examined in BALF, a similar change would have been 
observed. In models in which mice were not sensitised to ovalbumin, fish oil and safflower 
oil diets, fed for 6 weeks, have been shown to reduce IFN-γ, but have no effect on IL-4 
production by splenocytes, compared to a hydrogenated coconut oil diet 
[61]. Petursdottir 
and Hardardottir 
[198] found a reduction in IFN-γ, but no effect on IL-4 production by 
splenocytes in mice receiving fish oil compared to those corn oil diets for 6 weeks.  
 
3.4.8.  Histological Analysis  
Cortex / medulla ratio was examined because as previous research at the University 
of Utrecht suggested that DHA may reduce medulla regions in the thymus (A. 
Hogenkamp, unpublished personal communication). T-cells mature in the thymus. The 
cortex contains the immature T-cells, which migrate to the medulla as they mature. 
Therefore, any effect on ratio of cortex to medulla may alter the area available for T-cell   127 
maturation or may indicate an effect on maturation. However, the current study found no 
effect of diet on cortex / medulla ratio of mice thymuses.  
 
3.4.9.  Cell Analysis 
Asthma is characterised by constriction of smooth muscle in the airway and an 
increase in mucosal exudation. This mucus includes inflammatory cells such as 
eosinophils, basophils, macrophages, neutrophils and lymphocytes. The mucus also 
contains epithelial cells. The sequence of events that occurs during asthma is as follows. 
Binding of IgE and TH2 cells to mast cells causes their activation; this is the immediate-
phase reaction. Cytokines produced by mast cells and T-cells, such as IL-4 and IL-5, cause 
the recruitment of eosinophils, basophils, neutrophils and more TH2 cells; this is the late-
phase reaction. Activated eosinophils, basophils and macrophages release lipid mediators 
such as prostaglandins and leukotrienes, which are responsible for inflammation resulting 
in airway constriction.  
CD62L is a marker used for L-selectin expression and is responsible for the homing 
of lymphocytes to lymph nodes. CD62L is expressed on naïve lymphocytes, and its ligand 
on the high endothelial venules in the lymph node. Naïve lymphocytes adhere to the high 
endothelial venules in the lymph node, but since binding is weak, they role along the 
endothelial surface. This allows their circulation through the peripheral lymphatic system 
to secondary lymphoid tissues. CD62L is also expressed on neutrophils and monocytes, 
and allows their adherence to endothelium. Examining the level of CD62L expression, 
along with CD69 expression, a marker for activated leukocytes, gives an indication of the 
level of activated and naïve cells present in spleen. In addition, since blood cells generate 
from a common stem-cell progenitor, examining the balance of cells present in BALF and 
lymphoid tissue provides a means of assessing a mechanism of effect of fatty acids on 
asthma prevalence. However, there was no effect of diet on cells in BALF, or subsets of 
lymphocytes in spleens, thymuses or bone marrow. This is in agreement with the findings 
of the previous chapter, and section 1.4, where fatty acids were found not to affect the 
abundance of lymphocytes, T-cells, CTLs, TH cells, B-cells, NK cells, monocytes, 
macrophages, and neutrophils. Hessel et al. 
[175] found no difference in cell abundance in 
ovalbumin-sensitive mice challenged with inhaled ovalbumin. In non-sensitised animals, 
Sanderson and Calder 
[199] found no effect of 8 weeks of feeding fish oil, hydrogenated 
coconut oil or safflower oil on CD62L expression on lymph node lymphocytes of rats. 
Zhang et al. 
[200] found no effect of fish oil on CD25+ expression compared to corn oil in 
mice receiving diets for 2 weeks.   128 
 
3.4.10.  Limitations 
One limitation of this study is that a maximum of eight animals per diet group were 
studied; a larger sample size may have revealed stronger findings. A second limitation is 
that fatty acid composition data for immune cells were not available and erythrocyte fatty 
acids were used to examine the relationship between fatty acid status and immune 
response. Using data for immune cells would be more appropriate for this purpose. This 
study was carried out using male mice. It may be that a different effect would be observed 
in females, particularly in the linseed oil group, due to their increased efficiency to convert 
ALA to long chain n-3 PUFAs 
[201]. This effect of gender on ALA conversion has been 
observed in humans
[201], and more recently in rats
[202], but has not yet been examined in 
mouse models. Measurements of airway hyper-responsiveness should only be viewed as an 
indication that there may not be any effect of fatty acids in this model, due to the fact that it 
is not an accurate measure of resistance 
[177]. 
 
3.4.11.  Conclusions 
The study set out to test hypotheses of reduced severity of allergic inflammation 
with salmon and linseed oils and increased severity with sunflower oil and tallow. These 
hypotheses were supported to some extent in that there was reduced immediate 
hypersensitivity in the salmon oil group and increased immediate hypersensitivity in the 
tallow group. However, varying the types of fatty acids in diets given to 3 to 4 week old 
mice for 48 days did not appear to affect airway responsiveness to ovalbumin. The 
increased ear swelling in animals on the tallow diet compared those receiving the soybean 
oil diet is reflected by an increase in IgE concentration in mice fed the tallow diet. 
Differences in IgE levels were not observed between other dietary groups. This may have 
been due to several factors, such as short feeding time (48 days) or age of the animals. 
There did not appear to be changes induced in cell abundance in bronchoalveolar 
lavage fluid, or in cell subtypes in thymus, spleen and bone marrow, but these 
measurements do not determine the difference in balance of TH1 / TH2 cells. Examining the 
characteristic cytokines of these cells gave variable results. Splenocytes from mice 
receiving the tallow diet had increased IL-4 production in response to T-cell stimulation 
compared to control and sunflower oil groups, whilst there was no difference in response 
to ovalbumin stimulation. In addition, there was no difference observed in IFN-γ or IL-10 
production in splenocytes, or IL-5 levels in BALF.   129 
Thus, some of the diets (salmon oil, beef tallow) had effects on immediate 
hypersensitivity to ovalbumin in ovalbumin-sensitised mice. Beef tallow feeding also 
raised IgE in blood and elevated IL-4 production by anti-CD3 stimulated splenocytes. 
There was no effect of diet on lung function and salmon oil did not affect IgE or cytokine 
profiles. The diets were fed for 48 days beyond weaning and it may be that changing fatty 
acid availability earlier in life (i.e. pre-weaning) or a longer duration of feeding may have 
bigger effects. In the next two chapters studies in which mice were fed diets with varying 
fatty acid compositions during gestation and / or lactation are reported.   
 







Chapter 4.  Effect of Fatty Acids in Pregnancy 
on Markers of Immune Function in the 
Offspring   132   133 
4.1. Introduction 
Most studies on the effect of fatty acids on aspects of the immune response have 
been conducted in laboratory animals (rats, mice) post-weaning or on adult humans. 
However, it is possible that fatty acids may have a more pronounced effect on the immune 
system earlier in life. This is because significant development of the immune system 
occurs before and soon after birth. Furthermore, sensitisation to allergens has been shown 
to be present at birth indicating that those factors that lead to sensitisation  are active in the 
foetus 
[132, 135]. However, whether an alteration in exposure to different fatty acids does 
influence early development and sensitisation of the immune system is not yet known. This 
study aims to explore this idea, and to determine the effect of variations in maternal fatty 
acid intake in pregnancy in the rat on immune parameters in the offspring. 
 
4.1.1.  Fatty Acids and Pregnancy 
Fatty acids are of critical importance to foetal growth and development, because of 
their roles as components of membrane lipids, as regulators of gene expression, as 
eicosanoid precursors, and in cellular communication, and their direct interactions with 
proteins 
[203]. Exact mechanisms for fatty acid uptake across the placenta have not yet been 
fully clarified, but are thought to involve diffusion and membrane / cytosolic binding 
proteins including fatty acid binding protein (FABP), fatty acid transport protein (FATP) 
and fatty acid translocase (FAT) 
[204, 205]. FAT and FATP are integral proteins with 
membrane spanning regions, which may act as fatty acid translocators or transporters, 
whilst FABP is an extracellular (plasma membrane) binding protein, which is thought to 
act as an extracellular fatty acid acceptor 
[206]. These proteins show preferential uptake for 
particular fatty acids, favouring n-3and n-6 PUFAs over non-essential fatty acids, and AA / 
DHA over LA / ALA 
[204, 205].  
Fatty acids are taken up by the placenta in the form of NEFAs, either from NEFAs 
in maternal circulation, or as a product of maternal TAGs, broken down by placental 
lipase. Once in the cytoplasm of the syncytiotrophoblast, fatty acids are oxidised, used to 
form eicosanoids, or esterified, and then either stored or used. This is summarised in 
Figure 4-1.   134 
 
Figure 4-1: Fatty acid binding protein distribution on the microvillus / basal membranes, and 
within the cytoplasm of the syncytiotrophoblast (L-FABP, liver fatty acid binding protein; H-
FABP, heart fatty acid binding protein. Both of these FABPs are named after the tissues in 
which they were first identified). Only NEFAs are taken up across the plasma membrane, 
and these may be derived directly from the maternal circulation, or from TAGs after the 
actions of placental lipases. Export of PL, CE and TAG into foetal circulation has been 
suggested 
[207]. Taken from Haggarty 
[206]. 
Long chain PUFA content is higher in the foetal blood than maternal blood 
[204, 205]. 
Explanations for this include the selective transport of these fatty acids by the placenta, 
preferential accumulation of long chain PUFAs into esterified lipids, selective lipolysis of 
long chain PUFAs in maternal circulating TAGs by placental lipase, or increased 
mobilisation of maternal adipose tissues during late gestation. Long chain PUFAs can 
either be provided preformed from the mother, or synthesised from the shorter chain n-3 
and n-6 PUFAs derived from the mother. Studies have demonstrated, however, that 
preformed DHA is much more effectively stored in tissues as DHA than DHA produced 
from ALA 
[208-212]. This may well be due to the fact ∆-5 and ∆-6 desaturases, although 
present in foetal liver from early in gestation, have low activity before birth 
[213].  
In addition, expression of genes involved in fatty acid uptake, differentiation of the 
placental trophoblast, and production of human chorionic gonadotrophin are affected by 
maternal fatty acids; hence, maternal fatty acids may not only affect placental transport, 
but also placental biology 
[205].    135 
 
4.1.2.  Fatty Acids in Pregnancy and the Immune System 
Studies have suggested that stimuli or insults during “critical” periods of 
development in pregnancy may cause short-term survival adaptations in pregnancy, which 
in turn may result in development of diseases during child- or adult-hood (reviewed by 
Gluckman and Hanson 
[129, 214]). These critical periods may coincide with phases of rapid 
cell growth 
[215]. This long-lasting effect of in utero conditions is known as “foetal 
programming” or the “Barker hypothesis”. The later name exists as research into this 
phenomenon originated from a paper by Barker et al. 
[128], in which low birth weight was 
linked with high risk of development of ischemic heart disease in adulthood. 
Following on from this, it is possible that fatty acids in pregnancy could have long 
lasting effects on the immune system because of their effects on gene regulation 
influencing the development and maturation of the immune system. This effect of fatty 
acids may be even more pronounced perinatally than in adulthood as significant 
development of the immune system occurs before birth 
[216]. Furthermore sensitisation to 
allergens has been shown to be present at birth indicating that those factors that lead to 
sensitisation  are active in the foetus 
[132, 135]. However, whether an alteration in exposure to 
different fatty acids influences early development and sensitisation of the immune system 
is not yet known. Recent research has shown that the source of fat in the diet of pregnant 
rats has the potential to alter the immune system of offspring at around the time of birth; 
specifically feeding a diet rich in salmon oil diet increased the proportion of CTL and NK 
in the foetal thymus 
[133, 217, 218]. However, whether this change is maintained into later life 
remains to be determined as this has not been explored previously. 
 
4.1.3.  Aims of the study 
The study aims to investigate the effect of maternal diets differing in fatty acid 
composition, including different levels and different types of n-3 and n-6 fatty acids, on 
markers of immune status and function in the offspring of rats, in particular the types of 
lymphocytes in blood and lymphoid organs. Altering maternal fatty acid intake may cause 
structural changes in foetal and/or maternal immune cells, which in turn may affect 
immune function. The study aims to determine where, in this pathway, change occurs, and 
whether these differences in immune function are maintained later in life. The study is 
summarised in Figure 4-2.   136 
 
Figure 4-2: Causal chain linking altered maternal fatty acid intake to altered offspring 
immune function. Changes in fatty acid composition of the maternal diet may cause changes 
in structure of foetal and / or maternal immune cells. This in turn may alter their function.  
In order to achieve these aims, three experimental diets will be fed to dams from 
conception until birth; chow will be fed thereafter. One diet will contain salmon oil as the 
fat source; this diet is high in long chain n-3 fatty acids. The second diet will contain 
soybean oil as the fat source; this diet contains a balance of plant n-3 and n-6 fatty acids. 
The third diet will contain sunflower oil as the fat source; this diet is rich in n-6 fatty acids. 
These three experimental diets are high fat (13 %). Dams will be transferred to chow, a low 
fat (3 %) diet after birth, and offspring weaned onto chow at 3 weeks of age. 
 
4.1.4.  Hypotheses 
The study set out to test the following hypotheses: 
•  Feeding the salmon oil diet in pregnancy will result in increased levels of long chain n-
3 PUFAs in maternal plasma and tissues. Long chain n-3 PUFAs will be present at high 
levels in the plasma of offspring of the salmon oil group at 3 weeks, but the level will 
decrease with time 
•  Feeding the soybean oil diet in pregnancy will cause a balance of short chain n-3 and n-
6 PUFAs in plasma of dams and offspring, at higher levels than the long chain n-3 and 
n-6 PUFAs. Level of short chain n-3 and n-6 PUFAs in offspring plasma will not be 
affected by time as offspring are weaned onto chow whose fat source is soybean oil 
(albeit at a lower concentration) 
•  Feeding the sunflower oil diet in pregnancy will result in an increased level of n-6 
PUFAs in plasma of dams, and offspring at 3 weeks, but level of n-6 PUFAs in 
offspring plasma will decrease with time   137 
•  Immune cell abundance of offspring blood and lymphoid organs will be affected by 
altering the fatty acid composition of the diet pregnant rats: specifically offspring in the 
salmon oil group will have increased numbers of CTLs and NK cells. 
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4.2. Materials and Methods 
4.2.1.  Animals, Diets and Materials 
4.2.1.1.  Animals 
Male and female Wistar rats were obtained from the Biomedical Research Facility, 
University of Southampton (Southampton, UK). 
 
4.2.1.2.  Diets 
The high-fat experimental diets (sunflower oil, salmon oil and soybean oil) and 
low-fat soybean oil-based chow (CRM-1) were the same as those used previously (2.2.1.2). 
  
4.2.1.3.  Chemicals 
Heparin was from CP Pharmaceuticals Limited (Wrexham, Flintshire, UK). L-
Glutamine, streptomycin / penicillin, and RPMI-1640 (without L-glutamine) were from 
PAA Laboratories Limited (Yeovil, Somerset, UK).  Phosphate buffered saline (PBS) was 
from Oxoid Limited (Basingstoke, Hampshire, UK). Coulter Isoton Diluent II was from 
Beckman Coulter (UK) Limited (High Wycombe, Buckinghamshire, UK). Foetal calf 
serum (FCS), concanavalin A (Con A), histopaque (density 1.077 g/ml), bovine serum 
albumin (BSA), formaldehyde, sodium azide and all standard laboratory reagents were 
from Sigma-Aldrich Limited (Gillingham, Dorset, UK). FACs lysing solution was from 
BD Biosciences (Cowley, Oxford, UK). The following antibodies were from AbD Serotec 
(Kiddlington, Oxford, UK):  
•  Fluorescein isothiocyanate (FITC)-labelled mouse anti-human IgG1,  
•  FITC-labelled mouse anti-human IgM,  
•  r-phycoerythrein (RPE)-labelled mouse anti-human IgG1,  
•  FITC-labelled mouse anti-rat CD163 (IgG1),  
•  FITC-labelled mouse anti-rat CD161 (IgG1),  
•  FITC-labelled mouse anti-rat CD3 (IgM) / RPE-labelled mouse anti-rat CD8 
(IgG1) 
•  FITC-labelled mouse anti-rat CD3 FITC (IgM) / RPE-labelled mouse anti-rat CD4 
RPE (IgG1), 
•  FITC-labelled mouse anti-rat CD3 FITC (IgM) / RPE-labelled mouse anti-rat 
CD45RA RPE (IgG1).  
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4.2.2.  Methods 
An overview of the trial is shown in Figure 4-3. Eighteen 10-week old nulliparous 
Wistar rats were bred with six age-matched males. The presence of a vaginal plug was 
used as an indicator of potential conception and birth of offspring was designated day 0 of 
postpartum development. Following conception, animals were randomised into groups to 
receive one of the three experimental diets. Post-parturition, all animals were maintained 
on chow. Body weight of dams was measured weekly. At 2-7 days of age, litters were 
culled to 8 offspring (4 males, 4 females), in order to minimise variation in milk 
composition, milk yield, offspring nutrient intake and behavioural activities of offspring 
and dams 
[219, 220]. Post-parturition, offspring remained with dams until weaning at day 21. 
Pregnant dams and weaned offspring were housed separately in shoebox cages, and kept at 
21 ± 2 °C, under a 12 hour light : 12 hour dark cycle. At all times, animals had ad libitum 
access to food and water. All studies were carried out in accordance with the Home Office 
Animals (Scientific Procedures) Act of 1986, under project licence number 30/1889, and 
personal license number 70/20024.   140 
 
Figure 4-3: Schematic diagram of trial showing the timing of feeding and of sample collection 
and the outcomes measured. 
 
4.2.2.1.  Fatty Acid Analysis of Diets and Maternal Plasma 
To extract lipids, 100 mg of diet was homogenised in 0.8 ml of 0.9 % NaCl in 
triplicate. Samples of plasma were adjusted to 0.8 ml with 0.9 % NaCl, if 0.8 ml sample 
volume of plasma was not available. Internal standards were added at levels listed in Table 
4-1, and samples vortexed.    141 
Table 4-1: Internal standards used for FA analysis of corresponding lipid classes. Taken from 
Burdge et al. 
[221]. 















Phosphatidylcholine  15:0  Dipentadecanoyl 
PC 
n/a  100 
Phosphatidylethanolamine  17:0  Diheptadecanoyl 
PE 
n/a  2 
Non-esterified fatty acids  21:0  Heneicosanoic 
acid 
100  25 
Cholesteryl esters  17:0  Cholesteryl 
heptadecanoate 
n/a  500 
Triacylglycerol  15:0  Tripentadecanoin  n/a  150 
 
Lipid classes were separated by solid phase extraction, using the method of Burdge 
et al. 
[221]. Briefly, samples were dissolved in 1 ml dry chloroform, vortexed and allowed to 
drip through an aminopropylsilica solid phase extraction cartridge under gravity. The 
column was washed with 2 ml dry chloroform, and the chloroform washes (which 
contained TAG and CE were dried under nitrogen at 40°. PC was eluted by the addition of 
2ml dry choloroform / methanol (60:40, v/v) under vacuum, and dried under nitrogen at 
40°. NEFA was collected by the addition of 2 ml chloroform / methanol / glacial acetic 
acid (100 : 2 : 2, v/v/v) under vacuum, and dried under nitrogen at 40 °. 4 ml of dry hexane 
was added to fresh aminopropylsilica solid phase extraction cartridge. The TAG / CE 
elucidate was dissolved in 1 ml dry hexane and then added to this cartridge. CE was eluted 
by the addition of 2 ml dry hexane, and dried under nitrogen at 40 °. TAG was eluted by 
the addition of 2ml dry hexane / chloroform / ethyl acetate (100 : 5 : 5 v/v/v) under 
vacuum, and samples dried under nitrogen at 40 °. 
Fatty acid methyl esters of these lipid fractions were prepared, and samples 
analysed using the method described previously (2.2.2.3). 
 
4.2.2.2.  Preparation of Immune Cells from Lymphoid Organs 
3-, 6-, 9-, or 12-week old animals were euthanized by carbon dioxide inhalation and 
cervical dislocation. Two pups from each dam (one male, one female) were pooled to 
create one sample, in order to increase amount of tissue / blood available and reduce the 
effect of gender. Blood was collected into heparinised tubes by cardiac puncture, and 
placed on ice. The thymus, spleen, and both tibia and femurs were removed and 
immediately placed into RPMI culture medium on ice.   142 
Approximately 1 ml of the blood sample was decanted into an eppendorf, and 
stored at 4°C until required for flow cytometry. Bone marrow cells were collected by 
cutting between the metaphysis and diaphysis at both ends of the bone, and flushing out 
bone marrow using a 21G x 1 1/2" needle and 10 ml syringe containing RPMI. These cells, 
together with thymuses and spleens were pushed through a tea strainer to break up the 
tissue and to release cells. Cells were then filtered using a lens tissue to remove debris, and 
centrifuged at 1000 rpm for ten minutes. The supernatant was removed, and pelleted cells 
resuspended using RPMI. Cells were carefully layered onto 10 ml histopaque (density 
1.077 g/ml), and centrifuged at 2000 rpm for 15 minutes at 15 °C, without a brake. 
Mononuclear cells were removed into a fresh tube, to which RPMI was added, before 
being centrifuged at 1500 rpm for 7 minutes. The supernatant was removed, and the pellet 
resuspended in 1 ml RPMI. 
 
4.2.2.3.  Determination of Cell Numbers in Lymphoid Tissues 
10 µl of the cell suspension from the thymus, spleen and bone marrow samples 
were placed in 10 ml isoton, and cells counted using a Beckman Z1 Coulter Counter (High 
Wycombe, UK). This was repeated, values summed together and multiplied by 1000, to 
determine the cell count per 1 ml suspension. 
 
4.2.2.4.  Determination of Cell Subsets in Lymphoid Tissues 
using Flow Cytometry 
Thymus, spleen and bone marrow cells were diluted in RPMI (if necessary) to form 
a suspension of 1 x 10
7 cells/ml. Whole blood was not diluted. Eight tubes were set up, one 
for each of the antibody stains or controls listed in Table 4-2. A ninth tube was set up for 
splenic cells, which was used to identify splenic macrophages.    143 
Table 4-2: Antibodies used for FACs analysis. All antibodies were mouse anti-rat. 
Antibody  Cell type 
identified 
Spleen  Thymus  Bone 
Marrow 
Blank  (Control)  X  X  X 
FITC Anti-IgG1  (Control)  X  X  X 
FITC Anti-IgM  (Control)  X  X  X 
RPE Anti-IgG1   (Control)  X  X  X 
FITC (IgG1) Anti-CD161  NK cells  X  X  X 
FITC (IgM) Anti-CD3 / RPE 
(IgG1) Anti-CD8 
CTLs  X  X  X 
FITC (IgM) Anti-CD3 / RPE 
(IgG1) Anti-CD4  
TH cells  X  X  X 
FITC (IgM) Anti-CD3 / RPE 
(IgG1) Anti-CD45RA 
B-cells  X  X  X 
FITC (IgG1) Anti-CD163  Splenic 
macrophages 
X  -  - 
10 µl of each fluorescently labelled antibody was added to 100 µl of cell suspension 
or blood, and then vortexed. Samples were covered in parafilm, and incubated at room 
temperature for 30 minutes. 2 ml FACs lysing solution was added to whole blood samples, 
which were then vortexed, covered again, and incubated at 4 °C for a further 10 minutes. 
All tubes were centrifuged at 1000 rpm for seven minutes, following which the supernatant 
was discarded. 2 ml mPBS (PBS containing 1 g/l bovine serum albumin and 0.65 g/l 
sodium azide) was added, and samples vortexed before centrifugation at 1000 rpm for 
seven minutes, to wash cells. The supernatant was discarded, and the washing step 
repeated. Cells were suspended in 200 µl FACs fix (PBS containing 2 % formaldehyde), 
and vortexed. Samples were stored at 4 °C, until analysis, which took place within 24 
hours. Cell types were analysed using a Becton Dickinson FACSCalibur flow cytometer 
(Cowley, Oxford, UK) and CellQuest software, which recorded 10
4 events per sample.  
 
4.2.2.5.  Statistical Analysis 
Results were analysed using SPSS version 15.0. Parameters were analysed using 
Levene’s test of homogeneity to ensure groups had equal variances, in which case they 
were compared using one-way analysis of variance (ANOVA), followed by post-hoc 
testing (Tukey). If Levene’s test showed unequal variances to be present, groups were 
compared using the Kruskal-Wallis test. Where this was used, it is reported in the results 
section. If the Kruskal-Wallis test indicated a significant effect, Mann-Whitney U 
independent group comparisons tests were then carried out to compare each combination 
of groups.  
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4.3. Results 
4.3.1.  Gestational Data of Rats fed the Different Diets 
There were no significant differences among the dietary groups in terms of weight 
at conception or at days 7, 14 or 20 of gestation, number of offspring or gestation length 
(Table 4-3). 
Table 4-3: Weights of dams at conception and at days 7, 14 and 20 of pregnancy, number of 
offspring, and length of gestation in the different dietary groups. Results are shown as mean 
± SEM. There were no statistical differences among groups for any outcome (p>0.05). 






Weight at conception (g)   211.7 ± 3.9  214.9 ± 3.2  214.4 ± 3.8 
Weight at day 7 of gestation (g)   227.8 ± 3.5  233.7 ± 5.0  233.8 ± 3.9 
Weight at day 14 of gestation (g)   254.6 ± 4.5  258.9 ± 4.6  258.0 ± 4.2 
Weight at day 20 of gestation (g)   311.6 ± 6.5  308.8 ± 7.6  316.6 ± 6.1 
Number of offspring   12 ± 1  10 ± 1  11 ± 1 
Length of gestation (days)  21.4 ± 0.2  21.1 ± 0.3  21.7 ± 0.2 
 
4.3.2.  Body Weights of Offspring of Rats fed the Different 
Diets 
Body weights of male and female offspring are shown in Table 4-4. There was no 
difference in male or female body weight at any time point as a result of maternal diet. 
Across all diets, body weights increased with time, but there was no difference among 
dietary groups.   145 
Table 4-4: Bodyweights of offspring at different time points after weaning from dams that 
received different diets during pregnancy. There were no statistical differences among groups 
for either gender (p>0.05). 
Gender  Week    Salmon oil  Soybean oil  Sunflower oil 
n  11  7  9  3 
Mean ± SEM  44.3 ± 5.9  48.0 ± 8.7  44.8 ± 6.9 
n  8  7  9  6 
Mean ± SEM  125.8 ± 2.5  115.3 ± 5.3  122.1 ± 7.4 
n  12  11  12  9 
Mean ± SEM  169.7 ± 3.0  173.1 ± 3.8  178.3 ± 4.7 
n  10  10  12 
Female 
12 
Mean ± SEM  205.6 ± 6.0  199.6 ± 5.3  212.6 ± 3.9 
n  11  9  13  3 
Mean ± SEM  46.5 ± 6.2  49.0 ± 6.7  39.8 ± 5.4 
n  10  5  9  6 
Mean ± SEM  146.0 ± 7.4  155.8 ± 13.6  144.4 ± 8.4 
n  12  9  12  9 
Mean ± SEM  247.4 ± 7.3  256.2 ± 10.1  249.0 ± 6.4 
n  9  7  10 
Male 
12 
Mean ± SEM  323.3 ± 7.8  330.9 ± 14.2  329.1 ± 5.6 
 
4.3.3.  Tissue Weights of Offspring of Rats fed the 
Different Diets 
Spleen and thymus weights of offspring are shown in Table 4-5 and Table 4-6 
respectively. There was no effect of diet at any time point, although there was an effect of 
time. Spleens of females weighed less at week 3 than at other time points, but there was no 
significant difference in weight in weeks 6 to 9. In males, spleens increased in weight up 
until week 9. Thymus weights were significantly greater at weeks 6, 9 and 12 than at week 
3 in females and males of all groups.    146 
Table 4-5: Spleen weights of male and female offspring at different stages after birth (3, 6, 9 
and 12 weeks of age). Results are shown as mean ± SEM. Values with different letters denote 
differences in spleen weight in dietary groups between time points (p<0.05). 
  Week    Salmon oil  Soybean oil  Sunflower oil 
n  11  7  9  3 
Mean±SEM  0.19 ± 0.02
a  0.22 ± 0.03
a  0.19 ± 0.02
a 
n  8  7  9  6 
Mean±SEM  0.43 ± 0.04
b  0.38 ± 0.03
b  0.38 ± 0.03
b 
n  12  11  12  9 
Mean±SEM  0.45 ± 0.02
b  0.47 ± 0.02
b  0.45 ± 0.01
b 






Mean±SEM  0.52 ± 0.02
b  0.52 ± 0.01
b  0.50 ± 0.02
b 
n  11  9  13  3 
Mean±SEM  0.20 ± 0.02
a  0.20 ± 0.02
a  0.17 ± 0.02
a 
n  10  5  8  6 
Mean±SEM  0.52 ± 0.03
b  0.51 ± 0.05
b  0.48 ± 0.03
b 
n  12  9  12  9 
Mean±SEM  0.65 ± 0.03
bc  0.60 ± 0.04
b  0.62 ± 0.02
c 






Mean±SEM  0.72 ± 0.02
c  0.69 ± 0.04
b  0.70 ± 0.02
c 
 
Table 4-6: Thymus weights of male and female offspring at different stages after birth (3, 6, 9 
and 12 weeks of age). Results are shown as mean ± SEM. Values with different letters denote 
differences in thymus weight in dietary groups between time points (p<0.05). 
  Week    Salmon oil  Soybean oil  Sunflower oil 
n  11  7  9  3 
Mean±SEM  0.26 ± 0.03
a  0.25 ± 0.04
 a  0.26 ± 0.04
a 
n  8  7  9  6 
Mean±SEM  0.56 ± 0.02
b  0.50 ± 0.04
b  0.55 ± 0.04
b 
n  12  11  12  9 
Mean±SEM  0.59 ± 0.02
b  0.59 ± 0.04
b  0.58 ± 0.02
b 






Mean±SEM  0.58 ± 0.03
b  0.58 ± 0.03
b  0.56 ± 0.03
b 
n  11  9  13  3 
Mean±SEM  0.23 ± 0.02
a  0.28 ± 0.04
a  0.23 ± 0.02
a 
n  10  5  9  6 
Mean±SEM  0.57 ± 0.03
b  0.61 ± 0.04
b  0.55 ± 0.04
b 
n  12  9  12  9 
Mean±SEM  0.69 ± 0.03
b  0.69 ± 0.04
b  0.70 ± 0.02
b 






Mean±SEM  0.65 ± 0.02
b  0.66 ± 0.03
b  0.66 ± 0.04
b 
 
Thymus, spleen and body weights of offspring aged 3, 6, 9 and 12 weeks are shown 
graphically in Figure 4-4. These plots clearly demonstrate the lack of differences among 
dietary groups at any time point.   147 
 
Figure 4-4: Thymus (top), spleen (middle) and body (bottom) weights over time. 
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4.3.4.  Fatty Acid Analysis of Plasma of Rats fed the 
Different Diets 
Maternal plasma fatty acid profile is shown in detail in Appendix Three. Fatty acids 
of interest are shown in Figure 4-5. 18:2 n-6 content of CE was higher in the salmon oil 
group than the sunflower oil group. 20:5 n-3 and total n-3 contents and ratio of n-3 to n-6 
PUFAs in the CE fraction were higher in the salmon oil group than the soybean and 
sunflower oil groups. There was no difference in fatty acid profile in the NEFA fraction 
between dietary groups. This is as would be expected, since the NEFA fraction partly 
represents recently absorbed dietary fatty acids; dams from all groups had been receiving 
chow since parturition, three weeks previously. Trans 18:1 n-9 in the PC fraction of 
maternal plasma were highest, and 18:3 n-6 and 20:3 n-6 levels were lowest in the in the 
soybean oil group compared to other dietary groups. 20:5 n-3 levels were higher in the 
salmon oil group compared to the soybean oil group. Trans 18:1 n-9 levels in the TAG 
fraction were higher in the soybean oil group than the sunflower oil group. 
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Figure 4-5: Profile of certain fatty acids, total n-3 and n-6 PUFA contents of maternal plasma, three weeks after parturition and change for all groups to chow. 
Values with different letters denote differences in fatty acid abundance between dietary groups (p<0.05).  150 
4.3.5.  Fatty Acid Analysis of Tissues of Rats fed the 
Different Diets 
Maternal plasma fatty acid profile of liver, spleen and thymus is shown in detail in 
Appendix Three. Fatty acids of interest are shown in Figure 4-6 (liver), Figure 4-7 (spleen) 
and Figure 4-8 (thymus). 
Out of the fatty acids of interest, only the PC and PE fractions showed any 
differences between groups in the liver. In the PC fraction, AA content was higher in the 
sunflower oil group than the salmon oil group, and EPA, DHA and total n-3 contents were 
highest in the salmon oil group compared to other groups, whilst total n-6 content was 
lowest in this group compared to others. In the PE fraction, DHA and total n-3 contents 
were highest in the salmon oil group. 
In the spleen, differences were seen in NEFA fraction in addition to PC and PE. In 
NEFA, DHA and total n-3 contents were highest, whilst total n-6 content was lowest in the 
salmon oil group compared to both other groups. In the PC fraction of spleen tissue, LA, 
DHA and total n-3 content was higher in the salmon oil group compared to the sunflower 
oil group; the soybean oil group was not different for these fatty acids from either salmon 
oil or sunflower oil groups. The PE fraction of spleen showed a higher AA content in the 
sunflower oil group compared to the salmon oil group, whilst AA content of soybean oil 
group was not different from either other group. EPA content of the salmon oil group was 
higher than the soybean oil group in the same fraction. Also, DHA and n-3 contents were 
higher, whilst n-6 content was lowest in the salmon oil group compared to both soybean oil 
and sunflower oil groups. 
Differences in fatty acid content were observed in the same three lipid fractions in 
the thymus. In NEFA, DHA and total n-3 contents were highest in the salmon oil group 
compared to both other groups, which were not different from one another. AA content in 
the PC fraction was higher in the sunflower oil group than the salmon oil group, whilst 
soybean oil was not different from either other group. In the PE fraction of the thymus, 
EPA content was higher in the salmon oil group than the sunflower oil group; soybean oil 
EPA content of thymus was not different from the salmon or sunflower oil groups. DHA 
and n-3 contents of the salmon oil group were higher than that of the soybean oil and 
sunflower oil groups, which did not show statistical difference from one another.  151 
 
Figure 4-6: Profile of certain fatty acids, total n-3 and n-6 PUFA contents of maternal liver, three weeks after parturition and change for all groups to chow. 
Values with different letters denote differences in fatty acid abundance between dietary groups (p<0.05).   152 
 
Figure 4-7: Profile of certain fatty acids, total n-3 and n-6 PUFA contents of maternal spleen, three weeks after parturition and change for all groups to chow. 
Values with different letters denote differences in fatty acid abundance between dietary groups (p<0.05).   153 
 
Figure 4-8: Profile of certain fatty acids, total n-3 and n-6 PUFA contents of maternal thymus, three weeks after parturition and change for all groups to chow. 
Values with different letters denote differences in fatty acid abundance between dietary groups (p<0.05).  154 
4.3.6.  Fatty Acid Analysis of Plasma from Offspring of 
Rats fed the Different Diets 
Offspring plasma fatty acid profile is shown in detail in Appendix Three. Fatty 
acids of interest are shown in Figure 4-9 to Figure 4-12. In all cases there was no effect of 
diet, but there was an effect of time. Total n-6 content of the CE fraction was lower at 
week 3 than week 6 in the sunflower oil group.  
In the NEFA fraction, LA content was lowest at week 3 in the salmon oil and 
sunflower oil groups compared to all other groups. In the soybean oil group, LA content 
was lower at week 3 than at week 6. AA content was lower at week 3 than week 12 in the 
salmon oil group; in the sunflower oil group it was lower at week 3 than all other weeks. 
Total n-3 content was lower at week 3 than week 6 in the soybean oil group. Total n-6 
content was lower at week 9 than week 3 in the salmon oil group, and highest at week 3 
than weeks 9 and 12 in the sunflower oil group.   
In the PC fraction, AA content was lowest at week 3 than all other weeks in the 
salmon oil group. EPA content was highest at week 6 than all other weeks in the sunflower 
oil group.  
In the TAG fraction, LA content was lowest at week 3 compared to other weeks in 
the salmon oil group; in the sunflower oil group, LA content was lower at week 3 than 
week 6. ALA content was lower at week 3 than week 12 in the sunflower oil group. Total 
n-6 content was higher at week 9 than week 3 in the salmon oil group.  
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Figure 4-9: Profile of certain fatty acids, total n-3 and n-6 PUFA contents in the CE lipid fraction of offspring plasma. Values with different letters denote 
differences in fatty acid abundance between different time points within a dietary group (p<0.05).   156 
 
Figure 4-10: Profile of certain fatty acids, total n-3 and n-6 PUFA contents in the NEFA lipid fraction of offspring plasma. Values with different letters denote 
differences in fatty acid abundance between different time points within a dietary group (p<0.05).   157 
 
Figure 4-11: Profile of certain fatty acids, total n-3 and n-6 PUFA contents in the PC lipid fraction of offspring plasma. Values with different letters denote 
differences in fatty acid abundance between different time points within a dietary group (p<0.05).   158 
 
Figure 4-12: Profile of certain fatty acids, total n-3 and n-6 PUFA contents in the PE lipid fraction of offspring plasma. Values with different letters denote 
differences in fatty acid abundance between different time points within a dietary group (p<0.05).   159 
4.3.7.  Lymphoid Organ Cell Numbers in Offspring of Rats 
fed the Different Diets 
Cell counts of spleen, thymus and bone marrow are shown in Tables 1-9, 1-10 and 
1-11, respectively. There was no effect of time or diet on the number of spleen cells per mg 
of spleen tissue (Table 4-7). Absolute numbers of cells in the spleen were lower at week 3 
than weeks 6, 9 and 12 across all dietary groups. 
Table 4-7: Cell counts in spleen. Results are shown as mean ± SEM.  
  Week    Salmon oil  Soybean oil  Sunflower oil 
n  11  8  11  3 
Mean ± SEM  2.91 ± 0.46  3.57 ± 0.73  4.03 ± 0.59 
n  9  6  8  6 
Mean ± SEM  6.08 ± 1.06  3.57 ± 0.54  5.28 ± 0.57 
n  10  6  8  9 
Mean ± SEM  4.98 ± 0.62  7.06 ± 2.03  5.45 ± 1.01 
n  7  7  8 
Number of 
cells per mg 




Mean ± SEM  2.31 ± 0.76  4.16 ± 1.29  5.05 ± 1.97 
n  11  8  11  3 
Mean ± SEM  12.03 ± 2.47  15.37 ± 4.53  14.94 ± 2.80 
n  9  6  8  6 
Mean ± SEM  60.54 ± 12.04  30.53 ± 5.10  41.69 ± 6.68 
n  10  6  8  9 
Mean ± SEM  55.80 ± 8.09  73.19 ± 22.39  57.37 ± 9.64 








Mean ± SEM  40.32 ± 10.89  51.97 ± 19.17  59.66 ± 23.52 
Cell counts in the thymus were made only on a sample of the tissue (as some 
thymus was required for histological studies by another research group). Therefore it was 
not possible to show data as total number of cells in the thymus; data are shown as number 
of cells per mg of tissue. No effect of maternal diet on thymus cell numbers was found 
(Table 4-8). In the salmon oil group, cell counts were higher at week 6 than at other time 
points. In the soybean oil and sunflower oil groups, cell counts were lowest at week 12 
than at any other time point.   160 
Table 4-8: Cell counts in thymus. Results are shown as mean ± SEM.  
  Week    Salmon oil  Soybean oil  Sunflower oil 
n  11  7  11  3 
Mean ± SEM  16.13 ± 7.73  15.22 ± 3.40  20.11 ± 4.20 
n  9  6  9  6 
Mean ± SEM  42.65 ± 8.76  29.51 ± 10.63  32.39 ± 9.02 
n  10  6  8  9 
Mean ± SEM  10.07 ± 4.78  25.51 ± 13.47  25.31 ± 7.63 
n  7  7  8 
Cell  
number 





Mean ± SEM  16.21 ± 8.32  5.42 ± 1.84  8.12 ± 2.11 
It was not possible to record weight of bone marrow, and hence comparisons are 
made using the total number of cells counted. There was no effect of maternal diet on 
absolute cell counts of bone marrow (Table 4-9). There was no change in cell counts in the 
salmon oil or soybean oil groups over time. Cell counts in the sunflower oil group were 
higher at week 6 than at weeks 3 and 12. 
Table 4-9: Absolute cell counts in marrow of tibia and femurs. Results are shown as mean ± 
SEM. 
  Week    Salmon oil  Soybean oil  Sunflower oil 
n  11  8  11  3 
Mean ± SEM  11.87 ± 2.34  15.69 ± 2.51  10.13 ± 1.52 
n  9  6  7  6 
Mean ± SEM  19.97 ± 1.71  12.99 ± 1.57  25.28 ± 4.83 
n  10  5  8  9 
Mean ± SEM  15.09 ± 1.39  16.41 ± 2.16  17.56 ± 2.09 
n  7  8  9 
Absolute 
number 






Mean ± SEM  17.08 ± 4.77  15.22 ± 2.54  9.88 ± 1.95 
 
4.3.8.  Immune Cell subsets in the Thymus, Spleen, Blood 
and Bone Marrow of Offspring fed the Different Diets 
Cell types and numbers are shown below. Percentage abundance of subsets of bone 
marrow lymphocytes are shown in Table 4-10. There was no effect of maternal diet on 
abundance of cell subsets, but there were changes with time.   161 
Table 4-10: Subsets and abundance of bone marrow lymphocytes. Results are shown as mean 
± SEM. Abundance is shown as % of lymphocytes. Values with different letters denote 
differences in cell abundance in dietary groups between time points (p<0.05). 
   Week    Salmon oil  Soybean oil  Sunflower oil 
n  7  7  7  3 
Mean ± SEM  1.79 ±  0.30
a  1.80 ± 0.39
a  1.36 ± 0.17
a 
n  8  6  6  6 
Mean ± SEM  1.92 ± 0.26
a  2.36 ± 0.44
ab  1.83 ± 0.45
a 
n  10  5  7  9 
Mean ± SEM  2.15 ± 0.45
a  2.45 ± 0.42
ab  1.93 ± 0.27
a 
n  6  8  8 
CD3+CD8+ 
12 
Mean ± SEM  4.25 ± 0.39
b  3.88 ± 0.38
b  3.76 ± 0.40
b 
n  7  7  7  3 
Mean ± SEM  1.41 ± 0.28  1.53 ± 0.22  1.14 ± 0.19 
n  8  6  6  6 
Mean ± SEM  2.02 ± 0.28  1.88 ± 0.40  1.87 ± 0.24 
n  10  4  7  9 
Mean ± SEM  1.29 ± 0.24  1.89 ± 0.35  1.31 ± 0.26 
n  6  8  8 
CD3+CD4+ 
12 
Mean ± SEM  2.03 ± 0.21  1.75 ± 0.16  2.02 ± 0.37 
n  7  7  7  3 
Mean ± SEM  5.55 ± 0.85
a  5.77 ± 0.92
a  6.04 ± 1.04
a 
n  8  6  6  6 
Mean ± SEM  6.16 ± 1.00
a  8.04 ± 1.41
a  6.16 ± 1.11
a 
n  8  5  7  9 
Mean ± SEM  19.17 ± 1.57
b  13.24 ± 3.85
a  12.49 ± 1.13
a 
n  6  7  8 
CD161+ 
12 
Mean ± SEM  22.31 ± 2.13
b  22.29 ± 2.68
b  21.64 ± 3.04
b 
n  7  7  7  3 
Mean ± SEM  36.31 ± 1.80
c  29.11 ± 1.60  30.20 ± 2.95 
n  8  6  6  6 
Mean ± SEM  34.22 ± 2.32
bc  34.98 ± 3.17  35.52 ± 2.76 
n  10  5  7  9 
Mean ± SEM  29.20 ± 3.41
ab  24.37 ± 6.99  29.07 ± 5.32 




Mean ± SEM  23.71 ± 1.93
a  20.70 ± 3.80  21.10 ± 2.98 
n  7  7  7  3 
Mean ± SEM  54.94 ± 2.41  61.80 ± 1.43  61.26 ± 2.93 
n  8  6  6  6 
Mean ± SEM  55.68 ± 2.20  52.74 ± 2.36  54.62 ± 3.24 
n  10  5  7  9 
Mean ± SEM  52.02 ± 3.21  58.43 ± 8.85  55.20 ± 4.76 
n  6  8  8 
Unidentified 
12 
Mean ± SEM  47.70 ± 3.52  54.16 ± 4.16  51.48 ± 1.74 
  
Over time, the percentage of CD3+CD8+ cells (cytotoxic T cells) increased. In the salmon 
oil and sunflower oil groups CD3+CD8+ cells were more abundant at week 12 than at 
weeks 3, 6 and 9. In the soybean oil group percentage of CD3+CD8+ cells was higher at 
week 12 than at week 3. There was no change in percentage of CD3+CD4+ cells (T helper 
cells) across dietary groups. In the soybean oil and sunflower oil groups, percentage of 
CD161+ cells (NK cells) was higher at week 12 than at weeks 3, 6 and 9. In the salmon oil   162 
group, CD161+ cell abundance was higher at weeks 9 and 12 than at weeks 3 and 6. There 
was no effect of time in CD3-CD45RA+ abundance in the soybean oil group, but there was 
a gradual reduction seen in the salmon oil and sunflower oil groups. The “unidentified” 
section is the percentage of cells that are unaccounted for by the markers used. There was 
no effect of time or diet on level of unidentified cells. 
Percentage of subsets of splenic lymphocytes are shown in Table 4-11.   163 
Table 4-11: Abundance of subsets of splenic lymphocytes. Results are shown as mean ± SEM. 
Abundance is shown as % of splenocytes. Values with different letters denote differences in 
cell abundance in dietary groups between time points (p<0.05). 
   Week    Salmon oil  Soybean oil  Sunflower oil 
n  7  7  7  3 
Mean ± SEM  6.81 ± 0.40
a  7.94 ± 1.39
a  7.27 ± 0.43
a 
n  8  6  7  6 
Mean ± SEM  13.01 ± 1.10
ab  17.22 ± 2.55
ab  13.73 ± 1.78
ab 
n  8  4  6  9 
Mean ± SEM  17.75 ± 1.94
b  19.29 ± 1.50
b  14.31 ± 1.60
b 
n  7  8  8 
CD3+CD8+ 
12 
Mean ± SEM  17.26 ± 2.36
b  20.76 ± 2.86
b  20.61 ± 2.91
b 
n  7  7  7  3 
Mean ± SEM  13.08 ± 1.43
a  12.46 ± 1.64
a  12.86 ± 1.15
a 
n  8  6  7  6 
Mean ± SEM  22.19 ± 1.66
b  23.60 ± 2.66
b  23.56 ± 1.90
b 
n  8  4  7  9 
Mean ± SEM  25.14 ± 2.45
b  28.73 ± 3.07
b  30.23 ± 3.04
b 
n  7  8  8 
CD3+CD4+ 
12 
Mean ± SEM  28.15 ± 2.54
b  29.84 ± 2.88
b  27.77 ± 1.91
b 
3  n  7  7  7 
  Mean ± SEM  1.63 ± 0.22  1.57 ± 0.14  1.32 ± 0.26 
6  n  8  6  7 
  Mean ± SEM  1.52 ± 0.28  1.50 ± 0.23  1.40 ± 0.27 
9  n  8  4  7 
  Mean ± SEM  2.85 ± 0.60  1.94 ± 0.36  1.84 ± 0.22 
12  n  7  8  8 
CD161+ 
  Mean ± SEM  1.67 ± 0.33  1.84 ± 0.35  1.36 ± 0.19 
3  n  7  7  7 
  Mean ± SEM  56.72 ± 4.16
b  44.70 ± 2.39  40.23 ± 7.61 
6  n  8  6  7 
  Mean ± SEM  46.12 ± 2.27
ab  42.59 ± 1.83  39.69 ± 3.89 
9  n  8  4  7 
  Mean ± SEM  37.31 ± 5.28
a  39.12 ± 0.68  32.45 ± 6.68 
12  n  7  8  8 
CD3-CD45RA+ 
  Mean ± SEM  40.50 ± 3.25
a  41.10 ± 2.54  34.65 ± 5.15 
3  n  7  7  7 
  Mean ± SEM  4.84 ± 1.37
a  4.53 ± 1.41
a  3.14 ± 0.85
a 
6  n  8  6  7 
  Mean ± SEM  5.03 ± 0.55
a  9.27 ± 2.27
ab  5.21 ± 0.88
a 
9  n  8  4  7 
  Mean ± SEM  13.79 ± 1.53
b  14.55 ± 2.69
b  12.54 ± 1.25
b 
12  n  7  8  8 
CD163+ 
  Mean ± SEM  12.48 ± 1.60
b  14.75 ± 2.27
b  13.32 ± 2.35
b 
n  7  7  7  3 
Mean ± SEM  16.92 ± 2.22
b  28.81 ± 2.62
b  35.18 ± 8.63
b 
n  8  6  7  6 
Mean ± SEM  12.87 ± 3.54
ab  8.08 ± 2.96
a  16.41 ± 4.31
ab 
n  8  4  7  9 
Mean ± SEM  5.97 ± 2.20
ab  2.71 ± 2.22
a  10.70 ± 4.83
a 
n  7  8  8 
Unidentified 
12 
Mean ± SEM  3.85 ± 2.98
a  0.45 ± 0.45
a  7.36 ± 3.47
a 
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There was no effect of diet on abundance of any of the markers measured, although there 
was a trend towards diet affecting B-cell abundance (p = 0.058). In the salmon oil and 
soybean oil groups, percentage of CD3+CD8+ cells was lower at week 3 than at weeks 9 
and 12. In the sunflower oil group CD3+CD8+ cells were more abundant at week 12 than 
week 3. In all groups, CD3+CD4+ cells were less abundant at week 3 than at weeks 6, 9 
and 12. There was no effect of time on CD161+ cell abundance. The sunflower oil and 
soybean oil groups showed no change in CD3-CD45RA+ abundance with time, but in the 
salmon oil group, CD3-CD45RA+ were in greater abundance at week 3 than at weeks 9 
and 12. CD163+ cell expression in the salmon oil and sunflower oil groups were lower at 
weeks 3 and 6 than weeks 9 and 12. In the soybean oil group, CD163+ expression was in 
lower abundance at week 3 than weeks 9 and 12. The percentage of cells that were 
unidentified by the markers used decreased with time.  
Percentage abundance of thymocytes is shown in Table 4-12.   165 
Table 4-12: Abundance of subsets of thymic cells. Results are shown as mean ± SEM. 
Abundance is shown as % thymic cells. Values with different letters denote differences in cell 
abundance in dietary groups between time points (p<0.05). 
   Week    Salmon oil  Soybean oil  Sunflower oil 
n  6  6  7  3 
Mean ± SEM  9.88 ± 1.81
a  12.62 ± 2.46  11.99 ± 1.03 
n  9  6  8  6 
Mean ± SEM  12.76 ± 1.49
ab  13.27 ± 2.03  14.15 ± 1.65 
n  8  5  6  9 
Mean ± SEM  16.84 ± 2.06
ab  18.97 ± 3.97  16.90 ± 2.52 
n  7  8  9 
CD3+CD8+ 
12 
Mean ± SEM  19.26 ± 3.35
b  21.10 ± 3.09  17.78 ± 1.99 
n  7  6  7  3 
Mean ± SEM  20.47 ± 2.69  19.52 ± 3.51  21.09 ± 2.31 
n  8  6  8  6 
Mean ± SEM  20.44 ± 1.94  21.42 ± 3.78  23.46 ± 3.64 
n  8  6  6  9 
Mean ± SEM  30.48 ± 3.02  24.83 ± 3.57  25.83 ± 2.86 
n  7  8  9 
CD3+CD4+ 
12 
Mean ± SEM  28.00 ± 3.76  28.99 ± 2.03  30.63 ± 2.33 
n  7  6  6  3 
Mean ± SEM  0.39 ± 0.05
a  0.47 ± 0.18  0.50 ± 0.17
a 
n  9  5  8  6 
Mean ± SEM  0.32 ± 0.06
a  0.46 ± 0.13  0.33 ± 0.02
a 
n  8  6  6  9 
Mean ± SEM  1.12 ± 0.19
b  0.56 ± 0.17  0.54 ± 0.14
a 
n  7  6  9 
CD161+ 
12 
Mean ± SEM  1.17 ± 0.28
b  0.94 ± 0.24  1.24 ± 0.20
b 
n  7  6  6  3 
Mean ± SEM  0.54 ± 0.11
a  0.32 ± 0.05
a  0.68 ± 0.25
a 
n  9  6  8  6 
Mean ± SEM  0.46 ± 0.12
a  0.45 ± 0.04
a  0.47 ± 0.10
a 
n  8  6  6  9 
Mean ± SEM  1.81 ± 0.31
b  1.07 ± 0.18
b  1.27 ± 0.38
ab 
n  7  8  9 
CD3-CD45RA+ 
12 
Mean ± SEM  1.73 ± 0.31
b  2.03 ± 0.08
c  2.31 ± 0.35
b 
n  7  6  7  3 
Mean ± SEM  70.13 ± 3.78
b  67.07 ± 6.09  65.90 ± 2.91
b 
n  9  6  8  6 
Mean ± SEM  68.29 ± 4.13
ab  64.48 ± 5.67  61.59 ± 5.02
ab 
n  8  6  6  9 
Mean ± SEM  49.76 ± 5.25
a  57.74 ± 7.97  55.46 ± 5.10
ab 
n  7  8  9 
Unidentified 
12 
Mean ± SEM  49.84 ± 7.44
ab  47.18 ±4.47  48.04 ± 4.24
a 
 
There was no effect of diet on any of parameters measured. There was no change in 
CD3+CD8+ abundance over time in the soybean oil and sunflower oil groups, but the 
salmon oil group showed lower abundance at week 3 than week 12. There was no change 
in CD3+CD4+ expression across the time points measured. CD161+ cells were lower at 
week 3 and 6 compared to 9 and 12 in the salmon oil group, whilst there was no change in 
the soybean oil group. In the sunflower oil group, CD161+ cells were higher at week 12   166 
than at weeks 3, 6 and 9. CD3-CD45RA+ in the salmon oil group were significantly lower 
at weeks 3 and 6 than at weeks 9 and 12. In the soybean oil group, there was no difference 
between CD3-CD45RA+ cell abundance at weeks 3 and 6, but there was an increase at 
week 9 and again at week 12. CD3-CD45RA+ expression at week 12 in the sunflower oil 
group were higher than at weeks 3 and 6. There was no effect of time on percentage of 
cells that could not be identified in the soybean oil group, but there was a significant 
reduction between weeks 3 and 12 in the other two dietary groups. 
Effect of diet in pregnancy on offspring immune cells of whole blood is shown in 
Table 4-13.   167 
Table 4-13: Abundance of immune cells in whole blood. Results are shown as mean ± SEM. 
Abundance is shown as % of lymphocytes Values with different letters denote differences in 
cell abundance in dietary groups between time points (p<0.05). 
        Salmon oil  Soybean oil  Sunflower oil 
n  6  7  6  3  
Mean ± SEM  8.61 ± 1.23  7.96 ± 2.02  3.31 ± 0.82 
n  8  5  6  6  
Mean ± SEM  9.44 ± 2.85  5.99 ± 1.70  9.92 ± 0.61 
n  9  8  12  9  
Mean ± SEM  4.31 ± 0.80  4.69 ± 1.12  8.32 ± 1.91 
n  6  5  6 
CD3+CD8+ 
12  
Mean ± SEM  6.63 ± 1.53  5.99 ± 1.92  5.70 ± 1.59 
n  6  7  6  3  
Mean ± SEM  13.18 ± 2.96
a  14.08 ± 1.70  10.77 ± 3.32 
n  8  5  7  6  
Mean ± SEM  11.39 ± 1.85
b  11.86 ± 3.74  20.30 ± 2.02 
n  9  7  12  9  
Mean ± SEM  6.88 ± 1.47
ab  8.69 ± 1.90  13.86 ± 1.77 
n  6  5  6 
CD3+CD4+ 
12  
Mean ± SEM  10.44 ± 1.68
b  10.34 ± 3.71  8.17 ± 2.00 
n  6  7  6  3  
Mean ± SEM  5.18 ± 2.16
a  6.79 ± 2.55  5.54 ± 2.10 
n  7  5  7  6  
Mean ± SEM  6.07 ± 2.70
a  9.08 ± 2.60  7.61 ± 1.98 
n  9  8  11  9  
Mean ± SEM  10.48 ± 1.54
ab  9.99 ± 2.12  13.04 ± 1.99 
n  6  5  6 
CD161+ 
12  
Mean ± SEM  15.51 ± 0.94
b  10.30 ± 3.26  9.91 ± 2.06 
n  5  7  6  3  
Mean ± SEM  30.01 ± 7.06  20.90 ± 1.64  17.03 ± 3.44 
n  8  5  7  6  
Mean ± SEM  18.10 ± 3.81  16.84 ± 3.92  22.96 ± 2.89 
n  9  8  12  9  
Mean ± SEM  16.88 ± 2.51  21.83 ±1.92  23.40 ± 2.00 
n  6  5  6 
CD3-CD45RA+ 
12  
Mean ± SEM  22.95 ± 2.81  18.87 ± 3.71  19.51 ± 2.24 
n  5  7  6  3 
Mean ± SEM  42.33 ± 7.83  52.99 ± 5.98  63.35 ± 4.15
c 
n  7  5  6  6 
Mean ± SEM  53.76 ± 6.17  56.23 ±8.75  38.94 ± 3.20
a 
n  9  7  11  9 
Mean ± SEM  61.44 ± 4.38  55.89 ± 2.38  40.43 ± 3.60
ab 
n  6  5  6 
Unidentified 
12 




There was no effect of diet on the expression of cells measured in blood. In 
addition, there was no effect of time on abundance of CD3+CD8+ or CD3-CD45RA+ 
expression. There was no effect of time on the abundance of CD3+CD4+ in the salmon oil 
or soybean oil groups. CD3+CD4+ expression was higher at week 6 than at weeks 3 and 
12 in the sunflower oil group. There was no effect of time on the abundance of CD161+   168 
cells in the soybean or sunflower oil groups. Expression of CD161+ in the salmon oil 
group was higher at week 6 than at weeks 3 and 12. There was no effect of time on the 
abundance of unidentified cells in the salmon and soybean oil groups. In the sunflower oil 
group, unidentified cells were higher at week 3 than at weeks 6 and 9, and higher at week 
12 than at week 6. 
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4.4. Discussion 
4.4.1.  Summary of findings 
This study aimed to determine whether changes in fatty acid composition of the 
maternal diet may cause changes in the structure of foetal and / or maternal immune cells, 
which in turn may alter the immune system of offspring, following on from previous 
research, which found some effect in foetal rats at around the time of birth 
[133, 217]. The 
study also aimed to determine whether these changes were maintained in later life, at 
weaning and then beyond weaning when offspring are no longer directly affected by 
maternal diet. The study showed that altering maternal dietary fatty acid intake in 
pregnancy did not affect birthing outcomes, tissue weights, abundance of lymphocytes or 
subsets of immune cells in spleen, thymus, bone marrow or whole blood in the offspring at 
age 3, 6, 9 or 12 weeks. The fatty acid profile of maternal plasma at the end of weaning 
differed between dietary groups, and reflected fatty acid intake in pregnancy. There was no 
effect of diet on fatty acid profile of offspring, although there were changes with time. 
 
4.4.2.  Gestational Data  
In addition to their roles in modulation of the immune system, the importance of 
fatty acids in pregnancy has long been recognised 
[222]. Research has suggested that 
heightened n-3 PUFA intake in pregnancy may increase gestation length (reviewed by 
Abayasekara and Wathes 
[223] and Jensen 
[224]). This could occur as a result of decreasing 
PGE2 and increasing PGE3 level, the latter being thought to be less potent at inducing 
contractions than PGE2. However, the current study found no difference in terms of 
gestation length according to diet. This may be an artefact since births were recorded either 
early in the morning or at the end of the day; any births happening after 5 pm would 
therefore be recorded as having occurred the next day.  
Although twelve dams had originally been assigned to each dietary group, only 
nine (soybean oil group) or eleven (salmon oil and sunflower oil groups) animals had 
successful birthing outcomes (i.e. delivered and reared offspring). It is useful to note that 
the dietary groups had similar success rates of delivery, as failure of successful delivery is 
therefore unlikely to be the result of a particular fatty acid(s). However, it cannot be ruled 
out that it could be the result of a high fat diet, or a diet rich in PUFAs in pregnancy 
without the creation of an additional group(s) that would be fed a diet low in PUFAs (such 
as chow or one that uses beef tallow as a fat source) during gestation.  
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4.4.3.  Body and Tissue Weights of Offspring 
Spleen and thymus weights were highly correlated to body weight in both male and 
female offspring. However, there was no difference between body, spleen or thymus 
weight as a result of diet in pregnancy in either males or females. Korotkova et al. 
[152] 
found a gender-related long-term effect on body weights of offspring of feeding PUFAs in 
pregnancy. Rats were fed one of three diets; an n-3 diet (linseed oil), an n-3 / n-6 diet 
(soybean oil) or an n-6 diet (sunflower oil). Males in the soybean oil group were heavier 
than those in the linseed oil or sunflower oil groups. Females in the soybean oil group were 
heavier than those from the linseed oil group, which in turn were heavier than those in the 
sunflower oil group. However, this study used linseed oil as the n-3 source, which may 
induce a more obvious gender effect than using salmon oil (discussed further in 4.4.6). 
There has been much debate on the effect of n-3 PUFAs on body weight at birth 
(reviewed by Jensen 
[224] and Szajewska et al. 
[225]).Whilst it would have been interesting to 
determine the birth weight of the litter in the current trial, this was not carried out since 
handling in the immediate post-partum period can cause infanticide 
[3].  
 
4.4.4.  Fatty Acid Content of Maternal Plasma and 
Tissues, and Offspring Plasma 
The fatty acid profile of maternal plasma at the end of weaning to the most part 
reflected fatty acid intake in pregnancy, although changes were not as extreme as might be 
expected as animals had been receiving chow for three weeks prior to blood and tissue 
collection, and fatty acid profile of plasma reflects a more recent intake of fatty acid than 
fatty acid profile of other tissues or blood components, such as erythrocytes. 
In the CE fraction of maternal plasma, 18:2 n-6 content was higher in the salmon 
oil group than the sunflower oil group. This is not as was expected, as the 18:2 n-6 content 
of diet was lower in the salmon oil diet than the sunflower oil diet. However, the chow diet 
(which dams received following birth) contained a similar percentage of 18:2 n-6 as the 
soybean and sunflower oil diets, which may explain the higher content in plasma of 18:2 n-
6 in salmon oil group compared to sunflower oil group. Alternatively, 18:2 n-6 may have 
been sourced from the dam’s stores, laid down prior to pregnancy, in order to meet 
demands of lactation. 20:5 n-3, total n-3 contents and ratio of n-3 to n-6 PUFAs were 
highest in the plasma of the salmon oil dams.  
There was no difference in fatty acid profile in the NEFA fraction between dietary 
groups. This is as would be expected, since the NEFA fraction has a short half life in the   171 
blood, and partly represents recently absorbed dietary fatty acids 
[18]; dams from all groups 
had been receiving chow since parturition, three weeks previously.  
Trans 18:1 n-9 in the PC fraction of maternal plasma were highest, and 18:3 n-6 
and 20:3 n-6 levels were lowest in the in the soybean oil group compared to other dietary 
groups. Trans 18:1 n-9 content of diets was not determined. 20:5 n-3 levels were higher in 
the salmon oil group compared to the soybean oil group. That there was no significant 
difference between 20:5 n-3 plasma levels between the salmon oil and sunflower oil 
groups was not as expected. There may have been an increased demand of 20:5 n-3 in 
dams receiving the sunflower oil diet because of the lower intake of 20:5 n-3 in pregnancy. 
Whilst the soybean oil group had a low intake of 20:5 n-3 in pregnancy, they had a higher 
intake of its shorter chain precursor, and as such may not have shown an increased demand 
and subsequent circulation of 20:5 n-3 that dams in the sunflower oil group did. 
Trans 18:1 n-9 levels in the TAG fraction were higher in the soybean oil group than 
the sunflower oil group. In the fatty acid analysis of diets, the soybean oil group contained 
higher levels of trans 18:1 n-9 levels than the sunflower oil group, but lower levels than 
the salmon oil group. Trans 18:1 n-9 content of chow was not determined, but the fat 
source of chow is soybean oil, and therefore, it might be reasoned that chow would have a 
similar percentage abundance of this fatty acid (albeit a lower absolute amount). Trans 
18:1 n-9 was higher in the salmon oil diet compared to the soybean oil diet, this difference 
was not reflected in the fatty acid profile of plasma, and may be due to the chow received 
during lactation. Whilst, the soybean oil group continued receiving higher levels of trans 
18:1 n-9 during lactation, and plasma levels of trans 18:1 n-9 in the sunflower oil group 
increased, they did not do so to the level of that in the soybean oil group.  
To date, trials have not examined the effect of fatty acid intake in pregnancy on 
fatty acid profile of plasma of dams at the end of lactation. As such, it is important to also 
examine the effect on fatty acid profile of tissues of dams. As with the maternal plasma 
samples, tissue samples were taken three weeks after parturition, and changes that may 
have been seen if samples had been taken earlier, may not be seen. It was expected that 
tissues in which fatty acids were stored may be less susceptible to the change in diet and 
effect of time. In the liver, which acts as a short-term storage area for fatty acids, there 
were no differences in fatty acid content between groups except for the PC and PE 
fractions. In the thymus and spleen differences in fatty acid content were observed in both 
these fractions and also the NEFA fraction. In all three tissues, fatty acid content reflected 
differences in diet during pregnancy.   172 
Despite the differences observed in maternal tissue and plasma, there was no effect 
of diet in pregnancy on offspring fatty acid profile in plasma, although there was an effect 
of time. This is likely to be due to the fact that plasma reflects the more recent dietary fatty 
acid intake and changes may therefore have been detected in other samples, such as 
erythrocytes, which reflect the dietary fatty acid intake less recently, that were not 
observed here. The effect of time may be due to the fact that from birth, animals received 
milk from a mother who was consuming chow, or they were themselves receiving chow, 
which they were weaned onto at 3 weeks of age. Fatty acid profile of plasma may have 
“normalised” over time to reflect the effect of a longer intake of chow. Whilst differences 
between dietary groups were not significant, there may have been enough of a difference to 
account for there being no apparent difference between groups at a later time point, but 
there being an effect of time.  
 
4.4.5.  Cell Counts and Subsets in the Thymus, Spleen, 
Blood and Bone Marrow 
In agreement with the findings reported in Chapter 2 and Chapter 3, there was no 
effect of fatty acid intake in pregnancy on the abundance of lymphocytes, NK cell, TH 
cells, CTLs, or macrophages. Research has suggested that balance of n-3 and n-6 PUFAs 
may affect balance of TH1 and TH2 cells (1.4). It had originally been intended to examine 
the balance of these cells by analysis of IFN-γ (a characteristic cytokine of TH1 cells) and 
IL-4 (a characteristic cytokine of TH2 cells) abundance following cell culture. However, 
there were insufficient cells to allow this. 
 
4.4.6.  Limitations 
There are a few limitations of this trial; areas in which further investigation could 
be carried out. For example, it would be important to know whether the fatty acid 
manipulation of the gestational diet affected the fatty acids deposited in lymphoid organs 
or in the blood of offspring. However, there were insufficient cells available to allow this. 
It would also be prudent to determine whether changes can be determined in the fatty acid 
deposition in dams at the end of pregnancy. This was not carried out in this trial, however, 
as the dams were required for rearing offspring, which prohibited tissue collection. 
Samples were collected from dams at sacrifice when offspring were weaned, and remain to 
be analysed.   173 
It is possible to collect blood by tail vein sampling of dams, although this could 
further reduce likelihood of successful birthing outcomes and was outside the remit of the 
project and personal licenses. In addition it would have been beneficial to collect and 
analyse the fatty acid composition of breast milk, to determine whether the experimental 
diets are having an effect during lactation (by which time all animals were receiving 
chow). However, due to limitations of Home Office licenses, these investigations were not 
carried out in this trial. 
Several studies have suggested an effect of gender on the metabolism and usage of 
fatty acids, in particular n-3 PUFAs 
[133, 152, 201, 218, 226-228]. As such, there may be a gender-
effect of n-3 PUFAs in pregnancy due to the increased metabolism of ALA in females 
compared to males 
[201, 227], that would not have been realised in this study due to the fact 
that each offspring sample contained tissue from one male and one female pup. However, 
the salmon diets are naturally high in long-chain n-3 PUFAs, so any effect of gender 
conversion on ALA may be less important than it would be in, for example, groups fed 
diets high in the shorter n-3 PUFAs, such as in linseed oil-based feed. This may explain the 
reason that a difference in body weight was observed in the study by Korotkova et al. 
[152], 
who gave a linseed oil-based diet to pregnant rats, whilst a difference was not observed in 
the current study, which used a salmon oil-based diet.  
 
4.4.7.  Conclusions 
This study hypothesised that changes in fatty acid intake in pregnancy would affect 
the fatty acid composition of maternal plasma and tissues (at the end of lactation) and of 
offspring plasma at weaning and beyond, and would affect the abundance of immune cells 
in the lympoid tissues of the offspring. The fatty acid composition of the rat diet during 
pregnancy did affect the fatty acid composition of maternal plasma, liver, spleen and 
thymus at the end of lactation. However there was no effect on offspring fatty acid 
composition at weaning and beyond or on lymphoid organ immune cell subsets. Thus it is 
concluded that the effects of maternal fatty acids on late foetal fatty acid composition and 
thymus lymphocyte sub-populations 
[133, 217, 218]are not retained at weaning or beyond if the 
dams are transferred to a chow diet after giving birth. Thus, these parameters appear not to 
be programmed by maternal fatty acid exposures. However, n-3 and n-6 PUFA balance in 
pregnancy may affect immune markers not measured in this study, such as the balance of 
TH1 and TH2 cells, and subsequently immune reactions. In addition, the functional 
consequences of any changes (that were not measurable in this trial) remain to be 
determined. It may be of particular importance to examine these functional consequences   174 
in vivo, as the immune system is a complex of interacting factors and not the result of the 
action of one singular type of cell(s). For example, dietary intake in pregnancy may affect 
the development of allergy or immune response. These ideas will be explored further in the 









Chapter 5.  Effect of Early Exposure to Fatty 
Acids on Later Allergic Sensitisation 
Examined using a Mouse Model   178   179 
5.1. Introduction 
Findings from Chapter 3 suggest that allergic sensitisation in the mouse may be 
affected by dietary fatty acids. In addition, studies to date have examined either the effect 
of long chain n-3 PUFAs in pregnancy on allergic sensitisation of offspring, or the effect of 
short chain PUFAs in non-pregnant beings on allergic sensitisation. Therefore it was 
decided to examine the effect of short chain PUFAs in pregnancy and lactation on allergic 
sensitisation of the offspring, to see if the immune system was affected by these fatty acids 
at certain periods during development. In collaboration with the University of Utrecht, an 
experiment was carried out to determine the effect of fatty acids given during gestation and 
/ or lactation on development of allergic sensitisation in the offspring; mice were used. Due 
to the number of dietary groups that would be involved if all diets from Chapter 3were 
used, practical constraints limited the number of experimental diets to two; the two 
experimental diets were rich in either one of the essential fatty acids (EFAs) LA or ALA. 
The author was involved in tissue and data collection on the day of euthanisation, whilst 
Dr. Astrid Hogenkamp and Dr. Naomi van Vlies at the University of Utrecht carried out 
feeding and experiments prior to this. The author analysed all data produced. 
 
5.1.1.  EFAs and Pregnancy / Lactation 
A more in-depth discussion of fatty acids (including EFAs) in pregnancy is 
included in 1.6. However, it is important to note that in pregnancy ALA and LA are of 
critical importance to foetal growth and development, because of their roles as components 
of membrane lipids, regulators of gene expression, and precursors of longer chain PUFAs 
and subsequently eicosanoids, in cellular communication, and their direct interactions with 
proteins 
[203]. As ALA and LA cannot be formed de novo, during gestation they must be 
present in the maternal diet, and be transferred across the placenta; after birth ALA and LA 
must be obtained from the infant diet, including breast milk during lactation 
[204]. 
The fatty acid composition of milk varies due to several factors. Human breast milk 
composition varies over the course of the day, during the course of suckling, over the 
course of lactation, and between individuals 
[229]. Fatty acid composition of milk is affected 
by maternal diet before and during lactation, by maternal metabolism, and by the extent to 
which the breast was emptied of milk on the previous feed 
[229, 230]. Emmett and Rogers 
[229] 
suggest that fatty acid composition is the most variable component of breast milk.  
Fatty acids are synthesised in the mammary gland, from fatty acids sourced from 
recent dietary intake, from maternal adipose tissue or de novo synthesis or metabolism in   180 
the maternal liver 
[231]. LA and ALA are only sourced from recent dietary intake or 
maternal adipose tissue. Breast milk provides a wide range of lipids 
[231] which are present 
as globules emulsified in the aqueous fraction of milk. Fat in breast milk is composed 
predominately of TAGs (98 %) 
[232]. Phospholipids (PLs) are thought to contribute to 
approximately 0.8 % of milk fat, although content determined can be affected by the 
method of assessment used 
[232]. Cholesterol accounts for approximately 0.5 % of milk fat. 
The remainder of lipids in milk are made up by sphingomyelin, glycosphingolipids and 
glucosylceramide 
[232]. Lipids in milk are absorbed by the infant as described in 1.3.3, with 
absorption of fatty acids from breast milk aided by the presence of lipases secreted in milk 
[21]. 
 
5.1.2.  EFAs in Pregnancy and Allergy Development in 
Later Life 
The foetal immune system starts to develop before birth, and continues postnatally, 
and as such, the foetus and newborn may be more sensitive to the effects of dietary fatty 
acids than adults. Previous research has also suggested that fish oil in pregnancy has the 
potential to reduce allergic sensitisation 
[233, 234]. However, there is a dearth of research on 
the effect of EFAs in pregnancy and / or lactation on the development of allergies in later 
life. Duchén et al. 
[235] suggested a relationship between low ALA and long chain n-3 
PUFAs content of breast milk and an increase in symptoms of allergic disease at 18 
months. Research has suggested that diet in pregnancy may be similar in women to diet 
outside of pregnancy 
[236], and potentially, therefore, diet onto which the child is weaned 
could be similar to the mother’s diet after and during pregnancy. Therefore, Duchén et al. 
may have missed a critical window of effect, or rather, encompass this critical window, but 
also include other periods of time at which fatty acids may not affect the immune system. 
Whilst Duchén et al. does not provide a conclusive link, or identify any temporal effects, it 
does suggest that there is potentially a link between EFAs and allergy development. The 
effect of diet in lactation also needs further exploration; it is undetermined whether fatty 
acids either in lactation alone, or during both pregnancy and lactation, have any effect on 
development of allergy in offspring. 
 
5.1.3.  Aims of the Study 
This study aimed to determine the effect of diets containing differing levels of LA 
and ALA given during gestation and / or lactation, on the immune response in a mouse   181 
model of allergy to the egg protein ovalbumin. Altering intake of fatty acids may cause 
structural and functional changes in the immune system of the mouse, causing them to 
become more or less susceptible to their allergy. In addition, mice may be more susceptible 
to the effects of fatty acids at certain periods (i.e. gestation and / or lactation) if a critical 
window is in effect. 
In order to achieve this aim, three diets were fed to 8-week old mice during 
gestation and / or lactation. In contrast to previous experiments, experimental diets 
contained a synthetic blend of oils, in order to determine the effect of specific fatty acids 
on the immune system. The first diet was a high fat (10 %) LA-rich diet, and the second a 
high fat (10 %) ALA-rich diet. The third diet was chow, a lower fat (7 % diet) diet whose 
fat source is soybean oil (and therefore contained a balance of LA and ALA). Mice were 
then split into seven groups using these diets. One group received chow during both 
gestation and lactation (Control). The others received the LA diet in gestation and chow 
during lactation (LG), the LA diet during both gestation and lactation (LGL), chow during 
gestation and LA diet during lactation (LL), ALA during gestation and chow at lactation 
(AG), ALA during both gestation and lactation (AGL), or chow during gestation and ALA 
during lactation (AL). Following lactation, male offspring were weaned onto a diet 
formulated to represent a Western diet; this was rich in SFAs and MFAs (“Western” diet). 
This is summarised in Table 5-1. 
Table 5-1: Diets used in this trial. 
Group  Gestation Diet  Lactation Diet  Diet From Weaning 
Control  Chow  Chow  “Western” diet 
AG  ALA-rich  Chow  “Western” diet 
AGL  ALA-rich  ALA-rich  “Western” diet 
AL  Chow  ALA-rich  “Western” diet 
LG  LA-rich  Chow  “Western” diet 
LGL  LA-rich  LA-rich  “Western” diet 
LL  Chow  LA-rich  “Western” diet 
 
 
5.1.4.  Hypothesis 
This study set out to test the following hypotheses: 
•  Feeding the ALA-rich diet in pregnancy will reduce the severity of allergic reactions 
•  Feeding ALA-rich diet in pregnancy (but not lactation) will reduce the severity of 
allergic reactions more than feeding ALA-rich diet in lactation (but not pregnancy)   182 
•  Feeding the ALA-rich diet in both pregnancy and lactation will result in the same 
severity of allergic reactions as feeding the ALA-rich diet in pregnancy alone 
•  Feeding the LA-rich diet in pregnancy will increase the severity of allergic reactions 
•  Feeding the LA-rich diet in pregnancy (but not lactation) will increase the severity of 
allergic reactions more than feeding LA-rich diet in lactation (but not pregnancy) 
•  Feeding the LA-rich diet in both pregnancy and lactation will result in the same 
severity of allergic reactions as feeding the LA-rich diet in pregnancy alone 
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5.2. Materials and Methods 
5.2.1.  Animals, Diets and Materials 
5.2.1.1.  Animals 
8 week old non-nulliparous BALB/C mice were obtained from Charles River 
(Maastricht). Following mating, dams were housed in individually in shoebox cages, and 
kept at 22°C ± 2°C, under a 12 hour light: 12 hour dark cycle in temperature and light-
controlled room in the animal facility at the Pharmacology Department, University of 
Utrecht. Animals had ad libitum access to tap water and 150 g food was provided on 
alternate days. Animal care and use were performed in accordance with the guidelines of 
the Dutch Committee of Animal Experiments. 
 
5.2.1.2.  Diets 
Diets used in this experiment were different from those used previously in order to 
determine the effect of ALA and LA on allergic sensitisation. The high-fat experimental 
diets - ALA- and LA-rich diets - and the low-fat soybean oil-based chow (AIN-93) were 
obtained from Research Diet Services B.V. (Wijk bij Duurstede, Netherlands). 
Experimental diets were produced by replacing 3 % of the wheat content of AIN-93 with a 
fat blend high in LA or ALA. Macronutrient composition of the diets is shown in Table 5-2. 
Table 5-2: Macronutrient composition of AIN-93 (low fat), experimental (high fat) and 
“Western” diets. Taken from Research Diet Services 
[237]. 
Component  AIN-93  Experimental diets  “Western” diet 
Carbohydrate (g / 100 g)  64  60  60 
Protein (g / 100 g)  20  20  20 
Fat (g / 100 g)  7  10  10 
Fibre (g / 100g)  5  5  5 
Mineral Mix  (mg / 100 g)  35  35  35 
Vitamin Mix (mg / 100 g)   10  10  10 
 
The fatty acid content of diets is shown in Appendix Four and fatty acids of interest 
are shown in Figure 5-1.   184 
 
Figure 5-1: Profile of fatty acids of interest, total n-3 and n-6 PUFA contents. 
The control diet had a high percentage of LA and n-6 PUFAs, and low ALA, AA, 
EPA and total n-3 PUFAs. The ALA diet had a high percentage of ALA and n-3 PUFAs, 
but a low percentage of LA, AA, EPA, DHA and n-6 PUFAs. The LA diet was rich in LA, 
and total n-6 PUFAs, but low in ALA and n-3 PUFAs. The “Western” diet had a low LA, 
ALA, AA, EPA, DHA, n-3 and n-6 content, but was high in SFAs and MFAs. 
 
5.2.1.3.  Chemicals 
Sources of chemicals were identical to those used previously (3.2.1.3). 
 
5.2.2.  Methods 
An overview of the trial is provided in Figure 5-2. Sixteen 8-week old BALB/C 
female mice were randomised to one of seven dietary groups, and bred with age-matched 
controls. The dietary groups were a control diet (3%  fat, containing soybean oil), ALA-
rich diet in gestation only, ALA-rich diet in gestation and lactation, ALA-rich diet in 
lactation only, LA-rich diet in gestation only, LA-rich diet in gestation and lactation, LA-
rich diet in lactation only. Animals that received the ALA- or LA-rich diet in either 
gestation or lactation alone were transferred to the control diet in the alternate period. At   185 
21 days old, male pups were weaned onto a “Western” diet (rich in SFAs and MFAs, low 
in LA and ALA). Blood samples were taken from both dams and pups at this period by 
sampling from the cheek. 
Pups were sensitised to ovalbumin at days 43 and 50. Acute skin tests were carried 
out on day 63. Mice (offspring) were challenged on days 71, 74, and 77 ± 1. Airway 
responsiveness was measured on day 78 ± 1. Euthanisation occurred by intra peritoneal 
injection of 1 ml 10 % urethane on day 78 ± 1.  
 
Figure 5-2: Schematic diagram of experiment examining the effect of fatty acids in gestation 
and / or lactation on a mouse model of allergic asthma. 
 
5.2.2.1.  Sensitisation of Mice to Ovalbumin 
Mice were sensitised with ovalbumin at days 43 and 50, using the method 
described in 3.2.2.1. 
 
5.2.2.2.  Acute Skin Test to Ovalbumin Challenge 
An acute skin test was carried out at day 63, using the method described in 3.2.2.2.  
 
5.2.2.3.  Determination of Airway Responsiveness to 
Ovalbumin 
Mice were challenged with aerosolised ovalbumin at days 71 ± 1, 74 ± 1, 77 ± 1, 
and airway responsiveness to methacholine measured on day 78 + 1, using the method 
described in 3.2.2.3.    186 
 
5.2.2.4.  Fatty Acid Analysis of Diet and Erythrocytes 
At euthanisation, blood was collected, and erythrocytes separated, and together 
with samples of diet were analysed for fatty acids using the method previously described 
(2.2.2.3). 
 
5.2.2.5.  Analysis of Plasma Immunoglobulin Concentrations 
Plasma, collected at euthanisation, was collected and analysed for IgG1, IgG2a and 
IgE using sandwich ELISAs, following the manufacturer’s instructions. 
 
5.2.2.6.  Analysis of Bronchoalveolar Lavage Fluid 
Bronchoalveolar lavage fluid (BALF) was collected and analysed as described 
previously (3.2.2.6). 
 
5.2.2.7.  Determination of IL-5 Content of BALF 
BALF was analysed for IL-5 content using the method described previously 
(3.2.2.7). 
 
5.2.2.8.  Cytospin Analysis of BALF 
BALF cells were collected and analysed as described previously (3.2.2.8). 
 
5.2.2.9.  Analysis of Immune Tissue, Fat and Liver 
Spleen, thymus, epididymal fat pads and liver were removed and weighed. Bone 
marrow was collected as described previously (2.2.2.5). 
 
5.2.2.10.  Histological Analysis of the Thymus 
Sections of the thymus were analysed for cortex / medulla ratio as described 
previously (2.2.2.6). 
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5.2.2.11.  Determination of Cytokine Production by 
Splenocytes 
Splenocytes were prepared and cultured as described in 2.2.2.7. IFN-γ, IL-4 and IL-
10 production in response to ovalbumin and αCD3 by spleen cells were analysed using the 
method described in 3.3.7. 
 
5.2.2.12.  Determination of Cell Subsets in Lymphoid Tissues 
using Flow Cytometry 
Single cell suspensions of spleen, thymus and bone marrow were prepared and 
analysed for cell surface marker expression following the methods described in 2.2.2.8. 
 
5.2.2.13.  Statistical Analysis 
Results were analysed using SPSS version 15.0. Parameters were analysed using 
Levene’s test of homogeneity to ensure groups had equal variances, in which case they 
were compared using one-way analysis of variance (ANOVA), followed by post-hoc 
testing (Tukey). If Levene’s test showed unequal variances to be present, groups were 
compared using the Kruskal-Wallis test. Where this was used, it is reported in the results 
section. If the Kruskal-Wallis test indicated a significant effect, Mann-Whitney U 
independent group comparisons tests were then carried out to compare each combination 
of groups. Analysis of fatty acid content of erythrocytes at weaning and euthanisation was 
compared using two-way ANOVA. If variances were present, fatty acid content of dietary 
groups was compared using one-way ANOVA, followed by post-hoc testing (Tukey). 
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5.3. Results 
5.3.1.  Gestational Data 
Data on diet in gestation on numbers of offspring, males, females or ratio of males 
to females are shown in Table 5-3. There was no effect of diet on any of the parameters 
measured. 
Table 5-3: Effect of diet in gestation on number of offspring, males, females and ratio of 
males to females. Ratio of males to females was analysed using non-parametric testing. There 
was no effect of diet on any of the parameters measured. 
  Control 
(n = 7) 
ALA-rich 
(n = 6) 
LA-rich 
(n = 4) 
Offspring (n)  8.1 ± 0.5  6.5 ± 0.8  7.0 ± 1.1 
Males (n)  2.7 ± 0.4  2.7 ± 0.8  2.8 ± 0.5 
Females (n)  5.4 ± 0.5  3.8 ± 1.3  4.3 ± 1.4 
Ratio of males to females  0.6 ± 0.1  1.9 ± 1.0  1.2 ± 0.6 
 
5.3.2.  Body Weights of Offspring of Mice fed the Different 
Diets 
Changes in body weight in offspring mice from different dietary groups are shown 
in Figure 5-3.    189 
 
Figure 5-3: Body weight of offspring mice during the trial. Mice were born from day 0, 
weaning took place at day 21. 
At day 28, the AG and LG groups were heavier than the LL and LGL groups. At 
day 35, the AL, LG and AG groups were heavier than the AGL group. At day 42 the LG 
group was heavier than the AGL and LL groups. At day 49, the AG, AL and LG groups 
were heavier than the AGL group. At day 56 the LG group was heavier than the AGL 
group. At day 63 the LG group was heavier than the LL group. There were no differences 
in body weights between dietary groups at days 21, 70 or 78 ± 1 (day of euthanisation; data 
not shown). 
 
5.3.3.  Tissue weights of Offspring of Mice fed the 
Different Diets 
Tissue weights of mice fed the different experimental diets are shown in Table 5-4. 
Brains were lighter in the control group than all groups receiving high fat diets in gestation 
and / or lactation, when data was expressed both as an absolute value and in proportion to 
body weight. There were no differences in weight of immune tissues between dietary 
groups.    190 
Table 5-4: Effect of diet on tissue weights of mice. Values with different letters are statistically different from one another (p < 0.05). Epididymal fat (g and % of 
body weight) was analysed using non-parametric testing. 
  Control 
(n = 5) 
AG 
(n = 9) 
AGL 
(n = 3) 
AL 
(n = 7) 
LG 
(n = 5) 
LGL 
(n = 5) 
LL 
(n = 7) 
Spleen (g)  0.14 ± 0.01  0.15 ± 0.01  0.17 ± 0.01  0.16 ± 0.02  0.15 ± 0.01  0.16 ± 0.01  0.15 ± 0.00 
Spleen (% of body weight)  0.53 ± 0.05  0.58 ± 0.03  0.63 ± 0.04  0.61 ± 0.03  0.57 ± 0.02  0.63 ± 0.04  0.57 ± 0.02 
Thymus (g)  0.04 ± 0.01  0.04 ± 0.00  0.03 ± 0.00  0.04 ± 0.00  0.03 ± 0.00  0.04 ± 0.00  0.05 ± 0.00 
Thymus (% of body weight)  0.15 ± 0.02  0.14 ± 0.01  0.10 ± 0.01  0.15 ± 0.01  0.13 ± 0.01  0.18 ± 0.02  0.16 ± 0.02 
Liver (g)  1.52 ± 0.05  1.47 ± 0.03  1.49 ± 0.03  1.43 ± 0.06  1.47 ± 0.03  1.30 ± 0.06  1.42 ± 0.05 
Liver (% of body weight)  5.72 ± 0.10  5.62 ± 0.08  5.66 ± 0.29  5.66 ± 0.22  5.47 ± 0.11  5.17 ± 0.21  5.55 ± 0.11 
Epididymal fat (g)  0.49 ± 0.07  0.50 ± 0.03  0.48 ± 0.03  0.46 ± 0.06  0.44 ± 0.01  0.53 ± 0.04  0.44 ± 0.04 
Epididymal fat (% of body weight)  2.07 ± 0.22  1.90 ± 0.11  1.85 ± 0.20  1.94 ± 0.30  1.63 ± 0.04  2.04 ± 0.15  1.61 ± 0.17 
Brain (g)  3.96 ± 0.11
a  4.48 ± 0.07
b  4.68 ± 0.14
b  4.59 ± 0.08
b  4.78 ± 0.12
b  4.57 ± 0.09
b  4.73 ± 0.04
b 
Brain (% of body weight)  14.98 ± 0.61
a  17.15 ± 0.31
b  17.71 ± 0.78
b  18.23 ± 0.53
b  17.83 ± 0.51
b  18.19 ± 0.84
b  17.96 ± 0.41
b 
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5.3.4.  Fatty Acid Content of Erythrocytes of Offspring of 
Mice fed the Different Diets 
Erythrocytes from offspring taken at weaning and euthanisation were analysed for 
fatty acid content. Data are shown in detail in Appendix Four and data for fatty acids of 
interest are shown in Figure 5-4.   192 
 
Figure 5-4: Profile of certain fatty acids, total n-3 and n-6 PUFA contents of RBCs at euthanisation and weaning. Values with different letters denote differences 
in fatty acid abundance between dietary groups. Asterisks denote differences in fatty acids between time periods.  193 
At weaning, ALA content of erythrocytes was higher in the AGL group than the 
control, AG, LG, LGL and LL groups. The AA content was higher in the AG, LGL and LL 
groups than in the AL group at weaning. EPA content was higher in the AL group than all 
groups except AGL at weaning; EPA content in the AGL group was higher than in the 
control and groups receiving the LA-rich diet. At weaning, DHA content was higher in the 
AGL group than all other dietary groups with the exception of the AL group; DHA content 
was higher in groups receiving the ALA-rich diet than those on the control or LA-rich diet. 
At weaning, n-3 PUFA content was highest in the AGL and AL groups. n-6 PUFA content 
at weaning was higher in the LGL group than the AL group.  
At euthanisation, when mice had been receiving the “Western diet” for 57 ± 1 days, 
AA content was lower in the AGL group than all other groups, and n-6 content was lower 
in the AG and AGL groups than all other groups. Differences in ALA content between 
blood samples taken at weaning, and those taken at euthanisation were observed in the 
LGL and LL groups. AA content was higher in all groups at euthanisation compared to 
weaning. EPA content was higher in all groups at euthanisation except for the AL group, 
where no difference was observed. DHA and n-6 content were higher at euthanisation than 
weaning for all groups. n-3 content was higher in all groups except for the AGL and AL 
groups at euthanisation compared to weaning. 
 
5.3.5.  Airway Responsiveness in the Offspring of Mice 
fed the Different Diets 
 Airway responsiveness data is shown in Figure 5-5. There was no effect of maternal 
diet on airway responsiveness to methacholine in ovalbumin-sensitised mice. However, 
SEMs were large, and there may have been differences that were obscured due to this, and 
that may have been apparent if sample sizes were higher.   194 
 
Figure 5-5: Effect of diet on airway responsiveness to increasing doses of methacholine at day 
78 of the trial. 
 
5.3.6.  Acute Skin Test in Offspring of Mice fed the 
Different Diets 
The effect of the experimental diets on ear swelling in response to ovalbumin is 
shown in Figure 5-6.   195 
 
Figure 5-6: Effect of maternal diet on ear swelling in response to ovalbumin in ovalbumin-
sensitive offspring. Bars with different letters are statistically different from one another (p < 
0.05). 
Ear swelling in response to ovalbumin was lower in animals whose dams had 
received the ALA-rich in gestation and / or lactation, and those receiving the LA-rich diet 
in gestation compared to those receiving the low fat control diet for the whole period. 
Animals in the AL group had a lower ear swelling response than the LGL and LL groups. 
 
5.3.7.  Plasma Immunoglobulin Concentrations in 
Offspring of Mice Fed the Different Diets 
Antibody concentrations of plasma is shown in  Figure 5-7 (IgE), Figure 5-8 (IgG1) 
and Figure 5-9  (IgG2a). There was no effect of diet in gestation or lactation on any of the 
parameters measured.   196 
 
 Figure 5-7: IgE content of plasma of mice whose dams had received different diets during 
gestation and / or lactation. There was no significant difference between groups. Data was 
analysed using non-parametric testing. 
 
Figure 5-8: IgG1 content of plasma of mice whose dams had received different diets during 
gestation and / or lactation. There was no significant difference between groups. Data was 
analysed using non-parametric testing.   197 
 
Figure 5-9: IgG2a content of plasma of mice whose dams had received different diets during 
gestation and / or lactation. There was no significant difference between groups. Data was 
analysed using non-parametric testing. 
 
5.3.8.  Cytokine Production by Cultured Splenocytes from 
Offspring of Mice Fed the Different Diets 
Anti-CD3- and OVA-stimulated production of IL-4, IL-10, IL-5 and IFN-γ 
production of cultured spleen cells is shown in Figure 5-10 to Figure 5-17. There was no 
effect of diet on any of the parameters measured, but there was large variation observed.   198 
 
Figure 5-10: Effect of diet on OVA-stimulated IL-4 production in spleen cells. There was no 
significant difference between dietary groups. 
 
Figure 5-11: Effect of diet on CD3-stimulated IL-4 production in spleen cells. There was no 
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Figure 5-12: Effect of diet on OVA-stimulated IL-10 production in spleen cells. There was no 
significant difference between dietary groups. 
 
Figure 5-13: Effect of diet on CD3-stimulated IL-10 production in spleen cells. There was no 
significant difference between dietary groups. Data was analysed using non-parametric 
testing.   200 
 
Figure 5-14: Effect of diet on OVA-stimulated IL-5 production in spleen cells. There was no 
significant difference between dietary groups. Data was analysed using non-parametric 
testing. 
 
Figure 5-15: Effect of diet on CD3-stimulated IL-5 production in spleen cells. There was no 
significant difference between dietary groups.   201 
 
Figure 5-16: Effect of diet on OVA-stimulated IFN-γ production in spleen cells. There was no 
significant difference between dietary groups. Data was analysed using non-parametric 
testing. 
 
Figure 5-17: Effect of diet on CD3-stimulated IFN-γ production in spleen cells. There was no 
significant difference between dietary groups. 
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5.3.9.  IL-5 Content of BALF from Offspring of Mice Fed 
Different Diets 
IL-5 content of BALF is shown in Figure 5-18. There was no significant difference 
between dietary groups. 
 
Figure 5-18: IL-5 content of bronchoalveolar lavage fluid. There was no significant difference 
between any dietary groups. 
 
5.3.10.  Cytospin Analysis of BALF from Offspring of Mice 
Fed the Different Diets 
Results from the cytospin analysis of the bronchoalveolar lavage fluid (BALF) are 
shown in Figure 5-19. There was no effect of diet in gestation or lactation on any of the 
parameters measured.   203 
 
Figure 5-19: Cytospin analysis of bronchoalveolar lavage fluid. There was no effect of diet on 
any of the parameters measured. 
 
5.3.11.  Histological Analysis of Thymuses from Offspring 
of Mice Fed the Different Diets 
The cortex / medulla ratio of mice thymuses is shown in Figure 5-20. There were 
no significant differences between dietary groups.   204 
 
Figure 5-20: Cortex / Medulla ratio of thymuses. There were no significant differences as a 
result of diet. Due to errors in data collection, only one sample was usable for analysis in the 
AGL group. 
 
5.3.12.  Cell Subsets in the Thymus, Spleen and Bone 
Marrow from Offspring of Mice Fed the Different Diets 
Effect of diet on expression of cell surface markers of the thymus is shown in Table 
5-5. CD3+ expression in thymus cells was lowest in the control and AG groups, and higher 
in the LG, LGL and LL groups than in the AL group. CD3+ cells that also expressed CD4+ 
cells were lowest in the LG and LGL groups, and highest in the AGL and LL groups. 
CD3+ cells that also expressed CD8+ in the thymus were lower in the control, AG, AGL 
and AL groups than in the LG and LGL groups. There was no effect of diet on CD3+CD4+ 
cells that were also CD69+. Expression of CD62L+ on CD3+CD4+ thymus cells was 
higher in the control and AG groups than all other groups. CD4+CD25+ expression in 
thymus cells was higher in the AG and LL groups than the AGL and AL groups. 
Expression of FoxP3+ in the CD4+CD25+ thymus cells was lowest in the control group, 
and highest in the LG, LGL and LL groups.   205 
Table 5-5: Effect of diet on the expression of cell surface markers of the thymus. All parameters were analysed using non-parametric testing. Values with 
different letters denote differences in cell abundance between dietary groups. 
  Cells Identified  Control 
(n = 5) 
AG 
(n = 9) 
AGL 
(n = 3) 
AL 
(n = 7) 
LG 
(n = 5) 
LGL 
(n = 4) 
LL 
(n = 7) 
CD3+  T-cells  81.29 ± 1.58
a  77.59 ± 4.63
a  94.71 ± 1.30
bcd  94.12 ± 0.46
b  97.10 ± 0.80
cd  98.27 ± 0.25
d  96.64 ± 0.59
c 
CD3+ that are also CD4+  TH cells  91.87 ± 0.36
b  93.71 ± 0.68
b  97.52 ± 0.05
c  97.51 ± 0.05
c  84.05 ± 0.98
a  83.23 ± 0.85
a  97.22 ± 0.16
c 
CD3+ that are also CD8+  CTLs  83.25 ± 1.34
ab  73.96 ± 7.07
a  82.66 ± 0.56
ab  83.51 ± 1.47
ab  87.82 ± 0.95
c  89.76 ± 1.41
c  86.95 ± 1.27
bc 
CD3+CD4+ that are also CD62L+  L-selectin expression  95.21 ± 0.67
c  85.13 ± 4.69
c  64.66 ± 2.02
ab  67.51 ± 1.07
b  64.47 ± 1.00
a  63.57± 3.21
ab  67.97 ± 1.54
ab 
CD4+CD25+  T-regs  4.01 ± 0.83
abcd  4.30 ± 0.52
d  1.77 ± 0.05
a  2.24 ± 0.16
b  2.14 ± 0.21
ab  2.38 ± 0.55
abc  3.48 ± 0.50
cd 
CD4+CD25+ that are also FoxP3+  T-regs  8.74 ± 1.08
a  10.92 ± 2.48
ab  19.14 ± 1.42
bc  13.97 ± 3.04
b  20.14 ± 1.39
c  24.83± 2.03
c  29.62 ± 4.02
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Effect of diet on expression of cell surface markers of the spleen is shown in Table 
5-6. F4-80+ (macrophage) expression in the spleen was highest in the AL group, and 
lowest in the control, AG, LG and LL groups. There was no difference in CD3+ expression 
between dietary groups. CD3+ cells that also expressed CD4+ abundance was highest in 
the AGL, AL and LL groups; these groups also had the lowest expression of CD8+. 
CD3+CD4+ cells that also expressed CD62L+ abundance was lower in the LG and LGL 
groups than the LL group. CD3+CD4+ cells that were CD69+ were lowest in the LL 
group, and higher in the control group than the AGL and LGL groups. CD19+ expression 
was lower in the AGL, AL and LL groups than the control and AG groups. CD4+CD25+ 
expression was lower in the AL group than the AGL, LGL and LL groups, and lower in the 
LGL group than the LL group. FoxP3+ expression in CD4+CD25+ cells was lower in the 
control and AG groups than the AGL, AL, and LL groups. CD94+ expression was lower in 
the control group than in the LL group. 
Effect of diet on expression of cell surface markers of bone marrow is shown in 
Table 5-7; this was the only cell type measured in bone marrow. There was no effect of 
diet on CD19+ expression in bone marrow.    207 
Table 5-6: Effect of diet on the expression of cell surface markers of the spleen. Data is not available for CD19+ in the 2G and 2GL group due to errors in stain 
formulation. CD3+CD8+, CD3+CD4+CD69+ CD4+CD25+, and CD4+CD25+FoxP3+ were analysed using non-parametric testing. Values with different letters 
denote differences in cell abundance between dietary groups. 
  Cells Identified  Control 
(n = 5) 
AG 
(n = 9) 
AGL 
(n = 3) 
AL 
(n = 7) 
LG 
(n = 5) 
LGL 
(n = 5) 
LL 
(n = 7) 
F4-80  Macrophages  6.35 ± 0.63
a  7.23 ± 1.09
ab  14.60 ± 1.77
c  21.61 ± 1.13
d  8.93 ± 0.89
ab  11.48 ± 1.25
bc  4.71 ± 0.56
a 
CD3+  T-cells  29.17 ± 1.76  28.51 ± 1.02  28.95 ± 1.69  28.21 ± 2.06  31.47 ± 0.61  28.13 ± 1.18  25.14 ± 0.80 
CD3+ that are also CD4+  TH cells  54.15 ± 1.50
a  58.65 ± 2.35
ab  71.64 ± 2.08
c  64.49 ± 2.51
bc  51.07 ± 0.88
a  50.61 ± 2.80
a  66.68 ± 0.85
bc 
CD3+ that are also CD8+  CTLs  14.93 ± 0.66
d  10.63 ± 1.88
cd  1.50 ± 0.07
b  1.47 ± 0.12
ab  2.65 ± 0.91
bc  1.66 ± 0.07
bc  1.26 ± 0.04
a 
CD3+CD4+ that are also CD62L+  L-selectin expression  47.79 ± 2.90
ab  48.98 ± 2.73
ab  49.15 ± 2.96
ab  46.97 ± 1.13
ab  43.37 ± 2.22
a  40.65 ± 2.72
a  56.83 ± 1.59
b 
CD3+CD4+ that are also CD69+  Activated leukocytes  64.41 ± 2.20
c  73.36 ± 7.51
bc  42.14 ± 4.65
b  71.98 ± 8.36
bc  49.26 ± 5.20
bc  47.81 ± 2.33
b  28.98 ± 0.89
a 
CD19+  B-cells  16.16 ± 1.18
b  13.67 ± 1.23
b  8.25 ± 0.52
a  7.51 ± 0.67
a      6.01 ± 0.46
a 
CD4+CD25+  T-regs  5.73 ± 0.79
abc  4.43 ± 0.75
ab  4.83 ± 0.16
b  4.16 ± 0.11
a  4.85 ± 0.39
ab  5.11 ± 0.30
b  7.28 ± 0.47
c 
CD4+CD25+ that are also FoxP3+  T-regs  4.52 ± 2.19
a  8.12 ± 3.71
ab  31.52 ± 4.52
cd  31.42 ± 1.37
d  24.37 ± 1.71
bc  23.56 ± 1.90
bc
  23.18 ± 2.02
c 
CD94+  NK cells  36.30 ± 2.58
a  44.55 ± 0.99
ab  41.84 ± 2.48
ab  41.86 ± 2.67
ab  44.70 ± 0.68
ab  46.31 ± 1.75
ab  40.71 ± 0.97
b 
Table 5-7: Effect of diet on the expression of cell surface markers of bone marrow. There was no effect of diet on CD19+ expression. 
  Cells Identified  Control 
(n = 5) 
AG 
(n = 9) 
AGL 
(n = 3) 
AL 
(n = 7) 
LG 
(n = 5) 
LGL 
(n = 5) 
LL 
(n = 7) 
CD19+  B-cells  6.76 ± 0.84  13.80 ± 3.34  5.84 ± 0.82  9.48 ± 2.01  6.94 ± 4.00  8.59 ± 4.12  12.44 ± 3.18 
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5.4. Discussion 
5.4.1.  Summary of findings 
This study aimed to determine the effect of diets differing levels of ALA or LA 
given during gestation and / or lactation, on the immune response in a mouse model of 
allergy to the egg protein ovalbumin. The study set out to test hypotheses of reduced 
severity with ALA-rich diet in pregnancy / pregnancy and lactation and increased severity 
with LA-rich diet in pregnancy / pregnancy and lactation. It was hypothesised that 
increased ALA or LA intake in lactation would have less of an effect than increased ALA 
or LA intake in pregnancy. 
Using ear swelling in response to ovalbumin, to which the mice had been 
sensitised, as the outcome, animals whose dams had received the ALA-rich in gestation 
and lactation, and those receiving the LA-rich diet in gestation had lower ear swelling 
compared to those receiving the low fat control diet for the whole period. Animals 
receiving the ALA-rich diet in lactation had lower ear swelling response than those 
receiving the LA-rich diet in gestation and lactation, or lactation alone. Despite this, there 
were no effects on lung function or immune markers measured in BALF, plasma, 
thymocytes, bone marrow or splenocytes.  
Fatty acid analysis of diets showed that they contained the fatty acids expected; the 
control group had high a balance of n-3 and n-6 PUFAs, the LA-rich diet had high LA and 
n-6 PUFAs, the ALA-rich diet had high ALA and n-3 PUFAs, and the “Western” diet was 
rich in SFAs and MFAs. This was to the most part reflected in fatty acid analysis of 
erythrocytes taken at weaning, particularly in groups receiving experimental diets during 
lactation. By euthanisation, most of these differences in fatty acid composition of 
erythrocytes induced by diet had been lost.  
 
5.4.2.  Fatty Acid Content of Erythrocytes and Diets 
Fatty acid content of diet was to the most part reflected in fatty acid analysis of 
erythrocytes taken at weaning, particularly in groups receiving experimental diets during 
lactation. Animals receiving the ALA-rich diets had higher levels of the long chain n-3 
PUFAs EPA and DHA, presumably because of reduced competition for the elongase and 
desaturase enzymes from n-6 PUFAs. By euthanisation, most of these differences in fatty 
acid composition of erythrocytes induced by diet had been lost. The exceptions to this were 
the lower AA content of erythrocytes in the AGL group and the lower n-6 PUFA content 
of the AG and AGL groups. The AA content of the AGL group may have been lower as   209 
the lower-AA (ALA-rich) diet had been consumed for a longer period (six weeks) than the 
AG or AL groups (three weeks). Supplementing lactating women with flaxseed oil (10.7 g 
ALA per day) for six weeks reduced AA content of erythrocytes at end of 
supplementation, and four weeks after supplementation ceased compared to baseline 
values 
[238]. The reduction in AA content seen in women supplementing in lactation was 
not observed in the current study, which may have been due to the shorter period of 
supplementation, or the lower dose received by mice compared to that of the women. The 
n-6 PUFA content being lower in the AG and AGL groups is lower due to the n-3 rich diet 
received. It is possible that the AL group, in contrast to the other ALA-rich dietary groups, 
had not been receiving the diet long enough or perhaps too recently to have had 
erythrocytes affected by the diet. Fatty acid content of erythrocytes is a longer term 
reflection of fatty acid intake than fatty acid content of plasma, for example, because of a 
longer half life, and lower sensitivity to recent intake 
[239].  
 
5.4.3.  Gestational Data, Tissue and Body Weights 
There was no difference in number of offspring, males or females, or the ratio of 
males to females between dietary groups. However, due to circumstances beyond control, 
only four dams on the LA-rich diet had successful birthing outcomes; this is reflected in 
the sometimes higher SEMs of data. de Groot et al. 
[240] found no effect of 10.9 g LA 
supplementation compared to combined supplementation of 2.8 g ALA and 9.0 g LA on 
birthing outcomes of women, suggesting that successful birthing outcomes may not have 
been affected by high intake of LA or ALA. 
There were some variations of body weight between dietary groups at different 
stages of the trial, but not at day 21 (day of weaning) or day 78 (day of euthanisation). 
Variation at different days in the trial is in agreement with the findings of 2.3.2 and  3.3.1, 
and an increase in body weight is in agreement with the results of Poiley 
[157]. 
At euthanisation, brains of animals receiving the control diet were lighter than those 
on the experimental diets. This is as was expected, as the experimental diets were higher 
fat (10 %) than the control diet (3 %), and the brain has a high fat content. Mice undergo a 
period of rapid brain growth in the first 3 to 4 weeks of life 
[241], the period in which 
animals were receiving experimental and control diets. In previous chapters, experimental 
diets were consumed from 3 to 4 weeks of age. As such, dietary fatty acids may have more 
effect on brain weight during periods of rapid growth. Whether this increase in brain size 
had an influence on functional outcomes like learning behaviour etc, was beyond the scope   210 
of this experiment. There was no effect of diet on spleen, thymus, liver, or epididymal fat 
weight, in accordance with findings from previous chapters. 
 
5.4.4.  Airway Responsiveness 
There was no effect of diet on airway responsiveness to methacholine at any of the 
concentrations measured. This is in agreement with the findings of 3.3.4. In humans, links 
between dietary fat in pregnancy and atopic asthma in children have been suggested, but 
are often complicated by the nature of the design of the trial involved. Many of these 
studies tend to focus on the effect of the long chain n-3 PUFAs rather than their precursors. 
Retrospective studies rely on dietary recall, often several years later on, which may not be 
an accurate reflection of actual dietary intake 
[242], whilst cohort studies in humans may not 
allow examination of effect of diet on particular time periods. Crozier et al. 
[236] found no 
change in fruit and vegetable consumption during and after pregnancy; whilst this study 
did not examine all sources of ALA and LA, it does suggest that diet may not change 
during and after pregnancy, and as such, cohort studies may not be able to identify the 
effect of dietary fatty acids at a particular critical window of time. A more accurate human 
study would be an intervention study, but financial constraints can make them impractical, 
and as such human intervention studies examining the effect of LA and ALA in pregnancy 
on asthma of offspring has not yet been carried out. A prospective cohort study, carried out 
by Miyake et al. 
[243] showed a negative relationship between ALA intake in pregnancy and 
infantile wheeze (but not eczema), and a positive relationship between LA in pregnancy 
and eczema (but not wheeze) at 16 to 24 months of age.  
The fatty acid composition of cord blood is a useful indicator of foetal fatty acid 
status, and is affected by maternal dietary intake, placental transport, and maternal, 
placental and foetal metabolism 
[230]. Newson et al. 
[244] demonstrated a positive 
relationship between ratio of LA to ALA in cord blood, and onset of wheeze at 30 to 42 
months of age (there was no relationship with wheeze at six months of age). As such, it is 
possible that there may be an effect seen in later life that is not observed earlier in life; 
there may have been an increase in asthma in mice observed if airway responsiveness of 
mice had been tested at a different age. Dirix et al. 
[245], however, found no effect of AA 
content of umbilical cord plasma, and arterial and venous wall phospholipids, and lung 
function of children at 7 years of age. Whether a relationship would have been found if AA 
content of alternative lipid fractions (i.e. TAG etc) or lipid sources (i.e. erythrocytes etc) 
had been assessed remains to be determined. 
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5.4.5.  Acute Skin Test 
Ear swelling in response to ovalbumin was lower in animals whose dams had 
received the ALA-rich in gestation and / or lactation, and those receiving the LA-rich diet 
in gestation compared to those receiving the low fat control diet for the whole period. 
Animals in the AL group had a lower ear swelling response than the LGL and LL groups. 
Results from 3.3.5 suggested that there was no difference between ear swelling in animals 
receiving the ALA-rich linseed oil diet or the LA-rich sunflower oil diet. The apparent 
disparity between results from this and the current study may stem from two main reasons. 
Firstly, different diets were used – the current study used synthetic diets, formulated to be 
rich in either LA or ALA, whilst the study in 0 used linseed or sunflower oil as the fat 
source, which would, therefore, contain a different background of fatty acid composition. 
Secondly, there may be an effect of timing of fatty acid exposure. This is suggested by the 
findings of the current study, where animals receiving ALA-rich diet in lactation had a 
reduced ear swelling compared to those receiving the LA-rich diet in both gestation and 
lactation, or lactation alone. This apparent effect of time could be due to the nutritional 
insult occurring at a critical window of development, or simply because the fatty acids 
were consumed recently enough to have an effect. Studies to date on immediate 
hypersensitivity and fatty acid intake in pregnancy have tended to focus on the effect of 
fish oil, rather than the short chain n-3 or n-6 PUFAs, and as such, it is difficult to ascertain 
whether ALA and LA do have a critical window of effect in pregnancy on immediate 
hypersensitivity. 
 
5.4.6.  Antibody Production  
There was no effect of diet in gestation or lactation on IgE, IgG1 or IgG2a 
production. TH1 cells produce IFN-γ, which causes antibody isotype switching to IgG2a. 
TH2 cells, however, produce IL-4, which causes isotype switching to IgE, which is the 
antibody responsible for immediate hypersensitivity and promotes IgG1 production. These 
results, therefore, suggest that LA and ALA in gestation and / or lactation may not have a 
physiological effect on immediate hypersensitivity response in ovalbumin-sensitised mice 
as indicated by level of antibody production. As with previous discussions in this chapter, 
studies carried out to date have either focussed on the effect of LA or ALA outside of 
pregnancy, or have examined the effect of fish or fish oil in pregnancy on antibody 
production. There were no differences found in IgE, IgG1 or IgG2 levels in plasma 
between the ALA-rich linseed oil or LA-rich sunflower oil dietary groups. It is possible, 
however, that sensitisation may not have been effective, which would explain the reason   212 
for the 10-fold reduction in IgE production in the current study compared the previous 
allergic response study (3.3.6). 
 
5.4.7.  Cytokine Analysis 
There was no effect of diet in gestation or lactation on IL-5 content of BALF, or IL-
4, IL-10, IL-5 or IFN-γ production by cultured spleen cells in response to anti-CD3 or 
OVA. IL-4, IL-5 and IL-10 are produced by activated TH2 cells; IL-4 causes naïve T-cells 
to differentiate into TH2 cells, IL-5 increases production and activation of eosinophils, 
whilst IL-10 acts to inhibit activation and growth of TH1 cells. IL-4 and IL-5 are also 
produced by activated mast cells. IFN-γ is produced by NK cells, TH1 cells and CTLs; it is 
the signature cytokine of TH1 cells, in much the same way that IL-4 is the signature 
cytokine of TH2 cells. IFN-γ activates macrophages, causes isotype switching to opsonising 
and complement-fixing antibodies, and promotes differentiation of naïve T-cells to TH1 
cells, whilst inhibiting proliferation of TH2 cells. However, the reduction in level of 
cytokines produced in response to stimulant, compared to 3.3.7 suggests that sensitisation 
may not have been successful. 
Previous studies have either examined long chain n-3 PUFAs in pregnancy or short-
chain PUFAs in non-pregnant beings. In 3.3.7 there was no difference found between 
cytokine production between the (LA-rich) sunflower oil and (ALA-rich) linseed oil 
dietary groups. However, this chapter did not examine the effect of pregnancy, and since 
the current study did not appear to have successfully sensitised animals means that the 
effect of these fatty acids in pregnancy on allergic response in offspring is still unclear.  
 
5.4.8.  Histological Analysis  
Cortex / medulla ratio was examined because as previous research at the University 
of Utrecht suggested that DHA may reduce medulla regions in the thymus 
[246 unpublished work], 
and to allow continuum with other chapters of research carried out at the University of 
Utrecht. T-cells mature in the thymus. The cortex contains the immature T-cells, which 
migrate to the medulla as they mature. Therefore, any effect on ratio of cortex to medulla 
may alter the area available for T-cell maturation or may indicate an effect on maturation. 
In agreement with findings from previous chapters (2.3.8 and 3.3.10), there was no effect 
of diet on cortex / medulla ratio of thymuses. 
   213 
5.4.9.  Immune Cell Subset Analysis 
There was no effect of diet in gestation or lactation on abundance of eosinophils, 
neutrophils or macrophages in BALF, or cell surface expression markers in bone marrow. 
This is in agreement with findings from previous chapters and 1.4. However, in 
discordance with them, there were differences in expression of cell surface markers in the 
thymus, and spleen. CD3+ expression in thymus cells was lowest in the control and AG 
groups, and higher in the LG, LGL and LL groups than in the AL group. CD3+ cells that 
also expressed CD4+ cells were lowest in the LG and LGL groups, and highest in the AGL 
and LL groups. CD3+ cells that also expressed CD8+ in the thymus were lower in the 
control, AG, AGL and AL groups than in the LG and LGL groups. There was no effect of 
diet on CD3+CD4+ cells that were also CD69+. Expression of CD62L+ on CD3+CD4+ 
thymus cells was higher in the control and AG groups than all other groups. CD4+CD25+ 
expression in thymus cells was higher in the AG and LL groups than the AGL and AL 
groups. Expression of FoxP3+ in the CD4+CD25+ thymus cells was lowest in the control 
group, and highest in the LG, LGL and LL groups. F4-80 expression in the spleen was 
highest in the AL group, and lowest in the control, AG, LG and LL groups. There was no 
difference in CD3+ expression between dietary groups. CD3+ cells that also expressed 
CD4+ abundance was highest in the AGL, AL and LL groups; these groups also had the 
lowest expression of CD8+. CD3+CD4+ cells that also expressed CD62L+ abundance was 
lower in the LG and LGL groups than the LL group. CD3+CD4+ cells that were CD69+ 
were lowest in the LL group, and higher in the control group than the AGL and LGL 
groups. CD19+ expression was lower in the AGL, AL and LL groups than the control and 
1G groups. CD4+CD25+ expression was lower in the AL group than the AGL, LGL and 
LL groups, and lower in the LGL group than the LL group. FoxP3+ expression in 
CD4+CD25+ cells was lower in the control and AG groups than the AGL, AL, and LL 
groups. CD94+ expression was lower in the control group than in the LL group. Statistical 
calculations on insufficient sample sizes do not account for these differences. However, 
some dietary groups have large SEMs, which raises questions as to the accuracy of the 
data. 
 
5.4.10.  Limitations 
Due to the unpredictable nature of number of offspring in breeding trials, some 
groups had small sample sizes (AGL and LGL). This limits the usefulness of data as n-
numbers of some groups are too small to be statistically accurate; this is reflected in the 
large SEMs seen in data summaries. In addition, the reduction in IgE and cytokine   214 
production, compared to results from a previous chapter suggests that sensitisation may not 
have been successful. Time constraints have prevented the study from being repeated, and 
as such, differences seen in these groups should not be relied upon. They are included for 
completeness of the study. 
This study used male offspring; due to the gender differences in metabolism of short 
chain PUFAs to long chain PUFAs 
[201], differences may be observed in female offspring. 
This effect has been observed in humans, but not examined in mouse models. In addition, 
since the current study was carried out in mice, it may be questioned as to whether similar 
effects would be observed in humans 
 
5.4.11.  Conclusions 
This study set out to test hypotheses of reduced severity with ALA-rich diet in 
pregnancy / pregnancy and lactation and increased severity with LA-rich diet in pregnancy 
/ pregnancy and lactation. It was hypothesised that increased ALA or LA intake in 
lactation would have less of an effect than increased ALA or LA intake in pregnancy. 
Using ear swelling in response to ovalbumin, to which the mice had been sensitised, as the 
outcome, animals whose dams had received the ALA-rich in gestation and lactation, and 
those receiving the LA-rich diet in gestation had lower ear swelling compared to those 
receiving the low fat control diet for the whole period. Animals receiving the ALA-rich 
diet in lactation had lower ear swelling response than those receiving the LA-rich diet in 
gestation and lactation, or lactation alone. Despite these differences, there were no effects 
on lung function or immune markers measured in BALF, plasma, thymocytes, bone 
marrow or splenocytes. In addition, it does not appear that sensitisation was completely 
successful. 
Studies examining the effect of fatty acids in pregnancy to date have focussed on the 
long chain n-3 PUFAs. Studies examining the effect of the shorter chain fatty acids have 
instead focussed on non-pregnant beings. If there is a critical window of effect of the short 
chain PUFAs on allergic sensitisation, these studies may have been carried out at too late a 
stage of development for an effect to be observed. Problems with sample size have 
prevented, in certain groups, statistically reliable data from being produced, which is 
reflected in the large error ranges seen. Data from these groups are included in order to 
provide completeness of the study, but should not be reported as statistically accurate. The 
ideal situation would be to repeat the study, but financial and time constraints have 







Chapter 6.  Effect of a Low Protein Diet in 
Pregnancy on the Immune System of 
Offspring in Two Generations   218   219 
6.1. Introduction 
The previous chapters suggested that diet in pregnancy may affect the immune 
system of offspring. However, the effect of diet in pregnancy on the immune system of 
offspring in more than one generation has not been investigated to date. A rat model of 
protein restriction was employed as it has much-used in the department, and the effect of 
protein restriction on the physiology of the offspring has been well-established 
[247].  
 
6.1.1.  Low Protein Model 
The low protein model in pregnant rats (9% dietary protein vs. 18% in the control) 
has been shown to produce offspring with low birth weight that are hypertensive at birth 
and in later life 
[248]. Protein restriction reduces 11β-hydroxysteroid dehydrogenase in the 
placenta and therefore increases foetal exposure to glucocorticoids, thereby inducing 
hypertension in the offspring 
[248, 249]. Protein restriction in pregnancy and the resulting 
maternal stress therefore could affect the development of any organ system in the foetus, 
including the immune system. Experiments using this model have examined physiological 
and genetic effects of the maternal protein restriction, such as effects on hypertension 
[248], 
kidney function 
[250], vascular function 
[251], glucose tolerance 
[252], gene regulation 
[139, 253, 
254] and bone mass 
[255] in the offspring. More recently, an effect on the second generation 
of diet from the F0 generation has been discovered (see 6.1.3) 
[139]. There are no systematic 
studies of the effect of this maternal protein restriction on immune function in the offspring 
in the next or subsequent generations.   
 
6.1.2.  Effect of Pre-natal Stress on the Immune System 
Pre-natal stress can be induced by a number of different methods, and whilst the 
effect of protein restriction in pregnancy on the immune system has not been looked at 
directly, the effect of other types of pre-natal stress on the immune system have been. In 
rats, environmental stress in pregnancy has been shown to reduce T- and B-cell 
proliferation in offspring 
[136], and levels of IgG in serum 
[137], whilst social stress has been 
shown to reduce abundance of TH cells in the offspring 
[138].  
 
6.1.3.  Effects of Diet in Pregnancy on Later Generations 
Between November 1944 and May 1945, a severe rationing was imposed on the 
Netherlands by the Nazis, and as a consequence, calorific intake was reduced from about   220 
1800 to 400 – 800 calories per day 
[129], in a period named the Dutch Hunger Winter. On 
liberation of the Netherlands by the Allied forces, calorific intake returned to adequate 
levels almost immediately. It therefore provides a means of analysis of the effect of famine 
on a population with women in early, mid and late trimesters of pregnancy, who were used 
to sufficient nutritional intake. By following offspring of these women in later life, 
insufficient nutrient availability in utero has been linked to effects in the next generation, 
such as increased mortality 
[256], reduced birth weight 
[257], increased adiposity and poor 
health in later life 
[258]. Using the same rat model as will be used in the study described in 
this chapter, reduced protein intake in the F0 generation has been shown to alter the 
methylation of the PPAR-α and glucocorticoid receptor genes in both the F1 and F2 
generations 
[139], suggesting intergenerational effects of maternal diet. However, the effect 
of altered maternal diet in pregnancy across more than one generation is a relatively new 
area of research, and the effect on immunological status of the F2 generation has not been 
examined. 
 
6.1.4.  Aims of the Study 
This study aimed to determine the effect on the immune system over two 
generations of diets consumed during rat pregnancy that provided adequate or low protein. 
Altering maternal F0 protein intake is known to induce a stress response 
[247-249, 259] that 
may impact on foetal immune development, in particular T-, TH and B-cell abundance. 
Furthermore the low maternal protein diet may cause structural changes in foetal and/or 
maternal immune cells, which may affect immune function of the F0 and F1 generation. 
For example, offspring of mothers fed the low protein diet were demonstrated to have 
altered phospholipid fatty acid compositions in the plasma, liver, heart, lung and brain at 
weaning 
[260]. It is highly likely that such effects occurred within the immune system as 
well. The effects of early protein restriction on immune function (if they occur) may be 
passed to the F2 generation. The study aims to determine whether maternal protein 
restriction alters immune function in the F1 generation and whether such a change, if it 
occurs, is maintained in the later generation (i.e. F2). The study is summarised in Figure 
6-1.   221 
 
Figure 6-1: Causal chain linking altered maternal protein intake to altered offspring immune 
function. Changes in protein composition of the F0 maternal diet may cause changes in 
structure of foetal (F1) and / or maternal (F0) immune cells, or induce stress, all of which 
may in turn affect the function of F1 immune cells. This may cause structural and / or 
functional changes in the F2 generation. 
In order to achieve this aim, three diets were fed to rats in gestation over two 
generations, resulting in six dietary groups. This is summarised in Table 5-1. Additional 
folate was added to the in utero diets of the F2 generation, as folate has been shown to 
reverse the programming effects of a low protein diet 
[129, 261].  
Table 6-1: Diets used in this trial. 
Diet name  F0 Diet  F1 Diet 
C  Control  - 
PR  Protein Restricted  - 
C-C  Control  Control 
C-CF  Control  Control + Folate 
PR-C  Protein Restricted  Control 
PR-CF  Protein Restricted  Control + Folate 
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6.1.5.  Hypothesis 
This study set out to test the following hypotheses: 
•  The PR and PR-C groups will have a lower lymphoid tissue weights than other dietary 
groups 
•  TH cell and B-cell abundance will be reduced in PR offspring. 
•  Cytokine profiles representing TH1 and TH2 skewing will be altered in PR offspring. 
•  Any changes observed in the F1 generation, will be seen in the F2 generation. 
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6.2. Materials and Methods 
6.2.1.  Animals, Diets and Materials 
6.2.1.1.  Animals 
Male and female Wistar rats were obtained from the Biomedical Research Facility, 
University of Southampton (Southampton, UK). Following mating, dams were housed in 
groups of six for the first 14 days of pregnancy, and individually from day 14 of pregnancy 
to birth, in shoebox cages. Animals were kept at 22°C ± 2°C, under a 12 hour light: 12 
hour dark cycle in temperature and light-controlled room in the animal facility at the 
University of Southampton. Offspring remained with dams until day 28, when they were 
euthanized or moved into group cages until day 120. Animals had ad libitum access to tap 
water and food. All studies were carried out in accordance with the Home Office Animals 
(Scientific Procedures) Act of 1986, under project licence number 70/685, and personal 
license number 70/20024. 
 
6.2.1.2.  Diets 
F0 animals received a control (C; 18 % by weight protein) or protein restricted (PR; 
9 % by weight protein) diet during pregnancy. In the PR diet, protein was replaced by 
carbohydrate. C and PR diets were isocaloric. F1 animals received a control + folate (CF), 
or a control diet (without additional folate, same as the control diet used in the F0 
pregnancy) during pregnancy. The control and protein restricted diets contained 1 mg / kg 
folate. The control + folate diet contained 5 mg / kg folate. The increase in folate provided 
by this diet is comparable to the UK recommendation of folate intake for women in the 
first trimester of pregnancy 
[261]. During lactation, all animals received a lactation diet 
(AIN-93G). Animals were weaned onto a maintenance diet (AIN-93M). Diets were 
obtained from Test Diet (Richmond, IN, USA). Macronutrient composition of diets is 
shown in Table 6-2.   224 
Table 6-2: Macronutrient composition of control (C), control + folate (CF), protein restricted 
(PR), AIN-93G (lactation diet), and AIN-93M (maintenance diet) diets. Taken from Test Diet 
[262-266] 
Product  C  CF  PR  AIN-93G  AIN-93M 
Carbohydrate (g / 100 g)  63.9  63.9  73.0  63.9  73.0 
Protein (g / 100 g)  16.9  16.9  8.9  18.1  13.0 
Fat (g / 100 g)  10.1  10.1  10.1  7.1  4.1 
Fibre (g / 100g)  5.0  5.0  5.0  5.0  5.0 
Mineral Mix  (mg / 100 g)  20.0  20.0  20.0  35.0  35.0 
Vitamin Mix (mg / 100 g)   5.0  5.0  5.0  10  10.0 
Folate  1.1  5.1  1.1  2.0  2.1 
Diets were analysed for fatty acid content using the method described previously 
(2.2.2.3); fatty acid composition of diets is shown in Appendix Five and fatty acids of 
interest in Figure 6-2. There were no major differences in the fatty acid compositions of the 
different diets. 
 
Figure 6-2: Profile of individual and total n-3 and n-6 PUFAs in the diets used 
 
6.2.1.3.  Materials 
Materials used were sourced from the same origins as stated previously (2.2.1.3). In 
addition, ELISA plates were bought from Invitrogen (Paisley, UK).   225 
6.2.2.  Methods 
An overview of the trial is provided in Figure 2-4. Fourteen virgin 120 day old 
Wistar rats (F0) were mated and fed either a control (18 % protein) or protein-reduced (9 
% protein) diet; both diets contained 10.1 % fat with the source being soybean oil. Litters 
were reduced to 8, within 24 hours, maximising for females. During lactation, dams 
received a lactation diet (AIN-93G). Offspring (F1) were weaned onto a maintenance diet 
(AIN-93M), which contained 4.1 % fat, with the source being soybean oil. When F1 males 
were 28 days old, and females were 120 days old, animals were euthanized and tissues 
harvested. F1 females were mated before sacrifice and animals that had received the 
control diet in the F1 pregnancies were transferred to the same diet, or a control plus folate 
diet (same level and source of fat as for the F0 diets). The control + folate diet contained 5 
mg / kg folate; the control diet contained 1 mg / kg folate. Animals that had received the 
protein reduced diet were transferred to control diets with or without folate (same level and 
source of fat as for the F0 diets). Additional folate was added to these diets because it 
reverses the effects of protein restriction 
[261]. Lactating dams received the lactation diet 
(AIN-93G). Offspring (F2) were transferred to the maintenance diet (AIN-93M). F2 males 
were euthanized at 28 days, and females at 120 days. F2 females had also been mated prior 
to euthanisation (although samples of F3 offspring were not collected for this trial). 
Animals were euthanized using the method described in 4.2.2. From all sampling points, 
spleens and thymuses were collected and flow cytometry carried out to determine cell 
types present. For day 120 females, cells were cultured for lymphocyte proliferation and 
cytokine analysis. Supernatants from cell cultures were analysed for IFN-γ and IL-4 using 
ELISAs. It was not possible to do these measurements for day 28 males, as insufficient 
cells were available. Animals were housed separately in shoebox cages, and kept at 21 ± 2 
°C, under a 12 hour light : 12 hour dark cycle. At all times, animals had ad libitum access 
to food and water. All studies were carried out in accordance with the Home Office 
Animals (Scientific Procedures) Act of 1986, under project licence number 30/1889, and 
personal license number 70/20024.   226 
 
Figure 6-3: Schematic diagram of multi-generational low protein study. C, Control diet; CF, 
Control + Folate diet; PR, Protein Reduced Diet. 
 
6.2.2.1.  Preparation of Cells from Lymphoid Tissues 
Females aged 120 days, and males aged 28 days were euthanized and cells prepared 
for cell counting, flow cytometry, and cytokine production as described in 4.2.2.2. 
 
6.2.2.2.  Determination of Cell Numbers in Lymphoid Tissues 
Cells of spleen and thymus tissues were counted using the method described in 
4.2.2.3. 
 
6.2.2.3.  Determination of Cell Subsets in Lymphoid Tissues 
using Flow Cytometry 
Cells underwent flow cytometry (FACs) analysis using the method and antibody 
markers described in 4.2.2.4.  
 
6.2.2.4.  Determination of Cytokine Production by Spleen and 
Thymus Cells 
1 ml of a 5 x 10
6 cells / ml suspension of spleen or thymus cells was put in wells of 
a 12-well flat-bottom plate, and 100 µl foetal calf serum, 700 µl RPMI and 200 µl Con A 
(at concentrations 0, 2.5, 5, 10 or 20 µg/ml) added to each well. Plates were incubated at 
37°C in 5% CO2 for 48 h, and then centrifuged at 1000 rpm for five minutes, with a low   227 
brake. Cell culture supernatants were placed in eppendorfs, and stored at –20°C until 
analysis. Cell supernatants were analysed for IL-4 and IFN-γ content following the 
manufacturer’s instructions. 
 
6.2.2.5.  Statistical Analysis 
Results were analysed using SPSS version 15.0. Parameters were analysed using 
Levene’s test of homogeneity to ensure groups had equal variances, in which case they 
were compared using one-way analysis of variance (ANOVA), followed by post-hoc 
testing (Tukey). If Levene’s test showed unequal variances to be present, groups were 
compared using the Kruskal-Wallis test. Where this was used, it is reported in the results 
section. If the Kruskal-Wallis test indicated a significant effect, Mann-Whitney U 
independent group comparisons tests were then carried out to compare each combination 
of groups.  
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6.3. Results 
For all results, “dietary group of X generation” refers to the diet received whilst in 
utero, i.e. the diet of X’s mother during pregnancy. 
 
6.3.1.  Gestational Data for Rats fed the Different Diets in 
Pregnancy 
Effect of diet on duration of pregnancy, litter size, number of males and females, 
and the ratio of males to females in the litter is shown in Table 6-3. There was no effect of 
diet on any of these parameters measured at either the F1 or F2 generations. 
Table 6-3: Effect of diet on duration of pregnancy, litter size, number of males and females, 
and ratio of males to females as a result of diet in pregnancy over two generations. Ratio of 
males to females in the F1 generation were analysed using non-parametric testing.  
  Dietary group of F1 generation 
   C  
(n = 12) 
PR  
(n = 11) 
Duration of pregnancy (days)  22.0 ± 0.2  22.4 ± 0.2 
Litter size (n)  11.6 ± 0.6  12.7 ± 0.8 
Males (n)  5.8 ± 0.6  6.3 ± 0.6 
Females (n)  5.8 ± 0.8  6.3 ± 0.5 
Ratio of males to females  1.4 ± 0.3  1.0 ± 0.1 
  Dietary group of F2 generation 
   C-C 
(n = 10) 
C-CF 
(n = 11) 
PR-C 
(n = 10) 
PR-CF 
(n = 8) 
Duration of pregnancy (days)  21.9 ± 0.4  21.9 ± 0.2  22.8 ± 1.1  22.1 ± 0.4 
Litter size (n)  12.2 ± 0.6  12.5 ± 0.8  12.3 ± 0.6  10.9 ± 0.9 
Males (n)  6.3 ± 0.5  6.4 ± 0.8  6.2 ± 0.6  5.1 ± 0.7 
Females (n)  5.9 ± 0.6  6.1 ± 0.5  6.1 ± 0.6  5.8 ± 0.6 
Ratio of males to females  1.2 ± 0.2  1.1 ± 0.2  1.1 ± 0.2  1.0 ± 0.2 
 
 
6.3.2.   Lymphoid Tissue Weights of Offspring of Rats fed 
the Different Diets in Pregnancy 
Data on effect of diet in gestation on thymus, and spleen weights in F1 and F2 
generations are shown in Table 6-4 (day 28 males) and Table 6-5 (day 120 females).  There 
was no effect of thymus and spleen weight in the F1 or F2 males, or the F1 females. 
However, in the F2 females (120 days old), thymus weight was greater in the C-C group 
compared to the C-CF and PR-C groups, and spleen weight was greater in the C-C group 
compared to the PR-CF group.   229 
Table 6-4: Thymus and spleen weights of two generations of young (28 days old) male rats 
receiving experimental diets in utero. 
  Dietary group of F1 generation 
   C  
(n = 23) 
PR  
(n = 13) 
Thymus weight (g)  0.37 ± 0.01  0.40 ± 0.01 
Spleen weight (g)  0.35 ± 0.01  0.33 ± 0.01 
  Dietary group of F2 generation 
   C-C 
(n = 7) 
C-CF 
(n = 7) 
PR-C 
(n = 5) 
PR-CF 
(n = 4) 
Thymus weight (g)  0.37 ± 0.03   0.38 ± 0.02  0.45 ± 0.03  0.39 ± 0.02 
Spleen weight (g)  0.40 ± 0.04  0.35 ± 0.03  0.38 ± 0.04  0.32 ± 0.01 
 
Table 6-5: Thymus and spleen weights of two generations of adult (120 days old) female rats 
receiving experimental diets in utero. Values with different letters denote differences between 
dietary groups. 
  Dietary group of F1 generation 
   C  
(n = 7) 
PR  
(n = 12) 
Thymus weight (g)  0.60 ±  0.05  0.62 ± 0.03 
Spleen weight (g)  0.67 ± 0.03  0.68 ± 0.02 
  Dietary group of F2 generation 
   C-C 
(n = 7) 
C-CF 
(n = 11) 
PR-C 
(n = 7) 
PR-CF 
(n = 9) 
Thymus weight (g)  0.77 ± 0.03
b  0.64 ± 0.03
a  0.63 ± 0.04
a  0.69 ± 0.03
ab 
Spleen weight (g)  0.76 ± 0.05
b  0.70 ± 0.03
ab  0.66 ± 0.02
ab  0.61 ± 0.03
a 
 
6.3.3.  Cell Counts of Lymphoid Tissues of Offspring of 
Rats receiving the Different Diets in Pregnancy 
Data on effect of diet on cell counts of thymus and spleens are shown in Table 6-6 
and    230 
Table 6-7. There was no difference in cell counts of spleens and thymuses in the F1 
generation males. In the F2 generation, cell counts were highest in the PR-C generation 
than the C-C and C-CF diets for both spleens and thymuses. However, the large SEM 
suggests this may be an artefact of sample size. There was no difference between PR-C and 
PR-CF groups for absolute number of spleen cells, absolute or total number of cells in the 
thymus, but PR-C group had a higher total number of cells in the spleen than the PR-CF 
group. There was no difference in cell count between dietary groups in either the F1 or F2 
generations of the females.  231 
Table 6-6: Cell counts of thymus and spleens from two generations of young (28 days old) male rats receiving experimental diets in utero. Thymus cell count in 
the F2 generation was analysed using non-parametric testing. Values with different letters denote differences between dietary groups. 
  Dietary group of F1 generation 
  C 
(n = 23) 
PR 
(n = 13) 
Number of cells per mg of spleen (x 10
4)  40.91 ± 4.12  41.15 ± 5.66 
Absolute number of spleen cells (x 10
6)  14.06 ± 1.27  13.28 ± 1.64 
Number of cells per mg of thymus (x 10
4)  82.07 ± 24.99  97.48 ± 29.10 
Absolute number of thymus cells (x 10
6)  31.27± 10.46  42.26 ± 15.04 
  Dietary group of F2 generation 
  C-C 
(n = 7) 
C-CF 
(n = 7) 
PR-C 
(n = 5) 
PR-CF 
(n = 4) 
Number of cells per mg of spleen (x 10
4)  34.76 ± 11.29
a  41.95 ± 7.73
a  113.14 ± 7.31
b
  67.08 ± 6.12
a 
Absolute number of spleen cells (x 10
6)  15.92 ± 7.44
a  14.51 ± 2.75
a  41.50 ± 2.23
b  21.32 ± 1.98
ab 
Number of cells per mg of thymus (x 10
4)  13.35 ± 3.54
a  19.72 ± 5.25
a  109.17 ± 36.17
b  33.81 ± 7.18
ab 
Absolute number of thymus cells (x 10
6)  5.15 ± 1.61
a  7.81 ± 2.47
a  51.89 ± 19.48
b  13.62 ± 3.70
ab 
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Table 6-7: Cell counts of thymus and spleens from two generations of adult (120 days old) female rats receiving experimental diets in utero.  There was no effect 
of diet on any of the parameters measured. 
  Dietary group of F1 generation 
  C 
(n = 7) 
PR 
(n = 12) 
Number of cells per mg of spleen (x 10
4)  31.16 ± 4.25  31.01 ± 5.66 
Absolute number of spleen cells (x 10
6)  21.05 ± 3.71  21.70 ± 4.19 
Number of cells per mg of thymus (x 10
4)  21.17 ± 2.59  27.38 ± 3.71 
Absolute number of thymus cells (x 10
6)  12.70 ± 1.98  16.78 ± 2.16 
  Dietary group of F2 generation 
  C-C 
(n = 7) 
C-CF 
(n = 11) 
PR-C 
(n = 7) 
PR-CF 
(n = 9) 
Number of cells per mg of spleen (x 10
4)  45.22 ± 8.13  60.53 ± 14.06  35.46 ± 7.92  37.12 ± 8.10 
Absolute number of spleen cells (x 10
6)  32.24 ± 4.65
  42.87 ± 11.22  23.68 ± 5.39  23.41 ± 6.40 
Number of cells per mg of thymus (x 10
4)  52.98 ± 11.58  62.33 ± 22.71  55.44 ± 9.81  35.52 ± 5.72 
Absolute number of thymus cells (x 10
6)  40.98 ± 8.90  43.35 ± 19.27  34.21 ± 6.29  24.36 ± 3.81   233 
6.3.4.  Cell Subsets in the Thymus, Spleen, Blood and 
Bone Marrow of Offspring of Rats fed the Different Diets in 
Pregnancy 
Abundance of cell subsets in the spleen of young rats (Table 6-8), adult rats (Table 
6-9), and thymuses of young (Table 6-10) and adult rats (Table 6-11) are shown below. 
There were no differences in any of the parameters measured, except for the F2 generation 
males, where TH cell abundance was higher in C-CF group than the PR-C and PR-CF 
groups, and B-cell abundance was higher in the PR-C group than the C-C and C-CF 
groups. 
Table 6-8: Abundance of subsets of splenic lymphocytes of two generations of young (28 days 
old) male rats receiving experimental diets in utero. Results are shown as mean ± SEM. 
Abundance is shown as % of splenocytes.  
  Dietary group of F1 generation 




CTLs  11.40 ± 0.63  10.33 ± 0.88 
TH cells  17.75 ± 1.54  17.52 ± 1.90 
B cells  43.51 ± 3.00  46.46 ± 4.98 
NK cells  2.52 ± 0.16  2.67 ± 0.36 
Splenic Macrophages  4.68 ± 0.50  4.62 ± 0.58 
  Dietary group of F2 generation 
  C-C 
(n = 7) 
C-CF 
(n = 7) 
PR-C 
(n = 5) 
PR-CF 
(n = 4) 
CTLs  14.87 ± 1.81  16.39 ± 0.92  14.19 ± 1.94  19.01 ± 2.99 
TH cells  12.80 ± 2.14
ab  18.49 ± 2.18
b  7.74 ± 0.46
a  9.47 ± 0.26
a 
B cells  47.31 ± 3.35
a  44.21 ± 2.07
a  60.36 ± 2.23
b  49.37 ± 2.94
ab 
NK cells  5.37 ± 0.73  4.15 ± 0.81  2.76 ± 0.40  5.06 ± 1.99 
Splenic Macrophages  2.48 ± 0.43  3.57 ± 0.91  2.72 ± 0.94  4.62 ± 0.79 
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Table 6-9: Abundance of subsets of splenic lymphocytes of two generations of adult (120 days 
old) female rats receiving experimental diets in utero. Results are shown as mean ± SEM. 
Abundance is shown as % of splenocytes.  
  Dietary group of F1 generation 
  C 
(n = 7) 
PR 
(n = 12) 
CTLs  28.15 ± 3.82  21.58 ± 4.55 
TH cells  7.22 ± 1.36  12.71 ± 3.85 
B cells  40.86 ± 3.71  38.83 ± 6.75 
NK cells  9.30 ± 2.11  8.41 ± 2.58 
Splenic Macrophages  2.13 ± 0.46  1.96 ± 0.37 
  Dietary group of F2 generation 
  C-C 
(n = 7) 
C-CF 
(n = 11) 
PR-C 
(n = 7) 
PR-CF 
(n = 9) 
CTLs  29.04 ± 2.11  35.49 ± 3.39  31.59 ± 1.18  27.02 ± 1.11 
TH cells  4.20 ± 1.04  7.01 ± 0.75  5.82 ± 0.62  7.07 ± 0.98 
B cells  33.58 ± 5.76  33.63 ± 3.46  39.57 ± 3.23  40.72 ± 4.42 
NK cells  11.84 ± 4.74  7.64 ± 1.94  12.29 ± 2.18  14.06 ± 2.66 
Splenic Macrophages  1.51 ± 0.20  1.83 ± 0.31  2.72 ± 0.42  2.90 ± 0.50 
Table 6-10: Abundance of subsets of thymic lymphocytes of two generations of young (28 
days old) male rats receiving experimental diets in utero. Results are shown as mean ± SEM. 
Abundance is shown as % of thymocytes.  
  Dietary group of F1 generation 




CTLs  8.58 ± 0.66  11.03 ± 1.06 
TH cells  19.33 ± 1.60  23.97 ± 2.09 
B cells  0.42  ± 0.06  0.70 ± 0.17 
NK cells  0.27 ± 0.04  0.29 ± 0.03 
  Dietary group of F2 generation 
  C-C 
(n = 7) 
C-CF 
(n = 7) 
PR-C 
(n = 5) 
PR-CF 
(n = 4) 
CTLs  13.34 ± 4.36  12.57 ± 4.78  34.53 ± 5.03  24.79 ± 9.40 
TH cells  6.87 ± 0.54  8.84 ± 1.43  13.60 ± 1.02  14.42 ± 1.54 
B cells  0.54 ± 0.16  0.38 ± 0.07  0.86 ± 0.25  0.89 ± 0.19 
NK cells  0.17 ± 0.09  0.08 ± 0.01  0.33 ± 0.20  0.21 ± 0.04 
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Table 6-11: Abundance of subsets of thymic lymphocytes of two generations of adult (120 
days old) female rats receiving experimental diets in utero. Results are shown as mean ± 
SEM. Abundance is shown as % of thymocytes.  
  Dietary group of F1 generation 
  C 
(n = 7) 
PR 
(n = 12) 
CTLs  37.13 ± 4.15  24.16 ± 4.85 
TH cells  20.00 ± 2.25  22.45 ± 4.42 
B cells  5.33 ± 0.60  10.35 ± 6.11 
NK cells  1.12 ± 0.10  1.35 ± 0.40 
  Dietary group of F2 generation 
  C-C 
(n = 7) 
C-CF 
(n = 11) 
PR-C 
(n = 7) 
PR-CF 
(n = 9) 
CTLs  42.02 ± 3.43  49.09 ± 2.27  38.12 ± 2.16  39.01 ± 3.27 
TH cells  15.13 ± 2.66  19.59 ± 1.41  15.33 ± 1.35  14.47 ± 2.37 
B cells  4.35 ± 1.06  3.98 ± 0.84  3.28 ± 0.42  3.84 ± 1.33 
NK cells  0.93 ± 0.13  0.97 ± 0.13  0.76 ± 0.12  0.82 ± 0.16 
 
6.3.5.  Cytokine Production Analysis by Spleen and 
Thymus Cells from Offspring of Rats fed the Different Diets in 
Pregnancy 
Cytokine production from spleen and thymus cells was analysed from adult female 
tissues. Cytokine production analysis results are shown in Figure 6-4 (Spleen IFN-γ), 
Figure 6-5 (Thymus IFN-γ), Figure 6-6 (spleen IL-4), Figure 6-7 (Thymus IL-4), Figure 
6-8 (Spleen ratio of IFN-γ to IL-4), Figure 6-9 (Thymus ratio of IFN-γ to IL-4). On the 
whole, there was no significant difference between levels of cytokines produced within a 
generation, except for two cases. At 2.5 µg / ml Con A, level of IFN-γ produced by thymus 
cells from the C-C group was higher than level produced by the PR-C and PR-CF groups; 
there was no effect at any other concentration of Con A. At 10 µg / ml Con A, ratio of 
IFN-γ to IL-4 produced by spleen cells was higher in the PR group than the C group in the 
F1 generation.   236 
 
Figure 6-4: Level of IFN-γ γ γ γ produced by spleen cells from the F1 and F2 generations who 
received experimental diets in utero. There was no significant difference between cytokine 
level produced at any concentration of stimulant. 
 
Figure 6-5: Level of IFN-γ γ γ γ produced by thymus cells from the F1 and F2 generations who 
received experimental diets in utero. At 2.5 µ µ µ µg / ml Con A, level of IFN-γ γ γ γ produced in by 
thymus cells from the C-C group was higher than level produced by the PR-C and PR-CF 
groups.   237 
 
Figure 6-6: Level of IL-4 produced by spleen cells from the F1 and F2 generations who 
received experimental diets in utero. There was no significant difference between cytokine 
level produced at any concentration of stimulant. 
 
Figure 6-7: Level of IL-4 produced by thymus cells from the F1 and F2 generations who 
received experimental diets in utero. There was no significant difference between cytokine 
level produced at any concentration of stimulant.   238 
 
Figure 6-8: Ratio of IFN-γ γ γ γ to IL-4 produced by spleen cells from the F1 and F2 generations 
who received experimental diets in utero. At 10 µ µ µ µg / ml Con A, ratio of IFN-γ γ γ γ to IL-4 was 
higher in the PR group than the C group in the F1 generation. 
 
Figure 6-9: Ratio of IFN-γ γ γ γ to IL-4 produced by thymus cells of the F1 and F2 generation who 
received diets in utero. There was no significant difference between cytokine level produced 
at any concentration of stimulant.  239 
6.4. Discussion 
6.4.1.  Summary of Findings 
This study aimed to determine the effect in two generations, of diets during 
pregnancy of the F0 generation that provided adequate or low protein on the immune 
system of offspring (F1 and F2). The study set out to test the hypothesis of reduced 
lymphoid tissue, TH and B-cell abundance, and altered TH1 / TH2 balance (determined by 
IL-4 / IFN-γ production) in F1 offspring as a result of protein restriction in the F0 
generation, and that this effect would also be observed in the F2 generation. There was no 
effect of diet in pregnancy on duration of pregnancy, litter size, ratio or number of males 
and females in the litter. Males and F1 females showed no difference in thymus or spleen 
weight, but F2 females showed higher thymus weights in the C-C group compared to the 
C-CF and PR-C group, and higher spleen weight in the C-C group compared to the PR-CF 
group. There was no effect of diet on cell counts of the spleen or thymus in F1 and F2 
females, or F1 males. In F2 males, however, relative (to tissue weight) and absolute cell 
(total) numbers were higher in the PR-C generation than the C-C and C-CF diets in spleens 
and thymuses. There was no effect of diet in pregnancy on cell subset abundance in 
females or F1 males. In the F2 male group, TH cell abundance was higher in C-CF group 
than the PR-C and PR-CF groups, and B-cell abundance was higher in the PR-C group 
than the C-C and C-CF groups. Cytokine analysis from adult females did not show any 
significance, except for samples of thymocytes from the C-C group, which produced more 
IFN-γ when 2.5 µg / ml Con A was used as a stimulant, compared to thymocytes from the 
PR-C and PR-CF groups. At 10 µg / ml Con A, ratio of IFN-γ to IL-4 produced by spleen 
cells was higher in the PR group than the C group in the F1 generation. 
 
6.4.2.  Gestational Data 
There was no effect of diet in pregnancy on duration of pregnancy, litter size, ratio 
or number of males and females in the litter, in either generation. This supports the 
findings of other studies, which have shown to be no effect of protein restriction on 
duration of pregnancy 
[267], litter size 
[267, 268] or ratio or number of males and females in the 
litter of mice 
[267, 268]. 
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6.4.3.  Tissue Weights of Offspring 
Males and F1 females showed no difference in thymus or spleen weight, but F2 
females showed greater thymus weights in the C-C group compared to the C-CF and PR-C 
groups, and higher spleen weight in the C-C group compared to the PR-CF group. This 
suggests that folate supplementation and protein restriction may be reducing tissue weight 
compared to a control diet, in second generation females. Therefore there may be an effect 
of gender or age, as the same observation was not seen in young males. 
It may have been that an effect would have been observed in body weight between 
the PR and C groups, and the diets of the F2 generation. Body weight has been shown to be 
lower in new born pigs 
[269, 270] and rats 
[271, 272] as a result of protein restriction in 
pregnancy. In addition, there may have been a difference observed in tissue weight relative 
to body weight. However, body weight data was not available for analysis, and therefore 
lymphoid tissue weights were analysed as an alternative method of assessing the effect of 
protein restriction in pregnancy on physical parameters, as well as providing further insight 
into the effect on immune parameters. 
 
6.4.4.  Cell Counts and Subsets in the Thymus and Spleen 
There was no effect of diet on cell numbers of the spleen or thymus in F1 and F2 
females, or F1 males. In F2 males, however, relative (to tissue weight) and absolute (total) 
cell numbers in the spleens and thymuses were higher in the PR-C group than in the C-C 
and C-CF groups. However, this may be an artefact of analysis, due to the small sample 
size and large variation.  
There was no effect of diet in pregnancy on cell subset abundance in females or F1 
males. In the F2 male group, TH cell abundance was higher in C-CF group than the PR-C 
and PR-CF groups, and B-cell abundance was higher in the PR-C group than the C-C and 
C-CF groups. Other methods of inducing pre-natal stress have shown an reduction in 
abundance of TH cells 
[138, 273], proliferation of T- and B-cells 
[136], and reduction in serum 
levels of IgG 
[137]. The reduction in TH cells by Gotz et al. 
[138] is in agreement with the 
findings of this study. B-cell abundance was shown to be increased in this study by protein 
restriction, whilst Kay et al. 
[136] found a reduction in B cell proliferation, and Sobrian et al. 
[137] showed a reduction in serum IgG. It may therefore be that protein restriction increases 
B-cell abundance, but reduces proliferation in response to a stimulant and IgG production. 
However, this study did not examine proliferative response or antibody production, and 
therefore this cannot be confirmed. 
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6.4.5.  Cytokine Analysis 
Cytokine analysis from adult females did not show any significant differences 
between dietary groups, except for thymocytes from the C-C group, which produced more 
IFN-γ when 2.5 µg / ml Con A was used as a stimulant, compared to thymocytes from the 
PR-C and PR-CF groups. At 10 µg / ml Con A, ratio of IFN-γ to IL-4 produced by spleen 
cells was higher in the PR group than the C group in the F1 generation. However, as there 
are only two differences in all concentrations of Con A, and these changes occur at low 
concentrations of stimulant, it is likely that difference may not be important, and may be 
due to the small sample size and large error margin. 
 
6.4.6.  Limitations 
Females were required for the breeding of the subsequent generation, and as such it 
was not possible to analyse tissues from young female offspring. Therefore the effect of 
gender on any trans-generational effect on the immune system cannot be separated from 
effects introduced by age. It would have been preferable to have young and old males and 
females in order to control for both age and gender variables, but financial and operational 
constraints made this impossible. It is therefore impossible to determine whether any 
differences seen between 28 day old males and 70 day old females are due to age or 
gender. 
 
6.4.7.  Conclusions 
It was hypothesised that protein restriction in the F0 generation would affect the 
immune system of the F1 and subsequently F2 generations. However, in data from this 
study, changes in the F1 generation were not observed, but changes to the immune system 
of the F2 generation were evident. For instance, protein restriction reduced TH and B-cell 
abundance in the spleen and thymus of F2 males. It would be interesting to determine what 
the functional consequences of such a change would be on the F2 generation, and whether 
there had been any changes in the F1 generation that the study was not able to determine, 
due to the nature of the experiments carried out, such as the effect on immune cell 
proliferation in response to stimulant. The effect of gender on the alteration of immune 
system seen across subsequent generations requires further examination, however, the 
findings from this study add weight to the theory of programming, and suggest that 
physical, and possibly functional, changes to the immune system may not be observed in 
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7.1. Introduction 
Research to date has suggested that fatty acids may affect the immune system, 
through their (and those of their metabolites) effects on membranes, mediators, and gene 
expression. However, despite the research carried out, there still exist gaps of knowledge 
where further research is required. In addition, programming by diet in pregnancy may 
affect the immune system, due to stress and/or structural and functional changes to immune 
cells, but whether this effect is long-lasting is uncertain. In order to address some of these 
gaps in knowledge of the effect of programming and fatty acids on the immune system, 
several experiments were carried out. These experiments aimed to examine the effects of 
fatty acids and / or programming of foetal physiology on different aspects and at different 
stages of development of the immune system, and functional consequences of these 
changes, in models of clinical relevance. 
 
7.2. Summary of Experimental Data 
7.2.1.  Effect of Dietary Fatty Acids on the Murine Immune 
Response using Vaccination as an Immune Challenge 
(Chapter 2) 
The study described in Chapter 2 investigated the effect of diets differing in fatty 
acid composition on the recall response in a mouse model of vaccination, using Influvac 
(an influenza vaccine). The study set out to test the hypothesis that altering intake of fatty 
acids may cause structural and functional changes in the immune system of the mouse, 
causing an increased or decreased recall immune response to Influvac. Data from 
measuring ear swelling, suggest that mice had an increased TH1 response to vaccination 
following feeding with salmon oil, compared to linseed oil, sunflower oil or tallow, in 
accordance with some of the hypotheses being tested. However, analysis of plasma 
immunoglobulins showed no effect of diet on IgG2a levels, and plasma levels of IgG1 and 
spleen cell culture levels of IFN-γ, IL-4 and IL-10 were below detection limit, and 
therefore could not add weight to this conclusion. It may be that levels of IgG2a may have 
been affected by supplementation in comparison to baseline values, but this was not 
measured due to the size of animals at this point. Results from this chapter suggest that the 
n-3 PUFAs found in salmon oil may improve the TH1-mediated immune response and may 
not be detrimental to the response to immune challenges like infection as was suggested by 
Schwerbrock et al. 
[146]. Although the difference in DTH response between linseed oil and   248 
salmon oil may be due to the need to convert ALA to DHA, which appears to be rate-
limiting, the most important difference in fatty acid composition that is related to immune 
function appears to be the lower n-6 fatty acid status that occurs with salmon oil feeding. 
 
7.2.2.  The Effect of Dietary Fatty Acids on a Mouse Model 
of Allergic Sensitisation (Chapter 3) 
The study described in Chapter 3 aimed to determine the effect of diets differing in 
fatty acid composition, on the immune response in a mouse model of allergy to the egg 
protein ovalbumin. It set out to test the hypothesis that altering intake of fatty acids may 
cause structural and functional changes in the immune system of the mouse, causing 
increased or decreased susceptibility to the allergen to which the mice had been sensitised. 
These hypotheses were supported to some extent in that there was reduced immediate 
hypersensitivity in the salmon oil group and increased immediate hypersensitivity in the 
tallow group. However, varying the types of fatty acids in diets given to 3 to 4 week old 
mice for 48 days did not appear to affect airway responsiveness to ovalbumin. The 
increased ear swelling in animals on the tallow diet compared those receiving the soybean 
oil diet is reflected by an increase in IgE concentration in mice fed the tallow diet. 
Differences in IgE levels were not observed between other dietary groups. This may have 
been due to several factors, such as short feeding time (48 days) or age of the animals. 
There did not appear to be changes induced in cell abundance in bronchoalveolar 
lavage fluid, or in cell subtypes in thymus, spleen and bone marrow, but these 
measurements do not determine the difference in balance of TH1 / TH2 cells. Examining the 
characteristic cytokines of these cells gave variable results. Splenocytes from mice 
receiving the tallow diet had increased IL-4 production in response to T-cell stimulation 
compared to control and sunflower oil groups, whilst there was no difference in response 
to ovalbumin stimulation. In addition, there was no difference observed in IFN-γ or IL-10 
production in splenocytes, or IL-5 levels in BALF. 
Thus, some of the diets (salmon oil, beef tallow) had effects on immediate 
hypersensitivity to ovalbumin in ovalbumin-sensitised mice. Beef tallow feeding also 
raised IgE in blood and elevated IL-4 production by anti-CD3 stimulated splenocytes. 
There was no effect of diet on lung function and salmon oil did not affect IgE or cytokine 
profiles. The diets were fed for 48 days beyond weaning and it may be that changing fatty 
acid availability earlier in life (i.e. pre-weaning) or a longer duration of feeding may have 
bigger effects. Nevertheless the results suggest that the n-3 PUFAs found in salmon oil 
decrease the TH2-mediated response to an allergen and that this is increased by a diet rich   249 
in saturated fatty acids as found in beef tallow. The lowered TH2 response seen with 
salmon oil here is consistent with the enhanced TH1 response seen in the previous chapter.  
 
7.2.3.  Effect of Fatty Acids in Pregnancy on Markers of 
Immune Function in the Offspring (Chapter 4) 
The study described in Chapter 4 aimed to investigate the longevity of any effect of 
maternal dietary fatty acids in rat pregnancy on markers of immune status, in particular the 
types of T- and B-lymphocytes. It set out to test the hypothesis that altering maternal fatty 
acid intake can cause structural changes in foetal and / or maternal immune cells, which in 
turn may cause long-lasting effects on immune function. This study hypothesised that 
changes in fatty acid intake in pregnancy would affect the fatty acid composition of 
maternal plasma and tissues (at the end of lactation) and of offspring plasma at weaning 
and beyond, and would affect the abundance of immune cells in the lymphoid tissues of the 
offspring. The fatty acid composition of the rat diet during pregnancy did affect the fatty 
acid composition of maternal plasma, liver, spleen and thymus at the end of lactation. 
However there was no effect on offspring fatty acid composition at weaning and beyond or 
on lymphoid organ immune cell subsets. Thus it was concluded that the effects of maternal 
fatty acids on late foetal fatty acid composition and thymus lymphocyte sub-populations 
[133, 217, 218] are not retained at weaning or beyond if the dams are transferred to a chow diet 
after giving birth. Thus, these parameters appear not to be programmed by maternal fatty 
acid exposures. However, n-3 and n-6 PUFA balance in pregnancy may affect immune 
markers not measured in this study, such as the balance of TH1 and TH2 cells, and 
subsequently immune reactions. In addition, the functional consequences of any changes 
(that were not measurable in this trial) remain to be determined. It may be of particular 
importance to examine these functional consequences in vivo, as the immune system is a 
complex of interacting factors and not the result of the action of one singular type of 
cell(s). For example, dietary intake in pregnancy may affect the development of allergy or 
immune response. 
 
7.2.4.  Effect of Early Exposure to Fatty Acids on Later 
Allergic Sensitisation Examined using a Mouse Model 
(Chapter 5) 
The study described in Chapter 5 aimed to determine the effect of diets differing in 
fatty acid composition, given during gestation and / or lactation, on the immune response   250 
in a mouse model of allergy to the egg protein ovalbumin. It was hypothesized that altering 
intake of fatty acids may cause structural and functional changes in the immune system of 
the mouse, causing them to become more or less susceptible to their allergy. In addition, 
mice may be more susceptible to the effects of fatty acids during gestation than lactation, if 
this is a critical window of fatty acid effect on immune system development. Using ear 
swelling in response to ovalbumin, to which the mice had been sensitised, as the outcome, 
animals whose dams had received an ALA-rich diet in gestation and lactation, and those 
that received the LA-rich diet in gestation had lower ear swelling compared to those 
receiving the low fat control diet for the whole period. Animals receiving the ALA-rich 
diet in lactation had lower ear swelling response than those receiving the LA-rich diet in 
gestation and lactation, or lactation alone. Despite these differences, there were no effects 
on lung function or immune markers measured in BALF, plasma, thymocytes, bone 
marrow or splenocytes. In addition, it does not appear that sensitisation was completely 
successful. 
 
7.2.5.  Effect of a Low Protein Diet in Pregnancy on the 
Immune System of Offspring in Two Generations (Chapter 6) 
The study described in Chapter 6 aimed to determine the effect on the immune 
system over two generations of diets consumed during rat pregnancy that provided 
adequate or low protein. It was hypothesized that protein restriction in pregnancy would 
lead to reduced lymphoid tissue weight, reduce TH and B-cell prevalence of the F1 
generation, and alter the cytokine profile and that effects would also be seen in the F2 
generation. However, no differences were seen between groups in the F1 generation. In 
contrast some effects were seen in the F2 generation. For instance, protein restriction 
reduced TH and B-cell abundance in the spleen and thymus of F2 males. It would be 
interesting to determine what the functional consequences of such a change would be on 
the F2 generation, and whether there had been any changes in the F1 generation that the 
study was not able to determine, due to the nature of the experiments carried out, such as 
the effect on immune cell proliferation in response to stimulant. The effect of gender on the 
alteration of immune system seen across subsequent generations requires further 
examination, however, the findings from this study add weight to the theory of 
programming, and suggest that physical, and possibly functional, changes to the immune 
system may not be observed in the immediate generation. 
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7.3. Concluding Remarks 
Data from Chapter 2 and Chapter 3 suggest that dietary fatty acids have the 
potential to alter immune responses. Salmon oil, rich in long chain n-3 PUFAs was shown 
to reduce immediate hypersensitivity in TH2-dominant animals, in comparison to linseed 
oil (rich in short chain n-3 PUFAs), soybean oil (contain a balance of n-3 and n-6 PUFAs), 
sunflower oil (rich in n-6 PUFAs), and tallow (rich in SFAs), and to increase the cell-
mediated (delayed-type hypersensitivity) response in TH1-dominant animals, in 
comparison to linseed oil, sunflower oil and tallow. That these responses were seen in TH1- 
and TH2-dominant animals requires further research, since response to dietary fatty acids 
may differ between these animals, and potentially therefore, dietary fatty acids may have 
different effects in humans, depending on whether they are atopic (i.e. TH2-dominant) or 
not (i.e. TH1-dominant). 
Data from Chapter 4 and Chapter 5 suggest that dietary fatty acids in pregnancy 
may not affect the immune system of offspring later in life. However, Chapter 4 did not 
determine the functional consequences of any changes, and Chapter 5 was not sufficiently 
powered to determine functional consequences. In addition, sensitisation may not have 
been successful in Chapter 5. As such, further research is required to determine the effect 
of diet in pregnancy on immune system of offspring in later life. Data from Chapter 6 
suggests, however, that programming of the immune system induced by diet in pregnancy 
may have effects on the immune system in the second generation that are not seen in the 
first. Therefore, it is possible that physiological and functional changes may have been 
observed if animals from Chapters 4 and 5 had been bred to a second generation. It is 
likely that the effects seen in Chapter 6 are due to maternal stress, as some of the effects 
were similar to those reported using other models of maternal stress during pregnancy. 
In conclusion, whilst dietary fatty acids can alter immune responses, the longevity 
of effect of diet in pregnancy on the immune responses of offspring is less clear. Data 
detailed in this thesis suggests that there may not be an apparent effect of diet in pregnancy 
on immune system of the immediate generation, but there may be a longer lasting effect 
than has been realised to date, with effects of diet in pregnancy of the F0 generation 
affecting the immune system of the F2 generation. Further research is required to 
determine the functional consequences of any changes to the immune system induced in 
this model, whether dietary fatty acids could have a similar effect, and how many 
generations this effect of diet in pregnancy lasts for. 
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Appendix One – Data from Vaccination Study  
(Chapter Two) 
Table 1.1: Composition of control (low fat) and experimental (high fat) diets. Taken from Special 
Diet Services diet composition data sheets 
[1, 2]. 
  Control  Experimental diets 
Moisture (%)  10.00  10.00 
Crude Oil (%)  2.71  3.36 
Crude Protein (%)  14.38  18.35 
Crude Fibre (%)  4.65  4.23 
Ash (%)  6.00  6.27 
Total Dietary Fibre (%)  17.05  15.06 
Starch (%)  44.97  42.37 
Sugar (%)  4.05  3.90 
β-carotene (mg/kg)  0.16  1.28 
Retinol (µg/kg)  2566.38  5218.35 
Vitamin A (iu/kg)  8554.27  17376.38 
Cholecalciferol (µg/kg)  15.54  76.94 
Vitamin D (iu/kg)  621.70  3077.42 
α-Tocopherol (mg/kg)  76.45  93.03 
Vitamin E (iu/kg)  84.10  102.81 
Vitamin B1 (mg/kg)  8.58  15.84 
Vitamin B2 (mg/kg)  4.33  13.28 
Vitamin B6 (mg/kg)  4.81  17.65 
Vitamin B12 (µg/kg)  7.49  78.17 
Vitamin C (mg/kg)  2.59  1.80 
Vitamin K (mg/kg)  10.17  185.05 
Folic Acid (mg/kg)  0.79  4.30 
Nicotinic Acid (mg/kg)  61.32  78.92 
Pantothenic Acid (mg/kg)  20.17  25.24 
Choline (mg/kg)  1080.14  899.51 
Inositol (mg/kg)  2369.59  2253.88 
Biotin (µg/kg)  277.13  488.74 
The following are the same in both control and experimental diets 
Arginine (%)  1.19  Phenylalanine 
(%)   0.96  Histidine (%)  0.46  Glutamic 
Acid (%)  3.72 
Lysine (%)  1.04  Valine (%)  0.91  Threonine 
(%)  0.69  Proline 
(%)  1.34 
Methionine (%)  0.28  Tyrosine (%)  0.69  Isoleucine 
(%)  0.77  Serine (%)  0.78 
Cystine (%)  0.29  Glycine (%)  1.55  Leucine (%)  1.46  Alanine 
(%)  0.21 
Tryptophan (%)  0.22  Aspartic Acid 
(%)  1.00  Iron  (mg/kg)  130.65  Fluorine 
(mg/kg)  9.63 
Calcium (%)  0.83  Copper  (mg/kg)  16.42  Chloride (%)  0.40  Cobalt 
(mg/kg)  494.92  
Total 
Phosphorus (%)  0.64   Manganese  
(mg/kg)  91.05  Potassium 
(%)  0.69  Iodine 
(mg/kg)  390.43 
Sodium (%)  0.27  Zinc (mg/kg)  86.59  Magnesium 
(%)  0.22  Selenium 
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Table 1.2: Fatty acid composition of diets. Data is shown as percentage abundance. c-, cis-; dma, 
dimethyl acetal; t-, trans-. 
  Control  Linseed oil  Salmon oil  Soybean oil  Sunflower oil  Tallow 
14:0  0.09  0.17  3.34  0.18  0.21  2.17 
15:0  0.00  0.03  0.28  0.02  0.03  0.39 
16:0 dma  0.00  0.00  0.00  0.00  0.00  0.00 
16:0  10.92  6.88  13.08  10.59  7.71  20.72 
t- 16:1 n-7  0.00  0.00  0.25  0.00  0.00  0.33 
16:1 n-7  0.09  0.10  4.02  0.10  0.12  2.10 
17:0  0.09  0.08  0.27  0.10  0.07  1.08 
Unknown 4  0.00  0.00  0.13  0.02  0.00  0.00 
Unknown 5  0.04  0.04  0.18  0.04  0.04  0.05 
Unknown 6  0.00  0.00  0.36  0.04  0.00  0.00 
18:0  3.15  3.87  3.64  4.34  3.61  18.22 
t- 18:1 n-9  0.06  0.12  0.76  0.11  0.16  0.08 
18:1 n-9  22.29  18.04  20.71  20.98  29.43  30.70 
18:1 n-7  1.64  0.84  2.66  1.32  1.25  1.23 
19:0  0.00  0.00  0.09  0.00  0.00  0.23 
c- t- 18:2 n-6  0.00  0.05  0.13  0.07  0.15  0.00 
18:2 n-6  53.51  25.40  19.49  53.19  50.94  18.20 
20:0  0.33  0.19  0.27  0.35  0.33  0.24 
18:3 n-6  0.40  0.19  0.05  0.03  0.09  0.00 
20:1 n-9  0.62  0.18  4.42  0.20  0.42  0.20 
18:3 n-3  5.01  42.89  5.88  7.13  3.76  2.59 
18:4 n-3  0.08  0.04  0.03  0.05  0.05  0.18 
20:2 n-6  0.13  0.17  0.78  0.14  0.23  0.13 
22:0  0.50  0.26  0.22  0.48  0.65  0.17 
20:3 n-9  0.07  0.03  0.03  0.08  0.10  0.00 
20:3 n-6  0.00  0.02  0.14  0.05  0.06  0.00 
22:1 n-9  0.00  0.02  0.59  0.00  0.07  0.00 
20:3 n-3  0.00  0.06  0.22  0.00  0.00  0.00 
20:4 n-6  0.06  0.04  0.47  0.05  0.04  0.00 
24:0  0.17  0.11  0.09  0.14  0.21  0.06 
20:5 n-3  0.00  0.00  6.08  0.00  0.00  0.00 
24:1 n-9  0.04  0.00  0.50  0.00  0.00  0.00 
22:3 n-3  0.11  0.00  0.00  0.02  0.00  0.00 
22:4 n-6  0.00  0.00  0.10  0.00  0.00  0.00 
22:5 n-6  0.00  0.00  0.23  0.00  0.00  0.00 
22:5 n-3  0.00  0.00  2.35  0.00  0.00  0.00 
22:6 n-3   0.00  0.00  7.51  0.00  0.00  0.00 
n-3  5.20  42.98  22.08  7.21  3.81  2.77 
n-6  54.66  25.89  21.81  53.58  51.68  18.65 
n-3 : n-6  9.51  166.00  101.22  13.45  7.37  14.84 
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Table 1.3: Fatty acid composition of erythrocytes of mice fed the different diets for 37 ± 1 days. 
Data is shown as percentage abundance. c-, cis-; dma, dimethyl acetal; t-, trans-. 
  Control  Linseed oil  Salmon oil  Soybean oil  Sunflower oil  Tallow 
14:0  0.21 ± 0.01
b  0.23 ± 0.02
b  0.44 ± 0.02
c  0.13 ± 0.02
a  0.13 ± 0.02
a  0.23 ± 0.02
b 
15:0  0.11 ± 0.01
a  0.14 ± 0.02
a  0.29 ± 0.01
c  0.10 ± 0.00
a  0.10 ± 0.00
a  0.21 ± 0.01
b 
16:0 dma  1.34 ± 0.11  1.13 ± 0.08  1.18 ± 0.08  1.15 ± 0.07  1.01 ± 0.06  1.06 ± 0.10 
16:0  38.21 ± 0.79
bc  33.24 ± 2.57
ab  40.03 ± 1.07
c  34.59 ± 1.26
abc  35.11 ± 1.37
abc  31.40 ± 1.18
a 
t- 16:1 n-7  0.09 ± 0.01
a  0.05 ± 0.02
a  0.10 ± 0.00
a  0.05 ± 0.02
a  0.09 ± 0.01
a  0.28 ± 0.02
b 
16:1 n-7  0.71 ± 0.04
b  0.31 ± 0.04
 a  0.55 ± 0.02
b  0.20 ± 0.00
a  0.26 ± 0.02
a  0.65 ± 0.09
b 
17:0  0.31 ± 0.01
a  0.41 ± 0.04
b  0.56 ± 0.02
c  0.41 ± 0.01
b  0.36 ± 0.02








c  0.31 ± 0.06
bc  0.23 ± 0.04
ab  0.34 ± 0.02
bc  0.33 ± 0.06





c  0.08 ± 0.03
a  0.13 ± 0.03
ab  0.36 ± 0.04
bc  0.59 ± 0.08
c  0.09 ± 0.02
ab 
18:0  11.08 ± 0.34
a  14.46 ± 0.96
b  11.50 ± 0.43
a  14.05 ± 0.40
b  13.29 ± 0.50
ab  13.23 ± 0.32
ab 
t- 18:1 n-9  0.09 ± 0.02
a  0.08 ± 0.02
a  0.30 ± 0.00
b  0.10 ± 0.02
 a  0.10 ± 0.00
a  0.10 ± 0.00
a 
18:1 n-9  12.44 ± 0.22
b  13.01 ± 0.68
b  12.20 ± 0.11
b  10.33 ± 0.20
a  12.33 ± 0.20
b  15.44 ± 0.20
c 
18:1 n-7  2.15 ± 0.04
d  1.18 ± 0.08
a  1.94 ± 0.03
c  1.20 ± 0.03
a  1.24 ± 0.03
a  1.55 ± 0.06
b 
19:0  0.15 ± 0.02
a  0.14 ± 0.02
a  0.20 ± 0.00
ab  0.20 ± 0.00
ab  0.23 ± 0.02
b  0.15 ± 0.02
a 
t- t- 18:2 
n-6 
0.26 ± 0.10
b  0.15 ± 0.04
ab  0.00 ± 0.00
a  0.03 ± 0.02
a  0.00 ± 0.00
a  0.04 ± 0.03
a 
c- t- 18:2 
n-6 
0.16 ± 0.07  0.06 ± 0.05  0.08 ± 0.02  0.21 ± 0.04  0.18 ± 0.04  0.14 ± 0.03 
t- c- 18:2 
n-6 
0.03 ± 0.02
ab  0.00 ± 0.00
a  0.00 ± 0.00
a  0.00 ± 0.00
a  0.03 ± 0.02
ab  0.06 ± 0.02
b 
18:2 n-6  10.49 ± 0.34
ab  14.69 ± 0.83
c  8.76 ± 0.51
a  15.26 ± 0.75
c  12.64 ± 0.80
bc  11.43 ± 0.38
ab 
20:0  0.39 ± 0.01
a  0.45 ± 0.03
ab  0.38 ± 0.02
a  0.48 ± 0.02
b  0.45 ± 0.03
ab  0.43 ± 0.02
ab 
18:3 n-6  0.08 ± 0.02
abc  0.03 ± 0.02
ab  0.00 ± 0.00
a  0.10 ± 0.03
bc  0.11 ± 0.02
c  0.08 ± 0.02
abc 
20:1 n-9  0.43 ± 0.02
b  0.34 ± 0.02
a  1.03 ± 0.03
c  0.36 ± 0.02
ab  0.41 ± 0.01
b  0.41 ± 0.01
b 
18:3 n-3  0.23 ± 0.02
a  1.59 ± 0.10
b  0.21 ± 0.01
a  0.28 ± 0.03
a  0.16 ± 0.02




0.00 ± 0.00  0.03 ± 0.02  0.00 ± 0.00  0.00 ± 0.00  0.01 ± 0.01  0.03 ± 0.02 
18:4 n-3  0.23 ± 0.03  0.21 ± 0.06  0.20 ± 0.05  0.15 ± 0.03  0.20 ± 0.05  0.26 ± 0.03 
20:2 n-6  0.45 ± 0.03
bc  0.40 ± 0.03
abc  0.31 ± 0.02
a  0.51 ± 0.03
c  0.49 ± 0.04
c  0.35 ± 0.02
ab 
22:0  1.51 ± 0.09  1.46 ± 0.16  1.41 ± 0.13  1.63 ± 0.09  1.59 ± 0.15  1.91 ± 0.15 
20:3 n-9  0.03 ± 0.02  0.01 ± 0.01  0.01 ± 0.01  0.03 ± 0.02  0.04 ± 0.02  0.05 ± 0.02 
20:3 n-6  1.01 ± 0.06
c  0.65 ± 0.08
b  0.29 ± 0.03
a  0.93 ± 0.07
bc  0.96 ± 0.11
bc  1.21 ± 0.10
c 
22:1 n-9  0.11 ± 0.01
a  0.13 ± 0.02
a  0.23 ± 0.02
b  0.10 ± 0.00
a  0.10 ± 0.00
a  0.11 ± 0.01
a 
20:3 n-3  0.10 ± 0.00
a  0.19 ± 0.02
b  0.09 ± 0.01
a  0.05 ± 0.02
a  0.10 ± 0.00
a  0.10 ± 0.00
a 
20:4 n-6  6.68 ± 0.55
b  2.83 ± 0.31
a  2.13 ± 0.20
a  6.24 ± 0.61
b  7.03 ± 0.89
b  7.56 ± 0.92
b 
22:2 n-x  0.04 ± 0.02
a  0.03 ± 0.02
a  0.00 ± 0.00
a  0.10 ± 0.00
b  0.09 ± 0.01
b  0.00 ± 0.00
a   4 
  Control  Linseed oil  Salmon oil  Soybean oil  Sunflower oil  Tallow 
24:0  2.59 ± 0.13
ab  3.20 ± 0.32
b  2.28 ± 0.10
a  3.06 ± 0.18
ab  3.04 ± 0.18




0.28 ± 0.05  0.14 ± 0.05  0.18 ± 0.06  0.23 ± 0.03  0.25 ± 0.04  0.10 ± 0.04 
20:5 n-3  0.11 ± 0.03
a  1.76 ± 0.22
b  2.40 ± 0.25
c  0.13 ± 0.04
a  0.01 ± 0.01
a  0.19 ± 0.04
a 
24:1 n-9  1.71 ± 0.08
ab  1.39 ± 0.12
a  3.84 ± 0.10
c  1.45 ± 0.08
a  1.86 ± 0.09
b  1.64 ± 0.07
ab 
22:3 n-3  0.09 ± 0.01  0.06 ± 0.02  0.09 ± 0.01  0.08 ± 0.02  0.09 ± 0.01  0.08 ± 0.02 
22:4 n-6  0.96 ± 0.09
b  0.18 ± 0.03
a  0.13 ± 0.03
a  0.76 ± 0.07
b  1.03 ± 0.14
b  0.94 ± 0.15
b 
22:5 n-6  0.81 ± 0.07
b  0.43 ± 0.04
a  0.38 ± 0.05
a  0.90 ± 0.04
b  0.93 ± 0.15
b  0.61 ± 0.07
ab 
22:5 n-3  0.39 ± 0.06
a  1.39 ± 0.22
b  1.03 ± 0.13
b  0.48 ± 0.07
a  0.28 ± 0.04
a  0.45 ± 0.08
a 
22:6 n-3  2.14 ± 0.20
a  2.56 ± 0.36
a  4.15 ± 0.52
b  2.38 ± 0.30
a  1.91 ± 0.25
a  2.78 ± 0.36
ab 
n-3  3.32 ± 0.27
ab  7.79 ± 0.85
c  8.15 ± 0.87
c  3.54 ± 0.40
ab  2.72 ± 0.25
a  4.04 ± 0.45
b 
n-6  21.00 ± 1.08
b  19.41 ± 1.25
b  12.10 ± 0.79
a  24.97 ± 1.57
b  23.44 ± 1.96
b  22.41 ± 1.36
b 
n-3 : n-6  0.15 ± 0.02
ab  0.37 ± 0.03
c  0.65 ± 0.04
d  0.12 ± 0.02
a  0.10 ± 0.00
a  0.19 ± 0.01
b 
   5 
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Appendix Two – Data from Allergic Sensitisation 
Study (Chapter 3). 
Table 2-1: Fatty acid composition of erythrocytes of mice fed the experimental diets for 48 ± 1 
days. Data is shown as percentage abundance. c-, cis-; dma, dimethyl acetal; t-, trans-. 
  Control  Linseed oil  Salmon oil  Soybean oil  Sunflower 
oil 
Tallow 
14:0  0.18 ± 0.02
ab  0.17 ± 0.02
ab  0.25 ± 0.06
b  0.10 ± 0.00
a  0.12 ± 0.02
a  0.28 ± 0.03
b 
15:0  0.10 ± 0.00
a  0.10 ± 0.00
a  0.18 ± 0.02
b  0.10 ± 0.00
a  0.12 ± 0.02
a  0.20 ± 0.00
b 
16:0 dma  1.97 ± 0.03
b  1.73 ± 0.03
ab  1.67 ± 0.08
a  1.75 ± 0.02
ab  1.58 ± 0.02
a  1.80 ± 0.08
ab 
16:0  30.33 ± 0.24  30.08 ± 0.36  29.25 ± 0.88  29.20 ± 0.28  27.78 ± 0.47  28.95 ± 0.97 
t- 16:1 n-7  0.10 ± 0.00
abc  0.00 ± 0.00
a  0.12 ± 0.03
bc  0.00 ± 0.00
a  0.04 ± 0.04
ab 0.18 ± 0.03
c 
16:1 n-7  0.55 ± 0.04
b  0.27 ± 0.02
a  0.55 ± 0.08
b  0.18 ± 0.02
a  0.26 ± 0.06
a  0.63 ± 0.03
b 
17:0  0.27 ± 0.02  0.33 ± 0.02  0.52 ± 0.07  0.30 ± 0.00  0.38 ± 0.08  0.48 ± 0.08 
Unknown 4  1.07 ± 0.02
a  1.20 ± 0.00
ab  1.23 ± 0.10
ab  1.28 ± 0.02
b  1.20 ± 0.05
ab 1.26 ± 0.03
ab 
Unknown  5  0.70 ± 0.00
b  0.65 ± 0.02
b   0.18 ± 0.08
a  0.57 ± 0.02
b  0.62 ± 0.13
b  0.09 ± 0.01
a  
Unknown 6  0.15 ± 0.02  0.10 ± 0.00  0.10 ± 0.00  0.10 ± 0.00  0.10 ± 0.00  0.14 ± 0.02 
18:0  9.32 ± 0.14
a  10.87 ± 0.08
bc10.67 ± 0.44
bc  11.25 ± 0.17
 c 10.72 ± 0.08
bc10.08 ± 0.27
ab 
t- 18:1 n-9  0.10 ± 0.00
a  0.13 ± 0.02
a  0.40 ± 0.07
bc  0.20 ± 0.00
ab  0.26 ± 0.09
ab 0.55 ± 0.06
c 
18:1 n-9  11.92 ± 0.19
ab  12.75 ± 0.06
bc13.60 ± 0.41
bc  10.08 ± 0.09
a 12.50 ± 0.66
b 14.40 ± 0.61
c 
18:1 n-7  1.63 ± 0.10
b  0.85 ± 0.02
a  1.32 ± 0.12
b  0.92 ± 0.02
a  0.96 ± 0.02
a  1.38 ± 0.08
b  
19:0  0.10 ± 0.00  0.13 ± 0.02  0.17 ± 0.02  0.12 ± 0.02  0.12 ± 0.02  0.15 ± 0.02 
c- t- 18:2 n-6 0.10 ± 0.00  0.10 ± 0.00  0.10 ± 0.00  0.08 ± 0.02  0.10 ± 0.00  0.16 ± 0.07 
18:2 n-6  10.65 ± 0.21
a  13.57 ± 0.29
b  9.80 ± 0.59
a  14.37 ± 0.30
b 13.30 ± 0.35
b 10.13 ± 0.58
a 
20:0  0.37 ± 0.02  0.40 ± 0.00  0.40 ± 0.04  0.42 ± 0.02  0.38 ± 0.02  0.36 ± 0.03 
18:3 n-6  0.03 ± 0.02  0.00 ± 0.00  0.02 ± 0.02  0.05 ± 0.02  0.02 ± 0.02  0.03 ± 0.02 
20:1 n-9  0.45 ± 0.02
ab  0.33 ± 0.02
a  0.60 ± 0.08
b  0.33 ± 0.02
a  0.40 ± 0.00
ab 0.48 ± 0.08
ab 
18:3 n-3  0.22 ± 0.02
a  1.62 ± 0.07
b  0.27 ± 0.09
a  0.28 ± 0.02
a  0.20 ± 0.00
a  0.24 ± 0.02
a 
18:4 n-3  0.07 ± 0.02
ab  0.00 ± 0.00
a  0.08 ± 0.02
b  0.00 ± 0.00
a  0.02  ± 0.02
ab 0.05 ± 0.02
ab 
20:2 n-6  0.40 ± 0.00
ab  0.40 ± 0.00
ab  0.35 ± 0.03
a  0.52 ± 0.02
c  0.48 ± 0.05
bc 0.34 ± 0.03
a 
22:0  1.35 ± 0.05  1.25 ± 0.05  1.42 ± 0.17  1.30 ± 0.05  1.44 ± 0.08  1.38 ± 0.18 
20:3 n-9  0.10 ± 0.00  0.08 ± 0.02  0.07 ± 0.02  0.10 ± 0.00  0.10 ± 0.00  0.05 ± 0.02 
20:3 n-6  1.12 ± 0.04  0.90 ± 0.03  0.90 ± 0.13  1.17 ± 0.03  1.08 ± 0.02  0.88 ± 0.13 
22:1 n-9  0.10 ± 0.00  0.10 ± 0.00  0.12 ± 0.02  0.10 ± 0.00  0.12 ± 0.02  0.14 ± 0.02 
20:3 n-3  0.10 ± 0.00
a  0.30 ± 0.00
b  0.10 ± 0.00
a  0.07 ± 0.02
a  0.10 ± 0.00
a  0.10 ± 0.00
a 
20:4 n-6  12.70 ± 0.18
c  5.38 ± 0.12
a  8.98 ± 1.65
abc  11.78 ± 0.23
bc 12.42 ± 0.41
c 7.83 ± 1.42
ab 
24:0  1.95 ± 0.10
ab  2.52 ± 0.09
c  1.75 ± 0.15
ab  2.17 ± 0.10
bc 2.14 ± 0.10
abc 1.70 ± 0.07
a 
20:5 n-3  0.20 ± 0.00
a  2.20 ± 0.07
b  1.72 ± 0.71
ab  0.20 ± 0.00
a  0.12 ± 0.02
a  1.93 ± 0.63
ab 
24:1 n-9  1.77 ± 0.07
abc  1.40 ± 0.06
ab  2.10 ± 0.22
bc  1.25 ± 0.06
a  1.68 ± 0.07
abc 2.35 ± 0.24
c   2 
  Control  Linseed oil  Salmon oil  Soybean oil  Sunflower 
oil 
Tallow 
22:3 n-3  0.10 ± 0.00
b  0.10 ± 0.00
b  0.10 ± 0.00
b  0.03 ± 0.02
a  0.06 ± 0.02
ab 0.10 ± 0.00
b 
22:4 n-6  1.88 ± 0.04
c  0.32 ± 0.02
a  1.20 ± 0.30
bc  1.65 ± 0.02
bc  1.94 ± 0.09
c  0.88 ± 0.26
ab 
22:5 n-6  2.13 ± 0.05
c  0.55 ± 0.02
a  1.35 ± 0.27
b  1.52 ± 0.03
bc  2.02 ± 0.23
c  0.89 ± 0.12
ab 
22:5 n-3  0.65 ± 0.02
ab  2.65 ± 0.05
c   1.25 ± 0.33
ab  0.78 ± 0.02
ab  0.52 ± 0.05
a  1.63 ± 0.34
b 
22:6 n-3  4.93 ± 0.07
  6.47 ± 0.35  6.82 ± 1.07  5.55 ± 0.07  4.48 ± 0.11
  7.56 ± 1.03 
n-3  6.25 ± 0.10
ab  13.35 ± 0.32
c 10.32 ± 2.15
abc  6.92 ± 0.07
ab  5.42 ± 0.20
a  11.54 ± 1.99
bc
n-6  29.05 ± 0.16
bc  21.25 ± 0.22
a 22.78 ± 2.34
ab  31.15 ± 0.16
c 31.40 ± 0.77
c 21.20 ± 2.32
a 
n-3 : n-6  0.20 ± 0.00
a  0.63 ± 0.02
b  0.55 ±0.18
b  0.20 ±0.00
a  0.20 ± 0.00
a  0.66 ± 0.18
b 
 Appendix Three – Data  from Diet in Pregnancy Study 
(Chapter 4) 
Table 3-1: Fatty acid profile in CE fraction of maternal plasma, taken at weaning (3 weeks after 
birth of offspring). Results are shown as mean ± SEM. Values with different letters on the same 
line are statistically different from one another (p < 0.05). For all dietary groups, n = 6. Data 
shown as % abundance. 
  Salmon oil  Soybean oil  Sunflower oil 
12:0  0.15 ± 0.09  0.25 ± 0.25  0.21 ± 0.16 
14:0  0.24 ± 0.06  0.17 ± 0.07  0.24 ± 0.06 
16:0  9.07 ± 0.55  8.22 ± 0.71  9.04 ± 1.20 
16:1 n-7  4.49 ± 0.64  3.49 ± 0.46  3.15 ± 0.41 
18:0  2.22 ± 0.36  2.11 ± 0.42  6.60 ± 4.42 
18:1 n-9  16.22 ± 1.55  13.26 ± 1.68  12.71 ± 2.23 
trans 18:1 n-9  1.00 ± 0.07  1.17 ± 0.13  0.89 ± 0.12 
18:2 n-6  22.99 ± 0.75
b  21.79 ± 0.81
ab  18.28 ± 1.58
a
 
18:3 n-6  3.37 ± 0.32  2.18 ± 0.27  2.53 ± 0.44 
18:3 n-3  0.19 ± 0.08  0.36 ± 0.03  0.25 ± 0.09 
20:0  0.00 ± 0.00  0.00 ± 0.00  0.36 ± 0.24 
20:1 n-9  0.38 ± 0.38  0.22 ± 0.14  0.17 ± 0.13 
20:2 n-6  1.55 ± 0.25  1.07 ± 0.34  0.92 ± 0.37 
20:3 n-6  0.96 ± 0.15  0.52 ± 0.22  0.85 ± 0.15 
20:4 n-6  28.60 ± 2.36  39.43 ± 3.04  39.39 ± 5.23 
20:3 n-9  0.00 ± 0.00  7.60 ± 7.60  10.49 ± 10.49 
22:1 n-9  0.00 ± 0.00  0.00 ± 0.00  0.15 ± 0.15 
20:5 n-3  5.47 ± 0.29
b  2.62 ± 0.49
a  2.22 ± 0.39
a 
22:2 n-9  1.39 ± 0.41  1.95 ± 0.59  1.21 ± 0.40 
22:5 n-3  0.00 ± 0.00  0.10 ± 0.10  0.00 ± 0.00 
22:6 n-3  1.71 ± 0.40  1.09 ± 0.28  0.84 ± 0.26 
n-3  7.38 ± 0.55
b  4.17 ± 0.85
a  3.30 ± 0.54
a 
n-6  28.87 ± 0.87  33.16 ± 7.78  33.07 ± 9.59 
Ratio n-3:n-6  0.26 ± 0.02
b  0.14 ± 0.03
a  0.12 ± 0.03
a 
 
 Table 3.2: Fatty acid profile in NEFA fraction of maternal plasma, taken at weaning (3 weeks 
after birth of offspring). There was no difference in fatty acid profile between different dietary 
groups. For all dietary groups, n = 6. Data shown as % abundance. 
  Salmon oil  Soybean oil  Sunflower oil 
12:0  1.44 ± 0.84  0.53 ± 0.38  0.79 ± 0.49 
14:0  1.79 ± 0.19  1.83 ± 0.19  2.67 ± 0.71 
16:0  31.41 ± 1.02  30.14 ± 3.75  33.00 ± 1.39 
16:1 n-7  2.80 ± 0.58  2.06 ± 0.77  1.99 ± 0.77 
18:0  24.12 ± 4.29  24.13 ± 4.85  33.52 ± 3.70 
18:1 n-9  15.32 ± 3.61  10.06 ± 2.35  8.66 ± 1.97 
trans 18:1 n-9   1.50 ± 0.24  2.47 ± 0.74  0.77 ± 0.77 
18:2 n-6  8.66 ± 1.15  15.91 ± 9.24  6.55 ± 0.78 
18:3 n-6  1.22 ± 0.37  1.58 ± 0.46  1.62 ± 0.38 
18:3 n-3  1.16 ± 0.30  1.73 ± 0.32  1.07 ± 0.38 
20:0  0.21 ± 0.14  0.00 ± 0.00  0.19 ± 0.19 
20:1 n-9  1.06 ± 0.40  0.98 ± 0.42  0.70 ± 0.44 
20:2 n-6  0.67 ± 0.67  0.00 ± 0.00  0.00 ± 0.00 
20:3 n-6  0.66 ± 0.27  0.98 ± 0.54  1.26 ± 0.65 
20:4 n-6  3.05 ± 0.70  1.81 ± 0.72  3.88 ± 0.82 
20:3 n-9  0.00 ± 0.00  0.40 ± 0.40  0.00 ± 0.00 
22:0  0.00 ± 0.00  0.00 ± 0.00  0.00 ± 0.00 
22:1 n-9  0.11 ± 0.11  0.78 ± 0.48  0.09 ± 0.09 
20:5 n-3  1.18 ± 0.66  0.90 ± 0.42  0.23 ± 0.23 
22:2 n-9  0.82 ± 0.82  0.42 ± 0.31  0.00 ± 0.00 
22:4 n-6  0.67 ± 0.17  1.07 ± 0.55  0.74 ± 0.42 
24:0  0.83 ± 0.29  0.78 ± 0.35  0.43 ± 0.27 
24:1 n-9  0.16 ± 0.16  0.56 ± 0.28  0.29 ± 0.19 
22:5 n-3  0.95 ± 0.52  0.22 ± 0.15  1.24 ± 0.74 
22:6 n-3  0.21 ± 0.16  0.65 ± 0.42  0.30 ± 0.30 
n-3  3.51 ± 0.88  3.50 ± 0.48  2.84 ± 0.95 
n-6  15.76 ± 0.97  22.15 ± 8.49  14.48 ± 1.21 
Ratio n-3:n-6  0.22 ± 0.05  0.22 ± 0.05  0.22 ± 0.09 
 
 Table 3.3: Fatty acid profile in PC fraction of maternal plasma, taken at weaning (3 weeks after 
birth of offspring). Values with different letters on the same line are statistically different from 
one another (p < 0.05). For all dietary groups, n = 6. Data shown as % abundance. 
  Salmon oil  Soybean oil  Sunflower oil 
14:0  0.26 ± 0.03  0.31 ± 0.07  0.25 ± 0.01 
16:0  23.76 ± 0.39  23.20 ± 0.97  23.41 ± 0.47 
16:1 n-7  1.08 ± 0.10  1.20 ± 0.24  1.01 ± 0.10 
18:0  22.36 ± 0.31  23.09 ± 1.22  23.68 ± 1.09 
18:1 n-9  10.92 ± 0.69  9.00 ± 0.99  10.11 ± 0.69 
trans 18:1 n-9  1.52 ± 0.05
a  2.05 ± 0.08
b  1.57 ± 0.08
a 
18:2 n-6  19.90 ± 0.47  20.51 ± 0.65  19.75 ± 0.87 
18:3 n-6  0.42 ± 0.03
b  0.21 ± 0.06
a  0.40 ± 0.03
b 
18:3 n-3  0.07 ± 0.03  0.02 ± 0.02  0.14 ± 0.06 
20:0  0.01 ± 0.01  0.02 ± 0.02  0.00 ± 0.00 
20:1 n-9  0.05 ± 0.04  0.03 ± 0.03  0.09 ± 0.06 
20:2 n-6  1.10 ± 0.21  0.75 ± 0.20  0.80 ± 0.18 
20:3 n-6  2.23 ± 0.10
b  1.63 ± 0.17
a  2.01 ± 0.15
b 
20:4 n-6  10.48 ± 0.91  13.87 ± 1.36  12.54 ± 1.22 
20:5 n-3  1.34 ± 0.12
b  0.55 ± 0.17
a  0.85 ± 0.18
ab 
22:4 n-6  0.11 ± 0.07  0.05 ± 0.05  0.10 ± 0.06 
24:0  0.30 ± 0.16  0.61 ± 0.13  0.80 ± 0.20 
24:1 n-9  0.50 ± 0.25  0.23 ± 0.23  0.00 ± 0.00 
22:5 n-3  2.13 ± 0.82  1.03 ± 0.30  1.14 ± 0.28 
22:6 n-3  1.48 ± 0.61  1.65 ± 0.59  1.33 ± 0.89 
n-3  5.01 ± 0.65  3.24 ± 0.62  3.47 ± 0.97 
n-6  34.52 ± 1.10  37.63 ± 1.34  36.41 ± 1.67 
Ratio n-3:n-6  0.15 ± 0.02  0.09 ± 0.02  0.10 ± 0.03 
 
 Table 3.4: Fatty acid profile in TAG fraction of maternal plasma, taken at weaning (3 weeks after 
birth of offspring). Values with different letters on the same line are statistically different from 
one another (p < 0.05). For all dietary groups, n = 6. Data shown as % abundance. 
  Salmon oil  Soybean oil  Sunflower oil 
14:0  1.02 ± 0.11  1.04 ± 0.14  0.82 ± 0.09 
16:0  29.03 ± 1.66  25.71 ± 0.72  28.77 ± 1.21 
16:1 n-7  4.78 ± 0.29  4.87 ± 0.48  4.43 ± 0.23 
18:0  4.15 ± 0.61  3.70 ± 0.34  3.88 ± 0.38 
18:1 n-9  38.48 ± 1.30  33.75 ± 1.17  36.83 ± 2.46 
trans 18:1 n-9  3.25 ± 0.19
ab  4.07 ± 0.23
b  3.10 ± 0.32
a 
18:2 n-6  15.00 ± 1.50  19.84 ± 1.53  15.87 ± 1.64 
18:3 n-6  0.54 ± 0.06  0.63 ± 0.10  0.43 ± 0.09 
18:3 n-3  1.21 ± 0.17  1.47 ± 0.19  1.18 ± 0.21 
20:0  0.00 ± 0.00  0.00 ± 0.00  0.02 ± 0.02 
20:1 n-9  0.18 ± 0.06  0.61 ± 0.21  0.20 ± 0.08 
20:2 n-6  0.34 ± 0.07  0.46 ± 0.20  0.37 ± 0.09 
20:3 n-6  0.30 ± 0.11  0.58 ± 0.28  0.32 ± 0.13 
20:4 n-6  0.95 ± 0.09  2.07 ± 0.27  2.41 ± 0.81 
20:5 n-3  0.24 ± 0.11  0.52 ± 0.22  0.28 ± 0.09 
22:4 n-6  0.00 ± 0.00  0.06 ± 0.06  0.20 ± 0.20 
24:0  0.00 ± 0.00  0.04 ± 0.03  0.14 ±  0.14 
24:1 n-9  0.08 ± 0.05  0.00 ± 0.00  0.00 ± 0.00 
22:5 n-3  0.31 ± 0.15  0.24 ± 0.19  0.54 ± 0.54 
22:6 n-3  0.17 ± 0.08  0.35 ± 0.16  0.22 ± 0.17 
n-3  1.92 ± 0.26  2.57 ± 0.36  2.21 ± 0.65 
n-6  17.12 ± 1.64  23.68 ± 1.48  19.74 ± 2.20 
Ratio n-3: n-6  0.11 ± 0.01  0.11 ± 0.02  0.11 ± 0.02 
 
 Table 3.5: Fatty acid profile in CE fraction of maternal liver, taken at weaning (3 weeks after 
birth of offspring). There were no statistical differences between any dietary groups. For all 
dietary groups, n = 6. Data shown as % abundance. 
  Salmon oil  Soybean oil  Sunflower oil 
8:0  0.00 ± 0.00  0.00 ± 0.00  0.00 ± 0.00 
10:0  4.82 ± 0.24  5.22 ± 0.30  4.56 ± 0.36 
12:0  1.58 ± 0.19  1.60 ± 0.18  1.57 ± 0.20 
14:0  1.08 ± 0.11  1.46 ± 0.24  0.86 ± 0.05 
16:0   6.31 ± 1.39  9.79 ± 2.18  7.58 ± 2.47 
16:1 n-7  0.89 ± 0.16  1.10 ± 0.26  0.77 ± 0.10 
18:0  5.28 ± 0.13  4.83 ± 0.25  5.24 ± 0.20 
18:1 n-9  9.12 ± 0.13  8.72 ± 0.62  8.97 ± 0.44 
trans 18:1 n-9  0.62 ± 0.18  2.04 ± 1.50  0.44 ± 0.09 
18:2 n-6  7.64 ± 0.55  7.06 ± 0.83  7.67 ± 0.36 
18:3 n-6  12.03 ± 0.28  11.01 ± 0.49  11.73 ± 0.41 
18:3 n-3  0.00 ± 0.00  0.00 ± 0.00  0.00 ± 0.00 
20:0  0.58 ± 0.12  0.39 ± 0.16  0.37 ± 0.12 
20:1 n-9  0.00 ± 0.00  0.00 ± 0.00  0.00 ± 0.00 
20:2 n-6  0.77 ± 0.13  0.74 ± 0.10  0.79 ± 0.12 
20:3 n-6  0.97 ± 0.24  0.56 ± 0.37  1.35 ± 0.27 
20:4 n-6  16.28 ± 0.39  15.24 ± 0.62  16.05 ± 0.66 
22:0  1.08 ± 0.23  0.88 ± 0.50  1.83 ± 0.47 
22:1 n-9 / 20:4 n-3  0.00 ± 0.00  2.83 ± 2.83  0.00 ± 0.00 
20:5 n-3  15.53 ± 0.37  11.61 ± 2.69  14.68 ± 0.52 
24:0  0.00 ± 0.00  0.33 ± 0.33  0.00 ± 0.00 
22:4 n-6  0.00 ± 0.00  0.00 ± 0.00  0.00 ± 0.00 
22:5 n-6  4.12 ± 0.20  3.85 ± 0.50  4.93 ± 0.38 
24:1 n-9  0.48 ± 0.48  0.00 ± 0.00  0.00 ± 0.00 
22:5 n-3  3.40 ± 0.54  2.76 ± 0.26  2.82 ± 0.40 
22:6 n-3  7.41 ± 0.49  7.99 ± 0.52  7.78 ± 0.47 
n-3  26.35 ± 1.15  25.19 ± 0.88  25.28 ± 1.06 
n-6  41.82 ± 0.47  38.46 ± 2.04  42.52 ± 1.47 







 Table 3.6: Fatty acid profile in NEFA fraction of maternal liver, taken at weaning (3 weeks after 
birth of offspring). There were no statistical differences between any dietary groups. For all 
dietary groups, n = 6. Data shown as % abundance. 
  Salmon oil  Soybean oil  Sunflower oil 
8:0  0.00 ± 0.00  0.00 ± 0.00  0.00 ± 0.00 
10:0  0.00 ± 0.00  0.00 ± 0.00  0.00 ± 0.00 
12:0  0.00 ± 0.00  0.00 ± 0.00  0.00 ± 0.00 
14:0  1.17 ± 0.15  1.29 ± 0.12  1.25 ± 0.14 
16:0   26.02 ± 2.36  22.45 ± 1.94  25.39 ± 0.98 
16:1 n-7  4.67 ± 0.69  4.40 ± 0.72  4.43 ± 0.28 
18:0  11.97 ± 1.83  13.63 ± 0.33  14.07 ± 1.22 
18:1 n-9  23.32 ± 3.83  17.68 ± 2.38  19.14 ± 2.27 
trans 18:1 n-9  4.48 ± 0.90  4.42 ± 0.26  3.85 ± 0.50 
18:2 n-6  7.01 ± 1.66  6.51 ± 2.15  6.30 ± 2.05 
18:3 n-6  1.31 ± 1.31  3.98 ± 2.53  2.13 ± 1.35 
18:3 n-3  0.80 ± 0.20  0.95 ± 0.18  1.13 ± 0.38 
20:0  0.60 ± 0.16  1.06 ± 0.22  0.88 ± 0.26 
20:1 n-9  0.22 ± 0.22  0.57 ± 0.37  0.74 ± 0.47 
20:2 n-6  0.98 ± 0.24  0.97 ± 0.13  1.27 ± 0.54 
20:3 n-6  1.20 ± 0.27  1.71 ± 0.21  1.30 ± 0.30 
20:4 n-6  7.18 ± 1.55  10.82 ± 1.84  9.43 ± 1.03 
22:0  0.00 ± 0.00  0.00 ± 0.00  0.00 ± 0.00 
22:1 n-9 / 20:4 n-3  0.33 ± 0.33  0.62 ± 0.41  0.81 ± 0.52 
20:5 n-3  0.39 ± 0.39  0.69 ± 0.44  0.79 ± 0.43 
24:0  1.37 ± 0.93  0.69 ± 0.35  0.19 ± 0.19 
22:4 n-6  0.26 ± 0.26  0.96 ± 0.61  0.92 ± 0.59 
22:5 n-6  0.84 ± 0.23  1.56 ± 0.33  1.38 ± 0.23 
24:1 n-9  0.49 ± 0.15  1.04 ± 0.26  0.93 ± 0.31 
22:5 n-3  1.22 ± 0.30  1.54 ± 0.33  1.25 ± 0.26 
22:6 n-3  4.16 ± 0.97  2.46 ± 0.23  2.43 ± 0.45 
n-3  6.91 ± 1.69  6.27 ± 1.25  6.41 ± 1.76 
n-6  18.78 ± 2.77  26.50 ± 2.92  22.72 ± 1.49 
n-3 : n-6  0.33 ± 0.07  0.23 ± 0.03  0.28 ± 0.08 
   
 Table 3.7: Fatty acid profile in PC fraction of maternal liver, taken at weaning (3 weeks after 
birth of offspring). Values with different letters on the same line are statistically different from 
one another (p < 0.05). For all dietary groups, n = 6. Data shown as % abundance. 
  Salmon oil  Soybean oil  Sunflower oil 
8:0  0.00 ± 0.00  0.00 ± 0.00  0.00 ± 0.00 
10:0  0.00 ±  0.00  0.00 ± 0.00  0.00 ± 0.00 
12:0  0.05 ± 0.04  0.06 ± 0.04  0.02 ± 0.02 
14:0  0.39 ± 0.08  0.30 ± 0.02  0.26 ± 0.01 
16:0   21.22 ± 0.80  21.10 ± 1.30  20.39 ± 0.80 
16:1 n-7  1.74 ± 0.20  1.90 ± 0.13  1.66 ± 0.17 
18:0  23.45 ± 0.59  22.73 ± 0.61  23.43 ± 1.13 
18:1 n-9  10.45 ± 0.97  10.37 ± 1.16  10.20 ± 1.22 
trans 18:1 n-9  1.73 ± 0.14
a  2.30 ± 0.18
b  1.63 ± 0.12
a 
18:2 n-6  10.49 ± 0.28  10.95 ± 0.59  10.05 ± 0.43 
18:3 n-6  0.79 ± 0.09  0.85 ± 0.08  0.83 ± 0.13 
18:3 n-3  0.25 ± 0.07  0.27 ± 0.06  0.15 ± 0.02 
20:0  0.01 ± 0.01  0.00 ± 0.00  0.01 ± 0.01 
20:1 n-9  0.28 ± 0.11  0.13 ± 0.04  0.07 ± 0.01 
20:2 n-6  1.10 ± 0.16  0.93 ± 0.25  1.04 ± 0.23 
20:4 n-6  12.53 ± 1.05
a  17.40 ± 1.60
ab  18.99 ± 1.37
b 
22:0  0.00 ± 0.00  0.03 ± 0.02  0.01 ± 0.01 
22:1 n-9 / 20:4 n-3  0.14 ± 0.05  0.10 ± 0.04  0.15 ± 0.03 
20:5 n-3  2.18 ± 0.05
b  1.19 ± 0.17
a  1.10 ± 0.16
a 
24:0  0.03 ± 0.03  0.00 ± 0.00  0.02 ± 0.02 
22:4 n-6  0.61 ± 0.06  0.76 ± 0.06  0.84 ± 0.06 
22:5 n-6  0.65 ± 0.08
a  1.25 ± 0.19
b  1.90 ± 0.12
c 
24:1 n-9  0.09 ± 0.09  0.04 ± 0.04  0.00 ± 0.00 
22:5 n-3  1.65 ± 0.15  1.37 ± 0.08  1.22 ± 0.13 
22:6 n-3  7.57 ± 0.48
b  3.73 ± 0.50
a  3.67 ± 0.60
a 
n-3  11.79 ± 0.54
b  6.66 ± 0.44
a  6.30 ± 0.52
a 
n-6  28.77 ± 0.90
a  34.39 ± 1.31
b  36.00 ± 0.67
b 
n-3 : n-6  0.41 ± 0.02
b  0.19 ± 0.01
a  0.17 ± 0.01
a 
  Table 3.8: Fatty acid profile in PE fraction of maternal liver, taken at weaning (3 weeks after 
birth of offspring). Values with different letters on the same line are statistically different from 
one another (p < 0.05). For all dietary groups, n = 6. Data shown as % abundance. 
  Salmon oil  Soybean oil  Sunflower oil 
8:0  0.00 ± 0.00  0.00 ± 0.00  0.00 ± 0.00 
10:0  0.00 ± 0.00  0.00 ± 0.00  0.00 ± 0.00 
12:0  0.00 ± 0.00  0.20 ± 0.20  0.10 ± 0.10 
14:0  0.17 ± 0.11  0.32 ± 0.09  0.36  ± 0.27 
16:0   19.83 ± 0.64  19.08 ± 0.59  22.11  ± 3.05 
16:1 n-7  1.40 ± 0.20  1.47 ± 0.13  2.30 ± 0.77 
18:0  20.60 ± 0.91  21.57 ± 0.67  19.88± 2.90 
18:1 n-9  6.68 ± 0.43  6.73 ± 0.69  12.19  ± 5.26 
trans 18:1 n-9  3.50 ± 0.66  3.09 ± 0.46  2.20 ± 0.20 
18:2 n-6  2.93 ± 1.35  3.35 ± 1.37  3.20 ± 1.05 
18:3 n-6  3.04 ± 1.12  2.92 ± 1.62  2.45 ± 1.11 
18:3 n-3  0.47 ± 0.19  0.34 ± 0.21  0.50 ± 0.15 
20:0  0.34 ± 0.16  0.76 ± 0.20  0.25 ± 0.11 
20:1 n-9  1.03 ± 0.35  0.28 ± 0.17  0.53 ± 0.05 
20:2 n-6  1.58 ± 0.40  0.94 ± 0.17  0.71 ± 0.20 
20:3 n-6  1.67 ± 0.08  1.65 ± 0.24  1.40 ± 0.25 
20:4 n-6  15.49 ± 0.86  20.76 ± 0.65  19.08 ± 3.79 
22:0  0.00 ± 0.00  0.00 ± 0.00  0.00 ± 0.00 
22:1 n-9 / 20:4 n-3  0.95 ± 0.28  1.21 ± 0.35  0.55 ± 0.16 
20:5 n-3  1.82 ± 0.11  1.84 ± 0.29  1.03  ± 0.24 
24:0  0.00 ± 0.00  0.00 ± 0.00  0.00 ± 0.00 
22:4 n-6  1.83 ± 0.43  2.06  ± 0.11  1.80 ± 0.33 
22:5 n-6  1.50 ± 0.21  1.71 ± 0.14  2.66 ± 0.54 
24:1 n-9  0.52 ± 0.52  0.68 ± 0.48  0.00 ± 0.00 
22:5 n-3  3.16 ± 0.21
b  2.85 ± 0.30
ab  1.87 ± 0.37
a 
22:6 n-3  11.50 ± 1.46
b  6.20 ± 0.91
a  4.84 ± 1.24
a 
n-3  17.90 ± 1.19
b  12.43 ± 0.66
a  8.79 ± 1.74
a 
n-6  28.04 ± 0.94  33.40 ± 0.75  31.31 ± 5.03 
n-3 : n-6  0.65 ± 0.06
b  0.37 ± 0.01
a  0.26 ± 0.03
a 
 Table 3.9: Fatty acid profile in TAG fraction of maternal liver, taken at weaning (3 weeks after 
birth of offspring). There were no statistical differences between any dietary groups. For all 
dietary groups, n = 6. Data shown as % abundance. 
  Salmon oil  Soybean oil  Sunflower oil 
8:0  0.00 ± 0.00  0.00 ± 0.00  0.00 ± 0.00 
10:0  0.00 ± 0.00  0.00 ± 0.00  0.00 ± 0.00 
12:0  0.04 ± 0.04  0.26 ± 0.19  0.00 ± 0.00 
14:0  2.47 ± 0.44  2.42 ± 0.45  1.34 ± 0.18 
16:0   35.51 ± 1.64  28.13 ± 2.41  30.96 ± 2.89 
16:1 n-7  6.47 ± 0.42  6.45 ± 0.71  4.82 ± 0.72 
18:0  4.01 ± 0.96  5.00 ± 1.34  8.60 ± 2.60 
18:1 n-9  31.97 ± 4.02  29.79 ± 2.83  27.14 ± 4.00 
trans 18:1 n-9  3.25 ± 1.38  6.02 ± 2.78  3.12 ± 0.61 
18:2 n-6  7.24 ± 2.10  10.35 ± 2.08  4.04 ± 0.96 
18:3 n-6  1.11 ± 0.41  0.63 ± 0.43  2.41 ± 0.96 
18:3 n-3  0.36 ± 0.21  0.84 ± 0.34  0.71 ± 0.33 
20:0  0.55 ± 0.48  0.41 ± 0.35  0.16 ± 0.16 
20:1 n-9  0.47± 0.36  0.59 ± 0.33  0.25 ± 0.16 
20:2 n-6  0.74 ± 0.41  0.24 ± 0.14  1.06 ± 0.24 
20:3 n-6  0.92 ± 0.38  1.31 ± 0.72  2.26 ± 0.69 
20:4 n-6  0.66 ± 0.36  1.38 ± 0.50  5.59 ± 3.10 
22:0  0.70 ± 0.70  0.38 ± 0.38  0.09 ± 0.09 
22:1 n-9 / 20:4 n-3  0.68 ± 0.41  0.96 ± 0.76  1.12 ± 0.69 
20:5 n-3  0.03 ± 0.03  0.11 ± 0.11  0.33 ± 0.23 
24:0  0.00 ± 0.00  0.00 ± 0.00  0.00 ± 0.00 
22:4 n-6  0.48 ± 0.36  0.79 ± 0.34  0.72 ± 0.16 
22:5 n-6  0.73 ± 0.61  0.95 ± 0.58  1.06 ± 0.64 
24:1 n-9  0.44 ± 0.33  0.52 ± 0.30  0.72 ± 0.46 
22:5 n-3  0.68 ± 0.52  1.24 ± 0.52  1.24 ± 0.54 
22:6 n-3  0.48 ± 0.27  1.22 ± 0.52  2.26±  0.88 
n-3  2.23 ± 0.68  4.38 ± 1.58  5.65 ± 1.28 
n-6  11.88 ± 2.65  15.65 ± 3.78  17.14 ± 4.23 
n-3 : n-6  0.23 ± 0.06  0.24 ± 0.04  0.36 ± 0.06 
 
 
 Table 3.10: Fatty acid profile in CE fraction of maternal spleen, taken at weaning (3 weeks after 
birth of offspring). There were no statistical differences between any dietary groups. For all 
dietary groups, n = 6. Data shown as % abundance. 
  Salmon oil  Soybean oil  Sunflower oil 
8:0  0.00 ± 0.00  0.00 ± 0.00  0.00 ± 0.00 
10:0  3.73 ± 1.11  1.94 ± 1.20  5.00 ± 1.08 
12:0  1.63 ± 0.52  0.87 ± 0.50  2.09 ± 0.56 
14:0  1.31 ± 0.21  0.84 ± 0.45  0.76 ± 0.26 
16:0   11.76 ± 5.22  19.38 ± 7.05  6.04 ± 2.29 
16:1 n-7  2.36 ± 1.12  3.18 ± 1.08  1.02 ± 0.27 
18:0  5.20 ± 0.22  5.78 ± 0.67  5.07 ± 0.36 
18:1 n-9  16.01 ± 4.50  17.96 ± 4.17  8.62 ± 0.42 
trans 18:1 n-9  1.06 ± 0.56  3.56 ± 1.60  1.11 ± 0.68 
18:2 n-6  9.27 ± 3.05  2.95 ± 1.82  6.49 ± 0.53 
18:3 n-6  8.47 ± 2.46  12.30 ± 1.54  11.14 ± 1.06 
18:3 n-3  0.20 ± 0.13  0.67 ± 0.30  0.00 ± 0.00 
20:0  0.13 ± 0.10  1.29 ± 0.63  0.22 ± 0.14 
20:1 n-9  0.73 ± 0.52  1.45 ± 0.86  0.00 ± 0.00 
20:2 n-6  1.11 ± 0.30  0.76 ± 0.10  1.70 ± 0.32 
20:3 n-6  1.24 ± 0.36  1.62 ± 0.41  1.50 ± 0.11 
20:4 n-6  12.24 ± 3.48  8.26 ± 3.92  15.81 ± 1.36 
22:0  1.03 ± 0.62  0.42 ± 0.26  0.90 ± 0.48 
22:1 n-9 / 20:4 n-3  0.23 ± 0.17  1.44 ± 0.83  4.10 ± 2.67 
20:5 n-3  11.18 ± 3.26  6.99 ± 4.01  11.74 ± 2.95 
24:0  0.00 ± 0.00  0.00 ± 0.00  0.72 ± 0.72 
22:4 n-6  0.05 ± 0.05  0.30 ± 0.19  0.74 ± 0.74 
22:5 n-6  2.47 ± 1.11  1.34 ± 0.82  2.54 ± 0.86 
24:1 n-9  0.47 ± 0.47  0.00 ± 0.00  1.78 ± 1.78 
22:5 n-3  2.18 ± 0.65  1.97 ± 0.81  3.08 ± 0.48 
22:6 n-3  5.95 ± 1.63  4.73 ± 1.88  7.82 ± 0.29 
n-3  19.74 ± 5.07  15.80 ± 5.77  26.74 ± 0.76 
n-6  34.83 ± 4.60  27.53 ± 6.80  39.92 ± 2.54 
n-3 : n-6  0.50 ± 0.10  0.50 ± 0.09  0.68 ± 0.03 
  
 Table 3.11: Fatty acid profile in NEFA fraction of maternal spleen, taken at weaning (3 weeks 
after birth of offspring). Values with different letters on the same line are statistically different 
from one another (p < 0.05). For all dietary groups, n = 6. Data shown as % abundance. 
  Salmon oil  Soybean oil  Sunflower oil 
8:0  0.00 ± 0.00  0.00 ± 0.0 0  0.00 ± 0.00 
10:0  0.00 ± 0.00  0.00 ± 0.00  0.00 ± 0.00 
12:0  0.00 ± 0.00  0.00 ± 0.00  0.00 ± 0.00 
14:0  1.82 ± 0.28  1.07 ± 0.37  1.87 ± 0.24 
16:0   19.74 ± 1.32  18.20 ± 0.52  18.09 ± 0.35 
16:1 n-7  2.69 ± 0.76  1.98 ± 0.27  1.71 ± 0.17 
18:0  12.44 ± 1.88  14.43 ± 0.82  15.60 ± 0.40 
18:1 n-9  18.67 ± 1.92  14.44 ± 1.19  14.46 ± 0.48 
trans 18:1 n-9  3.60 ± 0.11  4.31 ± 1.00  3.11 ± 0.06 
18:2 n-6  16.76 ± 1.50  11.68 ± 3.01  14.07 ± 0.75 
18:3 n-6  0.00  ± 0.00  3.15 ± 3.15  0.00 ± 0.00 
18:3 n-3  0.48 ± 0.31  0.33 ± 0.21  0.33 ± 0.22 
20:0  1.10 ± 0.36  1.55 ± 0.43  0.52 ± 0.35 
20:1 n-9  0.10 ± 0.10  0.18 ± 0.18  0.00 ± 0.00 
20:2 n-6  1.18 ± 0.26  1.48 ± 0.25  1.37 ± 0.14 
20:3 n-6  1.17 ± 0.20  1.63 ± 0.20  1.83 ± 0.24 
20:4 n-6  10.59 ± 2.20  15.60 ± 1.33  16.24 ± 0.57 
22:0  0.00  ± 0.00  0.00 ± 0.00  0.00 ± 0.00 
22:1 n-9 / 20:4 n-3  0.43 ± 0.28  0.40 ± 0.40  0.00 ± 0.00 
20:5 n-3  0.00 ± 0.00  0.00 ± 0.00  0.00 ± 0.00 
24:0  0.00 ± 0.00  0.36 ± 0.28  0.00 ± 0.00 
22:4 n-6  0.00  ± 0.00  0.72 ± 0.72  0.00  ± 0.00 
22:5 n-6  2.25 ± 0.43
a  3.48 ± 0.54
ab  4.58  ± 0.40
b 
24:1 n-9  0.71  ± 0.38
a  1.04 ± 0.43
ab  1.95 ± 0.14
b 
22:5 n-3  2.66 ± 0.42  1.92 ± 0.17  1.84 ± 0.28 
22:6 n-3  3.61 ± 0.40
b  2.04 ± 0.31
a  2.43 ± 0.18
a 
n-3  7.18 ± 0.59
b  4.70 ± 0.44
a  4.60 ± 0.27
a 
n-6  31.96 ± 1.70
a  37.74 ± 1.75
b  38.09 ± 0.80
b 
n-3 : n-6  0.22 ± 0.01
b  0.13 ± 0.02
a  0.12 ± 0.01
a 
    
 Table 3.12: Fatty acid profile in PC fraction of maternal spleen, taken at weaning (3 weeks after 
birth of offspring). Values with different letters on the same line are statistically different from 
one another (p < 0.05). For all dietary groups, n = 6. Data shown as % abundance. 
  Salmon oil  Soybean oil  Sunflower oil 
8:0  0.00 ± 0.00  0.00 ± 0.00  0.00 ± 0.00 
10:0  0.00 ± 0.00  0.00 ± 0.00  0.00 ± 0.00 
12:0  0.26 ± 0.13  0.02 ± 0.02  0.13 ± 0.06 
14:0  0.61 ± 0.10  0.78 ± 0.31  0.54 ± 0.11 
16:0   38.49 ± 1.78  41.75 ± 1.68  42.65 ± 1.25 
16:1 n-7  1.02  ± 0.09  0.75 ± 0.09  0.78 ± 0.04 
18:0  11.77 ± 0.53  12.19 ± 0.31  12.79 ± 0.44 
18:1 n-9  9.73 ± 1.41  7.03 ± 0.39  7.26 ± 0.28 
trans 18:1 n-9  3.86 ± 0.14  3.78 ± 0.18  3.68 ± 0.12 
18:2 n-6  13.42 ± 1.17
b  10.21 ± 1.07
ab  9.40 ± 0.75
a 
18:3 n-6  0.50 ± 0.15  0.56  ± 0.19  0.37 ± 0.13 
18:3 n-3  0.55 ± 0.17  0.29 ± 0.02  0.34 ± 0.10 
20:0  0.00 ± 0.00  0.00 ± 0.00   0.00 ± 0.00 
20:1 n-9  1.03 ± 0.31  1.66 ± 0.58  1.68 ± 0.32 
20:2 n-6  0.47 ± 0.12  0.26 ± 0.11  0.24 ± 0.08 
20:3 n-6  1.10 ± 0.06  0.93 ± 0.13  0.85 ± 0.06 
20:4 n-6  10.02 ± 0.47  12.43 ± 1.38  12.86 ± 1.24 
22:0  0.00 ± 0.00  0.00 ± 0.00  0.00 ± 0.00 
22:1 n-9 / 20:4 n-3  0.90 ± 0.13  0.85 ± 0.14  0.65 ± 0.11 
20:5 n-3  0.72 ± 0.10  0.80 ± 0.35  0.59 ± 0.21 
24:0  0.00 ± 0.00  0.24 ± 0.15  0.10 ± 0.10 
22:4 n-6  1.38 ± 0.13
a  2.07 ± 0.17
b  2.12 ± 0.12
b 
22:5 n-6  0.67 ± 0.09  0.96 ± 0.20  1.01 ± 0.24 
24:1 n-9  0.66 ± 0.17  0.46 ± 0.25  0.35 ± 0.18 
22:5 n-3  1.38 ± 0.07
b  1.10 ± 0.06
ab  0.88 ± 0.11
a 
22:6 n-3  1.46 ± 0.27
b  0.88 ± 0.06
ab  0.73 ± 0.09
a 
n-3  5.01 ± 0.28
b  3.91 ± 0.48
ab  3.19 ± 0.46
a 
n-6  27.56 ± 1.02  27.42 ± 2.17  26.85 ± 1.48 
n-3 : n-6  0.18 ± 0.01  0.15 ± 0.03  0.12 ± 0.02 
 
 Table 3.13: Fatty acid profile in PE fraction of maternal spleen, taken at weaning (3 weeks after 
birth of offspring). Values with different letters on the same line are statistically different from 
one another (p < 0.05). For all dietary groups, n = 6. Data shown as % abundance. 
  Salmon oil  Soybean oil  Sunflower oil 
8:0  0.00 ± 0.00  0.00 ± 0.00  0.00 ± 0.00 
10:0  0.00 ± 0.00  0.00 ± 0.00  0.00 ± 0.00 
12:0  0.00 ± 0.00  0.00 ± 0.00  0.00 ± 0.00 
14:0  2.27 ± 0.25  2.21 ± 0.25  1.91 ± 0.20 
16:0   10.60 ± 0.82  9.70 ± 0.48  9.14 ± 0.29 
16:1 n-7  0.77 ± 0.12  1.06 ± 0.26  0.62 ± 0.15 
18:0  15.50 ± 0.73  15.74 ± 0.49  16.48 ± 0.18 
18:1 n-9  8.41 ± 1.59  6.93 ± 0.51  7.01 ± 0.17 
trans 18:1 n-9  2.24 ± 0.56  2.46 ± 0.17  2.70 ± 0.35 
18:2 n-6  7.39 ± 1.27  6.96 ± 0.73  5.67 ± 0.37 
18:3 n-6  0.70 ± 0.13  0.78 ± 0.33  0.58 ± 0.16 
18:3 n-3  0.46 ± 0.16  0.53 ± 0.14  0.51 ± 0.17 
20:0  0.09 ± 0.09  0.00 ± 0.00  0.00 ± 0.00 
20:1 n-9  1.36 ± 0.35  1.13 ± 0.30  1.06 ± 0.17 
20:2 n-6  1.14 ± 0.17  1.32 ± 0.26  0.82 ± 0.07 
20:3 n-6  1.66 ± 0.23  2.38 ± 0.75  1.59 ± 0.31 
20:4 n-6  27.10 ± 2.20
a  32.41 ± 1.84
ab  34.65 ± 1.53
b 
22:0  0.00 ± 0.00  0.00 ± 0.00  0.00 ± 0.00 
22:1 n-9 / 20:4 n-3  1.37 ± 0.42  1.37 ± 0.30  1.26 ± 0.32 
20:5 n-3  2.06 ± 0.26
b  0.54 ± 0.15
a  1.36 ± 0.30
ab 
24:0  0.00 ± 0.00  0.21 ± 0.21  0.00 ± 0.00 
22:4 n-6  4.08 ± 0.49
a  6.19 ± 0.57
b  6.74 ± 0.30
b 
22:5 n-6  1.49 ± 0.19  1.94 ± 0.29  2.29 ± 0.25 
24:1 n-9  0.41 ± 0.31  0.38 ± 0.31  0.58 ± 0.58 
22:5 n-3  5.66 ± 0.35
b  3.51 ± 0.23
a  2.94 ± 0.15
a 
22:6 n-3  5.26 ± 0.33
b  2.25 ± 0.25
a  2.09 ± 0.12
a 
n-3  14.81 ± 0.74
b  8.20 ± 0.31
a  8.16 ± 0.70
a 
n-6  43.55 ± 1.37
a  51.97 ± 0.44
b  52.34 ± 1.45
b 
n-3 : n-6  0.34 ± 0.02
b  0.16 ± 0.01




 Table 3.14: Fatty acid profile in TAG fraction of maternal spleen, taken at weaning (3 weeks 
after birth of offspring). Values with different letters on the same line are statistically different 
from one another (p < 0.05). For all dietary groups, n = 6. Data shown as % abundance. 
  Salmon oil  Soybean oil  Sunflower oil 
8:0  0.00 ± 0.00  0.00 ± 0.00  0.00  ± 0.00 
10:0  0.00 ± 0.00  0.00 ± 0.00  0.03 ± 0.03 
12:0  0.11 ± 0.05  0.53 ± 0.27  0.21 ± 0.11 
14:0  1.90 ± 0.39  1.59 ± 0.25  2.03 ± 0.34 
16:0   22.66 ± 3.48  22.25 ± 1.97  22.18 ± 1.76 
16:1 n-7  5.62 ± 1.35  4.94 ± 1.04  5.35 ± 0.68 
18:0  3.48 ± 0.26  3.71 ± 0.36  3.66 ± 0.32 
18:1 n-9  17.99 ± 5.33  22.50 ± 2.52  24.71 ± 1.61 
trans 18:1 n-9  5.23 ± 1.18  3.62 ± 0.51  3.62 ± 0.44 
18:2 n-6  19.99 ± 3.56  23.91 ± 4.63  26.85 ± 2.27 
18:3 n-6  2.37 ± 2.37  1.40 ± 1.29  0.05 ± 0.05 
18:3 n-3  0.67 ± 0.31  1.11 ± 0.33  0.62 ± 0.22 
20:0  1.03 ± 0.74  0.29 ± 0.29  0.91 ± 0.57 
20:1 n-9  1.69 ± 0.37  0.83 ± 0.33  0.99 ± 0.20 
20:2 n-6  1.61 ± 1.04  0.81 ± 0.20  1.42 ± 0.43 
20:3 n-6  3.28 ± 3.08  2.29 ± 1.83  0.68 ± 0.32 
20:4 n-6  1.00 ± 0.62  0.79 ± 0.42  0.51 ± 0.28 
22:0  0.63 ± 0.41  0.38 ± 0.23  1.52 ± 1.09 
22:1 n-9 / 20:4 n-3  4.48 ± 3.77  2.53 ± 2.53  0.00 ± 0.00 
20:5 n-3  0.21 ± 0.14  0.00 ± 0.00  0.00 ± 0.00 
24:0  0.00 ± 0.00  0.98 ± 0.98  0.67± 0.67 
22:4 n-6  0.31 ± 0.18  1.09 ± 0.48  1.18 ± 0.40 
22:5 n-6  1.03 ± 0.97  0.56 ± 0.41  1.44 ± 0.95 
24:1 n-9  0.89 ± 0.83  0.68 ± 0.61  0.00 ± 0.00 
22:5 n-3  1.49 ± 0.49  1.30 ± 0.39  0.37 ± 0.25 
22:6 n-3  2.33 ± 0.66  1.94 ± 0.86  0.99 ± 0.43 
n-3  9.19 ± 2.87  6.88 ± 2.60  1.98 ± 0.59 
n-6  29.58 ± 3.50  30.84 ± 3.58  32.13 ± 2.50 
n-3 : n-6  0.29 ± 0.05
b  0.22 ± 0.08





 Table 3.15: Fatty acid profile in CE fraction of maternal thymus, taken at weaning (3 weeks after 
birth of offspring). Values with different letters on the same line are statistically different from 
one another (p < 0.05). For all dietary groups, n = 6. Data shown as % abundance. 
  Salmon oil  Soybean oil  Sunflower oil 
8:0  0.00 ± 0.00  0.00 ± 0.00  0.00 ± 0.00 
10:0  0.78 ± 0.78  0.89 ± 0.89  0.00 ± 0.00 
12:0  0.75 ± 0.66  0.62 ± 0.52  0.09 ± 0.03 
14:0  3.17 ± 0.63  3.31 ± 0.71  3.47 ± 0.16 
16:0   31.55 ± 6.76  32.85 ± 5.71  36.40 ± 1.25 
16:1 n-7  5.04 ± 1.16  4.77 ± 1.01  6.84 ± 0.58 
18:0  9.25 ± 1.08  8.34 ± 2.51  8.82 ± 0.77 
18:1 n-9  19.87 ± 3.96
ab  16.12 ± 4.05
a  28.32 ± 1.49
b 
trans 18:1 n-9  9.32 ± 3.88  13.46 ± 6.37  5.60 ± 1.53 
18:2 n-6  2.44 ± 1.50  3.14 ± 1.94  0.65 ± 0.64 
18:3 n-6  5.89 ± 2.16  6.42 ± 1.75  7.88 ± 1.99 
18:3 n-3  0.03 ± 0.02  0.05 ± 0.04  0.01 ± 0.01 
20:0  0.23 ± 0.06  0.26 ± 0.08  0.27 ± 0.05 
20:1 n-9  0.83 ± 0.23
b  0.21 ± 0.10
a  0.28 ± 0.08
a 
20:2 n-6  0.23 ± 0.13  0.44 ± 0.34  0.13 ± 0.01 
20:3 n-6  0.08 ± 0.07  0.23 ± 0.11  0.12 ± 0.05 
20:4 n-6  3.92 ± 3.77  3.27 ± 3.01  0.30 ± 0.14 
22:0  0.22 ± 0.22  0.00 ± 0.00  0.00 ± 0.00 
22:1 n-9 / 20:4 n-3  0.08 ± 0.05  0.10 ± 0.09  0.17 ± 0.13 
20:5 n-3  3.55 ± 3.55  2.88 ± 2.88  0.00 ± 0.00 
24:0  0.00 ± 0.00  0.00 ± 0.00  0.00 ± 0.00 
22:4 n-6  0.00 ± 0.00
a  0.14 ± 0.06
ab  0.26 ± 0.08
b 
22:5 n-6  0.00 ± 0.00  0.00 ± 0.00  0.03 ± 0.02 
24:1 n-9  0.08 ± 0.08  0.00 ± 0.00  0.05 ± 0.05 
22:5 n-3  0.73 ± 0.57  0.43 ± 0.35  0.15 ± 0.10 
22:6 n-3  1.94 ± 1.81  2.07 ± 1.99  0.15 ± 0.06 
n-3  6.33 ± 5.91  5.52 ± 5.18  0.49 ± 0.28 
n-6  12.57 ± 6.81  13.64 ± 5.45  9.37 ± 1.53 
n-3 : n-6  0.21 ± 0.14  0.18 ± 0.14  0.06 ± 0.03 
  
 Table 3.16: Fatty acid profile in NEFA fraction of maternal thymus, taken at weaning (3 weeks 
after birth of offspring). Values with different letters on the same line are statistically different 
from one another (p < 0.05). For all dietary groups, n = 6. Data shown as % abundance. 
  Salmon oil  Soybean oil  Sunflower oil 
8:0  0.00 ± 0.00  0.00 ± 0.00  0.00 ± 0.00 
10:0  0.00 ± 0.00  0.00 ± 0.00  0.00 ± 0.00 
12:0  0.00 ± 0.00  0.00 ± 0.00  0.00 ± 0.00 
14:0  1.53 ± 0.23  1.53 ± 0.28  1.34 ± 0.17 
16:0   23.03 ± 1.16  22.73 ± 1.44  22.26 ±  0.61 
16:1 n-7  5.10 ± 0.62  5.53 ± 0.61  5.79 ± 0.33 
18:0  11.61 ± 0.63  11.59 ± 0.61  10.96 ± 0.26 
18:1 n-9  26.22 ± 1.74  26.56 ± 2.18  28.11 ± 0.79 
trans 18:1 n-9  3.67 ± 0.37  3.38 ± 0.30  3.48 ± 0.08 
18:2 n-6  10.81 ± 0.77  12.15 ± 1.58  11.39 ± 0.91 
18:3 n-6  0.00 ± 0.00  0.00 ± 0.00  0.00 ± 0.00 
18:3 n-3  0.00 ± 0.00  0.00 ± 0.00  0.27 ± 0.27 
20:0  0.69 ± 0.23  0.82 ± 0.23  0.74 ± 0.23 
20:1 n-9  0.34 ± 0.22  0.47 ± 0.47  0.00 ± 0.00 
20:2 n-6  0.98 ± 0.20  1.00 ± 0.18  1.11 ± 0.18 
20:3 n-6  1.55 ± 0.34  1.29 ± 0.20  1.22 ± 0.16 
20:4 n-6  8.52 ± 1.77  8.59 ± 1.12  9.25 ± 0.49 
22:0  0.00 ± 0.00  0.00 ± 0.00  0.00 ± 0.00 
22:1 n-9 / 20:4 n-3  0.49 ± 0.23  0.00 ± 0.00  0.00 ± 0.00 
20:5 n-3  0.15 ± 0.15  0.00 ± 0.00  0.00 ± 0.00 
24:0  0.29 ± 0.29  0.00 ± 0.00  0.00 ± 0.00 
22:4 n-6  0.00 ± 0.00  0.00 ± 0.00  0.00 ± 0.00 
22:5 n-6  1.42 ± 0.21  1.97 ± 0.44  2.20 ± 0.37 
24:1 n-9  0.08 ± 0.06
a  0.29 ± 0.21
ab  0.76 ± 0.15
b 
22:5 n-3  1.42 ± 0.13
b  1.06 ± 0.29
ab  0.40 ± 0.18
a 
22:6 n-3  2.10 ± 0.22
b  1.05 ± 0.20
a
  0.71 ± 0.27
a 
n-3  4.16 ± 0.33
b  2.11 ± 0.44
a  1.38 ± 0.58
a 
n-6  23.28 ± 2.08  25.00 ± 2.11  25.18 ± 0.99 
n-3 : n-6  0.18 ± 0.02
b  0.08 ± 0.02





 Table 3.17: Fatty acid profile in PC fraction of maternal thymus, taken at weaning (3 weeks after 
birth of offspring). Values with different letters on the same line are statistically different from 
one another (p < 0.05). For all dietary groups, n = 6. Data shown as % abundance. 
  Salmon oil  Soybean oil  Sunflower oil 
8:0  0.00 ± 0.00  0.00 ± 0.00  0.00 ± 0.00 
10:0  0.00 ± 0.00  0.00 ± 0.00  0.00 ± 0.00 
12:0  0.00 ± 0.00  0.00 ± 0.00  0.00 ± 0.00 
14:0  1.39 ± 0.22  0.94 ± 0.13  1.20 ± 0.11 
16:0   33.62 ± 0.67  35.92 ± 0.74  34.40 ± 0.95 
16:1 n-7  1.98 ± 0.15
b  1.54 ± 0.06
a  1.51 ± 0.03
a 
18:0  14.37 ± 1.08  15.32 ± 1.04  14.69 ± 0.68 
18:1 n-9  13.41 ± 1.23  12.98 ± 0.76  12.84 ± 0.96 
trans 18:1 n-9  5.20 ± 0.63  4.69 ± 0.39  4.51 ± 0.22 
18:2 n-6  8.55 ± 0.56  8.42 ± 0.61  8.11 ± 0.24 
18:3 n-6  0.26 ± 0.11  0.22 ± 0.09  0.15 ± 0.04 
18:3 n-3  0.08 ± 0.08  0.08 ± 0.08  0.09 ± 0.07 
20:0  0.37 ± 0.12  0.23 ± 0.12  0.17 ± 0.08 
20:1 n-9  1.47 ± 0.60  1.21 ± 0.41  1.26 ± 0.26 
20:2 n-6  1.25 ± 0.11  0.88 ± 0.23  1.24 ± 0.16 
20:3 n-6  1.58 ± 0.13  1.49 ± 0.17  1.59 ± 0.25 
20:4 n-6  9.65 ± 0.60
a  10.91 ± 0.68
ab  12.22 ± 0.65
b 
22:0  0.00 ± 0.00  0.00 ± 0.00  0.00 ± 0.00 
22:1 n-9 / 20:4 n-3  0.80 ± 0.44  0.62 ± 0.21  0.53 ± 0.12 
20:5 n-3  0.48 ± 0.16  0.17 ± 0.14  0.18 ± 0.12 
24:0  0.07  ± 0.07  0.00 ± 0.00  0.00 ± 0.00 
22:4 n-6  0.45  ± 0.34  0.85 ± 0.54  0.69 ± 0.32 
22:5 n-6  1.63 ± 0.37  1.41 ± 0.52  1.74 ± 0.55 
24:1 n-9  0.64 ± 0.22  0.55 ± 0.12  0.71 ± 0.15 
22:5 n-3  0.99 ± 0.19  0.62 ± 0.21  0.81 ± 0.35 
22:6 n-3  1.75 ± 0.34  0.96 ± 0.25  1.36 ± 0.56 
n-3  4.10 ± 0.54  2.46 ± 0.22  2.97 ± 0.72 
n-6  23.38 ± 0.49  24.17 ± 1.02  25.74 ± 0.81 
n-3 : n-6  0.17 ± 0.02  0.10 ± 0.01  0.11 ± 0.02 
 
 Table 3.18: Fatty acid profile in PE fraction of maternal thymus, taken at weaning (3 weeks after 
birth of offspring). Values with different letters on the same line are statistically different from 
one another (p < 0.05). For all dietary groups, n = 6. Data shown as % abundance. 
  Salmon oil  Soybean oil  Sunflower oil 
8:0  0.00 ± 0.00  0.00 ± 0.00  0.00 ± 0.00 
10:0  0.00 ± 0.00  0.00 ± 0.00  0.00 ± 0.00 
12:0  0.18 ± 0.18  0.00 ± 0.00  0.00 ± 0.00 
14:0  1.45 ± 0.34  1.29 ± 0.26  1.54 ± 0.29 
16:0   11.10 ± 0.89  9.45 ± 0.78  10.72 ± 0.74 
16:1 n-7  1.30 ± 0.35  0.99 ± 0.29  1.24 ± 0.22 
18:0  17.13 ± 1.06  18.68 ± 0.27  18.56 ± 0.34 
18:1 n-9  14.62 ± 1.23  11.11 ± 1.35  13.01 ± 0.71 
trans 18:1 n-9  1.47 ± 0.67  4.38 ± 0.62  2.86 ± 0.78 
18:2 n-6  5.28 ± 0.55  4.80 ± 0.76  4.51 ± 0.39 
18:3 n-6  0.34 ± 0.10  0.59 ± 0.15  0.57 ± 0.16 
18:3 n-3  0.56 ± 0.21  0.32 ± 0.14  0.38 ± 0.08 
20:0  0.00  ± 0.00  0.47 ± 0.32  0.00 ± 0.00 
20:1 n-9  1.66 ± 0.07  1.66 ± 0.56  1.67 ± 0.19 
20:2 n-6  1.19 ± 0.23  0.83 ± 0.11  0.78 ± 0.09 
20:3 n-6  1.70 ± 0.14  1.33 ± 0.11  1.50 ± 0.11 
20:4 n-6  26.59 ± 2.87  30.74 ± 0.91  31.64 ± 1.56 
22:0  0.00 ± 0.00  0.00 ± 0.00  0.00 ± 0.00 
22:1 n-9 / 20:4 n-3  0.96 ± 0.22  1.33 ± 0.18  0.97 ± 0.22 
20:5 n-3  1.45  ± 0.16
b  0.85 ± 0.19
ab  0.79 ± 0.17
a 
24:0  0.00  ± 0.00  0.00 ± 0.00  0.00 ± 0.00 
22:4 n-6  3.46 ± 0.22  5.08 ± 0.73  4.45 ± 0.42 
22:5 n-6  1.46 ± 0.31
b  2.49 ± 0.37
a  2.41 ± 0.17
a 
24:1 n-9  0.13 ± 0.09  0.25 ± 0.25  0.00 ± 0.00 
22:5 n-3  2.88 ± 0.28  1.49 ± 0.18  1.05 ± 0.13 
22:6 n-3  5.09 ± 0.59
b  1.90 ± 0.08
a  1.34 ± 0.21
a 
n-3  10.95 ± 1.14
b  5.89 ± 0.30
a  4.54 ± 0.35
a 
n-6  40.02 ± 2.42  45.84 ± 1.54  45.87 ± 1.48 
n-3 : n-6  0.28 ± 0.04
b  0.13 ± 0.01
a  0.10 ± 0.01
a 
  Table 3.19: Fatty acid profile in TAG fraction of maternal plasma, taken at weaning (3 weeks 
after birth of offspring). Values with different letters on the same line are statistically different 
from one another (p < 0.05). For all dietary groups, n = 6. Data shown as % abundance. 
  Salmon oil  Soybean oil  Sunflower oil 
8:0  0.00 ± 0.00  0.00 ± 0.00  0.00 ± 0.00 
10:0  0.23 ± 0.15  0.12 ± 0.12  0.00 ± 0.00 
12:0   0.29 ± 0.05  0.18 ± 0.06  0.22 ± 0.03 
14:0  4.15 ± 0.37  3.65 ± 0.45  3.53 ± 0.17 
16:0   31.99 ± 1.11  32.15 ± 1.45  31.48 ± 1.93 
16:1 n-7  6.91 ± 0.51  6.04 ± 0.38  7.65 ± 0.67 
18:0  4.77± 1.98  7.10 ± 1.87  1.92 ± 1.21 
18:1 n-9  21.57± 5.20  18.33 ± 6.00  15.39 ± 4.29 
trans 18:1 n-9  12.18 ± 6.64  13.59 ± 7.25  24.11 ± 7.10 
18:2 n-6  8.16 ± 1.03  8.42 ± 2.39  8.97 ± 2.73 
18:3 n-6  0.14 ± 0.12  3.17 ± 2.93  1.97 ± 1.69 
18:3 n-3  0.28 ± 0.09  0.31 ± 0.03  0.17 ± 0.06 
20:0  0.21 ± 0.17  0.12 ± 0.07  0.17 ± 0.05 
20:1 n-9  1.56 ± 0.35
b  0.30  ± 0.05
a  0.34 ± 0.08
a 
20:2 n-6  0.61 ± 0.40  0.90 ± 0.36  0.46 ± 0.34 
20:3 n-6  0.29 ± 0.14  0.54 ± 0.30  0.30 ± 0.16 
20:4 n-6  0.52 ± 0.31  0.30 ± 0.04  0.30 ± 0.04 
22:0  0.09 ± 0.09  0.01 ± 0.01  0.00 ± 0.00 
22:1 n-9 / 20:4 n-3  0.35 ± 0.16  0.29 ± 0.22  0.08 ± 0.08 
20:5 n-3  0.53 ± 0.31  0.11 ± 0.11  0.00 ± 0.00 
24:0  0.00 ± 0.00  0.00 ± 0.00  0.00 ± 0.00 
22:4 n-6  0.72 ± 0.26  1.09 ± 0.52  1.13 ± 0.68 
22:5 n-6  0.57 ± 0.23  0.95 ± 0.66  0.63 ± 0.37 
24:1 n-9  0.90 ± 0.44  0.35 ± 0.26  0.04 ± 0.04 
22:5 n-3  1.28 ± 0.24  0.83 ± 0.41  0.53 ± 0.31 
22:6 n-3  1.72 ± 0.42  1.18 ± 0.59  0.63 ± 0.28 
n-3  4.15 ± 0.86  2.72 ± 1.16  1.41 ± 0.62 
n-6  11.01 ± 1.26  15.36 ± 0.46  13.74 ± 3.46 
n-3 : n-6  0.41± 0.12
b  0.17 ± 0.07
ab  0.09 ± 0.03
a 
   Table 3.20: Fatty acid profile in CE fraction of offspring plasma, taken at various ages. There 
was no effect of diet on fatty acids, but there was an effect of time. Values with different letters on 
the same line are statistically different from one another (p < 0.05). 
      Week 3  Week 6  Week 9  Week 12 
Salmon oil  0.00 ± 0.00  0.00 ± 0.00  0.00 ± 0.00  0.00 ± 0.00 
Soybean oil  0.00 ± 0.00  0.00 ± 0.00  0.00 ± 0.00  0.00 ± 0.00 
12:0 
Sunflower oil  0.00 ± 0.00  0.00 ± 0.00  0.00 ± 0.00  0.00 ± 0.00 
Salmon oil  0.01 ± 0.00
b  0.00 ± 0.00
a  0.00 ± 0.00
a  0.00 ± 0.00
a 
Soybean oil  0.01 ± 0.01  0.00 ± 0.00  0.00 ± 0.00  0.00 ± 0.00 
14:0 
Sunflower oil  0.01 ± 0.00  0.00 ± 0.00  0.00 ± 0.00  0.00 ± 0.00 
Salmon oil  0.15 ± 0.02
b  0.09 ± 0.00
a  0.11 ± 0.01
a  0.09 ± 0.00
a 
Soybean oil  0.13 ± 0.02  0.09 ± 0.00  0.11 ± 0.01  0.11 ± 0.01 
16:0 
Sunflower oil  0.14 ± 0.01
b  0.09 ± 0.00
a  0.09 ± 0.01
a  0.11 ± 0.01
a 
Salmon oil  0.02 ± 0.01
a  0.03 ± 0.00
a  0.08 ± 0.01
b  0.04 ± 0.01
a 
Soybean oil  0.03 ± 0.01  0.04 ± 0.01  0.05 ± 0.01  0.04 ± 0.01 
16:1 n-
7 
Sunflower oil  0.02 ± 0.00
a  0.03 ± 0.00
a  0.09 ± 0.01
b  0.05 ± 0.01
ab 
Salmon oil  0.12 ± 0.02
b  0.07 ± 0.00
ab  0.05 ± 0.00
a  0.05 ± 0.00
a 
Soybean oil  0.10 ± 0.01
b  0.07 ± 0.00
ab  0.07 ± 0.01




Sunflower oil  0.11 ± 0.01  0.07 ± 0.01  0.07 ± 0.01  0.08 ± 0.03 
Salmon oil  0.01 ± 0.00  0.01 ± 0.00  0.01 ± 0.00  0.01 ± 0.00 
Soybean oil  0.01 ± 0.00  0.02 ± 0.01  0.01 ± 0.00  0.01 ± 0.00 
trans 
18:1 n-
9  Sunflower oil  0.01 ± 0.00  0.01 ± 0.00  0.01 ± 0.00  0.01 ± 0.00 
Salmon oil  0.26 ± 0.01  0.23 ± 0.00  0.23 ± 0.01  0.24 ± 0.02 
Soybean oil  0.24 ± 0.00  0.24 ± 0.01  0.26 ± 0.01  0.27 ± 0.02 
18:2 n-
6 
Sunflower oil  0.23 ± 0.01  0.24 ± 0.01  0.24 ± 0.01  0.24 ± 0.02 
Salmon oil  0.01 ± 0.00
c  0.01 ± 0.00
bc  0.00 ± 0.00
a  0.00 ± 0.00
ab 
Soybean oil  0.01 ± 0.00  0.01 ± 0.00  0.00 ± 0.00  0.00 ± 0.00 
18:3 n-
6 
Sunflower oil  0.01 ± 0.00
b  0.01 ± 0.00
b  0.00 ± 0.00
a  0.00 ± 0.00
a 
Salmon oil  0.00 ± 0.00  0.00 ± 0.00  0.00 ± 0.00  0.00 ± 0.00 
Soybean oil  0.00 ± 0.00  0.00 ± 0.00  0.00 ± 0.00  0.00 ± 0.00 
18:3 n-
3 
Sunflower oil  0.00 ± 0.00  0.00 ± 0.00  0.00 ± 0.00  0.00 ± 0.00 
Salmon oil  0.00 ± 0.00  0.00 ± 0.00  0.00 ± 0.00  0.00 ± 0.00 
Soybean oil  0.00 ± 0.00  0.00 ± 0.00  0.00 ± 0.00  0.00 ± 0.00 
20:0 
Sunflower oil  0.00 ± 0.00  0.00 ± 0.00  0.00 ± 0.00  0.00 ± 0.00 
Salmon oil  0.00 ± 0.00  0.00 ± 0.00  0.00 ± 0.00  0.00 ± 0.00 
Soybean oil  0.00 ± 0.00  0.00 ± 0.00  0.00 ± 0.00  0.00 ± 0.00 
20:1 n-
9 
Sunflower oil  0.00 ± 0.00  0.00 ± 0.00  0.00 ± 0.00  0.00 ± 0.00 
Salmon oil  0.00 ± 0.00  0.00 ± 0.00  0.00 ± 0.00  0.00 ± 0.00 
Soybean oil  0.00 ± 0.00  0.00 ± 0.00  0.00 ± 0.00  0.00 ± 0.00 
20:2 n-
6 
Sunflower oil  0.00 ± 0.00  0.00 ± 0.00  0.00 ± 0.00  0.00 ± 0.00 
Salmon oil  0.00 ± 0.00  0.00 ± 0.00  0.00 ± 0.00  0.00 ± 0.00 
Soybean oil  0.00 ± 0.00  0.00 ± 0.00  0.00 ± 0.00  0.00 ± 0.00 
20:3 n-
6 
Sunflower oil  0.00 ± 0.00  0.00 ± 0.00  0.00 ± 0.00  0.00 ± 0.00 
Salmon oil  0.29 ± 0.08
a  0.50 ± 0.01
b  0.44 ± 0.02
ab  0.49 ± 0.01
b 
Soybean oil  0.43 ± 0.02  0.47 ± 0.02  0.41 ± 0.03  0.45 ± 0.02 
20:4 n-
6 
Sunflower oil  0.29 ± 0.09
a  0.52 ± 0.01
b  0.44 ± 0.02
ab  0.44 ± 0.04
ab  
      Week 3  Week 6  Week 9  Week 12 
Salmon oil  0.05 ± 0.05  0.00 ± 0.00  0.00 ± 0.00  0.00 ± 0.00 
Soybean oil  0.00 ± 0.00  0.00 ± 0.00  0.00 ± 0.00  0.00 ± 0.00 
20:3 n-
9 
Sunflower oil  0.13 ± 0.08  0.00 ± 0.00  0.00 ± 0.00  0.00 ± 0.00 
Salmon oil  0.00 ± 0.00  0.00 ± 0.00  0.00 ± 0.00  0.00 ± 0.00 
Soybean oil  0.00 ± 0.00  0.00 ± 0.00  0.00 ± 0.00  0.00 ± 0.00 
22:0 
Sunflower oil  0.00 ± 0.00  0.00 ± 0.00  0.00 ± 0.00  0.00 ± 0.00 
Salmon oil  0.00 ± 0.00  0.00 ± 0.00  0.00 ± 0.00  0.00 ± 0.00 
Soybean oil  0.00 ± 0.00  0.00 ± 0.00  0.00 ± 0.00  0.00 ± 0.00 
22:1 n-
9 
Sunflower oil  0.00 ± 0.00  0.00 ± 0.00  0.00 ± 0.00  0.00 ± 0.00 
Salmon oil  0.01 ± 0.00  0.01 ± 0.00  0.01 ± 0.00  0.01 ± 0.00 
Soybean oil  0.01 ± 0.00  0.01 ± 0.00  0.01 ± 0.00  0.01 ± 0.00 
20:5 n-
3 
Sunflower oil  0.01 ± 0.00  0.01 ± 0.00  0.01 ± 0.00  0.01 ± 0.00 
Salmon oil  0.01 ± 0.00
a  0.02 ± 0.00
ab  0.02 ± 0.00
a  0.03 ± 0.00
b 
Soybean oil  0.01 ± 0.00  0.03 ± 0.01  0.02 ± 0.01  0.04 ± 0.01 
22:2 n-
9 
Sunflower oil  0.01 ± 0.00
a  0.02 ± 0.00
ab  0.03 ± 0.00
ab  0.03 ± 0.00
b 
Salmon oil  0.00 ± 0.00  0.00 ± 0.00  0.00 ± 0.00  0.00 ± 0.00 
Soybean oil  0.00 ± 0.00  0.00 ± 0.00  0.00 ± 0.00  0.00 ± 0.00 
22:4 n-
6 
Sunflower oil  0.00 ± 0.00  0.00 ± 0.00  0.00 ± 0.00  0.00 ± 0.00 
Salmon oil  0.00 ± 0.00  0.00 ± 0.00  0.00 ± 0.00  0.00 ± 0.00 
Soybean oil  0.00 ± 0.00  0.00 ± 0.00  0.00 ± 0.00  0.00 ± 0.00 
24:0 
Sunflower oil  0.00 ± 0.00  0.00 ± 0.00  0.00 ± 0.00  0.00 ± 0.00 
Salmon oil  0.00 ± 0.00  0.00 ± 0.00  0.00 ± 0.00  0.00 ± 0.00 
Soybean oil  0.00 ± 0.00  0.00 ± 0.00  0.00 ± 0.00  0.00 ± 0.00 
24:1 n-
9 
Sunflower oil  0.00 ± 0.00  0.00 ± 0.00  0.00 ± 0.00  0.00 ± 0.00 
Salmon oil  0.00 ± 0.00  0.00 ± 0.00  0.00 ± 0.00  0.00 ± 0.00 
Soybean oil  0.00 ± 0.00  0.00 ± 0.00  0.00 ± 0.00  0.00 ± 0.00 
22:5 n-
3 
Sunflower oil  0.00 ± 0.00  0.00 ± 0.00  0.00 ± 0.00  0.00 ± 0.00 
Salmon oil  0.02 ± 0.00  0.02 ± 0.00  0.01 ± 0.00  0.02 ± 0.01 
Soybean oil  0.01 ± 0.00  0.03 ± 0.00  0.02 ± 0.00  0.01 ± 0.01 
22:6 n-
3  
Sunflower oil  0.01 ± 0.00  0.01 ± 0.00  0.01 ± 0.00  0.02 ± 0.01 
Salmon oil  0.03 ± 0.00  0.03 ± 0.00  0.02 ± 0.00  0.03 ± 001 
Soybean oil  0.02 ± 0.00  0.04 ± 0.00  0.03 ± 0.01  0.02 ± 0.01 
n-3 
Sunflower oil  0.02 ± 0.00  0.02 ± 0.01  0.02 ± 0.00  0.03 ± 0.01 
Salmon oil  0.57 ± 0.07  0.74 ± 0.01  0.67 ± 0.02  0.73 ± 0.02 
Soybean oil  0.68 ± 0.02  0.71 ± 0.01  0.67 ± 0.03  0.72 ± 0.02 
n-6 
Sunflower oil  0.48 ± 0.10
a  0.76 ± 0.00
b  0.68 ± 0.02
ab  0.67 ± 0.05
ab 
Salmon oil  0.07 ± 0.02  0.04 ± 0.01  0.03 ± 0.01  0.04 ± 0.01 
Soybean oil  0.04 ± 0.01  0.06 ± 0.00  0.04 ± 0.01  0.03 ± 0.01 
n-3 : n-
6 
Sunflower oil  0.05 ± 0.01  0.03 ± 0.01  0.03 ± 0.01  0.04 ± 0.02   23 
Table 3.21: Fatty acid profile in NEFA fraction of offspring plasma, taken at various ages. There 
was no effect of diet on fatty acids, but there was an effect of time. Values with different letters on 
the same line are statistically different from one another (p < 0.05). 
      Week 3  Week 6  Week 9  Week 12 
Salmon oil  0.00 ± 0.00  0.00 ± 0.00  0.00 ± 0.00  0.00 ± 0.00 
Soybean oil  0.01 ± 0.01
b  0.00 ± 0.00
a  0.00 ± 0.00
a  0.00 ± 0.00
a 
12:0 
Sunflower oil  0.01 ± 0.01  0.00 ± 0.00  0.00 ± 0.00  0.00 ± 0.00 
Salmon oil  0.02 ± 0.00
b  0.00 ± 0.00
a  0.02 ± 0.00
b  0.02 ± 0.00
b 
Soybean oil  0.02 ± 0.01  0.00 ± 0.00  0.02 ± 0.00  0.02 ± 0.00 
14:0 
  
Sunflower oil  0.03 ± 0.00
b  0.00 ± 0.00
a  0.02 ± 0.00
b  0.03 ± 0.00
b 
Salmon oil  0.22 ± 0.02
a  0.27 ± 0.01
ab  0.29 ± 0.01
b  0.29 ± 0.01
b 
Soybean oil  0.27 ± 0.03  0.25 ± 0.02  0.29 ± 0.01  0.30 ± 0.01 
16:0 
Sunflower oil  0.19 ± 0.04
a  0.26 ± 0.01
ab  0.28 ± 0.01
b  0.29 ± 0.01
b 
Salmon oil  0.01 ± 0.01
a  0.03 ± 0.01
ab  0.05 ± 0.01
b  0.04 ± 0.00
b 
Soybean oil  0.02 ± 0.01  0.03 ± 0.00  0.04 ± 0.01  0.03 ± 0.00 
16:1 n-
7  
Sunflower oil  0.06 ± 0.04  0.03 ± 0.00  0.04 ± 0.00  0.04 ± 0.01 
Salmon oil  0.10 ± 0.02
a  0.20 ± 0.02
b  0.15 ± 0.01
ab  0.09 ± 0.00
a 
Soybean oil  0.18 ± 0.04  0.17 ± 0.02  0.16 ± 0.03  0.09 ± 0.01 
18:1 n-
9  
Sunflower oil  0.12 ± 0.02
a  0.21 ± 0.01
b  0.13 ± 0.01
a  0.11 ± 0.01
a 
Salmon oil  0.02 ± 0.01
a  0.15 ± 0.01
b  0.04 ± 0.02
a  0.02 ± 0.00
a 
Soybean oil  0.07 ± 0.03
ab  0.14 ± 0.01
b  0.05 ± 0.02




9   Sunflower oil  0.05 ± 0.02
a  0.14 ± 0.02
b  0.02 ± 0.00
a  0.02 ± 0.00
a 
Salmon oil  0.11 ± 0.02
a  0.19 ± 0.01
b  0.18 ± 0.01
b  0.18 ± 0.01
b 
Soybean oil  0.13 ± 0.02
a  0.18 ± 0.01
b  0.18 ± 0.00




Sunflower oil  0.10 ± 0.01
a  0.19 ± 0.01
b  0.16 ± 0.01
b  0.17 ± 0.01
b 
Salmon oil  0.01 ± 0.01  0.01 ± 0.01  0.00 ± 0.00  0.01 ± 0.01 
Soybean oil  0.01 ± 0.01  0.01 ± 0.01  0.00 ± 0.00  0.00 ± 0.00 
18:3 n-
6 
Sunflower oil  0.02 ± 0.01  0.01 ± 0.00  0.01 ± 0.01  0.01 ± 0.01 
Salmon oil  0.01 ± 0.00  0.02 ± 0.01  0.02 ± 0.00  0.01 ± 0.00 
Soybean oil  0.01 ± 0.01  0.02 ± 0.01  0.01 ± 0.00  0.01 ± 0.00 
18:3 n-
3 
Sunflower oil  0.01 ± 0.00  0.02 ± 0.01  0.01 ± 0.00  0.01 ± 0.00 
Salmon oil  0.00 ± 0.00  0.00 ± 0.00  0.00 ± 0.00  0.00 ± 0.00 
Soybean oil  0.00 ± 0.00  0.00 ± 0.00  0.00 ± 0.00  0.00 ± 0.00 
20:0 
  
Sunflower oil  0.00 ± 0.00  0.00 ± 0.00  0.00 ± 0.00  0.00 ± 0.00 
Salmon oil  0.01 ± 0.01  0.00 ± 0.00  0.00 ± 0.00  0.01 ± 0.01 
Soybean oil  0.01 ± 0.01  0.01 ± 0.01  0.00 ± 0.00  0.00 ± 0.00 
20:1 n-
9  
Sunflower oil  0.02 ± 0.01  0.00 ± 0.00  0.01 ± 0.01  0.01 ± 0.01 
Salmon oil  0.23 ± 0.10  0.00 ± 0.00  0.00 ± 0.00  0.01 ± 0.01 
Soybean oil  0.09 ± 0.09  0.00 ± 0.00  0.00 ± 0.00  0.00 ± 0.00 
20:2 n-
6 
Sunflower oil  0.19 ± 0.08
b  0.00 ± 0.00
a  0.01 ± 0.00
a  0.01 ± 0.00
a 
Salmon oil  0.01 ± 0.00  0.00 ± 0.00  0.00 ± 0.00  0.00 ± 0.00 
Soybean oil  0.00 ± 0.00  0.01 ± 0.01  0.00 ± 0.00  0.00 ± 0.00 
20:3 n-
6  
Sunflower oil  0.01 ± 0.01  0.01 ± 0.00  0.00 ± 0.00  0.00 ± 0.00 
Salmon oil  0.05 ± 0.01
a  0.09 ± 0.01
ab  0.07 ± 0.01
ab  0.10 ± 0.01
b 
Soybean oil  0.04 ± 0.01  0.07 ± 0.00  0.08 ± 0.00  0.08 ± 0.02 
20:4 n-
6  
Sunflower oil  0.04 ± 0.01
a  0.09 ± 0.01
b  0.08 ± 0.01
b  0.09 ± 0.01
b   24 
 
      Week 3  Week 6  Week 9  Week 12 
Salmon oil  0.00 ± 0.00  0.00 ± 0.00  0.01 ± 0.01  0.00 ± 0.00 
Soybean oil  0.00 ± 0.00  0.00 ± 0.00  0.00 ± 0.00  0.02 ± 0.02 
20:3 n-
9  
Sunflower oil  0.00 ± 0.00  0.00 ± 0.00  0.00 ± 0.00  0.00 ± 0.00 
Salmon oil  0.00 ± 0.00  0.00 ± 0.00  0.00 ± 0.00  0.00 ± 0.00 
Soybean oil  0.00 ± 0.00  0.00 ± 0.00  0.00 ± 0.00  0.00 ± 0.00 
22:0  
Sunflower oil  0.00 ± 0.00  0.00 ± 0.00  0.00 ± 0.00  0.00 ± 0.00 
Salmon oil  0.00 ± 0.00  0.00 ± 0.00  0.00 ± 0.00  0.01 ± 0.01 
Soybean oil  0.00 ± 0.00  0.01 ± 0.01  0.00 ± 0.00  0.01 ± 0.00 
22:1 n-
9  
Sunflower oil  0.01 ± 0.01  0.00 ± 0.00  0.01 ± 0.00  0.01 ± 0.00 
Salmon oil  0.00 ± 0.00
a  0.01 ± 0.00
b  0.00 ± 0.00
a  0.00 ± 0.00
a 
Soybean oil  0.00 ± 0.00  0.00 ± 0.00  0.00 ± 0.00  0.00 ± 0.00 
20:5 n-
3 
Sunflower oil  0.00 ± 0.00  0.00 ± 0.00  0.00 ± 0.00  0.00 ± 0.00 
Salmon oil  0.00 ± 0.00  0.00 ± 0.00  0.01 ± 0.01  0.00 ± 0.00 
Soybean oil  0.00 ± 0.00  0.00 ± 0.00  0.00 ± 0.00  0.00 ± 0.00 
22:2 n-
9 
Sunflower oil  0.01 ± 0.01  0.00 ± 0.00  0.02 ± 0.02  0.00 ± 0.00 
Salmon oil  0.01 ± 0.00  0.01 ± 0.01  0.00 ± 0.00  0.00 ± 0.00 
Soybean oil  0.01 ± 0.00
ab  0.04 ± 0.02
b  0.00 ± 0.00




Sunflower oil  0.01 ± 0.00
ab  0.02 ± 0.01
b  0.00 ± 0.00
a  0.01 ± 0.00
ab 
Salmon oil  0.01 ± 0.00  0.01 ± 0.00  0.00 ± 0.00  0.00 ± 0.00 
Soybean oil  0.01 ± 0.01  0.00 ± 0.00  0.00 ± 0.00  0.00 ± 0.00 
24:0  
Sunflower oil  0.00 ± 0.00  0.00 ± 0.00  0.00 ± 0.00  0.00 ± 0.00 
Salmon oil  0.01 ± 0.00  0.00 ± 0.00  0.00 ± 0.00  0.01 ± 0.00 
Soybean oil  0.01 ± 0.00  0.01 ± 0.01  0.00 ± 0.00  0.01 ± 0.00 
24:1 n-
9 
Sunflower oil  0.01 ± 0.00  0.00 ± 0.00  0.01 ± 0.00  0.01 ± 0.00 
Salmon oil  0.02 ± 0.00  0.02 ± 0.00  0.02 ± 0.00  0.02 ± 0.00 
Soybean oil  0.01 ± 0.00
a  0.03 ± 0.01
b  0.02 ± 0.00




Sunflower oil  0.01 ± 0.00  0.02 ± 0.00  0.02 ± 0.00  0.02 ± 0.01 
Salmon oil  0.00 ± 0.00  0.00 ± 0.00  0.00 ± 0.00  0.00 ± 0.00 
Soybean oil  0.00 ± 0.00  0.00 ± 0.00  0.00 ± 0.00  0.00 ± 0.00 
22:6 n-
3 
Sunflower oil  0.00 ± 0.00  0.00 ± 0.00  0.00 ± 0.00  0.00 ± 0.00 
Salmon oil  0.03 ± 0.00  0.04 ± 0.01  0.04 ± 0.01  0.04 ± 0.01 
Soybean oil  0.03 ± 0.01
a  0.06 ± 0.00
b  0.04 ± 0.00
ab  0.04 ± 0.00
ab 
n-3 
Sunflower oil  0.03 ± 0.00  0.04 ± 0.01  0.04 ± 0.01  0.05 ± 0.01 
Salmon oil  0.43 ± 0.06
b  0.31 ± 0.02
ab  0.25 ± 0.02
a  0.29 ± 0.02
ab 
Soybean oil  0.29 ± 0.07  0.32 ± 0.02  0.26 ± 0.01  0.27 ± 0.02 
n-6 
Sunflower oil  0.41 ± 0.06
b  0.31 ± 0.01
ab  0.26 ± 0.01
a  0.28 ± 0.01
a 
Salmon oil  0.08 ± 0.01
a  0.13 ± 0.02
ab  0.15 ± 0.02
b  0.15 ± 0.01
b 
Soybean oil  0.12 ± 0.05  0.18 ± 0.03  0.14 ± 0.01  0.14 ± 0.01 
n-3 : n-
6 
Sunflower oil  0.09 ± 0.03  0.13 ± 0.03  0.14 ± 0.02  0.16 ± 0.02 
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Table 3.22: Fatty acid profile in PC fraction of offspring plasma, taken at various ages. There 
was no effect of diet on fatty acids, but there was an effect of time. Values with different letters on 
the same line are statistically different from one another (p < 0.05). 
      Week 3  Week 6  Week 9  Week 12 
Salmon oil  0.00 ± 0.00  0.00 ± 0.00  0.00 ± 0.00  0.00 ± 0.00 
Soybean oil  0.00 ± 0.00  0.00 ± 0.00  0.00 ± 0.00  0.00 ± 0.00 
12:0  
Sunflower oil  0.00 ± 0.00  0.00 ± 0.00  0.00 ± 0.00  0.00 ± 0.00 
Salmon oil  0.01 ± 0.00
b  0.00 ± 0.00
a  0.00 ± 0.00
a  0.00 ± 0.00
a 
Soybean oil  0.00 ± 0.00  0.00 ± 0.00  0.00 ± 0.00  0.00 ± 0.00 
14:0  
Sunflower oil  0.01 ± 0.00
b  0.00 ± 0.00
a  0.00 ± 0.00
a  0.00 ± 0.00
a 
Salmon oil  0.27 ± 0.01
b  0.25 ± 0.01
ab  0.24 ± 0.00
a  0.24 ± 0.01
ab 
Soybean oil  0.29 ± 0.01
b  0.25 ± 0.01
a  0.24 ± 0.00
a  0.25 ± 0.01
a 
16:0  
Sunflower oil  0.31 ± 0.04  0.26 ± 0.00  0.23 ± 0.01  0.25 ± 0.01 
Salmon oil  0.01 ± 0.00  0.01 ± 0.00  0.01 ± 0.00  0.01 ± 0.00 
Soybean oil  0.01 ± 0.00  0.01 ± 0.00  0.01 ± 0.00  0.01 ± 0.00 
16:1 n-
7  
Sunflower oil  0.03 ± 0.03  0.01 ± 0.00  0.01 ± 0.00  0.01 ± 0.00 
Salmon oil  0.11 ± 0.03
a  0.22 ± 0.01
b  0.07 ± 0.03
a  0.04 ± 0.01
a 
Soybean oil  0.12 ± 0.04
ab  0.22 ± 0.02
b  0.08 ± 0.04




Sunflower oil  0.09 ± 0.04
a  0.23 ± 0.02
b  0.05 ± 0.00
a  0.05 ± 0.01
a 
Salmon oil  0.04 ± 0.01  0.05 ± 0.00  0.03 ± 0.00  0.03 ± 0.00 
Soybean oil  0.04 ± 0.01  0.06 ± 0.01  0.03 ± 0.00  0.03 ± 0.00 
trans 
18:1 n-
9   Sunflower oil  0.03 ± 0.02  0.06 ± 0.00  0.03 ± 0.00  0.03 ± 0.00 
Salmon oil  0.24 ± 0.02  0.22 ± 0.01  0.23 ± 0.01  0.23 ± 0.02 
Soybean oil  0.23 ± 0.01  0.23 ± 0.02  0.25 ± 0.01  0.25 ± 0.01 
18:2 n-
6  
Sunflower oil  0.21 ± 0.03  0.22 ± 0.02  0.22 ± 0.00  0.23 ± 0.01 
Salmon oil  0.01 ± 0.00  0.00 ± 0.00  0.00 ± 0.00  0.00 ± 0.00 
Soybean oil  0.00 ± 0.00  0.00 ± 0.00  0.00 ± 0.00  0.00 ± 0.00 
18:3 n-
6  
Sunflower oil  0.01 ± 0.01  0.00 ± 0.00  0.00 ± 0.00  0.00 ± 0.00 
Salmon oil  0.00 ± 0.00  0.00 ± 0.00  0.00 ± 0.00  0.00 ± 0.00 
Soybean oil  0.00 ± 0.00  0.00 ± 0.00  0.00 ± 0.00  0.00 ± 0.00 
18:3 n-
3  
Sunflower oil  0.00 ± 0.00  0.00 ± 0.00  0.00 ± 0.00  0.00 ± 0.00 
Salmon oil  0.00 ± 0.00  0.00 ± 0.00  0.00 ± 0.00  0.00 ± 0.00 
Soybean oil  0.00 ± 0.00  0.00 ± 0.00  0.00 ± 0.00  0.00 ± 0.00 
20:0  
Sunflower oil  0.00 ± 0.00  0.00 ± 0.00  0.00 ± 0.00  0.00 ± 0.00 
Salmon oil  0.00 ± 0.00  0.00 ± 0.00  0.00 ± 0.00  0.00 ± 0.00 
Soybean oil  0.00 ± 0.00  0.00 ± 0.00  0.01 ± 0.01  0.00 ± 0.00 
20:1 n-
9  
Sunflower oil  0.01 ± 0.01  0.00 ± 0.00  0.01 ± 0.00  0.00 ± 0.00 
Salmon oil  0.00 ± 0.00  0.00 ± 0.00  0.00 ± 0.00  0.00 ± 0.00 
Soybean oil  0.00 ± 0.00  0.00 ± 0.00  0.00 ± 0.00  0.00 ± 0.00 
20:2 n-
6  
Sunflower oil  0.00 ± 0.00  0.00 ± 0.00  0.00 ± 0.00  0.00 ± 0.00 
Salmon oil  0.01 ± 0.00  0.01 ± 0.00  0.01 ± 0.00  0.01 ± 0.00 
Soybean oil  0.01 ± 0.00  0.01 ± 0.00  0.01 ± 0.00  0.01 ± 0.00 
20:3 n-
6  
Sunflower oil  0.01 ± 0.01  0.01 ± 0.00  0.01 ± 0.00  0.01 ± 0.00 
Salmon oil  0.13 ± 0.01
a  0.17 ± 0.01
b  0.17 ± 0.00
b  0.17 ± 0.01
b 
Soybean oil  0.14 ± 0.01  0.16 ± 0.01  0.16 ± 0.01  0.16 ± 0.00 
20:4 n-
6  
Sunflower oil  0.13 ± 0.02  0.16 ± 0.01  0.17 ± 0.01  0.16 ± 0.01 
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      Week 3  Week 6  Week 9  Week 12 
Salmon oil  0.00 ± 0.00  0.00 ± 0.00  0.00 ± 0.00  0.00 ± 0.00 
Soybean oil  0.00 ± 0.00  0.00 ± 0.00  0.00 ± 0.00  0.00 ± 0.00 
20:3 n-
9  
Sunflower oil  0.00 ± 0.00  0.00 ± 0.00  0.00 ± 0.00  0.00 ± 0.00 
Salmon oil  0.00 ± 0.00  0.00 ± 0.00  0.00 ± 0.00  0.00 ± 0.00 
Soybean oil  0.00 ± 0.00  0.01 ± 0.01  0.00 ± 0.00  0.00 ± 0.00 
22:0  
Sunflower oil  0.00 ± 0.00  0.00 ± 0.00  0.00 ± 0.00  0.00 ± 0.00 
Salmon oil  0.00 ± 0.00  0.00 ± 0.00  0.00 ± 0.00  0.00 ± 0.00 
Soybean oil  0.00 ± 0.00  0.00 ± 0.00  0.00 ± 0.00  0.00 ± 0.00 
22:1 n-
9  
Sunflower oil  0.01 ± 0.01  0.00 ± 0.00  0.00 ± 0.00  0.00 ± 0.00 
Salmon oil  0.00 ± 0.00  0.00 ± 0.00  0.00 ± 0.00  0.00 ± 0.00 
Soybean oil  0.00 ± 0.00  0.00 ± 0.00  0.00 ± 0.00  0.00 ± 0.00 
20:5 n-
3  
Sunflower oil  0.00 ± 0.00
a  0.01 ± 0.00
b  0.00 ± 0.00
a  0.00 ± 0.00
a 
Salmon oil  0.00 ± 0.00  0.00 ± 0.00  0.00 ±  0.00  0.00 ± 0.00 
Soybean oil  0.00 ± 0.00  0.00 ± 0.00  0.00 ± 0.00  0.00 ± 0.00 
22:2 n-
9  
Sunflower oil  0.00 ± 0.00  0.00 ± 0.00  0.00 ± 0.00  0.00 ± 0.00 
Salmon oil  0.01 ± 0.00  0.01 ± 0.00  0.00 ± 0.00  0.00 ± 0.00 
Soybean oil  0.00 ± 0.00  0.00 ± 0.00  0.00 ± 0.00  0.00 ± 0.00 
22:4 n-
6  
Sunflower oil  0.01 ± 0.01  0.00 ± 0.00  0.00 ± 0.00  0.00 ± 0.00 
Salmon oil  0.01 ± 0.00  0.01 ± 0.00  0.00 ± 0.00  0.00 ± 0.00 
Soybean oil  0.01 ± 0.00  0.00 ± 0.00  0.00 ± 0.00  0.00 ± 0.00 
24:0  
Sunflower oil  0.00 ± 0.00  0.00 ± 0.00  0.00 ± 0.00  0.00 ± 0.00 
Salmon oil  0.01 ± 0.00  0.01 ± 0.00  0.01 ± 0.00  0.01 ± 0.00 
Soybean oil  0.00 ± 0.00  0.01 ± 0.00  0.01 ± 0.00  0.01 ± 0.00 
24:1 n-
9  
Sunflower oil  0.01 ± 0.00  0.01 ± 0.00  0.01 ± 0.00  0.01 ± 0.00 
Salmon oil  0.04 ± 0.01  0.04 ± 0.00  0.04 ± 0.00  0.05 ± 0.01 
Soybean oil  0.02 ± 0.01
a  0.03 ± 0.00
ab  0.04 ± 0.00




Sunflower oil  0.02 ± 0.00
a  0.03 ± 0.00
a  0.04 ± 0.00
b  0.04 ± 0.00
b 
Salmon oil  0.00 ± 0.00  0.00 ± 0.00  0.00 ± 0.00  0.00 ± 0.00 
Soybean oil  0.01 ± 0.00  0.00 ± 0.00  0.00 ± 0.00  0.00 ± 0.00 
22:6 n-
3  
Sunflower oil  0.00 ± 0.00  0.00 ± 0.00  0.00 ± 0.00  0.00 ± 0.00 
Salmon oil  0.05 ± 0.00  0.04 ± 0.00  0.04 ± 0.00  0.05 ± 0.01 
Soybean oil  0.03 ± 0.00  0.03 ± 0.00  0.04 ± 0.00  0.04 ± 0.00 
n-3  
Sunflower oil  0.03 ± 0.01  0.04 ± 0.00  0.04 ± 0.00  0.04 ± 0.00 
Salmon oil  0.41 ± 0.01  0.42 ± 0.01  0.42 ± 0.01  0.41 ± 0.01 
Soybean oil  0.40 ± 0.01  0.41 ± 0.01  0.42 ± 0.01  0.42 ± 0.01 
n-6  
Sunflower oil  0.37 ± 0.04  0.40 ± 0.01  0.41 ± 0.01  0.40 ± 0.01 
Salmon oil  0.12 ± 0.01  0.09 ± 0.01  0.11 ± 0.01  0.11 ± 0.02 
Soybean oil  0.07 ± 0.01  0.09 ± 0.01  0.10 ± 0.01  0.09 ± 0.01 
n-3 : n-
6  
Sunflower oil  0.09 ± 0.02  0.09 ± 0.00  0.09 ± 0.00  0.10 ± 0.01 
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Table 3.23: Fatty acid profile in TAG fraction of offspring plasma, taken at various ages. There 
was no effect of diet on fatty acids, but there was an effect of time. Values with different letters on 
the same line are statistically different from one another (p < 0.05). 
      Week 3  Week 6  Week 9  Week 12 
Salmon oil  0.05 ± 0.02
b  0.01 ± 0.01
a  0.00 ± 0.00
a  0.00 ± 0.00
a 
Soybean oil  0.02 ± 0.02  0.00 ± 0.00  0.00 ± 0.00  0.00 ± 0.00 
12:0 
Sunflower oil  0.04 ± 0.02
b  0.00 ± 0.00
a  0.00 ± 0.00
a  0.00 ± 0.00
a 
Salmon oil  0.06 ± 0.02  0.00 ± 0.00  0.01 ± 0.00  0.01 ± 0.00 
Soybean oil  0.03 ± 0.02  0.01 ± 0.00  0.01 ± 0.00  0.01 ± 0.00 
14:0  
Sunflower oil  0.06 ± 0.03
b  0.00 ± 0.00
a  0.01 ± 0.00
a  0.01 ± 0.00
a 
Salmon oil  0.27 ± 0.03  0.25 ± 0.01  0.25 ± 0.01  0.26 ± 0.00 
Soybean oil  0.27 ± 0.02  0.16 ± 0.08  0.24 ± 0.00  0.26 ± 0.01 
16:0  
Sunflower oil  0.28 ± 0.02  0.24 ± 0.01  0.23 ± 0.01  0.26 ± 0.01 
Salmon oil  0.02 ± 0.01  0.04 ± 0.01  0.04 ± 0.00  0.04 ± 0.00 
Soybean oil  0.03 ± 0.01  0.04 ± 0.01  0.04 ± 0.01  0.04 ± 0.01 
16:1 n-
7  
Sunflower oil  0.02 ± 0.00  0.04 ± 0.00  0.10 ± 0.06  0.05 ± 0.01 
Salmon oil  0.22 ± 0.02  0.24 ± 0.02  0.22 ± 0.01  0.21 ± 0.01 
Soybean oil  0.25 ± 0.03  0.28 ± 0.04  0.23 ± 0.02  0.19 ± 0.01 
18:1 n-
9  
Sunflower oil  0.23 ± 0.02  0.26 ± 0.01  0.21 ± 0.02  0.22 ± 0.01 
Salmon oil  0.04 ± 0.02  0.04 ± 0.01  0.05 ± 0.00  0.05 ± 0.00 
Soybean oil  0.02 ± 0.01
a  0.05 ± 0.01
b  0.05 ± 0.00




9   Sunflower oil  0.03 ± 0.01
a  0.05 ± 0.00
b  0.04 ± 0.00
b  0.05 ± 0.00
b 
Salmon oil  0.18 ± 0.03
a  0.28 ± 0.03
b  0.29 ± 0.01
b  0.28 ± 0.01
b 
Soybean oil  0.25 ± 0.02  0.31 ± 0.04  0.29 ± 0.02  0.29 ± 0.01 
18:2 n-
6  
Sunflower oil  0.20 ± 0.02
a  0.28 ± 0.01
b  0.25 ± 0.02
ab  0.26 ± 0.02
ab 
Salmon oil  0.02 ± 0.01  0.01 ± 0.00  0.00 ± 0.00  0.00 ± 0.00 
Soybean oil  0.01 ± 0.01  0.01 ± 0.01  0.00 ± 0.00  0.01 ± 0.00 
18:3 n-
6  
Sunflower oil  0.00 ± 0.00  0.01 ± 0.00  0.01 ± 0.00  0.01 ± 0.00 
Salmon oil  0.01 ± 0.00  0.01 ± 0.00  0.02 ± 0.00  0.02 ± 0.00 
Soybean oil  0.01 ± 0.00  0.02 ± 0.01  0.02 ± 0.00  0.02 ± 0.00 
18:3 n-
3  
Sunflower oil  0.01 ± 0.00
a  0.02 ± 0.00
ab  0.02 ± 0.00
ab  0.02 ± 0.00
b 
Salmon oil  0.00 ± 0.00  0.00 ± 0.00  0.00 ± 0.00  0.00 ± 0.00 
Soybean oil  0.00 ± 0.00  0.00 ± 0.00  0.00 ± 0.00  0.00 ± 0.00 
20:0  
Sunflower oil  0.00 ± 0.00  0.00 ± 0.00  0.00 ± 0.00  0.00 ± 0.00 
Salmon oil  0.01 ± 0.01  0.00 ± 0.00  0.00 ± 0.00  0.00 ± 0.00 
Soybean oil  0.01 ± 0.00  0.00 ± 0.00  0.00 ± 0.00  0.00 ± 0.00 
20:1 n-
9  
Sunflower oil  0.00 ± 0.00  0.00 ± 0.00  0.00 ± 0.00  0.01 ± 0.00 
Salmon oil  0.00 ± 0.00  0.00 ± 0.00  0.00 ± 0.00  0.00 ± 0.00 
Soybean oil  0.00 ± 0.00  0.00 ± 0.00  0.00 ± 0.00  0.00 ± 0.00 
20:2 n-
6  
Sunflower oil  0.01 ± 0.00
b  0.00 ± 0.00
a  0.00 ± 0.00
a  0.00 ± 0.00
a 
Salmon oil  0.01 ± 0.01  0.00 ± 0.00  0.00 ± 0.00  0.00 ± 0.00 
Soybean oil  0.01 ± 0.00  0.00 ± 0.00  0.00 ± 0.00  0.00 ± 0.00 
20:3 n-
6  
Sunflower oil  0.00 ± 0.00  0.00 ± 0.00  0.00 ± 0.00  0.00 ± 0.00 
Salmon oil  0.04 ± 0.01  0.04 ± 0.01  0.05 ± 0.00  0.05 ± 0.00 
Soybean oil  0.06 ± 0.01  0.05 ± 0.02  0.06 ± 0.01  0.06 ± 0.01 
20:4 n-
6  
Sunflower oil  0.05 ± 0.01  0.05 ± 0.01  0.05 ± 0.01  0.05 ± 0.01 
   28 
      Week 3  Week 6  Week 9  Week 12 
Salmon oil  0.00 ± 0.00  0.00 ± 0.00  0.00 ± 0.00  0.00 ± 0.00 
Soybean oil  0.00 ± 0.00  0.00 ± 0.00  0.00 ± 0.00  0.00 ± 0.00 
20:3 n-
9  
Sunflower oil  0.00 ± 0.00  0.00 ± 0.00  0.00 ± 0.00  0.00 ± 0.00 
Salmon oil  0.00 ± 0.00  0.00 ± 0.00  0.00 ± 0.00  0.00 ± 0.00 
Soybean oil  0.00 ± 0.00  0.00 ± 0.00  0.00 ± 0.00  0.00 ± 0.00 
22:0  
Sunflower oil  0.00 ± 0.00  0.00 ± 0.00  0.00 ± 0.00  0.00 ± 0.00 
Salmon oil  0.01 ± 0.00  0.00 ± 0.00  0.00 ± 0.00  0.00 ± 0.00 
Soybean oil  0.00 ± 0.00  0.00 ± 0.00  0.00 ± 0.00  0.00 ± 0.00 
22:1 n-
9  
Sunflower oil  0.00 ± 0.00  0.01 ± 0.00  0.00 ± 0.00  0.00 ± 0.00 
Salmon oil  0.00 ± 0.00  0.00 ± 0.00  0.01 ± 0.01  0.00 ± 0.00 
Soybean oil  0.00 ± 0.00  0.00 ± 0.00  0.01 ± 0.00  0.01 ± 0.00 
20:5 n-
3  
Sunflower oil  0.00 ± 0.00  0.00 ± 0.00  0.01 ± 0.00  0.01 ± 0.00 
Salmon oil  0.00 ± 0.00  0.00 ± 0.00  0.00 ± 0.00  0.00 ± 0.00 
Soybean oil  0.00 ± 0.00  0.00 ± 0.00  0.00 ± 0.00  0.00 ± 0.00 
22:2 n-
9  
Sunflower oil  0.00 ± 0.00  0.00 ± 0.00  0.00 ± 0.00  0.01 ± 0.00 
Salmon oil  0.02 ± 0.02  0.00 ± 0.00  0.01 ± 0.00  0.01 ± 0.00 
Soybean oil  0.01 ± 0.00  0.00 ± 0.00  0.01 ± 0.00  0.00 ± 0.00 
22:4 n-
6  
Sunflower oil  0.01 ± 0.00  0.00 ± 0.00  0.01 ± 0.00  0.01 ± 0.00 
Salmon oil  0.00 ± 0.00  0.00 ± 0.00  0.00 ± 0.00  0.00 ± 0.00 
Soybean oil  0.01 ± 0.00  0.01 ± 0.01  0.00 ± 0.00  0.00 ± 0.00 
24:0  
Sunflower oil  0.01 ± 0.00  0.00 ± 0.00  0.01 ± 0.00  0.00 ± 0.00 
Salmon oil  0.01 ± 0.00  0.01 ± 0.00  0.01 ± 0.00  0.01 ± 0.00 
Soybean oil  0.00 ± 0.00  0.00 ± 0.00  0.01 ± 0.00  0.00 ± 0.00 
24:1 n-
9  
Sunflower oil  0.01 ± 0.00  0.00 ± 0.00  0.01 ± 0.00  0.01 ± 0.00 
Salmon oil  0.02 ± 0.00  0.03 ± 0.02  0.01 ± 0.00  0.02 ± 0.00 
Soybean oil  0.01 ± 0.00  0.01 ± 0.00  0.02 ± 0.00  0.02 ± 0.00 
22:5 n-
3  
Sunflower oil  0.01 ± 0.01  0.02 ± 0.01  0.02 ± 0.00  0.01 ± 0.00 
Salmon oil  0.00 ± 0.00  0.04 ± 0.03  0.01 ± 0.01  0.00 ± 0.00 
Soybean oil  0.00 ± 0.00  0.00 ± 0.00  0.00 ± 0.00  0.00 ± 0.00 
22:6 n-
3  
Sunflower oil  0.00 ± 0.00  0.01 ± 0.01  0.00 ± 0.00  0.00 ± 0.00 
Salmon oil  0.04 ± 0.01  0.08 ± 0.04  0.05 ± 0.01  0.04 ± 0.00 
Soybean oil  0.03 ± 0.01  0.04 ± 0.01  0.04 ± 0.00  0.05 ± 0.01 
n-3  
Sunflower oil  0.02 ± 0.01  0.05 ± 0.01  0.04 ± 0.01  0.04 ± 0.00 
Salmon oil  0.26 ± 0.03
a  0.33 ± 0.02
ab  0.35 ± 0.01
b  0.34 ± 0.01
ab 
Soybean oil  0.32 ± 0.03  0.39 ± 0.04  0.36 ± 0.02  0.36 ± 0.02 
n-6  
Sunflower oil  0.27 ± 0.04  0.34 ± 0.01  0.33 ± 0.03  0.34 ± 0.02 
Salmon oil  0.16 ± 0.04  0.23 ± 0.12  0.14 ± 0.02  0.12 ± 0.01 
Soybean oil  0.08 ± 0.01  0.10 ± 0.01  0.13 ± 0.01  0.13 ± 0.01 
n-3 : n-
6  
Sunflower oil  0.09 ± 0.01  0.12 ± 0.02  0.12 ± 0.01  0.13 ± 0.01 
 
   1 
Appendix Four – Data from Effect of Early Exposure to 
Fatty Acids on Allergic Sensitisation Study  
(Chapter 5). 
Table 4-1: Fatty acid composition of diets. Data is shown as percentage abundance. 
   Control  ALA-rich  LA-rich  "Western" diet 
14:0  0.09  0.15  0.13  2.78 
16:0  10.92  7.57  10.69  22.31 
18:0  3.15  3.22  2.05  10.12 
20:0  0.33  0.28  0.42  0.32 
22:0  0.50  0.22  0.19  0.18 
24:0  0.17  0.14  0.18  0.07 
18:3 n-3  5.01  25.03  1.78  2.19 
18:4 n-3  0.08  0.05  0.05  0.05 
22:5 n-3  0.00  0.00  0.00  0.05 
22:6 n-3  0.00  0.00  0.03  0.03 
18:2 n-6  53.51  32.56  54.03  11.62 
18:3 n-6  0.40  2.61  0.18  0.06 
20:2 n-6  0.13  0.14  0.18  0.54 
20:3 n-6  0.00  0.00  0.07  0.04 
20:4 n-6  0.06  0.03  0.00  0.15 
22:4 n-6  0.00  0.00  0.00  0.04 
16:1 n-7  0.09  0.09  0.10  1.07 
18:1 n-7  1.64  0.63  0.54  1.97 
18:1 n-9  22.29  23.10  27.79  38.37 
20:1 n-9  0.62  2.88  0.42  0.73 
20:3 n-9  0.07  0.00  0.11  0.00 
22:1 n-9  0.00  0.03  0.00  0.04 
24:1 n-9  0.04  0.02  0.00  0.03 
n-3  5.20  25.31  1.88  2.37 
n-6  54.66  36.06  55.23  12.58 
n-3 : n-6  9.51  70.17  3.41  18.83 
   2 
Table 4.2: Fatty acid content of erythrocytes, taken at weaning, of mice fed the experimental diets 
during gestation and / or lactation.  Data are mean +/- SEM % of total fatty acids. Values with 
different letters denote differences in fatty acid abundance between dietary groups. 
  Control  AG  AGL  AL  LG  LGL  LL 
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b  1.58 ± 0.08












































1.02 ± 0.06  0.89 ± 0.08  1.13 ± 0.09  1.04 ± 0.08  1.10 ± 0.06  1.10 ± 0.06 




a  5.07 ± 0.34





































a  0.31 ± 0.02









   4 
Table 4.3: Fatty acid content of red blood cells, taken at euthanisation (age 78 days), of mice fed 
the experimental diets during gestation and / or lactation. Data are mean +/- SEM % of total 
fatty acids. Values with different letters denote differences in fatty acid abundance between 
dietary groups. 
  Control  AG  AGL  AL  LG  LGL  LL 
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Appendix Five – Data from the Effect of Intra-Uterine Growth 
Retardation on the Immune System of Offspring in Two 
Generations Study (Chapter 6) 
Table 5-1: Fatty acid composition of diets. Data is shown as percentage abundance. 








12:0  0.43  0.00  0.25  0.29  0.36 
14:0  0.39  0.40  0.43  0.28  0.36 
16:0   7.75  6.00  9.29  7.12  4.54 
16:1 n-7  0.18  0.22  0.14  0.00  0.49 
18:0  3.01  3.47  3.73  2.61  2.46 
18:1 n-9  4.04  4.60  8.47  6.89  3.01 
trans 18:1 n-9  0.46  1.00  0.81  0.73  0.29 
18:2 n-6  17.10  13.09  23.25  19.37  9.49 
18:3 n-6  0.53  0.60  0.35  0.00  0.09 
18:3 n-3  2.11  2.05  3.44  2.88  1.45 
20:0  0.00  0.00  0.00  0.00  0.00 
20:1 n-9  1.00  0.15  0.29  0.12  0.24 
20:2 n-6  59.98  65.98  46.95  57.57  75.65 
20:3 n-6  0.16  0.19  0.38  0.00  0.00 
20:4 n-6  0.45  0.26  0.37  0.28  0.13 
22:0  0.27  0.56  0.33  0.14  0.36 
22:1 n-9  0.00  0.00  0.00  0.00  0.00 
20:5 n-3  0.91  0.57  0.41  0.50  0.05 
24:0  0.00  0.00  0.00  0.00  0.00 
22:4 n-6  0.58  0.33  0.66  0.00  0.00 
22:5 n-6  0.00  0.00  0.00  0.21  0.19 
24:1 n-9  0.21  0.00  0.00  0.28  0.19 
22:5 n-6  0.45  0.52  0.18  0.73  0.46 
22:6 n-3  0.00  0.00  0.25  0.00  0.17 
n-3  3.50  3.10  4.30  4.10  2.10 
n-6  78.80  80.40  72.00  77.40  85.60 
n-3 : n-6  0.00  0.00  0.10  0.10  0.00 
 
 
 